                                                  ABSTRACT
  A method of generating an isolated progenitor cell line is disclosed which involves modulating the
  activity of a transcriptional regulator in a pluripotent stem cell and inducing the differentiation of said
5 pluripotent stem cell in vitro to generate a progenitor cell line.

       METHODS OF MODIFYING TRANSCRIPTIONAL REGULATORY NETWORKS IN
                                              STEM CELLS
           This is a divisional of Australian Patent Application No. <removed-apn>, which is a
 5 divisional of Australian Patent Application No. 2011316830, which is the Australian National
   Phase of PCT/US2011/057387, which claims priority from United States patent application
   USSN 61/406064, filed 22 October 2010 and USSN 61/415244, filed 18 November 2010. The
   contents of each application listed in this paragraph are fully incorporated by reference herein.
10                                          INTRODUCTION
            The comprehensive differentiation potential of human pluripotent stem cells such as
   human embryonic stem (hES) and human induced pluripotent stem (hiPS) cells opens new
   opportunities in research and cell-based therapy. Their potential to cascade through all of the
   somatic cell lineages and to display all of the transcriptional pathways of development has
15 generated interest in the use of these cells to map the precise structure of the human
   transcriptional regulatory network and to generate cell-based therapies for a potential wide
   array of disorders. However, many in vitro differentiation technologies yield only partially
   purified cell formulations that may pose the risk of ectopic tissue formation at engraftment
   sites. Embryoid bodies, or other similar differentiation modalities in vitro contain dozens or
20 hundreds of discrete cell types in a mixture. The clonal isolation and propagation of progenitors
   greatly facilitates the generation of highly purified and identified formulations for research and
   therapeutic purposes (see, e.g., West et al, 2008. Regen. Med. 3(3): 287-308; U.S. Patent
   applications 11/604,047, filed on November 21, 2006 (US Patent Pub. No. 2008/0070303) and
   12/504,630, filed on July 16, 2009 (US Patent Pub. No. 2010/0184033), all of which are
25 incorporated herein by reference). Nevertheless, other cell types have yet to be isolated and
   propagated from normal pluripotent and multipotent cells. Thus, methods of isolating such
   novel cell types, as well as methods for introducing perturbations into the transcriptional
   regulatory network in stem cells in order to construct a computer model of the entire human
   transcriptional regulatory network, would greatly benefit basic research as well as
30 manufacturing technology for cell-based therapies.
                                               SUMMARY
            We have demonstrated that the long initial telomere length of hES cells, together with
   the robust proliferative capacity of primitive hES-derived progenitor cell types facilitates the
35 industrial expansion and characterization of >140 diverse and scalable clonal lineages with
   diverse site and temporal-specific homeobox gene expression (West et al, 2008. Regen. Med.
   3(3): 287-308; see also U.S. Patent application 11/604,047, filed on November 21 , 2006 (US
                                                      1

  Patent Pub. No. 2008/0070303); U.S. Patent application 12/504,630, filed on July 16, 2009 (US
  Patent Pub. No. 2010/0184033); PCT Patent application serial no. PCT/US2011/037969, filed
  on May 25, 2011 titled "Improved Methods of Screening Embryonic Progenitor Cell Lines";
  and U.S. Provisional application 61/496,436, filed on June 13, 2011 titled "Methods and
5 Compositions for Producing Endothelial Progenitor Cells From Pluripotent Stem Cells", each
  of which is incorporated herein by reference). We describe a technology to generate such novel
  and scalable cell lines through the
                                                 1A

   exogenous or endogenous up or down-regulation of the activity of transcriptional regulators. Such
   exogenously or endogenously-introduced modifications to the activity of transcriptional regulators
   may include transcription factors constitutively expressed in pluripotent stem cells such as hES cells
   or somatic cells reprogrammed to pluripotency such as hiPS cells. Such transcriptional regulators can
 5 be introduced in a manner that allows the precise regulation of the level and timing of their
   expression including but not limited to the use of an inducible promoter driving the expression or
   inhibition of expression of a number of transcription factors. The exogenously-administered
   transcriptional regulators with precise control of level and timing of expression are introduced in
   pluripotent stem cells which also have inducible levels of expression of a gene capable of forcing cell
10 proliferation (cell cycle driver). Also described herein are computer algorithms useful in assembling
   a computer model of the transcriptional regulatory network of human and other animal species.
                                     BRIEF DESCRIPTION OF THE DRAWINGS
            Figure 1: Constitutive expression of the transcription factor OCT4 in clonal iPS-derived
15 progenitorprogenitor cell lines compared to normal hES-derived diverse clonal progenitorprogenitors
   and normal hES cells.
            Figure 2: Graph of microarray data for LHX3 isoform 1 and RESP18 transcript levels in
   diverse clonal progenitorprogenitors, cultured somatic cell types, hES cells, and hiPS cells as well as
   clonal progenitors made from hiPS cells constitutively expressing the transcriptional regulator OCT4.
20          Figure 3: Microarray gene expression analysis of the expression of IL19 (Accession number
   NM_013371.2) in diverse normal cultured cell types, diverse normal clonal progenitor cell lines
   derived from hES cells, hES and iPS cells, and select cell lines of the present invention including
   14SMOO8X, 14PEND11X, and 14PEND20X.
            Figure 4: Microarray gene expression analysis of the expression of Gastrin-releasing peptide
25 (GRP) (Accession number NM_001012513.1) in diverse normal cultured cell types, diverse normal
   clonal progenitor cell lines derived from hES cells, hES and iPS cells, and select cell lines of the
   present invention including 14SKEL14Z, 14SKEL15Z, 14SKEL20Z, 14SKEL24Z, and
   14PEND20X.
            Figure 5: Microarray gene expression analysis of the expression of paraoxonase 3
30 (PON3) (Accession number NM_000940.1) in diverse normal cultured cell types, diverse normal
   clonal progenitor cell lines derived from hES cells, hES and iPS cells, and the select cell lines of the
   present invention 14PEND2X.
                                  DETAILED DESCRIPTION OF THE INVENTION
35 Abbreviations
   AFP           -      Alpha fetoprotein
   BMP           -      Bone Morphogenic Protein
                                                        2

   BRL        -  Buffalo rat liver
   BSA        -  Bovine serum albumin
   CD         -  Cluster Designation
   cGMP       -  Current Good Manufacturing Processes
 5 CNS        -  Central Nervous System
   DMEM       -  Dulbecco's modified Eagle's medium
   DMSO       -  Dimethyl sulphoxide
   DPBS       -  Dulbecco's Phosphate Buffered Saline
   EBs        -  Embryoid bodies
10 EC         -  Embryonal carcinoma
   EC Cells   -  Embryonal carcinoma cells; hEC cells are human embryonal carcinoma cells
   ECAPCs     -  Embryonic cutaneous adipocyte progenitor cells
   ECM        -  Extracellular Matrix
   ED Cells   -  Embryo-derived cells; hED cells are human ED cells
15 EDTA       -  Ethylenediamine tetraacetic acid
   EG Cells   -  Embryonic germ cells; hEG cells are human EG cells
   EP Cells   - Embryonic progenitor cells are cells derived from primordial stem cells that are more
                differentiated than primordial stem cells, in that they no longer display markers such as
                SSEA4, TRA1-60 or TRA-1-81 seropositivity in the case of the human species, but have not
20              fully differentiated. Embryonic progenitor cells correspond to the embryonic stages as
                opposed to the postnatal stage of development.
   ES Cells   -  Embryonic stem cells; hES cells are human ES cells
   FACS       -  Fluorescence activated cell sorting
   FBS        -  Fetal bovine serum
25 FCS        -  Fetal calf serum
   FGF        -  Fibroblast Growth Factor
   GFP        -  Green Fluorescent Protein
   GMP        -  Good Manufacturing Practices
   hED Cells  -  Human embryo-derived cells
30 hEG Cells  - Human embryonic germ cells are stem cells derived from the primordial germ cells of fetal
                tissue.
   hEP Cells  -  Human embryonic progenitor cells are embryonic progenitor cells from the human
   species.
   hiPS Cells -  Human induced pluripotent stem cells.
35 HSE        -  Human skin equivalents are mixtures of cells and biological or synthetic matrices
                  manufactured for testing purposes or for therapeutic application in promoting wound
                  repair.
   HUVEC      -  Human umbilical vein endothelial cell
   1CM        -  Inner cell mass of the mammalian blastocyst-stage embryo.
40 iPS cells  -  Induced pluripotent stem cells.
                                                    3

   LOH            -     Loss of Heterozygosity
   MEM            -     Minimal essential medium
   miRNA          -     Micro RNA
   MSC            -     Mesenchymal Stem Cell
 5 NT             -     Nuclear Transfer
   PBS            -     Phosphate buffered saline
   PEGDA          -     Polyethylene glycol diacrylate
   PS fibroblasts   -  Pre-scarring fibroblasts are fibroblasts derived from the skin of early gestational skin or
                       derived from ED cells that display a prenatal pattern of gene expression in that they
10                     promote the rapid healing of dermal wounds without scar formation.
   RA             -     Retinoic acid
   RFU            -     Relative Fluorescence Units
   SCNT           -     Somatic Cell Nuclear Transfer
   SFM            -     Serum-Free Medium
15 SPF            -     Specific Pathogen-Free
   SV40           -     Simian Virus 40
   Tag            -     Large T-antigen
   T-EDTA         -     Trypsin EDTA
20 Definitions
           The term "analytical reprogramming technology" refers to a variety of methods to reprogram
   the pattern of gene expression of a somatic cell to that of a more pluripotent state, such as that of an
   iPS, ES, ED, EC or EG cell, wherein the reprogramming occurs in multiple and discrete steps and
   does not rely simply on the transfer of a somatic cell into an oocyte and the activation of that oocyte.
25 Such techniques include the use of cytoplasm such as EC cell-derived cytoplasm that is enriched in
   factors such as OCT4, LIN28, SOX2, NANOG, KLF4, and modifications that decrease the expression
   of SP100 (see U.S. application nos. 60/332,510, filed November 26, 2001; 10/304,020, filed
   November 26, 2002; PCT application no. PCT/US02/37899, filed November 26, 2003; U.S.
   application no. 60/705625, filed August 3, 2005; U.S. application no. 60/729173, filed August 20,
30 2005; U.S. application no. 60/818813, filed July 5, 2006, PCT/US06/30632, filed August 3, 2006.
           The term "blastomere/morula cells" refers to blastomere or morula cells in a mammalian
   embryo or blastomere or morula cells cultured in vitro with or without additional cells including
   differentiated derivatives of those cells.
           The term "cell expressing gene X", "gene X is expressed in a cell" (or cell population), or
35 equivalents thereof, means that analysis of the cell using a specific assay platform provided a positive
   result.   The converse is also true (i.e., by a cell not expressing gene X, or equivalents, is meant that
   analysis of the cell using a specific assay platform provided a negative result).         Thus, any gene
   expression result described herein is tied to the specific probe or probes employed in the assay
                                                            4

   platform (or platforms) for the gene indicated.
           The term "cell line" refers to a mortal or immortal population of cells that is capable of
   propagation and expansion in vitro.
           The term "clonal" or alternatively "monoclonal" refers to a population of cells obtained the
 5 expansion of a single cell into a population of cells all derived from that original single cells and not
   containing other cells.
           The term "colony in situ differentiation" refers to the differentiation of colonies of cells (e.g.,
   hES, hEG, hiPS, hEC or hED) in situ without removing or disaggregating the colonies from the
   culture vessel in which the colonies were propagated as undifferentiated stem cell lines. Colony in
10 situ differentiation does not utilize the intermediate step of forming embryoid bodies, though
   embryoid body formation or other aggregation techniques such as the use of spinner culture may
   nevertheless follow a period of colony in situ differentiation.
           The term "differentiated cells" when used in reference to cells made by methods of this
   invention from pluripotent stem cells refer to cells having reduced potential to differentiate when
15 compared to the parent pluripotent stem cells.      The differentiated cells of this invention comprise
   cells that could differentiate further (i.e., they may not be terminally differentiated).
           The term "direct differentiation" refers to process of differentiating: blastomere cells, morula
   cells, ICM cells, ED cells, or somatic cells reprogrammed to an undifferentiated state (such as in the
   process of making iPS cells but before such cells have been purified in an undifferentiated state)
20 directly without the intermediate state of propagating isolated undifferentiated stem cells such as hES
   cells as undifferentiated cell lines. A nonlimiting example of direct differentiation would be the
   culture of an intact human blastocyst into culture and the derivation of ED cells without the
   generation of a human ES cell line as was described (Bongso et al, 1994. Human Reproduction
   9:2110).
25         The term "embryonic stem cells" (ES cells) refers to cells derived from the inner cell mass of
   blastocysts, blastomeres, or morulae that have been serially passaged as cell lines while maintaining
   an undifferentiated state (e.g. expressing TERT, OCT4, and SSEA and TRA antigens specific for ES
   cells of the species). The ES cells may be derived from fertilization of an egg cell with sperm or
   DNA, nuclear transfer, parthenogenesis, or by means to generate hES cells with hemizygosity or
30 homozygosity in the MHC region. While ES cells have historically been defined as cells capable of
   differentiating into all of the somatic cell types as well as germ line when transplanted into a
   preimplantation embryo, candidate ES cultures from many species, including human, have a more
   flattened appearance in culture and typically do not contribute to germ line differentiation, and are
   therefore called "ES-like cells." It is commonly believed that human ES cells are in reality "ES-like",
35 however, in this application we will use the term ES cells to refer to both ES and ES-like cell lines.
           The term "histotypic culture" refers to cultured cells that are aggregated to create a three
   dimensional structure with tissue-like cell density such as occurs in the culture of some cells over a
                                                         5

   layer of agar or such as occurs when cells are cultured in three dimensions in a collagen gel, sponge,
   or other polymers such as are commonly used in tissue engineering.
          The term "human embryo-derived" ("hED") cells refers to blastomere-derived cells, morula
   derived cells, blastocyst-derived cells including those of the inner cell mass, embryonic shield, or
 5 epiblast, or other totipotent or pluripotent stem cells of the early embryo, including primitive
   endoderm, ectoderm, mesoderm, and neural crest and their derivatives up to a state of differentiation
   correlating to the equivalent of the first eight weeks of normal human development, but excluding
   cells derived from hES cells that have been passaged as cell lines (see, e.g., U.S. Patents 7,582,479;
   7,217,569; 6,887,706; 6,602,711; 6,280,718; and 5,843,780 to Thomson, incorporated herein by
10 reference). The hED cells may be derived from preimplantation embryos produced by fertilization of
   an egg cell with sperm or DNA, nuclear transfer, or chromatin transfer, an egg cell induced to form a
   parthenote through parthenogenesis, analytical reprogramming technology, or by means to generate
   hES cells with hemizygosity or homozygosity in the HLA region.
            The term "human embryonic germ cells" (hEG cells) refer to pluripotent stem cells derived
15 from the primordial germ cells of fetal tissue or maturing or mature germ cells such as oocytes and
   spermatogonial cells, that can differentiate into various tissues in the body. The hEG cells may also
   be derived from pluripotent stem cells produced by gynogenetic or androgenetic means, i.e., methods
   wherein the pluripotent cells are derived from oocytes containing only DNA of male or female origin
   and therefore will comprise all female-derived or male-derived DNA (see U.S. application nos.
20 60/161,987, filed October 28, 1999; 09/697,297, filed October 27, 2000; 09/995,659, filed November
   29,2001; 10/374,512, filed February 27, 2003; PCT application no. PCT/US/00/29551, filed October
   27, 2000; the disclosures of which are incorporated herein in their entirety).
          The term "human embryonic stem cells" (hES cells) refers to human ES cells.
          The term "iPS cells" or "human iPS cells" refers to cells with properties similar to ES cells or
25 hES cells, including the ability to form all three germ layers when transplanted into
   immunocompromised mice wherein said iPS cells are derived from cells of varied somatic cell
   lineages following exposure to de-differentiation factors, for example hES cell-specific transcription
   factor combinations: KLF4, SOX2, MYC, and OCT4 or SOX2, OCT4, NANOG, and LIN28. Any
   convenient combination of de-differentiation factors may be used to produce iPS cells. Said iPS cells
30 may be produced by the expression of these genes through vectors such as retroviral, lentiviral or
   adenoviral vectors as is known in the art, or through the introduction of the factors as proteins, e.g.,
   by permeabilization or other technologies. For descriptions of such exemplary methods see: PCT
   application number PCT/US2006/030632, filed on August 3, 2006; U.S. Application Ser. No.
   11/989,988; PCT Application PCT/US2000/018063, filed on June 30, 2000; U.S. Application Ser.
35 No. 09,736,268 filed on December 15, 2000; U.S. Application Ser. No. 10/831,599, filed April 23,
   2004; and U.S. Patent Publication 20020142397 (App. Ser. No. 10/015,824, entitled "Methods for
   Altering Cell Fate"); U.S. Patent Publication 20050014258 (App. Ser. No. 10/910,156, entitled
                                                        6

   "Methods for Altering Cell Fate"); U.S. Patent Publication 20030046722 (App. Ser. No. 10/032,191,
   entitled "Methods for cloning mammals using reprogrammed donor chromatin or donor cells"); and
   U.S. Patent Publication 20060212952 (App. Ser. No. 11/439,788, entitled "Methods for cloning
   mammals using reprogrammed donor chromatin or donor cells") all of which are incorporated herein
 5 by reference in their entirety.
          The term "ICM cells" refers to the cells of the inner cell mass of a mammalian embryo or the
   cells of the inner cell mass cultured in vitro with or without the surrounding trophectodermal cells.
          The term "oligoclonal" refers to a population of cells that originated from a small population
   of cells, typically 2-1000 cells, that appear to share similar characteristics such as morphology or the
10 presence or absence of markers of differentiation that differ from those of other cells in the same
   culture. Oligoclonal cells are isolated from cells that do not share these common characteristics, and
   are allowed to proliferate, generating a population of cells that are essentially entirely derived from
   the original population of similar cells.
          The term "organotypic culture" refers to cultured cells that are aggregated to create a three
15 dimensional structure with tissue-like cell density such as occurs in the culture of some cells over a
   layer of agar, cultured as teratomas in an animal, otherwise grown in a three dimensional culture
   system but wherein said aggregated cells contain cells of different cell lineages, such as, by way of
   nonlimiting examples, the combination of epidermal keratinocytes and dermal fibroblasts, or the
   combination of parenchymal cells with their corresponding tissue stroma, or epithelial cells with
20 mesenchymal cells.
          The term "pluripotent stem cells" refers to animal cells capable of differentiating into more
   than one differentiated cell type. Such cells include hES cells, blastomere/morula cells and their
   derived hED cells, hiPS cells, hEG cells, hEC cells, and adult-derived cells including mesenchymal
   stem cells, neuronal stem cells, and bone marrow-derived stem cells. Pluripotent stem cells may be
25 genetically modified or not genetically modified. Genetically modified cells may include markers
   such as fluorescent proteins to facilitate their identification within the egg.
             The term "pluripotent stem cell not derived from a human embryo" (and grammatical
   equivalents thereof) refers to human plutipotent stem cells whose derivation does not require the
   destruction of a human embryo at any point during the derivation process, where a humn embryo
30 includes any human ovum after fertilisation, any non-fertilised human ovum into which the cell
   nucleus from a mature human cell has been transplanted, and any non-fertilised human ovum whose
   division and further development have been stimulated by parthenogenesis. Any of the methods and
   compositions described herein that employ or are drawn to any human pluripotent stem cells (e.g.,
   hES cells, hED cells, hiPS cells, hEG cells, hEC, and the like) include embodiments in which the
35 human pluripotent setm cells are not derived from a human embryo.
          The term "pooled clonal" refers to a population of cells obtained by combining two or more
   clonal populations to generate a population of cells with a uniformity of markers such as markers of
                                                         7

   gene expression, similar to a clonal population, but not a population wherein all the cells were
   derived from the same original clone. Said pooled clonal lines may include cells of a single or mixed
   genotypes. Pooled clonal lines are especially useful in the cases where clonal lines differentiate
   relatively early or alter in an undesirable way early in their proliferative lifespan.
 5          The term "primordial stem cells" refers to animal cells capable of differentiating into more
   than one differentiated cell type. Such cells include hES cells, blastomere/morula cells and their
   derived hED cells, hiPS cells, hEG cells, hEC cells, and adult-derived cells including mesenchymal
   stem cells, neuronal stem cells, and bone marrow-derived stem cells. Primordial stem cells may be
   genetically modified or not genetically modified. Genetically modified cells may include markers
10 such as fluorescent proteins to facilitate their identification in vitro or in vivo.
            Before the present invention is described in greater detail, it is to be understood that this
   invention is not limited to particular embodiments described, as such may, of course, vary. It is also
   to be understood that the terminology used herein is for the purpose of describing particular
15 embodiments only, and is not intended to be limiting, since the scope of the present invention will be
   limited only by the appended claims.
            Where a range of values is provided, it is understood that each intervening value, to the tenth
   of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and
   lower limit of that range and any other stated or intervening value in that stated range, is
20 encompassed within the invention. The upper and lower limits of these smaller ranges may
   independently be included in the smaller ranges and are also encompassed within the invention,
   subject to any specifically excluded limit in the stated range. Where the stated range includes one or
   both of the limits, ranges excluding either or both of those included limits are also included in the
   invention.
25          Certain ranges are presented herein with numerical values being preceded by the term
   "about." The term "about" is used herein to provide literal support for the exact number that it
   precedes, as well as a number that is near to or approximately the number that the term precedes. In
   determining whether a number is near to or approximately a specifically recited number, the near or
   approximating unrecited number may be a number which, in the context in which it is presented,
30 provides the substantial equivalent of the specifically recited number.
            Unless defined otherwise, all technical and scientific terms used herein have the same
   meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
   Although any methods and materials similar or equivalent to those described herein can also be used
   in the practice or testing of the present invention, representative illustrative methods and materials
35 are now described.
            All publications and patents cited in this specification are herein incorporated by reference as
   if each individual publication or patent were specifically and individually indicated to be
                                                         8

   incorporated by reference and are incorporated herein by reference to disclose and describe the
   methods and/or materials in connection with which the publications are cited. The citation of any
   publication is for its disclosure prior to the filing date and should not be construed as an admission
   that the present invention is not entitled to antedate such publication by virtue of prior invention.
 5 Further, the dates of publication provided may be different from the actual publication dates which
   may need to be independently confirmed.
             It is noted that, as used herein and in the appended claims, the singular forms "a", "an", and
   "the" include plural referents unless the context clearly dictates otherwise. It is further noted that the
   claims may be drafted to exclude any optional element. As such, this statement is intended to serve
10 as antecedent basis for use of such exclusive terminology as "solely," "only" and the like in
   connection with the recitation of claim elements, or use of a "negative" limitation.
             As will be apparent to those of skill in the art upon reading this disclosure, each of the
   individual embodiments described and illustrated herein has discrete components and features which
   may be readily separated from or combined with the features of any of the other several embodiments
15 without departing from the scope or spirit of the present invention. Any recited method can be carried
   out in the order of events recited or in any other order which is logically possible.
             As summarized above, aspects of the present invention include methods of generating an
   isolated progenitor cell line by modulating the activity of a transcriptional regulator in a pluripotent
20 stem cell; and inducing the differentiation of said pluripotent stem cell in vitro to generate a
   progenitor cell line. In certain embodiments, the activity of the transcriptional regulator is increased,
   where in some instances the transcriptional regulator is selected from: OCT4, SOX2, KLF4, NANOG,
   MYC, or the gene LIN28, or downregulated in some instances with genes such as SP100 and
   combinations thereof. Such transcriptional modulators may be introduced in any convenient manner,
25 e.g., via exogenous expression from an expression vector (constitutive expression vector, inducible
   expression vector, retroviral vector, lentiviral vector, transient expression vector, and the like) or as a
   protein factor. In certain embodiments, the method further includes the modulation by up or down
   regulating the levels of transcription factors or other factors that modify chromatin structure in
   pluripotent stem cells, or in somatic cells that are subsequently reprogrammed to pluripotency such
30 as iPS cells, wherein said modified pluripotent cells may be used to generate clonal, oligoclonal, or
   polyclonal progenitor cell lines dependent on the introduced factor or factors. In certain
   embodiments, the method further includes increasing cell division in the derivatives of pluripotent
   stem cells, e.g., by providing a cell cycle regulator that overcomes cell cycle inhibition in the
   pluripotent stem cell (p53, SV40 T-antigen, adenovirus proteins ElA and ELiB, papillomavirus
35 proteins E6 and/or E7, CDK4, for example). The isolated progenitor cell lines produced according to
   aspects of the present invention have unique gene expression and developmental capabilities,
   including constitutively expressing one or more transcriptional regulator (or transcription factor),
                                                          9

   including but not limited to OCT4 and LHX3. Any convenient pluripotent stem cell may be
   employed in the methods, e.g., embryonic stem cells (ES cells), induced pluripotent stem cells (iPS
   cells), embryo-derived cells (ED cells), embryonic germ cells (EG cells), embryonal carcinoma cells
   (EC cells), pluripotent stem cell not derived from a human embryo, and the like.
 5           Aspects of the invention also include isolated progenitor cell lines produced by the methods
   described herein. Exemplary progenitor cell lines include, but are not limited to, 14SKEL7X,
   14SKEL18X, 14SKEL12Z, 14SKEL14Z, 14SKEL15Z, 14SKEL20Z, 14SKEL24Z, 14PEND2X,
   14PEND11X, 14PEND12X, 14PEND14X, 14PEND20X, 14PEND23X, 14PEND24X, 14SMOO2X,
   14SM008X, and 14PEND17Z with the specific gene expression profiles described herein.
10
   METHODS
             In addition to the methods described below, methods that find use in the production and use
   of the cell lines described herein can be found in the following: U.S. Patent Publication
   2008/0070303, entitled "Methods to accelerate the isolation of novel cell strains from pluripotent
15 stem cells and cells obtained thereby"; U.S. Patent Application Serial No. 12/504,630, filed on July
   16, 2009 (US Patent Pub. No. 2010/0184033) entitled "Methods to accelerate the isolation of novel
   cell strains from pluripotent stem cells and cells obtained thereby"; and PCT Application
   PCT/US2006/013519, filed on April 11, 2006, entitled "NOVEL USES OF CELLS WITH
   PRENATAL PATTERNS OF GENE EXPRESSION"; PCT Application Serial No.
20 PCT/US2006/030632, filed on August 3, 2006, entitled "Improved Methods of Reprogramming
   Animal Somatic Cells"; U.S. Application Ser. No. 11/989,988, filed on August 3, 2006, entitled
   "Methods of Reprogramming Animal Somatic Cells"; PCT Application PCT/US2000/018063, filed
   on June 30, 2000; U.S. Application Ser. No. 09/736,268 filed on December 15, 2000; U.S.
   Application Ser. No. 10/831,599, filed April 23, 2004; U.S. Patent Publication 2002/0142397 (App.
25 Ser. No. 10/015,824, entitled "Methods for Altering Cell Fate"); U.S. Patent Publication
   2005/0014258 (App. Ser. No. 10/910,156, entitled "Methods for Altering Cell Fate"); U.S. Patent
   Publication 2003/0046722 (App. Ser. No. 10/032,191, entitled "Methods for cloning mammals using
   reprogrammed donor chromatin or donor cells"); U.S. Patent Publication 2006/0212952 (App. Ser.
   No. 11/439,788, entitled "Methods for cloning mammals using reprogrammed donor chromatin or
30 donor cells"; U.S. Patent Publication 2009/0068742 entitled "Nuclear Reprogramming Factor"; U.S.
   Patent Publication 2009/0047263 entitled "Nuclear reprogramming factor and induced pluripotent
   stem cells"; U.S. Patent Publication 2009/0191159 entitled "Multipotent/pluripotent cells and
   methods"; U.S. Patent Publication 2008/0280362 entitled "Methods for reprogramming somatic
   cells"; U.S. Patent Publication 2008/0233610 entitled " Somatic cell reprogramming"; U.S.
35 Provisional application 61/492,329 filed on June 1, 2011 entitled "Embryonic Stem Cell and
   Embryonic Progenitor-Associated Molecules Useful in the Management of Cancer and Cellular
   Reprogramming"; and Negorev et al., Cancer Research (2010) vol. 70(23) pp. 9991-10001, entitled
                                                       10

   "Sp100 as a Potent Tumor Suppressor: Accelerated Senescence and Rapid Malignant Transformation
   of Human Fibroblasts through Modulation of an Embryonic Stem Cell Program"; each of which is
   incorporated by reference herein in its entirety.
 5 Methods for the perturbation of one or more transcriptional regulators.
            We use the term "transcriptional regulator" to refer to a molecule directly modifying the
   transcriptional complex in the regulatory regions of a given gene. Therefore, for the purposes of this
   application, transcription factors or factors that modify chromatin in association with transcription
   factor complexes such as but not limited to kinases, phosphatases, acetylases, deacetylases,
10 methylases, and demethylases that modify histones are "transcriptional regulators" as defined herein.
   However, growth factors that bind to cell surface receptors stimulating cell signaling pathways that
   indirectly modulate transcription complexes are not considered "transcriptional regulators" for the
   purposes of this application. Pluripotent cells can respond to diverse inductive stimuli, including
   growth factors and cytokines, to ultimately modulate transcriptional regulators and consequently the
15 differentiated state of the cell. Said inductive stimuli may be utilized to promote the differentiation of
   pluripotent stem cells into clonal, oligoclonal, or polyclonal lineages of progenitor cell lines as
   previsouly described (West et al, 2008. Regen. Med. 3(3): 287-308; see also U.S. Patent applications
   11/604,047, filed on November 21, 2006 (US Patent Pub. No. 2008/0070303) and 12/504,630, filed
   on July 16, 2009 (US Patent Pub. No. 2010/0184033), incorporated herein by reference). Such
20 transcriptional regulators are important in determining the differentiated fate of a cell and include
   transcription factors, which are generally nuclear or cytoplasmic and can either be constitutively
   expressed within the cell or be expressed in an inducible manner. Transcription factor proteins bind
   specific sequences found in the promoter regions of genes (target genes) whose expression they then
   regulate by either increasing or decreasing the transcription of that gene into RNA (e.g., mRNA).
25 These binding sequences are generally 6-10 base pairs in length and are occasionally found in
   multiple copies within the promoter regions of target genes.
            Although the transcription factor protein-DNA interaction is sequence-specific, the binding
   site for one given transcription factor may vary by several base pairs within different target genes.
   Therefore when we describe the specific DNA binding sequence for a transcription factor we refer to
30 the non-variable part of the binding sequence, that is, the transcription factor consensus sequence.
   For example, the AP-1 transcription factor made up of Fos and Jun proteins binds to the TGACTCA
   consensus sequence. In comparison, the consensus sequence for the Smad transcription factor family
   which mediate TGF-P, activin and BMP induced changes in gene expression, is CAGACA.
35 I.       Starting cell types
            The cell types used in the present invention may include any animal cell type, where the
   animal is generally a vertebrate, e.g., a mammal, reptile, bird, amphibian, fish, etc. In some
                                                        11

   embodiments, the animal is a primate, e.g., a human. By way of nonlimiting example, hES cells,
   somatic cells reprogrammed to pluripotency such as hiPS, or human somatic cells may be used
   wherein said hES, hiPS, or somatic cells are genetically modified to constitutively express or up or
   down-regulate a transcriptional regulator or combination of transcriptional regulators as described
 5 below. The pluripotent stem cells may result from the reprogramming of a somatic cell that is
   genetically modified to constitutively overexpress a transcription factor. The constitutive expression
   may be accomplished by a number of means well-known in the art, including but not limited to stable
   transfection or retroviral or lentiviral infection. In addition, the transcriptional regulator may be
   introduced in a manner such that it is transiently expressed or transiently present as a protein, or in
10 the case of somatic cells, the cells, when genetically modified to regulate the expression of a
   transcriptional regulator, may subsequently be reprogrammed or transdifferentiated such as to an iPS
   cell line. In these embodiments, the transcriptional regulator modifies the gene expression pattern of
   the iPS-derived cell types, such as clonal or oligoclonal progenitor cell lines with a prenatal pattern
   of gene expression.
15
   II. Transcriptional regulators
             The transcriptional regulators of the present invention include transcription factors and
   chromatin-modifying molecules. The transcription factors of the present invention include those
   encoded in the human genome as well as homologs and orthologs from other species. Human
20 transcription factors include the following: Apoptosis antagonizing transcription factor (AATF), also
   known as (aka) CHEl, DED, CHE-1 ACCESSION NUMBER NM_012138.3; activity-dependent
   neuroprotector homeobox (ADNP), transcript variant 1, aka ADNP1, KIAA0784 ACCESSION
   NUMBER NM_015339.2; activity-dependent neuroprotector homeobox (ADNP), transcript variant
   2, aka ADNP1, KIAA0784 ACCESSION NUMBER NM_181442.1; ADNP homeobox 2 (ADNP2),
25 aka KIAA0863, ZNF508, ACCESSION NUMBER NM_014913.2; AE binding protein 1 (AEBP1),
   aka FLJ33612, ACLP, ACCESSION NUMBER NM_001129.3; AF4/FMR2 family, member 1
   (AFF1), aka MLLT2, MGC134969, AF4-MLL, MLL/AF4, PBM1, AF4, AF-4, ACCESSION
   NUMBER NM_005935.1; AF4/FMR2 family, member 4 (AFF4), aka AF5Q31, MGC75036, MCEF,
   ACCESSION NUMBER NM_014423.3; aryl hydrocarbon receptor (AHR), ACCESSION
30 NUMBER NM_001621.3; autoimmune regulator (autoimmune polyendocrinopathy candidiasis
   ectodermal dystrophy) (AIRE), transcript variant AIRE-1, aka PGA1, APECED, AIRE1, APSI,
   APS1 ACCESSION NUMBER NM_000383.1; autoimmune regulator (AIRE), transcript variant
   AIRE-2, aka PGA1, APECED, AIRE1, APSI, APSI ACCESSION NUMBER NM_000658.1;
   aristaless-like homeobox 3 (ALX3), aka MGC138212, MGC141988 ACCESSION NUMBER
35 NM_006492.2; aristaless-like homeobox 4 (ALX4), aka KIAA1788, PFM2, FPP, PFMI, PFM
   ACCESSION NUMBER NM_021926.2; ankyrin repeat domain 30A (ANKRD30A), accession
   number XM_001131823.1; ankyrin repeat domain 30A (ANKRD30A), accession number
                                                         12

   XM_001131823.1; androgen receptor (AR), transcript variant 2, aka DHTR, SMAX1, TFM,
   HUMARA, AIS, NR3C4, KD, SBMA, ACCESSION NUMBER NM_001011645.1; androgen
   receptor (AR), transcript variant 2, aka DHTR, SMAXI, TFM, HUMARA, AIS, NR3C4, KD,
   SBMA, ACCESSION NUMBER NM_001011645.1; androgen receptor (dihydrotestosterone
 5 receptor, testicular feminization, spinal and bulbar muscular atrophy, Kennedy disease) (AR),
   transcript variant 1, aka DHTR, SMAXI, TFM, HUMARA, AIS, NR3C4, KD, SBMA,
   ACCESSION NUMBER NM_000044.2; arginine-fifty homeobox (ARGFX), ACCESSION
   NUMBER NM_001012659.1; AT rich interactive domain 3A (BRIGHT-like) (ARID3A), aka
   E2FBP1, DRIL3, BRIGHT, DRIL1, ACCESSION NUMBER NM_005224.2; AT rich interactive
10 domain 4A (RBP1-like) (ARID4A), transcript variant 3, aka RBP1, RBP-1, RBBP1, ACCESSION
   NUMBER NM_023001.2; AT rich interactive domain 4A (RBP1-like) (ARID4A), transcript variant
   2, aka RBP1, RBP-1, RBBP1, ACCESSION NUMBER NM_023000.2; AT rich interactive domain
   4A (RBP1-like) (ARID4A), transcript variant 1, aka RBP1, RBP-1, RBBP1, ACCESSION
   NUMBER NM_002892.3; aryl hydrocarbon receptor nuclear translocator (ARNT), transcript variant
15 1, aka HIF-Ibeta, HIF1BETA, TANGO, HIF1B, ACCESSION NUMBER NM_001668.2; aryl
   hydrocarbon receptor nuclear translocator (ARNT), transcript variant 2, aka HIF-Ibeta, HIF1BETA,
   TANGO, HIF1B, ACCESSION NUMBER NM_178426.1; aryl-hydrocarbon receptor nuclear
   translocator 2 (ARNT2), aka KIAA0307, ACCESSION NUMBER NM_014862.3; aryl hydrocarbon
   receptor nuclear translocator-like (ARNTL), transcript variant 2, aka MOP3, BMAL1, BMAL1c,
20 TIC, PASD3, MGC47515, JAP3, ACCESSION NUMBER NM_001030272.1; aryl hydrocarbon
   receptor nuclear translocator-like (ARNTL), transcript variant 3, aka MOP3, BMAL1, BMAL1c,
   TIC, PASD3, MGC47515, JAP3, ACCESSION NUMBER NM_001030273.1; aryl hydrocarbon
   receptor nuclear translocator-like 2 (ARNTL2), aka PASD9, CLIF, BMAL2, MOP9, MGC149671,
   MGC149672, ACCESSION NUMBER NM_020183.3; aristaless related homeobox (ARX), aka
25 MRX43, MRX29, MRX32, MRXS1, ISSX, MRX38, PRTS, MRX54, MRX36, MRX33,
   ACCESSION NUMBER NM_139058.1; achaete-scute complex homolog 1 (Drosophila) (ASCL1),
   aka MASHI, ASHI, HASHI, ACCESSION NUMBER NM_004316.2; achaete-scute complex
   homolog 2 (Drosophila) (ASCL2), aka ASH2, MASH2, HASH2, ACCESSION NUMBER
   NM_005170.2; activating transcription factor 1 (ATF1), aka TREB36, FUS/ATF-1, EWS-ATF1,
30 ACCESSION NUMBER NM_005171.3; activating transcription factor 2 (ATF2), aka MGC 111558,
   CRE-BP1, CREB2, TREB7, HB16, ACCESSION NUMBER NM_001880.2; activating transcription
   factor 3 (ATF3), transcript variant 3, ACCESSION NUMBER NM_001030287.2; activating
   transcription factor 3 (ATF3), transcript variant 4, ACCESSION NUMBER NM_001040619.1;
   activating transcription factor 3 (ATF3), transcript variant 4, ACCESSION NUMBER
35 NM_001040619.1; activating transcription factor 4 (tax-responsive enhancer element B67) (ATF4),
   transcript variant 1, aka TXREB, TAXREB67, CREB2, CREB-2, ACCESSION NUMBER
   NM_001675.2; activating transcription factor 4 (tax-responsive enhancer element B67) (ATF4),
                                                       13

   transcript variant 1, aka TXREB, TAXREB67, CREB2, CREB-2, ACCESSION NUMBER
   NM_001675.2; activating transcription factor 4 (tax-responsive enhancer element B67) (ATF4),
   transcript variant 2, aka TXREB, TAXREB67, CREB2, CREB-2 ACCESSION NUMBER
   NM_182810.1; activating transcription factor 5 (ATF5), aka ATFX, FLJ34666, HMFNO395,
 5 ACCESSION NUMBER NM_012068.3; activating transcription factor 6 (ATF6), ACCESSION
   NUMBER NM_007348.2; activating transcription factor 7 (ATF7), aka MGC57182, ATFA,
   ACCESSION NUMBER NM_006856.1; atonal homolog 1 (Drosophila) (ATOH1), aka MATH-1,
   ATHI, HATHI, ACCESSION NUMBER NM_005172.1; alpha thalassemia/mental retardation
   syndrome X-linked (RAD54 homolog, S. cerevisiae) (ATRX), transcript variant 3, aka XNP, ZNF
10 HX, MRXHF1, XH2, ATR2, SFMi, SHS, MRXS3, RAD54L, RAD54, MGC2094, ACCESSION
   NUMBER NM_138271.1; alpha thalassemia/mental retardation syndrome X-linked (RAD54
   homolog, S. cerevisiae) (ATRX), transcript variant 1, aka XNP, ZNF-HX, MRXHF1, XH2, ATR2,
   SFMi, SHS, MRXS3, RAD54L, RAD54, MGC2094, ACCESSION NUMBER NM_000489.3; alpha
   thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae) (ATRX),
15 transcript variant 1, aka XNP, ZNF-HX, MRXHF1, XH2, ATR2, SFMi, SHS, MRXS3, RAD54L,
   RAD54, MGC2094, ACCESSION NUMBER NM_000489.2; BTB and CNC homology 1, basic
   leucine zipper transcription factor 1 (BACH1), transcript variant 3, aka ACCESSION NUMBER
   NM_001011545.1; BTB and CNC homology 1, basic leucine zipper transcription factor 1 (BACH1),
   transcript variant 3, ACCESSION NUMBER NM_001011545.1; BTB and CNC homology 1, basic
20 leucine zipper transcription factor 1 (BACH1), transcript variant 1, ACCESSION NUMBER
   NM_206866.1; BTB and CNC homology 1, basic leucine zipper transcription factor 2 (BACH2),
   ACCESSION NUMBER NM_021813.1; BTB and CNC homology 1, basic leucine zipper
   transcription factor 2 (BACH2), ACCESSION NUMBER NM_021813.1; bagpipe homeobox
   homolog 1 (Drosophila) (BAPX1), aka NKX3B, NKX3-2, MGC138171, NKX3.2, ACCESSION
25 NUMBER NM_001189.2; BarH-like homeobox 1 (BARHL1), ACCESSION NUMBER
   NM_020064.2; BarH-like homeobox 2 (BARHL2), ACCESSION NUMBER NM_020063.1; BARX
   homeobox 1 (BARX1), ACCESSION NUMBER NM_021570.3; BARX homeobox 2 (BARX2), aka
   MGC133368, MGC133369, ACCESSION NUMBER NM_003658.4; basic leucine zipper
   transcription factor, ATF-like (BATF), aka B-ATF, BATF1, SFA-2, ACCESSION NUMBER
30 NM_006399.2; basic leucine zipper transcription factor, ATF-like 2 (BATF2), aka MGC20410,
   ACCESSION NUMBER NM_138456.3; basic leucine zipper transcription factor, ATF-like 3
   (BATF3), aka JUNDM1, BATF3, SNFT, ACCESSION NUMBER NM_018664.1; bromodomain
   adjacent to zinc finger domain, lB (BAZIB), transcript variant 1, aka WBSCR9, WBSCRIO, WSTF,
   ACCESSION NUMBER NM_023005.2; B-cell CLL/lymphoma 3 (BCL3), aka D19S37, BCL4,
35 ACCESSION NUMBER NM_005178.2; B-cell CLL/lymphoma 6 (zinc finger protein 51) (BCL6),
   transcript variant 1, aka ZBTB27, ZNF51, LAZ3, BCL6A, BCL5, ACCESSION NUMBER
   NM_001706.2; B-cell CLL/lymphoma 6 (zinc finger protein 51) (BCL6), transcript variant 2, aka
                                                     14

   ZBTB27, ZNF51, LAZ3, BCL6A, BCL5, ACCESSION NUMBER NM_138931.1; basic helix-loop
   helix domain containing, class B, 2 (BHLHB2), aka DECI, STRA13, Stra14, SHARP-2,
   ACCESSION NUMBER NM_003670.1; basic helix-loop-helix domain containing, class B, 3
   (BHLHB3), aka SHARP, DEC2, SHARP-1, ACCESSION NUMBER NM_030762.1; basic leucine
 5 zipper nuclear factor 1 (BLZF1), aka GOLGIN-45, MGC22497, JEM1, JEM-1, JEM-Is,
   ACCESSION NUMBER NM_003666.2; basonuclin 1 (BNC1), aka BNC, HsT19447, BSN1,
   ACCESSION NUMBER NM_001717.2; basonuclin 1 (BNC1), aka BNC, HsT19447, BSN1,
   ACCESSION NUMBER NM_001717.2; bromodomain containing 8 (BRD8), transcript variant 3,
   aka SMAP, p120, SMAP2, ACCESSION NUMBER NM_183359.1; bromodomain containing 8
10 (BRD8), transcript variant 2, aka SMAP, p120, SMAP2, ACCESSION NUMBER NM_139199.1;
   BRF1 homolog, subunit of RNA polymerase III transcription initiation factor IIIB (S. cerevisiae)
   (BRF1), transcript variant 1, aka FLJ43034, TAF3C, TAF11190, MGC105048, BRF, hBRF, TAF3B2,
   GTF3B, FLJ42674, TFIIIB90, TF3B90, ACCESSION NUMBER NM_001519.2; BRF1 homolog,
   subunit of RNA polymerase III transcription initiation factor IIIB (S. cerevisiae) (BRF1), transcript
15 variant 1, aka   FLJ43034, TAF3C, TAFIII90, MGC105048, BRF, hBRF, TAF3B2, GTF3B,
   FLJ42674, TFIIIB90, TF3B90, ACCESSION NUMBER NM_001519.2; BRF1 homolog, subunit of
   RNA polymerase III transcription initiation factor IIIB (S. cerevisiae) (BRF1), transcript variant 2,
   aka FLJ43034, TAF3C, TAFIII90, MGC105048, BRF, hBRF, TAF3B2, GTF3B, FLJ42674,
   TFIIIB90, TF3B90, ACCESSION NUMBER NM_145696.1; BTAF1 RNA polymerase II, B-TFIID
20 transcription factor-associated, 170kDa (Motl homolog, S. cerevisiae) (BTAF1), aka TAF172,
   KIAA0940, TAF(II)170, TAFII170, MOTI, MGC138406, ACCESSION NUMBER NM_003972.2;
   BTG family, member 2 (BTG2), aka PC3, TIS21, MGC126064, MGC126063, ACCESSION
   NUMBER NM_006763.2; BUD31 homolog (S. cerevisiae) (BUD31), aka MGC111202, YCR063W,
   EDG-2, EDG2, G10, ACCESSION NUMBER NM_003910.2; chromosome 11 open reading frame 9
25 (C1 1orf9), transcript variant 1, aka MGC10781, KIAA0954, ACCESSION NUMBER
   NM_013279.1; chromosome 21 open reading frame 66 (C21orf66), transcript variant 1, aka
   FLJ90561, GCFC, BM-020, ACCESSION NUMBER NM_016631.3; chromosome 21 open reading
   frame 66 (C21orf66), transcript variant 1, aka FLJ90561, GCFC, BM-020, ACCESSION NUMBER
   NM_016631.3; chromosome 21 open reading frame 66 (C21orf66), transcript variant 4, aka
30 FLJ90561, GCFC, BM-020, ACCESSION NUMBER NM_058191.3; chromosome 21 open reading
   frame 66 (C21orf66), transcript variant 2, aka FLJ90561, GCFC, BM-020, ACCESSION NUMBER
   NM_013329.3; chromosome 2 open reading frame 3 (C2orf3), aka TCF9, GCF, DNABF,
   ACCESSION NUMBER NM_003203.3; chromosome 5 open reading frame 41 (C5orf4l), aka
   DKFZp686G2059, DKFZp313F2319, ACCESSION NUMBER NM_153607.1; cartilage paired-class
35 homeoprotein 1 (CART1), ACCESSION NUMBER NM_006982. 1; core-binding factor, runt
   domain, alpha subunit 2, translocated to, 2 (CBFA2T2), transcript variant 2, aka MTGRI, EHT,
   ZMYND3, DKFZp313F2116, ACCESSION NUMBER NM_005093.3; core-binding factor, runt
                                                     15

   domain, alpha subunit 2, translocated to, 2 (CBFA2T2), transcript variant 2, aka MTGRI, EHT,
   ZMYND3, DKFZp313F2116, ACCESSION NUMBER NM_005093.3; core-binding factor, runt
   domain, alpha subunit 2, translocated to, 2 (CBFA2T2), transcript variant 3, aka MTGRI, EHT,
   ZMYND3, DKFZp313F2116, ACCESSION NUMBER NM_001032999.2; core-binding factor, runt
 5 domain, alpha subunit 2, translocated to, 3 (CBFA2T3), transcript variant 1, aka ZMYND4, MTGR2,
   MTG16, ET02, ACCESSION NUMBER NM005187.4; core-binding factor, runt domain, alpha
   subunit 2, translocated to, 3 (CBFA2T3), transcript variant 1, aka ZMYND4, MTGR2, MTG16,
   ET02, ACCESSION NUMBER NM_005187.4; core-binding factor, runt domain, alpha subunit 2,
   translocated to, 3 (CBFA2T3), transcript variant 2, aka ZMYND4, MTGR2, MTG16, ETO2,
10 ACCESSION NUMBER NM_175931.1; core-binding factor, beta subunit (CBFB), transcript variant
   2, aka PEBP2B, ACCESSION NUMBER NM_001755.2; core-binding factor, beta subunit (CBFB),
   transcript variant 2, aka PEBP2B, ACCESSION NUMBER NM_001755.2; Cas-Br-M (murine)
   ecotropic retroviral transforming sequence (CBL), aka C-CBL, CBL2, RNF55, ACCESSION
   NUMBER NM_005188.2; CCR4 carbon catabolite repression 4-like (S. cerevisiae) (CCRN4L), aka
15 CCR4L, MGC142060, MGC142054, MGC4120817, MGC78549, NOC, ACCESSION NUMBER
   NM_012118.2; caudal type homeobox 1 (CDX1), aka MGC116915, ACCESSION NUMBER
   NM_001804.2; caudal type homeobox 2 (CDX2), aka CDX3, CDX-3, ACCESSION NUMBER
   NM_001265.2; caudal type homeobox 4 (CDX4), ACCESSION NUMBER NM_005193.1;
   CCAAT/enhancer binding protein (C/EBP), alpha (CEBPA), aka CEBP, C/EBP-alpha, ACCESSION
20 NUMBER NM_004364.2; CCAAT/enhancer binding protein (C/EBP), beta (CEBPB), aka CRP2,
   LAP, IL6DBP, C/EBP-beta, TCF5, NF-IL6, MGC32080, ACCESSION NUMBER NM_005194.2;
   CCAAT/enhancer binding protein (C/EBP), delta (CEBPD), aka NF-IL6-beta, C/EBP-delta, CELF,
   CRP3, ACCESSION NUMBER NM_005195.3; CCAAT/enhancer binding protein (C/EBP), epsilon
   (CEBPE), aka C/EBP-epsilon, CRP1, ACCESSION NUMBER NM_001805.2; CCAAT/enhancer
25 binding protein (C/EBP), gamma (CEBPG), aka GPElBP, IG/EBP-1, ACCESSION NUMBER
   NM_001806.2; checkpoint suppressor 1 (CHES1), aka C14orfl16, FOXN3, PRO1635,
   ACCESSION NUMBER NM_005197.2; ceh-10 homeodomain containing homolog (C. elegans)
   (CHX1O), aka HOX1O, MCOPCB3, MCOP2, RETI, ACCESSION NUMBER NM_182894.1;
   Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 (CITED 1), aka
30 MSG1, ACCESSION NUMBER NM_004143.2; Cbp/p300-interacting transactivator, with Glu/Asp
   rich carboxy-terminal domain, 2 (CITED2), aka P35SRJ, MRG1, ACCESSION NUMBER
   NM_006079.3; clock homolog (mouse) (CLOCK), aka KIAA0334,, ACCESSION NUMBER
   NM_004898.2; CCHC-type zinc finger, nucleic acid binding protein (CNBP), aka ZCCHC22,
   CNBP1, RNF163, PROMM, ZNF9, DM2, ACCESSION NUMBER NM_003418.1; CCR4-NOT
35 transcription complex, subunit 7 (CNOT7), transcript variant 2, aka CAF1, hCAF-1, ACCESSION
   NUMBER NM_054026.2; CCR4-NOT transcription complex, subunit 7 (CNOT7), transcript variant
   1, aka CAF1, hCAF-1, ACCESSION NUMBER NM_013354.5; CCR4-NOT transcription complex,
                                                     16

   subunit 7 (CNOT7), transcript variant 1, aka CAF1, hCAF-1, ACCESSION NUMBER
   NM_013354.5; CCR4-NOT transcription complex, subunit 8 (CNOT8), aka hCAF1, POP2, CAF1,
   CALIF, ACCESSION NUMBER NM_004779.4; cAMP responsive element binding protein 1
   (CREB 1), transcript variant A, aka MGC9284, CREB, ACCESSION NUMBER NM_004379.2;
 5 cAMP responsive element binding protein 3 (CREB3), aka LZIP, LUMAN, MGC15333,
   MGC19782, ACCESSION NUMBER NM_006368.4; cAMP responsive element binding protein 3
   like 1 (CREB3L1), aka OASIS, ACCESSION NUMBER NM_052854.2; cAMP responsive element
   binding protein 3-like 2 (CREB3L2), aka BBF2H7, MGC131709, MGC71006, ACCESSION
   NUMBER NM_194071.2; cAMP responsive element binding protein 3-like 3 (CREB3L3), aka
10 MGC126557, CREB-H, HYST1481, MGC126553, ACCESSION NUMBER NM_032607.1; cAMP
   responsive element binding protein 3-like 4 (CREB3L4), aka CREB4, ATCE1, JAL, hJAL, CREB3,
   AIBZIP, ACCESSION NUMBER NM_130898.2; cAMP responsive element binding protein 5
   (CREB5), transcript variant 4, aka CRE-BPA, ACCESSION NUMBER NM_001011666.1; cAMP
   responsive element binding protein 5 (CREB5), transcript variant 2, aka CRE-BPA, ACCESSION
15 NUMBER NM_004904.2; cAMP responsive element binding protein 5 (CREB5), transcript variant
   1, aka CRE-BPA, ACCESSION NUMBER NM_182898.2; cAMP responsive element binding
   protein 5 (CREB5), transcript variant 1, aka CRE-BPA, ACCESSION NUMBER NM_182898.2;
   cAMP responsive element binding protein 5 (CREB5), transcript variant 3, aka    CRE-BPA,
   ACCESSION NUMBER NM_182899.3; CREB binding protein (CREBBP), transcript variant 2, aka
20 CBP, KAT3A, RTS, RSTS, ACCESSION NUMBER NM_001079846.1; CREB binding protein
   (CREBBP), transcript variant 1, aka CBP, KAT3A, RTS, RSTS, ACCESSION NUMBER
   NM_004380.2; cAMP responsive element binding protein-like 1 (CREBLI), aka FLJ10066, G13,
   CREB-RP, ACCESSION NUMBER NM_004381.3; cAMP responsive element binding protein-like
   2 (CREBL2), aka MGC138362, MGC117311, ACCESSION NUMBER NM_001310.2; CREB/ATF
25 bZIP transcription factor (CREBZF), aka ZF, ACCESSION NUMBER NM_001039618.1; cAMP
   responsive element modulator (CREM), transcript variant 2, aka MGC1 11110, ICER, MGC41893,
   MGC17881, hCREM-2, ACCESSION NUMBER NM_001881.2; cone-rod homeobox (CRX), aka
   OTX3, CRD, LCA7, CORD2, ACCESSION NUMBER NM_000554.3; cold shock domain protein
   A (CSDA), aka CSDA1, DBPA, ZONAB,                 ACCESSION NUMBER NM_003651.3; C-terminal
30 binding protein 1 (CTBP1), transcript variant 1, aka BARS, MGC104684, ACCESSION NUMBER
   NM_001328.2; C-terminal binding protein 1 (CTBP1), transcript variant 2, aka BARS, MGC104684,
   ACCESSION NUMBER NM_001012614.1; C-terminal binding protein 1 (CTBP1), transcript
   variant 2, aka BARS, MGC104684, ACCESSION NUMBER NM_001012614.1; CCCTC-binding
   factor (zinc finger protein) (CTCF), ACCESSION NUMBER NM_006565.2; cut-like 1, CCAAT
35 displacement protein (Drosophila) (CUTL1), transcript variant 1, aka p 110, CASP, CUX,
   Nbla10317, p75, COY1, p200, p100, CDP, ACCESSION NUMBER NM_181552.1; cut-like
   homeobox 1 (CUX 1), transcript variant 2, aka p 1 10, CASP, GOLIM6, CUX, CDP1, Cux/CDP,
                                                     17

   Nbla10317, Clox, p75, CUTL1, COY1, p200, p100, CDP, CDP/Cut, ACCESSION NUMBER
   NM_001913.2; cut-like homeobox 1 (CUX1), transcript variant 3, aka p110, CASP, GOLIM6, CUX,
   CDP1, Cux/CDP, Nbla10317, Clox, p75, CUTL1, COY1, p200, p100, CDP, CDP/Cut, ACCESSION
   NUMBER NM_181500.1; cut-like homeobox 2 (CUX2), aka CUTL2, CUX2, CDP2, ACCESSION
 5 NUMBER NM_015267.2; dachshund homolog 1 (Drosophila) (DACH1), transcript variant 1, aka
   DACH, FLJ10138, ACCESSION NUMBER NM_080759.3; dachshund homolog 1 (Drosophila)
   (DACHI), transcript variant 2, aka DACH, FLJ10138, ACCESSION NUMBER NM_080760.3;
   dachshund homolog 1 (Drosophila) (DACH1), transcript variant 2, aka DACH, FLJ10138,
   ACCESSION NUMBER NM_080760.3; D site of albumin promoter (albumin D-box) binding
10 protein (DBP), aka DABP, ACCESSION NUMBER NM_001352.2; developing brain homeobox 1
   (DBX1), ACCESSION NUMBER NM_001029865.1; developing brain homeobox 2 (DBX2), aka
   FLJ16139, ACCESSION NUMBER NM_001004329.2; DNA-damage-inducible transcript 3
   (DDIT3), aka MGC4154, CEBPZ, CHOP1O, CHOP, GADD153, ACCESSION NUMBER
   NM_004083.4; distal-less homeobox 1 (DLX1), transcript variant 2, ACCESSION NUMBER
15 NM_001038493.1; distal-less homeobox 1 (DLX1), transcript variant 1, ACCESSION NUMBER
   NM_178120.4; distal-less homeobox 2 (DLX2), aka TESI, TES-1, ACCESSION NUMBER
   NM_004405.3; distal-less homeobox 3 (DLX3), aka TDO, ACCESSION NUMBER NM_005220.2;
   distal-less homeobox 4 (DLX4), transcript variant 1, aka BP1, DLX9, DLX8, DLX7, ACCESSION
   NUMBER NM_138281.1; distal-less homeobox 4 (DLX4), transcript variant 1, aka BP1, DLX9,
20 DLX8, DLX7, ACCESSION NUMBER NM_138281.1; distal-less homeobox 4 (DLX4), transcript
   variant 2, aka BP1, DLX9, DLX8, DLX7, ACCESSION NUMBER NM_001934.2; distal-less
   homeobox 5 (DLX5), ACCESSION NUMBER NM_005221.5; distal-less homeobox 6 (DLX6), aka
   MGC125283, MGC125282, MGC125285, MGC125284, ACCESSION NUMBER NM_005222.2;
   diencephalon/mesencephalon homeobox 1 (DMBX 1), transcript variant 1, aka OTX3, PAXB, MBX,
25 ACCESSION NUMBER NM_172225.1; doublesex and mab-3 related transcription factor 1
   (DMRT1), aka DMT1, ACCESSION NUMBER NM_021951.2; doublesex and mab-3 related
   transcription factor 2 (DMRT2), transcript variant 1, ACCESSION NUMBER NM_006557.4;
   doublesex and mab-3 related transcription factor 2 (DMRT2), transcript variant 1, ACCESSION
   NUMBER NM_006557.4; doublesex and mab-3 related transcription factor 3 (DMRT3), aka
30 MGC142144, DMRTA3, ACCESSION NUMBER NM_021240.2; DMRT-like family Al
   (DMRTA1), aka MGC163307, DMO, MGC163309, ACCESSION NUMBER NM_022160.1;
   DMRT-like family B with proline-rich C-terminal, 1 (DMRTB 1), ACCESSION NUMBER
   NM_033067.1; DMRT-like family C2 (DMRTC2), ACCESSION NUMBER NM_001040283.1;
   cyclin D binding myb-like transcription factor 1 (DMTF1), aka DMP1, DMTF, hDMP1, FLJ41265,
35 ACCESSION NUMBER NM_021145.2; divergent-paired related homeobox (DPRX), ACCESSION
   NUMBER NM_001012728.1; DRI-associated protein 1 (negative cofactor 2 alpha) (DRAP1), aka
   NC2-alpha, ACCESSION NUMBER NM_006442.2; dorsal root ganglia homeobox (DRGX), aka
                                                     18

   DRG11, PRRXL1, ACCESSION NUMBER NM_001080520.1; double homeobox, 1 (DUXI),
   ACCESSION NUMBER NM_012146.1; double homeobox, 2 (DUX2), ACCESSION NUMBER
   NM_012147.2; double homeobox, 3 (DUX3), ACCESSION NUMBER NM_012148.2; double
   homeobox, 4 (DUX4), aka DUX10, ACCESSION NUMBER NM_033178.2; double homeobox 4c
 5 (DUX4C), ACCESSION NUMBER NM_001099853.1; double homeobox, 5 (DUX5), ACCESSION
   NUMBER NM_012149.2; double homeobox A (DUXA), ACCESSION NUMBER
   NM_001012729.1; E2F transcription factor 1 (E2F1), aka E2F-1, RBP3, RBBP3, ACCESSION
   NUMBER NM_005225.1; E2F transcription factor 2 (E2F2), aka E2F-2, ACCESSION NUMBER
   NM_004091.2; E2F transcription factor 3 (E2F3), aka KIAA0075, E2F-3, MGC104598,
10 DKFZp686C18211, ACCESSION NUMBER NM_001949.2; E2F transcription factor 4, p107/pl3O
   binding (E2F4), aka E2F-4, ACCESSION NUMBER NM_001950.3; E2F transcription factor 5,
   p130-binding (E2F5), transcript variant 1, aka E2F-5, ACCESSION NUMBER NM_001951.3; E2F
   transcription factor 6 (E2F6), aka E2F-6, MGC1 11545, ACCESSION NUMBER NM_198256.2;
   E2F transcription factor 6 (E2F6), transcript variant e, aka E2F-6, MGC 111545, accession number
15 NR_003095.1; E2F transcription factor 7 (E2F7), aka FLJ12981, ACCESSION NUMBER
   NM_203394.2; E2F transcription factor 8 (E2F8), aka FLJ2331 1, ACCESSION NUMBER
   NM_024680.2; E4F transcription factor 1 (E4F1), aka MGC99614, E4F, ACCESSION NUMBER
   NM_004424.3; ECSIT homolog (Drosophila) (ECSIT), aka SITPEC, ACCESSION NUMBER
   NM_016581.2; endothelial differentiation-related factor 1 (EDF1), transcript variant alpha, aka EDF
20 1, MBF1, MGC9058, ACCESSION NUMBER NM_003792.2; endothelial differentiation-related
   factor 1 (EDF1), transcript variant alpha, aka EDF-1, MBF1, MGC9058 , ACCESSION NUMBER
   NM_003792.2; early growth response 1 (EGRI), aka GOS30, AT225, TIS8, ZNF225, NGFI-A,
   KROX-24, ZIF-268, ACCESSION NUMBER NM_001964.2; early growth response 2 (Krox-20
   homolog, Drosophila) (EGR2), aka KROX20, FLJ14547, DKFZp686J1957, CMT4E, CMT1D,
25 ACCESSION NUMBER NM_000399.2; early growth response 3 (EGR3), aka PILOT,
   MGC138484, ACCESSION NUMBER NM_004430.2; early growth response 3 (EGR3), aka
   PILOT, MGC138484, ACCESSION NUMBER NM_004430.2; early growth response 4 (EGR4),
   aka NGFI-C, NGFIC, PAT133, ACCESSION NUMBER NM_001965.1; ets homologous factor
   (EHF), aka ESE3, ESEJ, ACCESSION NUMBER NM_012153.3; E74-like factor 1 (ets domain
30 transcription factor) (ELF1), ACCESSION NUMBER NM_172373.2; E74-like factor 2 (ets domain
   transcription factor) (ELF2), transcript variant 2, aka NERF, NERF-1A, NERF-2, EU32, NERF-1B,
   ACCESSION NUMBER NM_006874.2; E74-like factor 2 (ets domain transcription factor) (ELF2),
   transcript variant 2, aka NERF, NERF-1A, NERF-2, EU32, NERF-1B, ACCESSION NUMBER
   NM_006874.2; E74-like factor 2 (ets domain transcription factor) (ELF2), transcript variant 1, aka
35 NERF, NERF-1A, NERF-2, EU32, NERF-1B, ACCESSION NUMBER NM_201999.1; E74-like
   factor 3 (ets domain transcription factor, epithelial-specific ) (ELF3), aka ESX, ESE-1, EPR-1, ERT,
   ACCESSION NUMBER NM_004433.3; E74-like factor 4 (ets domain transcription factor) (ELF4),
                                                       19

   aka MEF, ELFR, ACCESSION NUMBER NM_001421.2; E74-like factor 5 (ets domain
   transcription factor) (ELF5), transcript variant 2, aka ESE2, ACCESSION NUMBER NM_001422.2;
   E74-like factor 5 (ets domain transcription factor) (ELF5), transcript variant 1, aka ESE2,
   ACCESSION NUMBER NM_198381.1; ELKI, member of ETS oncogene family (ELKI),
 5 ACCESSION NUMBER NM_005229.2; ELK3, ETS-domain protein (SRF accessory protein 2)
   (ELK3), aka SAP2, NET, ERP, ACCESSION NUMBER NM_005230.2; ELK4, ETS-domain
   protein (SRF accessory protein 1) (ELK4), transcript variant a, aka SAPI, ACCESSION NUMBER
   NM_001973.2; ELK4, ETS-domain protein (SRF accessory protein 1) (ELK4), transcript variant a,
   aka SAPI, ACCESSION NUMBER NM_001973.2; ELK4, ETS-domain protein (SRF accessory
10 protein 1) (ELK4), transcript variant b, aka SAPI, ACCESSION NUMBER NM_021795.2; empty
   spiracles homolog 1 (Drosophila) (EMX 1), ACCESSION NUMBER NM_004097.1, empty spiracles
   homeobox 1 (EMX1), transcript variant 2, ACCESSION NUMBER NM_001040404.1, empty
   spiracles homeobox 2 (EMX2), ACCESSION NUMBER NM_004098.2; engrailed homeobox 1
   (ENI), ACCESSION NUMBER NM_001426.3; engrailed homeobox 2 (EN2), aka AUTSI,
15 AUTS10, ACCESSION NUMBER NM_001427.3; eomesodermin homolog (Xenopus laevis)
   (EOMES), aka TBR2, ACCESSION NUMBER NM_005442.2; ElA binding protein p300 (EP300),
   aka p300, KAT3B, ACCESSION NUMBER NM_001429.2; endothelial PAS domain protein 1
   (EPASI), aka HIF2A, HLF, ECYT4, MOP2, PASD2, ACCESSION NUMBER NM_001430.3; Ets2
   repressor factor (ERF), aka PE-2 ACCESSION NUMBER NM_006494.1; v-ets erythroblastosis
20 virus E26 oncogene homolog (avian) (ERG), transcript variant 1, aka erg-3, p55, ACCESSION
   NUMBER NM_182918.2; v-ets erythroblastosis virus E26 oncogene homolog (avian) (ERG),
   transcript variant 1, aka erg-3, p55, ACCESSION NUMBER NM_182918.2; v-ets erythroblastosis
   virus E26 oncogene homolog (avian) (ERG), transcript variant 2, aka erg-3, p55, ACCESSION
   NUMBER NM_004449.3; estrogen receptor 1 (ESRI), aka major ORF, ESR, Era, ER, NR3A1,
25 ESRA, DKFZp686N23123, ACCESSION NUMBER NM_000125.2; estrogen receptor 2 (ER beta)
   (ESR2), transcript variant b, aka ESR-BETA, ESTRB, ESRB, Erb, ER-BETA, NR3A2,
   ACCESSION NUMBER NM_001040275.1; estrogen receptor 2 (ER beta) (ESR2), transcript variant
   b, aka ESR-BETA, ESTRB, ESRB, Erb, ER-BETA, NR3A2, ACCESSION NUMBER
   NM_001040275.1; estrogen-related receptor alpha (ESRRA), aka NR3B1, ERRalpha, ERRa, ERR1,
30 ESRL1, ACCESSION NUMBER NM_004451.3; estrogen-related receptor beta (ESRRB), aka
   ESRL2, ERRbeta, NR3B2, ERRb, ERRbeta-2, ERR2, ACCESSION NUMBER NM_004452.2;
   estrogen-related receptor gamma (ESRRG), transcript variant 1, aka DKFZp781L1617, ERR3,
   KIAA0832, FLJ16023, NR3B3; ACCESSION NUMBER NM_001438.2; estrogen-related receptor
   gamma (ESRRG), transcript variant 2, aka DKFZp781L1617, ERR3, KIAA0832, FLJ16023,
35 NR3B3, ACCESSION NUMBER NM_206594.1; estrogen-related receptor gamma (ESRRG),
   transcript variant 2, aka DKFZp781L1617, ERR3, KIAA0832, FLJ16023, NR3B3, ACCESSION
   NUMBER NM_206594.1; ESX homeobox 1 (ESX1), aka ESXR1, ESX1L, ACCESSION NUMBER
                                                       20

   NM_153448.2; v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) (ETS1), aka ETS-1,
   FLJ10768, EWSR2, ACCESSION NUMBER NM_005238.2; v-ets erythroblastosis virus E26
   oncogene homolog 2 (avian) (ETS2), ACCESSION NUMBER NM_005239.4; ets variant gene 1
   (ETVI), aka MGC120533, DKFZp781LO674, MGC104699, ER81, MGC120534, ACCESSION
 5 NUMBER NM_004956.3; ets variant gene 2 (ETV2), aka MGC129835, ETSRP71, ER71,
   MGC129834, ACCESSION NUMBER NM_014209.1; ets variant 3 (ETV3), aka bA11OJ1.4, PE-1,
   PEl, METS, ACCESSION NUMBER NM_005240.1; ets variant 3-like (ETV3L), aka FLJ16478,
   ACCESSION NUMBER NM_001004341.1; ets variant 4 (ETV4), transcript variant 1, aka PEA3,
   ElA-F, E1AF, PEAS3, ACCESSION NUMBER NM_001986.2; ets variant gene 4 (E1A enhancer
10 binding protein, E1AF) (ETV4), aka ElA-F, PEA3, E1AF, PEAS3, ACCESSION NUMBER
   NM_001986.1; ets variant gene 5 (ets-related molecule) (ETV5), aka ERM, ACCESSION NUMBER
   NM_004454.1; ets variant gene 5 (ets-related molecule) (ETV5), aka ERM, ACCESSION NUMBER
   NM_004454.1; ets variant 6 (ETV6), aka TEL, TEL/ABL, ACCESSION NUMBER NM_001987.4;
   ecotropic viral integration site 1 (EVIl), aka EVI-i, PRDM3, MGC163392, MDSI-EVII, AMLI
15 EVI-i, ACCESSION NUMBER NM_005241.1; even-skipped homeobox 1 (EVXi), ACCESSION
   NUMBER NM_001989.3; even-skipped homeobox 2 (EVX2), ACCESSION NUMBER
   NM_001080458.1; FEV (ETS oncogene family) (FEV), aka PET-1, HSRNAFEV, ACCESSION
   NUMBER NM_017521.2; Friend leukemia virus integration 1 (FLIl), aka SIC-1, EWSR2,
   ACCESSION NUMBER NM_002017.2; FLJ46838 protein (FLJ46838), ACCESSION NUMBER
20 NM_001007546.2; formin-like 2 (FMNL2), aka FLJ37546, FHOD2, ACCESSION NUMBER
   NM_052905.3; v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS), aka c-fos,
   ACCESSION NUMBER NM_005252.2; FBJ murine osteosarcoma viral oncogene homolog B
   (FOSB), aka GOS3, GOS3, MGC42291, GOSB, DKFZp686CO818, ACCESSION NUMBER
   NM_006732.1; FOS-like antigen 1 (FOSLI), aka fra-1, FRA1, ACCESSION NUMBER
25 NM_005438.2; FOS-like antigen 2 (FOSL2), aka FRA2, FLJ23306, ACCESSION NUMBER
   NM_005253.3; forkhead box Al (FOXAI), aka MGC33105, TCF3A, HNF3A, ACCESSION
   NUMBER NM_004496.2; forkhead box A2 (FOXA2), transcript variant 1, aka MGC19807, TCF3B,
   HNF3B, ACCESSION NUMBER NM_021784.3; forkhead box A2 (FOXA2), transcript variant 2,
   aka MGC19807, TCF3B, HNF3B, ACCESSION NUMBER NM_153675.1; forkhead box A2
30 (FOXA2), transcript variant 2, aka MGC19807, TCF3B, HNF3B, ACCESSION NUMBER
   NM_153675.1; forkhead box A3 (FOXA3), aka HNF3G, TCF3G, MGCI0179, FKHH3,
   ACCESSION NUMBER NM_004497.2; forkhead box BI (FOXB 1), aka FKH5, HFKH-5,
   ACCESSION NUMBER NM_012182.2; forkhead box B2 (FOXB2), aka bA159H20.4,
   ACCESSION NUMBER NM_001013735.1; forkhead box CI (FOXC1), aka FREAC3, FKHL7,
35 IHGI, ARA, IRIDI, IGDA, ACCESSION NUMBER NM_001453.1; forkhead box C2 (MFH-1,
   mesenchyme forkhead 1) (FOXC2), aka MFHI, MFH-I, FKHL14, LD, ACCESSION NUMBER
   NM_005251.1; forkhead box DI (FOXDI), aka FREAC4, FKHL8, ACCESSION NUMBER
                                                     21

   NM_004472.2; forkhead box D2 (FOXD2), aka FREAC-9, FKHL17, FREAC9, ACCESSION
   NUMBER NM_004474.3; forkhead box D3 (FOXD3), aka HFH2, Genesis, ACCESSION
   NUMBER NM_012183.1; forkhead box D4 (FOXD4), aka FOXD4A, FKHL9, MGC105106,
   FREAC5, ACCESSION NUMBER NM_207305.2; forkhead box D4-like 1 (FOXD4L1), aka
 5 bA395L14.1, ACCESSION NUMBER NM_012184.3; FOXD4-like 2 (FOXD4L2), aka
   MGC119257, ACCESSION NUMBER NM_199135.1; forkhead box D4-like 3 (FOXD4L3), aka
   FOXD6, ACCESSION NUMBER NM_199358.1; forkhead box El (thyroid transcription factor 2)
   (FOXE1), aka TTF-2, TTF2, TITF2, HFKH4, FOXE2, FKHL15, HFKL5, ACCESSION NUMBER
   NM_004473.3; forkhead box E3 (FOXE3), aka FREAC8, FKHL12, ASMD, ACCESSION
10 NUMBER NM_012186.2; forkhead box E3 (FOXE3), aka FREAC8, FKHL12, ASMD,
   ACCESSION NUMBER NM_012186.2; forkhead box F1 (FOXF1), aka MGC105125, FKHL5,
   FREACi, ACCESSION NUMBER NM_001451.2; forkhead box F2 (FOXF2), aka FREAC2,
   FKHL6, ACCESSION NUMBER NM_001452.1; forkhead box GI (FOXG1), aka FKHLi, KHL2,
   HFK3, HBF2, FOXG1C, QIN, FKHL2, HBF-2, HBF-1, FKH2, HFKi, FKHL4, HBF-G2, BF2,
15 FHKL3, BF1, HFK2, HBF-3, FOXG1B, FKHL3, FOXG1A, ACCESSION NUMBER
   NM_005249.3; forkhead box HI (FOXH1), aka FAST1, FAST-1, ACCESSION NUMBER
   NM_003923.1; forkhead box Il (FOXI1), transcript variant 1, aka HFH3, FKHL1O, MGC34197,
   FREAC6, ACCESSION NUMBER NM_012188.4; forkhead box Il (FOXI1), transcript variant 1,
   aka HFH3, FKHL1O, MGC34197, FREAC6, ACCESSION NUMBER NM_012188.4; forkhead box
20 12 (FOXI2), aka FOXI2, FLJ46831, ACCESSION NUMBER NM_207426.1; forkhead box Ji
   (FOXJi), aka HFH-4, HFH4, MGC35202, FKHL13, ACCESSION NUMBER NM_001454.2;
   forkhead box J2 (FOXJ2), aka FHX, ACCESSION NUMBER NM_018416.2; forkhead box J3
   (FOXJ3), aka MGC176686, MGC165036, ACCESSION NUMBER NM_014947.3; forkhead box
   Ki (FOXKi), aka FLJ14977, FOXKi, ACCESSION NUMBER NM_001037165.1; forkhead box
25 Ki (FOXKi), aka FLJ14977, FOXKIL, ACCESSION NUMBER NM_001037165.1; forkhead box
   K2 (FOXK2), aka ILF-i, ILF, ILF1, ACCESSION NUMBER NM_004514.3; forkhead box K2
   (FOXK2), aka ILF-i, ILF, ILF1, ACCESSION NUMBER NM_004514.3; forkhead box LI
   (FOXLI), aka FREAC7, FKH6, FKHLi 1, ACCESSION NUMBER NM_005250.2; forkhead box L2
   (FOXL2), aka BPESI, PINTO, BPES, PFRK, POF3, ACCESSION NUMBER NM_023067.2;
30 forkhead box L2 (FOXL2), accession number XM_001131060.1; forkhead box MI (FOXMI),
   transcript variant 3, aka TGT3, PIG29, HFH-i1, FKHL16, MPP-2, INS-1, HFHI1, MPP2,
   TRIDENT, MPHOSPH2, HNF-3, FOXMIB, ACCESSION NUMBER NM_202003.1; forkhead box
   MI (FOXM1), transcript variant 2, aka TGT3, PIG29, HFH-11, FKHL16, MPP-2, INS-1, HFH11,
   MPP2, TRIDENT, MPHOSPH2, HNF-3, FOXMIB, ACCESSION NUMBER NM_021953.2;
35 forkhead box NI (FOXNI), aka FKHL20, WHN, RONU, ACCESSION NUMBER NM_003593.2;
   forkhead box N2 (FOXN2), aka HTLF, ACCESSION NUMBER NM_002158.3; forkhead box N3
   (FOXN3), transcript variant 1, aka CHESI, C14orfl 16, PRO1635, ACCESSION NUMBER
                                                   22

   NM_001085471.1; forkhead box N4 (FOXN4), aka FLJ35967, ACCESSION NUMBER
   NM_213596.1; forkhead box 01 (FOXO1), aka FKHR, FKH1, FOXO1A, ACCESSION NUMBER
   NM_002015.3; forkhead box 03 (FOXO3), transcript variant 2, aka FOXO2, FKHRL1, AF6q21,
   DKFZp781A0677, MGC12739, FKHRL1P2, MGC31925, FOXO3A, ACCESSION NUMBER
 5 NM_201559.2; forkhead box 03 (FOXO3), transcript variant 1, aka FOXO2, FKHRL1, AF6q21,
   DKFZp781A0677, MGC12739, FKHRL1P2, MGC31925, FOXO3A ACCESSION NUMBER
   NM_001455.3; forkhead box 04 (FOXO4), aka AFXI, AFX, FOXO4, MGC120490, MLLT7,
   ACCESSION NUMBER NM_005938.2; forkhead box P1 (FOXP1), transcript variant 2, aka
   MGC99551, QRF1, hFKHIB, MGC88572, 12CC4, HSPC215, MGC12942, FLJ23741,
10 ACCESSION NUMBER NM_001012505.1; forkhead box P1 (FOXP1), transcript variant 1, aka
   MGC99551, QRF1, hFKHIB, MGC88572, 12CC4, HSPC215, MGC12942, FLJ23741,
   ACCESSION NUMBER NM_032682.4; forkhead box P1 (FOXP1), transcript variant 1, aka
   MGC99551, QRF1, hFKHIB, MGC88572, 12CC4, HSPC215, MGC12942, FLJ23741,
   ACCESSION NUMBER NM_032682.4; forkhead box P2 (FOXP2), transcript variant 2, aka
15 TNRC1O, SPCH1, DKFZp686H1726, CAGH44, ACCESSION NUMBER NM_148898.2; forkhead
   box P2 (FOXP2), transcript variant 1, aka TNRC10, SPCH1, DKFZp686H1726, CAGH44,
   ACCESSION NUMBER NM_014491.1; forkhead box P3 (FOXP3), aka PIDX, AIID, MGC141961,
   JM2, DIETER, XPID, MGC141963, IPEX, ACCESSION NUMBER NM_014009.2; forkhead box
   P4 (FOXP4), transcript variant 1, aka FLJ44184, FLJ40908, hFKHLA, ACCESSION NUMBER
20 NM_001012426.1; forkhead box P4 (FOXP4), transcript variant 1, aka FLJ44184, FLJ40908,
   hFKHLA, ACCESSION NUMBER NM_001012426.1; forkhead box QI (FOXQ1), aka HFH1,
   ACCESSION NUMBER NM_033260.3; forkhead box RI (FOXR1), aka FOXN5, MGC149486,
   DLNB13, ACCESSION NUMBER NM_181721.2; forkhead box RI (FOXR1), aka FOXN5,
   MGC149486, DLNB 13, ACCESSION NUMBER NM_181721.2; forkhead box R2 (FOXR2), aka
25 MGC21658, FOXN6, ACCESSION NUMBER NM_198451.1; forkhead box Sl (FOXS1), aka
   MGC4544, FREAC10, ACCESSION NUMBER NM_004118.3; far upstream element (FUSE)
   binding protein 1 (FUBP1), aka FBP, FUBP, ACCESSION NUMBER NM_003902.3; GA binding
   protein transcription factor, alpha subunit 60kDa (GABPA), aka NRF2A, NFT2, E4TF1-60,
   E4TF1A, NRF2, ACCESSION NUMBER NM_002040.2; GA binding protein transcription factor,
30 beta subunit 2 (GABPB2), transcript variant gamma-1, aka NRF2B2, GABPB, E4TF1-47, E4TF1,
   NRF2B1, E4TF1B, E4TF1-53, BABPB2, GABPB1, ACCESSION NUMBER NM_002041.3; GA
   binding protein transcription factor, beta subunit 2 (GABPB2), transcript variant gamma-2, aka
   NRF2B2, GABPB, E4TFI-47, E4TFI, NRF2BI, E4TFIB, E4TFI-53, BABPB2, GABPB1,
   ACCESSION NUMBER NM_016655.3; GA binding protein transcription factor, beta subunit 2
35 (GABPB2), aka RPI1-68118.1, ACCESSION NUMBER NM_144618.1; growth arrest-specific 7
   (GAS7), transcript variant a, aka MGC1348, MLL/GAS7, KIAA0394, ACCESSION NUMBER
   NM_003644.2; growth arrest-specific 7 (GAS7), transcript variant b, aka MGC1348, MLL/GAS7,
                                                      23

   KIAA0394, ACCESSION NUMBER NM_201432.1; growth arrest-specific 7 (GAS7), transcript
   variant c, aka MGC1348, MLL/GAS7, KIAA0394, ACCESSION NUMBER NM_201433.1; growth
   arrest-specific 7 (GAS7), transcript variant c, aka MGC1348, MLL/GAS7, KIAA0394, ACCESSION
   NUMBER NM_201433.1; GATA binding protein 1 (globin transcription factor 1) (GATA1), aka
 5 ERYF1, GF1, NFE1, ACCESSION NUMBER NM_002049.2; GATA binding protein 2 (GATA2),
   aka NFElB, MGC2306, ACCESSION NUMBER NM_032638.3; GATA binding protein 3
   (GATA3), transcript variant 2, aka HDR, MGC5199, MGC5445, MGC2346, ACCESSION
   NUMBER NM_002051.2; GATA binding protein 4 (GATA4), aka MGC126629, ACCESSION
   NUMBER NM_002052.2; GATA binding protein 5 (GATA5), aka bB379024.1, ACCESSION
10 NUMBER NM_080473.3; GATA binding protein 6 (GATA6), ACCESSION NUMBER
   NM_005257.3; GATA zinc finger domain containing 1 (GATADI), aka FLJ40695, FLJ22489,
   ODAG, RG083M05.2, ACCESSION NUMBER NM_021167.3; GATA zinc finger domain
   containing 2A (GATAD2A), aka FLJ20085, p66alpha, ACCESSION NUMBER NM_017660.2;
   GATA zinc finger domain containing 2B (GATAD2B), aka MGC138285, P66beta, RP1 1-216N14.6,
15 KIAA1 150, FLJ37346, MGC138257, ACCESSION NUMBER NM_020699.1; gastrulation brain
   homeobox 2 (GBX2), ACCESSION NUMBER NM_001485.2; glial cells missing homolog 1
   (Drosophila) (GCM1), aka GCMA, hGCMa, ACCESSION NUMBER NM_003643.2; glioma
   associated oncogene homolog 1 (zinc finger protein) (GLIl), aka GLI, ACCESSION NUMBER
   NM_005269.1; GLI-Kruppel family member GLI2 (GLI2), aka HPE9, THP2, ACCESSION
20 NUMBER NM_005270.3; GLI-Kruppel family member GLI3 (Greig cephalopolysyndactyly
   syndrome) (GLI3), aka PHS, PAP-A, PAPAl, GCPS, PAPB, PAPA, ACLS, PPDIV, ACCESSION
   NUMBER NM_000168.2; GLIS family zinc finger 3 (GLIS3), transcript variant 2, aka ZNF515,
   FLJ38999, MGC33662, FLJ90578, ACCESSION NUMBER NM_152629.3; GLIS family zinc
   finger 3 (GLIS3), transcript variant 2, aka ZNF515, FLJ38999, MGC33662, FLJ90578,
25 ACCESSION NUMBER NM_152629.3; GLIS family zinc finger 3 (GLIS3), transcript variant 2, aka
   ZNF515, FLJ38999, MGC33662, FLJ90578, ACCESSION NUMBER NM_152629.3; GLIS family
   zinc finger 3 (GLIS3), transcript variant 2, aka ZNF515, FLJ38999, MGC33662, FLJ90578,
   ACCESSION NUMBER NM_152629.3; glucocorticoid modulatory element binding protein 1
   (GMEB 1), transcript variant 2, aka P96PIF, PIF96, ACCESSION NUMBER NM_024482.1;
30 glucocorticoid modulatory element binding protein 1 (GMEB 1), transcript variant 2, aka P96PIF,
   PIF96, ACCESSION NUMBER, NM_024482.1; goosecoid homeobox (GSC), ACCESSION
   NUMBER NM_173849.2; goosecoid homeobox 2 (GSC2), aka GSCL, ACCESSION NUMBER
   NM_005315.1; GS homeobox 1 (GSX1), aka Gsh-1, GSH1, ACCESSION NUMBER
   NM_145657.1; GS homeobox 2 (GSX2), aka GSH2, ACCESSION NUMBER NM_133267.1;
35 general transcription factor IIA, 2, 12kDa (GTF2A2), aka TIIA, TF2A2, HsTI18745, ACCESSION
   NUMBER NM_004492.1; general transcription factor IIH, polypeptide 2, 44kDa (GTF2H2), aka T
   BTF2P44, MGC102806, BTF2, TFIIH, BTF2P44, ACCESSION NUMBER NM_001515.3; general
                                                      24

   transcription factor IIH, polypeptide 3, 34kDa (GTF2H3), aka BTF2, TFIIH, ACCESSION
   NUMBER NM_001516.3; general transcription factor IIH, polypeptide 4, 52kDa (GTF2H4), aka
   TFIIH, ACCESSION NUMBER NM_001517.4; general transcription factor II, i (GTF2I), transcript
   variant 3, aka 1B291, DIWS, TFII-I, SPIN, BAP135, BAP-135, BTKAPI, WBSCR6, WBS,
 5 ACCESSION NUMBER NM_033001.1; general transcription factor II, i (GTF2I), transcript variant
   1, aka 1B291, DIWS, TFII-I, SPIN, BAP135, BAP-135, BTKAPI, WBSCR6, WBS, ACCESSION
   NUMBER NM_032999.1; heart and neural crest derivatives expressed 1 (HAND1), aka Thing1,
   eHand, Hxt, ACCESSION NUMBER NM_004821.1; heart and neural crest derivatives expressed 2
   (HAND2), aka MGC125304, Thing2, Hed, dHand, MGC125303, DHAND2, FLJ16260,
10 ACCESSION NUMBER NM_021973.2; host cell factor C1 (VP16-accessory protein) (HCFC1), aka
   HFCI, MGC70925, VCAF, HCF-1, CFF, HCF1, ACCESSION NUMBER NM_005334.2;
   hematopoietic cell-specific Lyn substrate 1 (HCLS1), aka HSI, CTTNL, ACCESSION NUMBER
   NM_005335.3; histone deacetylase 1 (HDACI), aka GON-10, DKFZp686H12203, HDI, RPD3,
   RPD3L1, ACCESSION NUMBER NM_004964.2; histone deacetylase 2 (HDAC2), aka YAF1,
15 RPD3, ACCESSION NUMBER NM_001527.2; highly divergent homeobox (HDX), aka
   DO30011NO1Rik, FLJ30678, MGC126771, CXorf43, MGC126769, ACCESSION NUMBER
   NM_144657.3; HES/HEY-like transcription factor (HELT), aka HCM1228, Mgn, HESL,
   ACCESSION NUMBER NM_001029887.1; hairy and enhancer of split 6 (Drosophila) (HES6),
   ACCESSION NUMBER NM_018645.3; HESX homeobox 1 (HESX1), aka RPX, ANF,
20 MGC138294, ACCESSION NUMBER NM_003865.1; hairy/enhancer-of-split related with YRPW
   motif 1 (HEYl), transcript variant 2, aka MGC1274, CHF2, HERP2, HRT-1, HESRI, OAF1,
   ACCESSION NUMBER NM_001040708.1; hairy/enhancer-of-split related with YRPW motif 1
   (HEYl), transcript variant 2, aka MGC1274, CHF2, HERP2, HRT-1, HESRI, OAF1, ACCESSION
   NUMBER NM_001040708.1; hairy/enhancer-of-split related with YRPW motif 2 (HEY2), aka
25 GRL, HERPI, ACCESSION NUMBER NM_012259.1; hairy/enhancer-of-split related with YRPW
   motif-like (HEYL), aka MGC12623, HRT3, ACCESSION NUMBER NM_014571.3;
   hematopoietically expressed homeobox (HHEX), aka HEX, PRH, PRHX, HOX1 IL-PEN, HMPH,
   ACCESSION NUMBER NM_002729.4; hypermethylated in cancer 1 (HICI), transcript variant 2,
   aka hic-1, ZBTB29, ACCESSION NUMBER NM_001098202.1; hypoxia-inducible factor 1, alpha
30 subunit (basic helix-loop-helix transcription factor) (HIF1A), transcript variant 2, aka HIF-lalpha,
   MOPI, PASD8, HIF1-ALPHA, HIF1, ACCESSION NUMBER NM_181054.1; hypoxia-inducible
   factor 1, alpha subunit (basic helix-loop-helix transcription factor) (HIF1A), transcript variant 1, aka
   HIF-lalpha, MOPI, PASD8, HIF1-ALPHA, HIF1, ACCESSION NUMBER NM_001530.2; hypoxia
   inducible factor 3, alpha subunit (HIF3A), transcript variant 2, aka MOP7, HIF-3A2, HIF-3A4,
35 PASD7, IPAS, HIF-3A, ACCESSION NUMBER NM_022462.3; hypoxia inducible factor 3, alpha
   subunit (HIF3A), transcript variant 2, aka MOP7, HIF-3A2, HIF-3A4, PASD7, IPAS, HIF-3A,
   ACCESSION NUMBER NM_022462.3; hypoxia inducible factor 3, alpha subunit (HIF3A),
                                                       25

   transcript variant 2, aka MOP7, HIF-3A2, HIF-3A4, PASD7, IPAS, HIF-3A, ACCESSION
   NUMBER NM_022462.3; hypoxia inducible factor 3, alpha subunit (HIF3A), transcript variant 1,
   aka IPAS, HIF-3A, MOP7, HIF-3A4, PASD7, ACCESSION NUMBER NM_152794.2; hypoxia
   inducible factor 3, alpha subunit (HIF3A), transcript variant 3, aka IPAS, HIF-3A, MOP7, HIF-3A2,
 5 HIF-3A4, PASD7, ACCESSION NUMBER NM_152795.2; huntingtin interacting protein 2 (HIP2),
   aka LIG, UBE2K, HYPG, ACCESSION NUMBER NM_005339.3; HIR histone cell cycle regulation
   defective homolog A (S. cerevisiae) (HIRA), aka TUPI, TUPLE1, DGCR1, ACCESSION
   NUMBER NM_003325.3; hepatic leukemia factor (HLF), aka MGC33822, ACCESSION NUMBER
   NM_002126.4; H2.0-like homeobox (HLX), aka HB24, HLX1, ACCESSION NUMBER
10 NM_021958.2; homeobox HB9 (HLXB9), aka HB9, SCRA1, HOXHB9, ACCESSION NUMBER
   NM_005515.2; homeobox containing 1 (HMBOX1), aka FLJ21616, HNF1LA, PBHNF,
   ACCESSION NUMBER NM_024567.2; high-mobility group 20A (HMG20A), aka HMGX1,
   FLJ10739, ACCESSION NUMBER NM_018200.2; high-mobility group 20B (HMG20B), aka
   SMARCEIr, FLJ26127, HMGX2, pp8857, PP7706, BRAF35, SOXL, BRAF25, ACCESSION
15 NUMBER NM_006339.1; high mobility group AT-hook 1 (HMGA1), transcript variant 1, aka
   MGC12816, MGC4854, HMG-R, MGC4242, HMGIY, ACCESSION NUMBER NM_145899.1;
   high mobility group AT-hook 1 (HMGA1), transcript variant 4, aka MGC12816, MGC4854, HMG
   R, MGC4242, HMGIY, ACCESSION NUMBER NM_145902.1; high mobility group AT-hook 1
   (HMGA1), transcript variant 6, aka MGC12816, MGC4854, HMG-R, MGC4242, HMGIY,
20 ACCESSION NUMBER NM_145904.1; high mobility group AT-hook 1 (HMGA1), transcript
   variant 7, aka MGC12816, MGC4854, HMG-R, MGC4242, HMGIY, ACCESSION NUMBER
   NM_145905.1; high-mobility group box 2 (HMGB2), aka HMG2, ACCESSION NUMBER
   NM_002129.2; homeobox (116 family) 1 (HMX1), aka H6, ACCESSION NUMBER NM_018942.1;
   H6 family homeobox 2 (HMX2), aka Nkx5-2, H6L, ACCESSION NUMBER NM_005519.1;
25 hepatocyte nuclear factor 4, alpha (HNF4A), transcript variant 3, aka TCF, NR2A21, HNF4, NR2A1,
   HNF4a9, HNF4a7, TCF14, FLJ39654, HNF4a8, MODY1, MODY, ACCESSION NUMBER
   NM_178850.1; hepatocyte nuclear factor 4, alpha (HNF4A), transcript variant 6, aka TCF, NR2A21,
   HNF4, NR2A1, HNF4a9, HNF4a7, TCF14, FLJ39654, HNF4a8, MODY1, MODY, ACCESSION
   NUMBER NM_001030004.1; hepatocyte nuclear factor 4, gamma (HNF4G), aka NR2A2,
30 ACCESSION NUMBER NM_004133.3; homeobox and leucine zipper encoding (HOMEZ), aka
   HOMEZ, KIAA1443, ACCESSION NUMBER NM_020834.1; HOP homeobox (HOPX), transcript
   variant 1, aka HOP, MGC20820, LAGY, Cameo, SMAP31, OBI, Toto, NECCI, ACCESSION
   NUMBER NM_032495.4; HOP homeobox (HOPX), transcript variant 3, aka HOP, MGC20820,
   LAGY, Cameo, SMAP31, OB1, Toto, NECC1, ACCESSION NUMBER NM_139212.2; HOP
35 homeobox (HOPX), transcript variant 2, aka HOP, MGC20820, LAGY, Cameo, SMAP31, OB1,
   Toto, NECCI, ACCESSION NUMBER NM_139211.2; homeobox Al (HOXA1), transcript variant
   2, aka BSAS, HOXI, HOXIF, MGC45232, ACCESSION NUMBER NM_153620.2; homeobox Al
                                                     26

   (HOXA1), transcript variant 1, aka BSAS, HOXI, HOXIF, MGC45232, ACCESSION NUMBER
   NM_005522.4; homeobox A1O (HOXA1O), transcript variant 2, aka MGC12859, PL, HOXIH,
   HOXI, HOX1.8, ACCESSION NUMBER NM_153715.2; homeobox A1O (HOXA1O), transcript
   variant 1, aka MGC12859, PL, HOXIH, HOXI, HOX1.8, ACCESSION NUMBER NM_018951.3;
 5 homeobox A1O (HOXA1O), transcript variant 1, aka MGC12859, PL, HOXIH, HOXI, HOX1.8,
   ACCESSION NUMBER NM_018951.3; homeobox All (HOXA1 1), aka HOXII, HOXI,
   ACCESSION NUMBER NM_005523.5; homeobox A13 (HOXA13), aka HOXI, HOX1J,
   ACCESSION NUMBER NM_000522.3; homeobox A2 (HOXA2), aka HOXIK, ACCESSION
   NUMBER NM_006735.3; homeobox A3 (HOXA3), transcript variant 1, aka MGC10155, HOXIE,
10 HOXI, ACCESSION NUMBER NM_030661.4; homeobox A3 (HOXA3), transcript variant 2, aka
   MGC10155, HOXIE, HOXI, ACCESSION NUMBER NM_153631.2; homeobox A3 (HOXA3),
   transcript variant 3, aka MGC10155, HOXIE, HOXI, ACCESSION NUMBER NM_153632.2;
   homeobox A3 (HOXA3), transcript variant 3, aka MGC10155, HOXIE, HOXI, ACCESSION
   NUMBER NM_153632.2; homeobox A4 (HOXA4), aka HOXID, HOXI, ACCESSION NUMBER
15 NM_002141.4; homeobox A5 (HOXA5), aka MGC9376, HOXIC, HOX1.3, HOXI, ACCESSION
   NUMBER NM_019102.2; homeobox A6 (HOXA6), aka HOXIB, HOX1.2, HOXI, ACCESSION
   NUMBER NM_024014.2; homeobox A7 (HOXA7), aka ANTP, HOX 1.1, HOXIA, HOX1,
   ACCESSION NUMBER NM_006896.3; homeobox A9 (HOXA9), aka MGC1934, HOX1.7,
   HOXIG, HOXI, ABD-B, ACCESSION NUMBER NM_152739.3; homeobox A9 (HOXA9), aka
20 MGC1934, HOX1.7, HOXIG, HOXI, ABD-B, ACCESSION NUMBER NM_152739.3; homeobox
   BI (HOXB1), aka HOX2, HOX2I, MGC116843, Hox-2.9, MGC116844, MGC116845,
   ACCESSION NUMBER NM_002144.3; homeobox B13 (HOXB13), aka PSGD, ACCESSION
   NUMBER NM_006361.5; homeobox B2 (HOXB2), aka HOX2H, K8, Hox-2.8, HOX2,
   ACCESSION NUMBER NM_002145.3; homeobox B3 (HOXB3), aka HOX2, HOX2G, Hox-2.7,
25 ACCESSION NUMBER NM_002146.4; homeo box B4 (HOXB4), aka HOX2, HOX-2.6, HOX2F,
   ACCESSION NUMBER NM_024015.3; homeobox B5 (HOXB5), aka HU-1, HOX2, HHO.C1O,
   HOX2A, Hox2.1, ACCESSION NUMBER NM_002147.3; homeobox B6 (HOXB6), aka Hox-2.2,
   HOX2B, HOX2, HU-2, ACCESSION NUMBER NM_018952.4; homeobox B6 (HOXB6), aka Hox
   2.2, HOX2B, HOX2, HU-2, ACCESSION NUMBER NM_018952.4; homeobox B7 (HOXB7), aka
30 HOX2C, HOX2, HHO.C1, Hox-2.3, ACCESSION NUMBER NM_004502.3; homeobox B8
   (HOXB8), aka Hox-2.4, HOX2, HOX2D, ACCESSION NUMBER NM_024016.3; homeo box B9
   (HOXB9), aka HOX2, HOX-2.5, HOX2E, ACCESSION NUMBER NM_024017.3; homeobox C1O
   (HOXC1O), aka MGC5259, HOX3I, ACCESSION NUMBER NM_017409.3; homeobox ClI
   (HOXC 11), aka MGC4906, HOX3H, ACCESSION NUMBER NM_014212.3; homeobox C12
35 (HOXC12), aka HOC3F, HOX3F, HOX3, ACCESSION NUMBER NM_173860.1; homeobox C13
   (HOXC13), aka HOX3, HOX3G, ACCESSION NUMBER NM_017410.2; homeobox C4 (HOXC4),
   transcript variant 1, aka cp19, HOX3E, HOX3, ACCESSION NUMBER NM_014620.4; homeobox
                                                 27

   C4 (HOXC4), transcript variant 1, aka cp19, HOX3E, HOX3, ACCESSION NUMBER
   NM_014620.4; homeobox C5 (HOXC5), transcript variant 1, aka HOX3D, CP 11, HOX3,
   ACCESSION NUMBER NM_018953.2; homeobox C6 (HOXC6), transcript variant 1, aka HOX3C,
   HOX3, CP25, HHO.C8, ACCESSION NUMBER NM_004503.3; homeobox C6 (HOXC6),
 5 transcript variant 1, aka HOX3C, HOX3, CP25, HHO.C8, ACCESSION NUMBER NM_004503.3;
   homeobox C6 (HOXC6), transcript variant 2, aka HOX3C, HOX3, CP25, HHO.C8, ACCESSION
   NUMBER NM_153693.3; homeobox C8 (HOXC8), aka HOX3, HOX3A, ACCESSION NUMBER
   NM_022658.3; homeobox C9 (HOXC9), aka HOX3, HOX3B, ACCESSION NUMBER
   NM_006897.1; homeobox D1 (HOXD1), aka HOX4G, HOX4, Hox-4.7, ACCESSION NUMBER
10 NM_024501.1; homeobox D1O (HOXD1O), aka Hox-4.4, HOX4, HOX4E, HOX4D, ACCESSION
   NUMBER NM_002148.3; homeobox D1I (HOXD 11), aka HOX4F, HOX4, ACCESSION
   NUMBER NM_021192.2; homeobox D12 (HOXD12), aka HOX4H, ACCESSION NUMBER
   NM_021193.2; homeobox D13 (HOXD13), aka SPD, BDE, HOX4I, BDSD, ACCESSION
   NUMBER NM_000523.3; homeobox D3 (HOXD3), aka HOX4, MGC10470, Hox-4.1, HOXID,
15 HOX4A, ACCESSION NUMBER NM_006898.4; homeobox D4 (HOXD4), aka HOX4B,
   HHO.C13, HOX4, HOX-5.1, Hox-4.2, ACCESSION NUMBER NM_014621.2; homeobox D8
   (HOXD8), aka HOX4, HOX4E, HOX5.4, ACCESSION NUMBER NM_019558.2; homeobox D9
   (HOXD9), aka Hox-5.2, HOX4C, HOX4, Hox-4.3, ACCESSION NUMBER NM_014213.2; hairless
   homolog (mouse) (HR), transcript variant 1, aka AU, HSA277165, ALUNC, ACCESSION
20 NUMBER NM_005144.3; hairless homolog (mouse) (HR), transcript variant 2, aka AU,
   HSA277165, ALUNC, ACCESSION NUMBER NM_018411.3; heat shock transcription factor 1
   (HSF1), aka HSTF1, ACCESSION NUMBER NM_005526.2; heat shock transcription factor 2
   (HSF2), aka MGC 117376, MGC75048, MGC156196 ACCESSION NUMBER NM_004506.2; heat
   shock transcription factor 4 (HSF4), transcript variant 1, aka CTM, ACCESSION NUMBER
25 NM_001538.2; heat shock transcription factor 4 (HSF4), transcript variant 2, aka CTM,
   ACCESSION NUMBER NM_001040667.1; heat shock transcription factor family member 5
   (HSF5), aka FLJ40311, MGC134827, ACCESSION NUMBER NM_001080439.1; heat shock
   transcription factor family, X linked 1 (HSFXI), aka LW-i, ACCESSION NUMBER NM_016153.1;
   heat shock transcription factor, Y-linked 1 (HSFYl), transcript variant 3, aka HSF2L, HSFY,
30 accession number NR_003510.1; heat shock transcription factor, Y-linked 1 (HSFYl), transcript
   variant 2, aka HSF2L, HSFY, ACCESSION NUMBER NM_152584.1; heat shock transcription
   factor, Y linked 2 (HSFY2), transcript variant 1, aka HSF2L, HSFY, FLJ25453, ACCESSION
   NUMBER NM_153716.1; heat shock transcription factor, Y linked 2 (HSFY2), transcript variant 1,
   aka HSF2L, HSFY, FLJ25453, ACCESSION NUMBER NM_153716.1; IKAROS family zinc finger
35 1 (Ikaros) (IKZF1), aka Hs.54452, IKI, PR00758, hlk-1, IKAROS, LYF1, ZNFN1A1,
   ACCESSION NUMBER NM_006060.3; IKAROS family zinc finger 3 (Aiolos) (IKZF3), transcript
   variant 2, aka AIOLOS, ZNFN1A3, ACCESSION NUMBER NM_183228.1; IKAROS family zinc
                                                      28

   finger 3 (Aiolos) (IKZF3), transcript variant 1, aka AIOLOS, ZNFN1A3, ACCESSION NUMBER
   NM_012481.3; IKAROS family zinc finger 4 (Eos) (IKZF4), aka ZNFN1A4, KIAA1782, EOS,
   ACCESSION NUMBER NM_022465.3; insulin promoter factor 1, homeodomain transcription
   factor (IPF1), aka IDX-1, IUF1, STF-i, MODY4, PDX-1, PDX1, ACCESSION NUMBER
 5 NM_000209.1; interferon regulatory factor 1 (IRF1), aka IRF-i, MAR, ACCESSION NUMBER
   NM_002198.1; interferon regulatory factor 2 (IRF2), aka IRF-2, DKFZp686F0244, ACCESSION
   NUMBER NM_002199.2; interferon regulatory factor 3 (IRF3), ACCESSION NUMBER
   NM_001571.2; interferon regulatory factor 4 (IRF4), aka MUMi, LSIRF, ACCESSION NUMBER
   NM_002460.1; interferon regulatory factor 5 (IRF5), transcript variant 1, ACCESSION NUMBER
10 NM_002200.3; interferon regulatory factor 6 (IRF6), aka VWS, LPS, PIT, OFC6, PPS,
   ACCESSION NUMBER NM_006147.2; interferon regulatory factor 7 (IRF7), transcript variant b,
   aka IRF7A, IRF-7H, ACCESSION NUMBER NM_004029.2; interferon regulatory factor 7 (IRF7),
   transcript variant b, aka IRF7A, IRF-7H, ACCESSION NUMBER NM_004029.2; interferon
   regulatory factor 7 (IRF7), transcript variant d, aka IRF7A, IRF-7H, ACCESSION NUMBER
15 NM_004031.2; interferon regulatory factor 8 (IRF8), aka H-ICSBP, ICSBP, IRF-8, ICSBP1,
   ACCESSION NUMBER NM_002163.2; interferon regulatory factor 9 (IRF9), aka IRF9, p48,
   ISGF3, IRF-9, ACCESSION NUMBER NM_006084.4; iroquois homeobox 1 (IRX1), aka IRX-5,
   ACCESSION NUMBER NM_024337.3; iroquois homeobox 2 (IRX2), ACCESSION NUMBER
   NM_033267.3; iroquois homeobox 3 (IRX3), aka IRX-1, ACCESSION NUMBER NM_024336.1;
20 iroquois homeobox 4 (IRX4), aka MGC131996, ACCESSION NUMBER NM_016358.1; iroquois
   homeobox protein 5 (IRX5), aka IRX-2a, ACCESSION NUMBER NM_005853.4; iroquois
   homeobox 6 (IRX6), aka IRX-3, IRX7, ACCESSION NUMBER NM_024335.2; ISL LIM
   homeobox 2 (ISL2), aka FLJ10160, ACCESSION NUMBER NM_145805.1; intestine-specific
   homeobox (ISX), aka MGC138417, DKFZp781N2395, Pix-1, RAXLX, ACCESSION NUMBER
25 NM_001008494.1; jumonji, AT rich interactive domain 1A (JARID1A), transcript variant 2, aka
   KDM5A, RBP2, RBBP2, ACCESSION NUMBER NM_005056.2; Jun dimerization protein 2
   (JDP2), aka JUNDM2, ACCESSION NUMBER NM_130469.2; jun oncogene (JUN), aka API, c
   Jun, ACCESSION NUMBER NM_002228.3; jun B proto-oncogene (JUNB), ACCESSION
   NUMBER NM_002229.2; jun D proto-oncogene (JUND), ACCESSION NUMBER NM_005354.3;
30 potassium voltage-gated channel, subfamily H (eag-related), member 8 (KCNH8), aka elk3, ELKi,
   Kv12.1, ELK, ACCESSION NUMBER NM_144633.2; Kruppel-like factor 1 (erythroid) (KLF1),
   aka EKLF,ACCESSION NUMBER NM_006563.2; Kruppel-like factor 10 (KLF1O), transcript
   variant 1, aka TIEG, EGRA, TIEGI, ACCESSION NUMBER NM_005655.1; Kruppel-like factor 10
   (KLFIO), transcript variant 1, aka TIEG, EGRA, TIEGI, ACCESSION NUMBER NM_005655.1;
35 Kruppel-like factor 10 (KLFIO), transcript variant 2, aka TIEG, EGRA, TIEGI, ACCESSION
   NUMBER NM_001032282.1; Kruppel-like factor II (KLFi1), accession number XM_001129527.1;
   Kruppel-like factor II (KLFi 1), accession number XM_001129527.1; Kruppel-like factor 12
                                                       29

   (KLF12), aka AP-2rep, AP2REP, HSPC122, ACCESSION NUMBER NM_007249.4; Kruppel-like
   factor 12 (KLF12), aka AP-2rep, AP2REP, HSPC122, ACCESSION NUMBER NM_007249.4;
   Kruppel-like factor 15 (KLF15), aka KKLF, ACCESSION NUMBER NM_014079.2; Kruppel-like
   factor 16 (KLF16), aka BTEB4, DRRF, NSLP2, ACCESSION NUMBER NM_031918.1; Kruppel
 5 like factor 17 (KLF17), aka ZNF393, Zfp393, RP4-675G8.1, FLJ40160, ACCESSION NUMBER
   NM_173484.3; Kruppel-like factor 2 (lung) (KLF2), aka LKLF, ACCESSION NUMBER
   NM_016270.2; Kruppel-like factor 3 (basic) (KLF3), aka BKLF, MGC48279, ACCESSION
   NUMBER NM_016531.3; Kruppel-like factor 4 (gut) (KLF4), aka GKLF, EZF, ACCESSION
   NUMBER NM_004235.3; Kruppel-like factor 5 (intestinal) (KLF5), aka BTEB2, CKLF, IKLF,
10 ACCESSION NUMBER NM_001730.3; Kruppel-like factor 6 (KLF6), transcript variant 2, aka
   GBF, ZF9, ST12, CPBP, BCD1, PACI, DKFZp686NO199, COPEB, ACCESSION NUMBER
   NM_001300.4; Kruppel-like factor 6 (KLF6), transcript variant 1, aka GBF, ST12, ZF9, CPBP,
   BCD1, DKFZp686NO199, PACI, COPEB, ACCESSION NUMBER NM_001008490.1; Kruppel
   like factor 7 (ubiquitous) (KLF7), aka UKLF, ACCESSION NUMBER NM_003709.2; Kruppel-like
15 factor 9 (KLF9), aka BTEB, BTEBI, ACCESSION NUMBER NM_001206.2; kinetochore
   associated 1 (KNTC1), aka FLJ36151, KIAA0166, ROD, ACCESSION NUMBER NM_014708.3;
   keratin associated protein 5-1 (KRTAP5-1), aka KRN1L, KRTAP5.1, ACCESSION NUMBER
   NM_001005922.1; 1(3)mbt-like (Drosophila) (L3MBTL), transcript variant I, aka L3MBTL1,
   dJ138B7.3, FLJ41181, DKFZp586P1522, KIAA0681, H-L(3)MBT, ACCESSION NUMBER
20 NM_015478.5; 1(3)mbt-like (Drosophila) (L3MBTL), transcript variant II, aka L3MBTL1,
   dJ138B7.3, DKFZp586P1522, KIAA0681, H-L(3)MBT, ACCESSION NUMBER NM_032107.2;
   1(3)mbt-like (Drosophila) (L3MBTL), transcript variant II, aka L3MBTL1, dJ138B7.3, FLJ41181,
   DKFZp586P1522, KIAA0681, H-L(3)MBT, ACCESSION NUMBER NM_032107.3; l(3)mbt-like
   (Drosophila) (L3MBTL), transcript variant II, aka L3MBTL1, dJ138B7.3, FLJ41181,
25 DKFZp586P1522, KIAA0681, H-L(3)MBT, ACCESSION NUMBER NM_032107.3; l(3)mbt-like 4
   (Drosophila) (L3MBTL4), aka HsT1031, ACCESSION NUMBER NM_173464.2; LAGI homolog,
   ceramide synthase 2 (LASS2), transcript variant 1, aka SP260, CerS2, MGC987, TMSG1, L3,
   FLJ10243, ACCESSION NUMBER NM_181746.2; LAGI homolog, ceramide synthase 2 (LASS2),
   transcript variant 2, aka SP260, CerS2, MGC987, TMSG1, L3, FLJ10243, ACCESSION NUMBER
30 NM_022075.3; LAGI homolog, ceramide synthase 3 (LASS3), aka MGC27091, CerS3,
   ACCESSION NUMBER NM_178842.3; LAGI homolog, ceramide synthase 4 (LASS4), aka
   FLJ12089, Trhl, CerS4, ACCESSION NUMBER NM_024552.1; LAGI homolog, ceramide
   synthase 5 (S. cerevisiae) (LASS5), aka Trh4, MGC4541 1, FLJ25304, ACCESSION NUMBER
   NM_147190.1; LAGI homolog, ceramide synthase 6 (LASS6), aka CerS6, MGC129950,
35 MGC129949, ACCESSION NUMBER NM_203463.1; ladybird homeobox 1 (LBX1), aka LBX1H,
   HPX6, HPX-6, ACCESSION NUMBER NM_006562.4; ladybird homeobox 2 (LBX2), aka LP3727,
   ACCESSION NUMBER NM_001009812.1; ligand dependent nuclear receptor corepressor (LCOR),
                                                    30

   aka FLJ38026, MLR2, KIAA1795, RP11-175019.1, ACCESSION NUMBER NM_032440.1;
   lymphoid enhancer-binding factor 1 (LEF1), aka TCFlALPHA, DKFZp586HO919, ACCESSION
   NUMBER NM_016269.2; LIM homeobox 1 (LHX1), aka LIM-1, LIMI, MGC138141,
   MGC126723, ACCESSION NUMBER NM_005568.2; LIM homeobox 2 (LHX2), aka LH2, hLhx2,
 5 MGC138390, ACCESSION NUMBER NM_004789.3; LIM homeobox 3 (LHX3), transcript variant
   1, aka M2-LHX3, DKFZp762A2013, ACCESSION NUMBER NM_178138.2; LIM homeobox 3
   (LHX3), transcript variant 2, aka M2-LHX3, DKFZp762A2013, ACCESSION NUMBER
   NM_014564.2; LIM homeobox 3 (LHX3), transcript variant 2, aka M2-LHX3, DKFZp762A2013,
   ACCESSION NUMBER NM_014564.2; LIM homeobox 3 (LHX3), transcript variant 2, aka M2
10 LHX3, DKFZp762A2013, ACCESSION NUMBER NM_014564.2; LIM homeobox 3 (LHX3),
   transcript variant 1, aka M2-LHX3, DKFZp762A2013, ACCESSION NUMBER NM_178138.3;
   LIM homeobox 4 (LHX4), aka Gsh4, Gsh-4, ACCESSION NUMBER NM_033343.2; LIM
   homeobox 5 (LHX5), aka MGC129689, ACCESSION NUMBER NM_022363.2; LIM homeobox 6
   (LHX6), transcript variant 1, aka MGC1 19545, MGC1 19542, MGC119544, LHX6.1, ACCESSION
15 NUMBER NM_014368.3; LIM homeobox 6 (LHX6), transcript variant 2, aka MGC1 19545,
   MGC1 19542, MGC1 19544, LHX6.1, ACCESSION NUMBER NM_199160.2; LIM homeobox 8
   (LHX8), aka Lhx7, ACCESSION NUMBER NM_001001933.1; LIM homeobox 9 (LHX9),
   transcript variant 1, ACCESSION NUMBER NM_020204.2; LIM homeobox 9 (LHX9), transcript
   variant 2, ACCESSION NUMBER NM_001014434.1; LIM domain only 1 (rhombotin 1) (LMO1),
20 aka RBTN1, MGC116692, TTG1, RHOM1, ACCESSION NUMBER NM_002315.1; LIM domain
   only 4 (LMO4), ACCESSION NUMBER NM_006769.2; LIM homeobox transcription factor 1,
   alpha (LMX1A), transcript variant 2, aka MGC87616, LMX-1, LMX1.1, LMX1, ACCESSION
   NUMBER NM_177399.2; LIM homeobox transcription factor 1, alpha (LMX1A), transcript variant
   3, aka MGC87616, LMX-1, LMX1.1, LMX1, ACCESSION NUMBER NM_001033507.1; LIM
25 homeobox transcription factor 1, alpha (LMX1A), transcript variant 1, aka MGC87616, LMX-1,
   LMX1.1, LMX1, ACCESSION NUMBER NM_177398.2; LIM homeobox transcription factor 1,
   alpha (LMX1A), transcript variant 1, aka MGC87616, LMX-1, LMX1.1, LMX1, ACCESSION
   NUMBER NM_177398.2; LIM homeobox transcription factor 1, beta (LMX1B), aka LMX1.2,
   MGC142051, NPS1, MGC138325, ACCESSION NUMBER NM_002316.1; leucine-zipper-like
30 transcription regulator 1 (LZTR1), aka MGC21205, TCFL2, LZTR-1, ACCESSION NUMBER
   NM_006767.3; leucine zipper, putative tumor suppressor 1 (LZTS 1), aka FEZ1, F37, ACCESSION
   NUMBER NM_021020.1; v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian)
   (MAF), transcript variant 2, aka MGC71685, ACCESSION NUMBER NM_001031804.1; v-maf
   musculoaponeurotic fibrosarcoma oncogene homolog (avian) (MAF), transcript variant 1, aka
35 MGC71685, ACCESSION NUMBER NM_005360.3; v-maf musculoaponeurotic fibrosarcoma
   oncogene homolog A (avian) (MAFA), aka RIPE3b 1, hMafA, ACCESSION NUMBER
   NM_201589.2; v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) (MAFB), aka
                                                  31

   KRML, MGC43127, ACCESSION NUMBER NM_005461.3; v-maf musculoaponeurotic
   fibrosarcoma oncogene homolog F (avian) (MAFF), transcript variant 1, aka U-MAF, ACCESSION
   NUMBER NM_012323.2; v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)
   (MAFF), transcript variant 1, aka U-MAF, ACCESSION NUMBER NM_012323.2; v-maf
 5 musculoaponeurotic fibrosarcoma oncogene homolog F (avian) (MAFF), transcript variant 2, aka U
   MAF, ACCESSION NUMBER NM_152878.1; v-maf musculoaponeurotic fibrosarcoma oncogene
   homolog G (avian) (MAFG), transcript variant 1, aka MGC20149, MGC13090, ACCESSION
   NUMBER NM_002359.2; v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian)
   (MAFG), transcript variant 2, aka MGC20149, MGC13090, ACCESSION NUMBER
10 NM_032711.2; v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) (MAFK), aka
   FLJ32205, MGC71717, NFE2U, P18, ACCESSION NUMBER NM_002360.3; mastermind-like 3
   (Drosophila) (MAML3), aka GDN, MAM-2, MAM2, TNRC3, ERDA3, CAGH3, ACCESSION
   NUMBER NM_018717.3; MYC associated factor X (MAX), transcript variant 2, aka MGC34679,
   MGC36767, MGC1 1225, MGC10775, orfl, MGC18164, ACCESSION NUMBER NM_145112.1;
15 MYC associated factor X (MAX), transcript variant 3, aka MGC34679, MGC36767, MGC 11225,
   MGC10775, orfl, MGC18164, ACCESSION NUMBER NM_145113.1; MYC associated factor X
   (MAX), transcript variant 4, aka MGC34679, MGC36767, MGC1 1225, MGC10775, orfl,
   MGC18164, ACCESSION NUMBER NM_145114.1; MYC associated factor X (MAX), transcript
   variant 5, aka MGC34679, MGC36767, MGC11225, MGC10775, orfl, MGC18164, ACCESSION
20 NUMBER NM_145116.1; MYC associated factor X (MAX), transcript variant 1, aka MGC34679,
   MGC36767, MGC1 1225, MGC10775, orfl, MGC18164, ACCESSION NUMBER NM_002382.3;
   methyl-CpG binding domain protein 1 (MBD1), transcript variant 3, aka PCM1, RFT, CXXC3,
   ACCESSION NUMBER NM_015844.1; methyl-CpG binding domain protein 1 (MBD1), transcript
   variant 2, aka PCM1, RFT, CXXC3, ACCESSION NUMBER NM_015845.2; myelodysplasia
25 syndrome 1 (MDS1), aka PRDM3, MDS1-EVI1, ACCESSION NUMBER NM_004991.1; myocyte
   enhancer factor 2A (MEF2A), aka ADCAD1, RSRFC9, RSRFC4, ACCESSION NUMBER
   NM_005587.1; myocyte enhancer factor 2B (MEF2B), aka FLJ46391, RSRFR2, FLJ32599,
   ACCESSION NUMBER NM_005919.1; myocyte enhancer factor 2C (MEF2C), ACCESSION
   NUMBER NM_002397.2; myocyte enhancer factor 2D (MEF2D), aka DKFZp686I1536,
30 ACCESSION NUMBER NM_005920.2; Meis homeobox 2 (MEIS2), transcript variant a, aka
   MGC2820, MRG1, HsT18361, ACCESSION NUMBER NM_170677.2; Meis homeobox 2
   (MEIS2), transcript variant h, aka MGC2820, MRG1, HsT18361, ACCESSION NUMBER
   NM_172316.1; Meis homeobox 2 (MEIS2), transcript variant g, aka MGC2820, MRG1, HsT18361,
   ACCESSION NUMBER NM_172315.1; Meis homeobox 2 (MEIS2), transcript variant f, aka
35 MGC2820, MRG1, HsT18361, ACCESSION NUMBER NM_002399.2; Meis homeobox 3
   (MEIS3), transcript variant 2, aka DKFZp547H236, MRG2, ACCESSION NUMBER
   NM_001009813.1; Meis homeobox 3 pseudogene 1 (MEIS3P1), MEIS3, MRG2, MEIS4, accession
                                                  32

   number NR_002211.1; mesenchyme homeobox 1 (MEOX1), transcript variant 3, aka MOX1,
   ACCESSION NUMBER NM_001040002.1; mesenchyme homeobox 1 (MEOX1), transcript variant
   3, aka MOX1, ACCESSION NUMBER NM_001040002.1; mesenchyme homeobox 1 (MEOX1),
   transcript variant 3, aka MOXI, ACCESSION NUMBER NM_001040002.1; mesenchyme
 5 homeobox 2 (MEOX2), aka MOX2, GAX, ACCESSION NUMBER NM_005924.4; mesoderm
   posterior 1 homolog (mouse) (MESPI), aka MGC10676, ACCESSION NUMBER NM_018670.2;
   MAX gene associated (MGA), aka MAD5, MXD5, FLJ12634, KIAA0518, ACCESSION NUMBER
   NM_001080541.1; microphthalmia-associated transcription factor (MITF), transcript variant 3, aka
   WS2A, ACCESSION NUMBER NM_006722.1; microphthalmia-associated transcription factor
10 (MITF), transcript variant 1, aka WS2A, ACCESSION NUMBER NM_198159.1; microphthalmia
   associated transcription factor (MITF), transcript variant 5, aka WS2A, ACCESSION NUMBER
   NM_198158.1; MixI homeobox-like 1 (Xenopus laevis) (MIXL1), aka MIXL, MIX, MGC138179,
   MILD1, ACCESSION NUMBER NM_031944.1; mohawk homeobox (MKX), aka MGC39616,
   IFRX, IRXL1, ClOorf48, ACCESSION NUMBER NM_173576.1; myeloid/lymphoid or mixed
15 lineage leukemia (trithorax homolog, Drosophila) (MLL), aka TRX1, HRX, KMT2A, MLL/GAS7,
   ALL-1, CXXC7, MLL1A, HTRX1, FLJ1 1783, ACCESSION NUMBER NM_005933.2;
   myeloid/lymphoid or mixed-lineage leukemia 4 (MLL4), aka MLL2, HRX2, KIAA0304, WBP7,
   TRX2, ACCESSION NUMBER NM_014727.1; myeloid/lymphoid or mixed-lineage leukemia
   (trithorax homolog, Drosophila), translocated to, 10 (MLLT10), transcript variant 1, aka AF1O,
20 DKFZp686E10210, MGC75086, ACCESSION NUMBER NM_004641.2; myeloid/lymphoid or
   mixed-lineage leukemia (trithorax homolog, Drosophila), translocated to, 10 (MLLT10), transcript
   variant 1, aka AF1O, DKFZp686EI0210, MGC75086, ACCESSION NUMBER NM_004641.2;
   MAX-like protein X (MLX), transcript variant 1, aka MXD7, MAD7, TCFL4, ACCESSION
   NUMBER NM_198205.1; MAX-like protein X (MLX), transcript variant 2, aka TCFL4, MXD7,
25 MAD7, ACCESSION NUMBER NM_198204.1; MAX binding protein (MNT), aka MXD6, ROX,
   MAD6, ACCESSION NUMBER NM_020310.2; mortality factor 4 (MORF4), aka CSR, SENI,
   SEN, CSRB, ACCESSION NUMBER NM_006792.2; musculin (activated B-cell factor-1) (MSC),
   aka ABF-i, ABF1, MYOR, ACCESSION NUMBER NM_005098.3; male-specific lethal 3-like 1
   (Drosophila) (MSL3LI), transcript variant 4, aka DKFZP586J1822, ACCESSION NUMBER
30 NM_078628.1; male-specific lethal 3-like 1 (Drosophila) (MSL3LI), transcript variant 3, aka
   DKFZP586J1822, ACCESSION NUMBER NM_006800.2; male-specific lethal 3-like 1
   (Drosophila) (MSL3LI), transcript variant 1, aka DKFZP586J1822, ACCESSION NUMBER
   NM_078629.1; male-specific lethal 3-like 1 (Drosophila) (MSL3LI), transcript variant 2, aka
   DKFZP586J1822, ACCESSION NUMBER NM_078630.1; methionine sulfoxide reductase B2
35 (MSRB2), aka PILB, CBS-i, MSRB, CGI-131, CBSI, MGC26104, ACCESSION NUMBER
   NM_012228.2; msh homeobox 1 (MSX1), aka HOX7, HYDI, ACCESSION NUMBER
   NM_002448.3; msh homeobox 2 (MSX2), aka FPP, PFMI, CRS2, MSH, PFM, HOX8,
                                                      33

   ACCESSION NUMBER NM_002449.4; metastasis associated 1 (MTA1), ACCESSION NUMBER
   NM_004689.3; metastasis associated 1 family, member 2 (MTA2), aka MTA1LI, PID,
   DKFZp686F2281, ACCESSION NUMBER NM_004739.2; metastasis associated 1 family, member
   3 (MTA3), aka KIAA1266, ACCESSION NUMBER NM_020744.2; metal-regulatory transcription
 5 factor 1 (MTFI), aka MTF-1, MGC23036, ZRF, ACCESSION NUMBER NM_005955.2; MAX
   dimerization protein 1 (MXD1), aka MGC104659, MAD, MADI, ACCESSION NUMBER
   NM_002357.2; v-myb myeloblastosis viral oncogene homolog (avian)-like 2 (MYBL2), aka B
   MYB, MGC15600, BMYB, ACCESSION NUMBER NM_002466.2; v-myc myelocytomatosis viral
   oncogene homolog (avian) (MYC), aka c-Myc, ACCESSION NUMBER NM_002467.3; v-myc
10 myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian) (MYCL1), transcript
   variant 3, aka MYCL, LMYC, ACCESSION NUMBER NM_005376.3; v-myc myelocytomatosis
   viral oncogene homolog 1, lung carcinoma derived (avian) (MYCL1), transcript variant 1, aka
   MYCL, LMYC, ACCESSION NUMBER NM_001033081.1; v-myc myelocytomatosis viral
   oncogene homolog 1, lung carcinoma derived (avian) (MYCL1), transcript variant 2, aka MYCL,
15 LMYC, ACCESSION NUMBER NM_001033082.1; v-myc myelocytomatosis viral related
   oncogene, neuroblastoma derived (avian) (MYCN), aka ODED, NMYC, MODED, N-myc,
   ACCESSION NUMBER NM_005378.4; myogenic factor 5 (MYF5), ACCESSION NUMBER
   NM_005593.1; myogenic factor 6 (herculin) (MYF6), aka HERCULIN, MRF4, ACCESSION
   NUMBER NM_002469.1; myoneurin (MYNN), aka ZBTB3 1, SBBIZ1, OSZF, ACCESSION
20 NUMBER NM_018657.3; myogenic differentiation 1 (MYOD1), aka MYOD, PUM, MYF3,
   ACCESSION NUMBER NM_002478.4; myogenin (myogenic factor 4) (MYOG), aka MYF4,
   MYOGENIN, ACCESSION NUMBER NM_002479.4; MYST histone acetyltransferase 2
   (MYST2), aka KAT7, HBOA, HBO, ACCESSION NUMBER NM_007067.3; myelin transcription
   factor 1 (MYTI), aka MYTI, MTFI,       C20orf36, PLPB1, ACCESSION NUMBER NM_004535.2;
25 myelin transcription factor 1-like (MYTIL), aka NZF1, ACCESSION NUMBER NM_015025.2;
   myeloid zinc finger 1 (MZF1), transcript variant 2, aka MZF1B, ZSCAN6, ZNF42, MZF-1, Zfp98,
   ACCESSION NUMBER NM_198055.1; myeloid zinc finger 1 (MZF1), transcript variant 2, aka
   MZF1B, ZSCAN6, ZNF42, MZF-1, Zfp98, ACCESSION NUMBER NM_198055.1; Nanog
   homeobox (NANOG), ACCESSION NUMBER NM_024865.1; neurogenic differentiation 2
30 (NEUROD2), aka NDRF, ACCESSION NUMBER NM_006160.2; neurogenin 1 (NEUROGI), aka
   Math4C, ngnl, NEUROD3, AKA, ACCESSION NUMBER NM_006161.2; nuclear factor of
   activated T-cells 5, tonicity-responsive (NFAT5), transcript variant 2, aka NFATLI, OREBP,
   TONEBP, NF-AT5, KIAA0827, NFATZ, ACCESSION NUMBER NM_138713.2; nuclear factor of
   activated T-cells 5, tonicity-responsive (NFAT5), transcript variant 5, aka NFATLI, OREBP,
35 TONEBP, NF-AT5, KIAA0827, NFATZ, ACCESSION NUMBER NM_173215.1; nuclear factor of
   activated T-cells 5, tonicity-responsive (NFAT5), transcript variant 5, aka NFATLI, OREBP,
   TONEBP, NF-AT5, KIAA0827, NFATZ, ACCESSION NUMBER NM_173215.1; nuclear factor of
                                                     34

   activated T-cells, cytoplasmic, calcineurin-dependent 1 (NFATC 1), transcript variant 3, aka NFATc,
   MGC138448, NFAT2, NF-ATC, ACCESSION NUMBER NM_172387.1; nuclear factor of activated
   T-cells, cytoplasmic, calcineurin-dependent 1 (NFATC 1), transcript variant 1, aka NFATc,
   MGC138448, NFAT2, NF-ATC, ACCESSION NUMBER NM_172390.1; nuclear factor of activated
 5 T-cells, cytoplasmic, calcineurin-dependent 1 (NFATCI), transcript variant 2, aka NFATc,
   MGC138448, NFAT2, NF-ATC, ACCESSION NUMBER NM_006162.3; nuclear factor of activated
   T-cells, cytoplasmic, calcineurin-dependent 1 (NFATCI), transcript variant 4, aka NFATc,
   MGC138448, NFAT2, NF-ATC, ACCESSION NUMBER NM_172388.1; nuclear factor of activated
   T-cells, cytoplasmic, calcineurin-dependent 2 (NFATC2), transcript variant 1, aka KIAA061 1,
10 NFATP, NFATI, ACCESSION NUMBER NM_012340.3; nuclear factor of activated T-cells,
   cytoplasmic, calcineurin-dependent 2 (NFATC2), transcript variant 1, aka KIAA061 1, NFATP,
   NFAT1, ACCESSION NUMBER NM_012340.3; nuclear factor of activated T-cells, cytoplasmic,
   calcineurin-dependent 3 (NFATC3), transcript variant 1, aka NFAT4, NFATX, ACCESSION
   NUMBER NM_173165.1; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3
15 (NFATC3), transcript variant 2, aka NFAT4, NFATX, ACCESSION NUMBER NM_004555.2;
   nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 (NFATC3), transcript
   variant 2, aka NFAT4, NFATX, ACCESSION NUMBER NM_004555.2; nuclear factor of activated
   T-cells, cytoplasmic, calcineurin-dependent 3 (NFATC3), transcript variant 4, aka NFAT4, NFATX,
   ACCESSION NUMBER NM_173164.1; nuclear factor of activated T-cells, cytoplasmic,
20 calcineurin-dependent 3 (NFATC3), transcript variant 3, aka NFAT4, NFATX, ACCESSION
   NUMBER NM_173163.1; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
   (NFATC4), aka NFAT3, NF-ATc4, ACCESSION NUMBER NM_004554.3; nuclear factor
   (erythroid-derived 2), 45kDa (NFE2), aka p45, NF-E2, ACCESSION NUMBER NM_006163.1;
   nuclear factor (erythroid-derived 2)-like 1 (NFE2L1), aka FLJO0380, TCF1 1, NRF1, LCR-E1,
25 ACCESSION NUMBER NM_003204.1; nuclear factor (erythroid-derived 2)-like 2 (NFE2L2), aka
   NRF2, ACCESSION NUMBER NM_006164.2; nuclear factor (erythroid-derived 2)-like 3
   (NFE2L3), aka NRF3, ACCESSION NUMBER NM_004289.5; nuclear factor I/A (NFIA), aka
   KIAA1439, NFI-L, DKFZp434L0422, ACCESSION NUMBER NM_005595.1; nuclear factor I/B
   (NFIB), aka NFIB2, NFIB3, HMGIC/NFIB, NFI-RED, ACCESSION NUMBER NM_005596.2;
30 nuclear factor I/C (CCAAT-binding transcription factor) (NFIC), transcript variant 2, aka CTF5,
   CTF, NF-I, NFI, MGC20153, ACCESSION NUMBER NM_205843.1; nuclear factor I/C (CCAAT
   binding transcription factor) (NFIC), transcript variant 1, aka CTF5, CTF, NF-I, NFI, MGC20153,
   ACCESSION NUMBER NM_005597.2; nuclear factor I/C (CCAAT-binding transcription factor)
   (NFIC), transcript variant 1, aka CTF5, CTF, NF-I, NFI, MGC20153, ACCESSION NUMBER
35 NM_005597.2; nuclear factor, interleukin 3 regulated (NFIL3), aka IL3BP1, NF-IL3A, E4BP4,
   NFIL3A, ACCESSION NUMBER NM_005384.2; nuclear factor I/X (CCAAT-binding transcription
   factor) (NFIX), aka NF1A, ACCESSION NUMBER NM_002501.2; nuclear factor of kappa light
                                                      35

   polypeptide gene enhancer in B-cells 1 (p10 5 ) (NFKB 1), aka NF-kappa-B, NFKB-p105, EBP-1,
   KBF1, DKFZp686CO1211, MGC54151, NFKB-p50, ACCESSION NUMBER NM_003998.2;
   nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) (NFKB2), transcript
   variant 1, aka LYT1O, LYT-10, ACCESSION NUMBER NM_001077494.1; nuclear factor of kappa
 5 light polypeptide gene enhancer in B-cells 2 (p49/p100) (NFKB2), transcript variant 3, aka LYT1O,
   LYT-10, ACCESSION NUMBER NM_001077493.1; nuclear factor of kappa light polypeptide gene
   enhancer in B-cells 2 (p49/p100) (NFKB2), transcript variant 2, aka LYT1O, LYT-10, ACCESSION
   NUMBER NM_002502.3; nuclear transcription factor, X-box binding 1 (NFX 1), transcript variant 3,
   aka MGC20369, NFX2, DKFZp779G2416, ACCESSION NUMBER NM_147134.1; nuclear
10 transcription factor, X-box binding 1 (NFX 1), transcript variant 2, aka MGC20369, NFX2,
   DKFZp779G2416, ACCESSION NUMBER NM_147133.1; nuclear transcription factor, X-box
   binding 1 (NFXI), transcript variant 2, aka MGC20369, NFX2, DKFZp779G2416, ACCESSION
   NUMBER NM_147133.1; nuclear transcription factor, X-box binding 1 (NFXI), transcript variant 1,
   aka MGC20369, NFX2, DKFZp779G2416, ACCESSION NUMBER NM_002504.3; nuclear
15 transcription factor, X-box binding-like 1 (NFXL 1), aka HOZFP, FLJ 16294, ACCESSION
   NUMBER NM_152995.4; nuclear transcription factor Y, alpha (NFYA), transcript variant 1, aka
   CBF-B, HAP2, NF-YA, CBF-A, ACCESSION NUMBER NM_002505.3; nuclear transcription
   factor Y, alpha (NFYA), transcript variant 1, aka CBF-B, HAP2, NF-YA, CBF-A, ACCESSION
   NUMBER NM_002505.3; nuclear transcription factor Y, beta (NFYB), aka HAP3, NF-YB, CBF-B,
20 CBF-A, ACCESSION NUMBER NM_006166.3; nuclear transcription factor Y, gamma (NFYC),
   aka HAP5, NF-YC, hCBF-C, DKFZp667G242, H1TF2A, CBFC, CBF-C, HSM, FLJ45775,
   ACCESSION NUMBER NM_014223.2; NK2 homeobox 1 (NKX2-1), transcript variant 2, aka
   BCH, TEBP, TITF1, TTFI,      NKX2.1, NK-2, TTF-i, BHC, NKX2A, ACCESSION NUMBER
   NM_003317.3; NK2 homeobox 1 (NKX2-1), transcript variant 2, aka BCH, TEBP, TITF1, TTFI,
25 NKX2.1, NK-2, TTF-i, BHC, NKX2A, ACCESSION NUMBER NM_003317.3; NK2 homeobox 2
   (NKX2-2), aka NKX2B, NKX2.2, ACCESSION NUMBER NM_002509.2; NK2 transcription factor
   related, locus 3 (Drosophila) (NKX2-3), aka CSX3, NKX2.3, NKX2C, NKX4-3, ACCESSION
   NUMBER NM_145285.2; NK2 transcription factor related, locus 5 (Drosophila) (NKX2-5), aka
   NKX2E, NKX2.5, NKX4-1, CSX, CSX1, ACCESSION NUMBER NM_004387.2; NK2 homeobox
30 8 (NKX2-8), aka NKX2H, NKX2.8, Nkx2-9, ACCESSION NUMBER NM_014360.2; NK3
   homeobox 1 (NKX3-1), aka NKX3A, BAPX2, NKX3, NKX3.1, ACCESSION NUMBER
   NM_006167.2; NK6 transcription factor related, locus 1 (Drosophila) (NKX6-1), aka NKX6A,
   NKX6.1, ACCESSION NUMBER NM_006168.1; NK6 homeobox 2 (NKX6-2), aka MGC126684,
   GTX, NKX6.2, NKX6B, ACCESSION NUMBER NM_177400.2; non-metastatic cells 2, protein
35 (NM23B) expressed in (NME2), transcript variant 1, aka MGC1 11212, NM23-H2, NM23B, puf,
   NDPKB, NDPK-B, ACCESSION NUMBER NM_002512.2, non-metastatic cells 2, protein
   (NM23B) expressed in (NME2), transcript variant 3, aka MGC1 11212, NM23-H2, NM23B, puf,
                                                     36

   NDPKB, NDPK-B, ACCESSION NUMBER NM_001018138.1; non-metastatic cells 2, protein
   (NM23B) expressed in (NME2), transcript variant 4, aka MGC1 11212, NM23-U2, NM23B, puf,
   NDPKB, NDPK-B, ACCESSION NUMBER NM_001018139.1; non-metastatic cells 2, protein
   (NM23B) expressed in (NME2), transcript variant 2, aka MGC1 11212, NM23-U2, NM23B, puf,
 5 NDPKB, NDPK-B, ACCESSION NUMBER NM_001018137.1; NOBOX oogenesis homeobox
   (NOBOX), accession number XM_001134424.1; NOBOX oogenesis homeobox (NOBOX), aka
   OG2, OG-2, POF5, TCAG 12042, Og2x, ACCESSION NUMBER NM_001080413.1; neuronal
   PAS domain protein 1 (NPAS 1), aka PASD5, MOP5, ACCESSION NUMBER NM_002517.2;
   neuronal PAS domain protein 2 (NPAS2), aka MGC71151, PASD4, MOP4, FLJ23138,
10 ACCESSION NUMBER NM_002518.3; nuclear protein, ataxia-telangiectasia locus (NPAT), aka
   E14, ACCESSION NUMBER NM_002519.1; nuclear receptor subfamily 0, group B, member 1
   (NROB1), aka AHC, NROB1, AHX, DSS, AHCH, GTD, DAX-1, DAXI, HHG, ACCESSION
   NUMBER NM_000475.3; nuclear receptor subfamily 0, group B, member 2 (NROB2), aka SHP,
   SHP1, ACCESSION NUMBER NM_021969.1; nuclear receptor subfamily 1, group D, member 1
15 (NR1D1), aka THRA1, hRev, ear-1, THRAL, EARl, ACCESSION NUMBER NM_021724.2;
   nuclear receptor subfamily 1, group D, member 2 (NR1D2), accession number XM_001130839.1;
   nuclear receptor subfamily 1, group H, member 2 (NR1U2), aka NER, LXR-b, UNR, RIP15, NER-I,
   LXRB, ACCESSION NUMBER NM_007121.2; nuclear receptor subfamily 1, group H, member 3
   (NR1H3), aka LXR-a, LXRA, RLD-1, ACCESSION NUMBER NM_005693.1; nuclear receptor
20 subfamily 1, group H, member 4 (NR1H4), aka HRRI, MGC163445, FXR, HRR-1, RIP14, BAR,
   ACCESSION NUMBER NM_005123.1; nuclear receptor subfamily 1, group I, member 2 (NR1I2),
   transcript variant 3, aka PAR, PRR, SAR, PARI, ONRI, BXR, SXR, PXR, PAR2, PARq,
   ACCESSION NUMBER NM_033013.1; nuclear receptor subfamily 1, group I, member 2 (NR1I2),
   transcript variant 2, aka PAR, PRR, SAR, PARI, ONRI, BXR, SXR, PXR, PAR2, PARq,
25 ACCESSION NUMBER NM_022002.1; nuclear receptor subfamily 1, group I, member 3 (NR1I3),
   transcript variant 6, aka MB67, CARl, CAR, MGC97209, MGC150433, MGC97144, ACCESSION
   NUMBER NM_001077469.1; nuclear receptor subfamily 1, group I, member 3 (NR1I3), transcript
   variant 15, aka MB67, CARl, CAR, MGC97209, MGC150433, MGC97144, ACCESSION
   NUMBER NM_001077475.1; nuclear receptor subfamily 2, group C, member 1 (NR2C1), transcript
30 variant 2, aka TR2-11, TR2, ACCESSION NUMBER NM_001032287.1; nuclear receptor subfamily
   2, group C, member 1 (NR2C 1), transcript variant 2, aka TR2-1 1, TR2, ACCESSION NUMBER
   NM_001032287.1; nuclear receptor subfamily 2, group C, member 1 (NR2C1), transcript variant 1,
   aka TR2-l 1, TR2, ACCESSION NUMBER NM_003297.1; nuclear receptor subfamily 2, group C,
   member 2 (NR2C2), aka TAKI, hTAKI, TR4, TR2Rl, ACCESSION NUMBER NM_003298.3;
35 nuclear receptor subfamily 2, group E, member 1 (NR2El), aka TLX, TLL, XTLL, ACCESSION
   NUMBER NM_003269.2; nuclear receptor subfamily 2, group E, member 3 (NR2E3), transcript
   variant 2, aka rd7, ESCS, PNR, RNR, MGC49976, ACCESSION NUMBER NM_014249.2; nuclear
                                                    37

   receptor subfamily 2, group E, member 3 (NR2E3), transcript variant 2, aka rd7, ESCS, PNR, RNR,
   MGC49976, ACCESSION NUMBER NM_014249.2; nuclear receptor subfamily 2, group E,
   member 3 (NR2E3), transcript variant 1, aka rd7, ESCS, PNR, RNR, MGC49976, ACCESSION
   NUMBER NM_016346.2; nuclear receptor subfamily 2, group F, member 1 (NR2F1), aka ERBAL3,
 5 COUP-TFI, TFCOUPI, EAR3, TCFCOUPI, EAR-3, NR2F2, SVP44, ACCESSION NUMBER
   NM_005654.4; nuclear receptor subfamily 2, group F, member 2 (NR2F2), aka COUP-TFII,
   TFCOUP2, MGC1 17452, COUPTFB, SVP40, ARPI, ACCESSION NUMBER NM_021005.2;
   nuclear receptor subfamily 2, group F, member 6 (NR2F6), aka EAR-2, EAR2, ERBAL2,
   ACCESSION NUMBER NM_005234.3; nuclear receptor subfamily 3, group C, member 1
10 (glucocorticoid receptor) (NR3C1), transcript variant 4, aka GCCR, GRL, GCR, GR, ACCESSION
   NUMBER NM_001018076.1; nuclear receptor subfamily 3, group C, member 1 (glucocorticoid
   receptor) (NR3C1), transcript variant 1, aka GCCR, GRL, GCR, GR, ACCESSION NUMBER
   NM_001018077.1; nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
   (NR3C1), transcript variant 6, aka GCCR, GRL, GCR, GR, ACCESSION NUMBER
15 NM_001020825.1; nuclear receptor subfamily 3, group C, member 2 (NR3C2), aka MGC133092,
   MR, MLR, MCR, ACCESSION NUMBER NM_000901.1; nuclear receptor subfamily 4, group A,
   member 1 (NR4A1), transcript variant 2, aka N10, NUR77, NP1O, NAK-1, MGC9485, GFRPI,
   NGFIB, HMR, TR3, ACCESSION NUMBER NM_173157.1; nuclear receptor subfamily 4, group
   A, member 1 (NR4A1), transcript variant 3, aka N10, NUR77, NP1O, NAK-1, MGC9485, GFRPI,
20 NGFIB, HMR, TR3, ACCESSION NUMBER NM_173158.1; nuclear receptor subfamily 4, group
   A, member 1 (NR4A1), transcript variant 1, aka N10, NUR77, NP1O, NAK-1, MGC9485, GFRPI,
   NGFIB, HMR, TR3, ACCESSION NUMBER NM_002135.3; nuclear receptor subfamily 4, group
   A, member 2 (NR4A2), transcript variant 1, aka RNR1, NOT, TINUR, NURRI, HZF-3,
   ACCESSION NUMBER NM_006186.2; nuclear receptor subfamily 4, group A, member 3
25 (NR4A3), transcript variant 4, aka CHN, CSMF, TEC, NORI, MINOR, ACCESSION NUMBER
   NM_173199.1; nuclear receptor subfamily 4, group A, member 3 (NR4A3), transcript variant 3, aka
   CHN, CSMF, TEC, NORI, MINOR, ACCESSION NUMBER NM_173200.1; nuclear receptor
   subfamily 4, group A, member 3 (NR4A3), transcript variant 1, aka CHN, CSMF, TEC, NORI,
   MINOR, ACCESSION NUMBER NM_006981.2; nuclear receptor subfamily 4, group A, member 3
30 (NR4A3), transcript variant 2, aka CHN, CSMF, TEC, NORI, MINOR, ACCESSION NUMBER
   NM_173198.1; nuclear receptor subfamily 4, group A, member 3 (NR4A3), transcript variant 2, aka
   CHN, CSMF, TEC, NORI, MINOR, ACCESSION NUMBER NM_173198.1; nuclear receptor
   subfamily 5, group A, member 1 (NR5A1), aka SF1, FTZ1, ELP, FTZF1, AD4BP, SF-i,
   ACCESSION NUMBER NM_004959.3; nuclear receptor subfamily 5, group A, member 2
35 (NR5A2), transcript variant 1, aka FTF, B1F2, FTZ-FIbeta, hB1F, hB1F-2, LRH-1, BF, FTZ-F1,
   CPF, ACCESSION NUMBER NM_205860.1; nuclear receptor subfamily 5, group A, member 2
   (NR5A2), transcript variant 2, aka FTF, B1F2, FTZ-FIbeta, hB1F, hB1F-2, LRH-1, BF, FTZ-F1,
                                                    38

   CPF, ACCESSION NUMBER NM_003822.3; nuclear receptor subfamily 5, group A, member 2
   (NR5A2), transcript variant 2, aka FTF, B1F2, FTZ-FIbeta, hB1F, hB1F-2, LRH-1, BF, FTZ-F1,
   CPF, ACCESSION NUMBER NM_003822.3; nuclear receptor subfamily 6, group A, member 1
   (NR6A1), transcript variant 2, aka NR61, GCNF1, RTR, GCNF, ACCESSION NUMBER
 5 NM_001489.3; nuclear receptor subfamily 6, group A, member 1 (NR6A1), transcript variant 2, aka
   NR61, GCNF1, RTR, GCNF, ACCESSION NUMBER NM_001489.3; nuclear respiratory factor 1
   (NRF1), transcript variant 2, aka ALPHA-PAL, ACCESSION NUMBER NM_001040110.1; nuclear
   respiratory factor 1 (NRF1), transcript variant 1, aka ALPHA-PAL, ACCESSION NUMBER
   NM_005011.3; nuclear respiratory factor 1 (NRF1), transcript variant 1, aka ALPHA-PAL,
10 ACCESSION NUMBER NM_005011.3; Nik related kinase (NRK), aka DKFZp686A17109,
   FLJ16788, NESK, MGC131849, ACCESSION NUMBER NM_198465.2; neural retina leucine
   zipper (NRL), aka D14S46E, RP27, ACCESSION NUMBER NM_006177.3; oligodendrocyte
   lineage transcription factor 2 (OLIG2), aka PRKCBP2, RACK17, OLIGO2, BHLHB1, ACCESSION
   NUMBER NM_005806.2; one cut homeobox 1 (ONECUTI), aka HNF-6, HNF6, HNF6A,
15 ACCESSION NUMBER NM_004498.1; one cut homeobox 2 (ONECUT2), aka OC-2, OC2,
   MGC120378, MGC120377, ACCESSION NUMBER NM_004852.2; one cut homeobox 3
   (ONECUT3), ACCESSION NUMBER NM_001080488.1; orthopedia homeobox (OTP), aka
   MGC3161, ACCESSION NUMBER NM_032109.2; orthodenticle homeobox 1 (OTX1), aka
   FLJ38361, MGC15736, ACCESSION NUMBER NM_014562.2; orthodenticle homeobox 2
20 (OTX2), transcript variant 2, aka MCOPS5, MGC45000, ACCESSION NUMBER NM_172337.1;
   orthodenticle homeobox 2 (OTX2), transcript variant 2, aka MCOPS5, MGC45000, ACCESSION
   NUMBER NM_172337.1; orthodenticle homeobox 2 (OTX2), transcript variant 1, aka MCOPS5,
   MGC45000, ACCESSION NUMBER NM_021728.2; ovo-like 1(Drosophila) (OVOL1), aka
   HOVO1, ACCESSION NUMBER NM_004561.2; proliferation-associated 2G4, 38kDa (PA2G4),
25 aka p38-2G4, HG4-1, EBP1, ACCESSION NUMBER NM_006191.2; paired box 3 (PAX3),
   transcript variant PAX3, aka WS1, MGC120381, HUP2, CDHS, MGC120383, MGC 120384,
   MGC134778, MGC120382, ACCESSION NUMBER NM_181457.1; paired box 3 (PAX3),
   transcript variant PAX3A, aka WS1, MGC120381, HUP2, CDHS, MGC120383, MGC120384,
   MGC134778, MGC120382, ACCESSION NUMBER NM_000438.3; paired box 3 (PAX3),
30 transcript variant PAX3A, aka WS1, MGC120381, HUP2, CDHS, MGC120383, MGC120384,
   MGC134778, MGC120382, ACCESSION NUMBER NM_000438.3; paired box 3 (PAX3),
   transcript variant PAX3D, aka WS1, MGC120381, HUP2, CDHS, MGC120383, MGC120384,
   MGC134778, MGC120382, ACCESSION NUMBER NM_181458.1; paired box 4 (PAX4), aka
   MGC129960, ACCESSION NUMBER NM_006193.1; paired box 5 (PAX5), aka BSAP,
35 ACCESSION NUMBER NM_016734.1; paired box 6 (PAX6), transcript variant 1, aka WAGR,
   D11S812E, AN2, MGDA, MGC17209, AN, ACCESSION NUMBER NM_000280.2; paired box 6
   (PAX6), transcript variant 2, aka WAGR, D 1S812E, AN2, MGDA, MGC17209, AN, ACCESSION
                                                      39

   NUMBER NM_001604.3; paired box 7 (PAX7), transcript variant 1, aka PAX7B, HUPI,
   ACCESSION NUMBER NM_002584.1; paired box 8 (PAX8), transcript variant PAX8D,
   ACCESSION NUMBER NM_013953.3; paired box 8 (PAX8), transcript variant PAX8A,
   ACCESSION NUMBER NM_003466.3; paired box 8 (PAX8), transcript variant PAX8A,
 5 ACCESSION NUMBER NM_003466.3; pre-B-cell leukemia homeobox 1 (PBX1), aka
   DKFZp686B09108, MGC126627, ACCESSION NUMBER NM_002585.1; pre-B-cell leukemia
   homeobox 2 (PBX2), aka G17, PBX2MHC, HOX12, ACCESSION NUMBER NM_002586.4; pre
   B-cell leukemia homeobox 3 (PBX3), ACCESSION NUMBER NM_006195.4; pre-B-cell leukemia
   homeobox 4 (PBX4), ACCESSION NUMBER NM_025245.1; polycomb group ring finger 2
10 (PCGF2), aka MGC10545, RNF1 10, MEL-18, ZNF144, ACCESSION NUMBER NM_007144.2;
   polycomb group ring finger 6 (PCGF6), transcript variant 2, aka MBLR, MGC15678, MGC17541,
   RNF 134, ACCESSION NUMBER NM_032154.3; polycomb group ring finger 6 (PCGF6), transcript
   variant 1, aka MBLR, MGC15678, MGC17541, RNF134, ACCESSION NUMBER
   NM_001011663.1; paternally expressed 3 (PEG3), aka DKFZp781AO95, ZSCAN24, KIAA0287,
15 PW1, ACCESSION NUMBER NM_006210.1; prefoldin subunit 1 (PFDNI), aka PDF, PFDI,
   ACCESSION NUMBER NM_002622.4; piggyBac transposable element derived 1 (PGBD1), aka
   dJ874C20.4, SCAND4, HUCEP-4, ACCESSION NUMBER NM_032507.2; progesterone receptor
   (PGR), aka PR, NR3C3, ACCESSION NUMBER NM_000926.3; PHD finger protein 1 (PHF1),
   transcript variant 1, aka PHF2, ACCESSION NUMBER NM_002636.3; PHD finger protein 1
20 (PHF1), transcript variant 2, aka PHF2, ACCESSION NUMBER NM_024165.1; PHD finger protein
   1 (PHF1), transcript variant 2, aka PHF2, ACCESSION NUMBER NM_024165.1; PHD finger
   protein 2 (PHF2), aka MGC176680, KIAA0662, GRC5, JHDM1E, ACCESSION NUMBER
   NM_005392.3; PHD finger protein 2 (PHF2), aka MGC176680, KIAA0662, GRC5, JHDM1E,
   ACCESSION NUMBER NM_005392.3; PHD finger protein 5A (PHF5A), aka INI, bK223H9.2,
25 SF3bl4b, MGC1346, ACCESSION NUMBER NM_032758.3; paired-like homeobox 2a
   (PHOX2A), aka NCAM2, MGC52227, CFEOM2, PMX2A, FEOM2, ARIX, ACCESSION
   NUMBER NM_005169.2; paired-like homeobox 2b (PHOX2B), aka PMX2B, NBPhox,
   ACCESSION NUMBER NM_003924.2; putative homeodomain transcription factor 1 (PHTFI), aka
   PHTF, ACCESSION NUMBER NM_006608.1; paired-like homeodomain transcription factor 1
30 (PITXI), aka POTX, PTXI, BFT, ACCESSION NUMBER NM_002653.3; paired-like
   homeodomain 2 (PITX2), transcript variant 2, aka MGC 111022, IGDS, RS, IDG2, RIEG, PTX2,
   IGDS2, Brx1, ARPI, RIEGI, IHG2, IRID2, RGS, Otlx2, MGC20144, ACCESSION NUMBER
   NM_153426.1; paired-like homeodomain 2 (PITX2), transcript variant 1, aka MGC111022, IGDS,
   RS, IDG2, RIEG, PTX2, IGDS2, Brx1, ARPI, RIEGI, IHG2, IRID2, RGS, Otlx2, MGC20144,
35 ACCESSION NUMBER NM_153427.1; paired-like homeodomain 2 (PITX2), transcript variant 3,
   aka MGC111022, IGDS, RS, IDG2, RIEG, PTX2, IGDS2, Brx1, ARPI, RIEGI, IHG2, IRID2, RGS,
   Otlx2, MGC20144, ACCESSION NUMBER NM_000325.5; paired-like homeodomain 3 (PITX3),
                                                   40

   aka PTX3, MGC12766, ACCESSION NUMBER NM_005029.3; PBX/knotted 1 homeobox 1
   (PKNOX1), aka PREPI, pkonxlc, ACCESSION NUMBER NM_004571.3; PBX/knotted 1
   homeobox 1 (PKNOX1), aka PREPI, pkonxlc, ACCESSION NUMBER NM_004571.3;
   PBX/knotted 1 homeobox 2 (PKNOX2), aka FLJ13074, PREP2, ACCESSION NUMBER
 5 NM_022062.2; pleiomorphic adenoma gene 1 (PLAGI), aka PSA, SGPA, ACCESSION NUMBER
   NM_002655.1; pleiomorphic adenoma gene 1 (PLAGI), Accession number XM_001126483.1;
   pleiomorphic adenoma gene-like 2 (PLAGL2), aka FLJ23283, ACCESSION NUMBER
   NM_002657.2; promyelocytic leukemia (PML), transcript variant 2, aka PP8675, RNF71, MYL,
   TRIM19, ACCESSION NUMBER NM_033240.2; promyelocytic leukemia (PML), transcript variant
10 1, aka PP8675, RNF71, MYL, TRIM19, ACCESSION NUMBER NM_033238.2; promyelocytic
   leukemia (PML), transcript variant 9, aka PP8675, RNF71, MYL, TRIM19             ACCESSION
   NUMBER NM_033239.2; promyelocytic leukemia (PML), transcript variant 9, aka PP8675, RNF71,
   MYL, TRIM19, ACCESSION NUMBER NM_033239.2; promyelocytic leukemia (PML), transcript
   variant 7, aka PP8675, RNF71, MYL, TRIM19, ACCESSION NUMBER NM_033246.2; POU class
15 1 homeobox 1 (POU1F1), aka GHF-1, Pit-i beta, PIT1, Pit-1, ACCESSION NUMBER
   NM_000306.1; POU class 2 homeobox 1 (POU2F1), aka OCTI, OTF1, ACCESSION NUMBER
   NM_002697.2; POU domain, class 2, transcription factor 2 (POU2F2), aka OCT2, OTF2, Oct-2,
   ACCESSION NUMBER NM_002698.1; POU domain, class 2, transcription factor 3 (POU2F3), aka
   MGC126698, Skn-la, FLJ40063, PLA-1, OCT11, Epoc-1, ACCESSION NUMBER NM_014352.1;
20 POU class 3 homeobox 1 (POU3F1), aka OCT6, SCIP, OTF6, ACCESSION NUMBER
   NM_002699.3; POU class 3 homeobox 2 (POU3F2), aka OTF7, OCT7, BRN2, POUF3,
   ACCESSION NUMBER NM_005604.2; POU class 3 homeobox 3 (POU3F3), aka BRN1, OTF8,
   ACCESSION NUMBER NM_006236.1; POU class 3 homeobox 4 (POU3F4), aka BRN4, OTF9,
   BRAIN-4, DFN3, ACCESSION NUMBER NM_000307.2; POU class 4 homeobox 1 (POU4F1), aka
25 RDC-1, Oct-TI, BRN3A, FLJ13449, ACCESSION NUMBER NM_006237.3; POU class 4
   homeobox 2 (POU4F2), aka Brn-3b, BRN3.2, BRN3B, ACCESSION NUMBER NM_004575.2;
   POU class 4 homeobox 3 (POU4F3), aka DFNA15, MGC138412, BRN3C, ACCESSION NUMBER
   NM_002700.1; POU class 5 homeobox 1 (POU5F1), transcript variant 1, aka OTF4, OCT3, OCT4,
   MGC22487, OTF3, ACCESSION NUMBER NM_002701.4; POU domain class 5, transcription
30 factor 2 (POU5F2), aka FLJ25680, DKFZp686PO2123, SPRM-1, ACCESSION NUMBER
   NM_153216.1; POU class 6 homeobox 1 (POU6F1), aka BRN5, MPOU, TCFB1, ACCESSION
   NUMBER NM_002702.2; POU class 6 homeobox 2 (POU6F2), aka WTSL, RPF-1, WT5,
   ACCESSION NUMBER NM_007252.2; peroxisome proliferator-activated receptor alpha (PPARA),
   transcript variant 3, aka PPAR, hPPAR, MGC2452, NR1C1, MGC2237, ACCESSION NUMBER
35 NM_001001928.2; peroxisome proliferator-activated receptor alpha (PPARA), transcript variant 3,
   aka PPAR, hPPAR, MGC2452, NR1C1, MGC2237, ACCESSION NUMBER NM_001001928.2;
   peroxisome proliferator-activated receptor alpha (PPARA), transcript variant 3, aka PPAR, hPPAR,
                                                     41

   MGC2452, NR1C1, MGC2237, ACCESSION NUMBER NM_001001928.2; peroxisome
   proliferative activated receptor, delta (PPARD), transcript variant 1, aka PPARB, NUCI, FAAR,
   PPAR-beta, NUCI, NUCII, MGC3931, NR1C2, ACCESSION NUMBER NM_006238.2;
   peroxisome proliferator-activated receptor delta (PPARD), aka PPARB, NUCI, FAAR, PPAR-beta,
 5 NUCI, NUCII, MGC3931, NR1C2, ACCESSION NUMBER NM_006238.3; peroxisome
   proliferator-activated receptor gamma (PPARG), transcript variant 3, aka NR1C3, PPARG1,
   PPARG2, ACCESSION NUMBER NM_138711.3; peroxisome proliferator-activated receptor
   gamma (PPARG), transcript variant 2, aka NR1C3, PPARG1, PPARG2, ACCESSION NUMBER
   NM_015869.4; peroxisome proliferator-activated receptor gamma (PPARG), transcript variant 2, aka
10 NR1C3, PPARG1, PPARG2, ACCESSION NUMBER NM_015869.4; peroxisome proliferator
   activated receptor gamma (PPARG), transcript variant 1, aka NR1C3, PPARG1, PPARG2,
   ACCESSION NUMBER NM_138712.3; PR domain containing 1, with ZNF domain (PRDM1),
   transcript variant 2, aka MGC118922, BLIMPI, PRDI-BF1, MGC118925, MGC118924,
   MGC1 18923, ACCESSION NUMBER NM_182907.1; PR domain containing 1, with ZNF domain
15 (PRDM1), transcript variant 1, aka MGC118922, BLIMP1, PRDI-BF1, MGC118925, MGC118924,
   MGC1 18923, ACCESSION NUMBER NM_001198.2; PR domain containing 1, with ZNF domain
   (PRDM1), transcript variant 1, aka MGC118922, BLIMP1, PRDI-BF1, MGC118925, MGC118924,
   MGC1 18923, ACCESSION NUMBER NM_001198.2; PR domain containing 1, with ZNF domain
   (PRDM1), transcript variant 1, aka MGC118922, BLIMP1, PRDI-BF1, MGC118925, MGC118924,
20 MGC118923, ACCESSION NUMBER NM_001198.2; PR domain containing 16 (PRDM16),
   transcript variant 1, aka PFM13, MEL1, KIAA1675, ACCESSION NUMBER NM_022114.2; PR
   domain containing 16 (PRDM16), transcript variant 1, aka PFM13, MEL1, KIAA1675,
   ACCESSION NUMBER NM_022114.2; PR domain containing 16 (PRDM16), transcript variant 1,
   aka PFM13, MEL1, KIAA1675, ACCESSION NUMBER NM_022114.2; PR domain containing 2,
25 with ZNF domain (PRDM2), transcript variant 1, aka RIZI, MTB-ZF, HUMHOXYl, RIZ2, RIZ,
   ACCESSION NUMBER NM_012231.3; PR domain containing 2, with ZNF domain (PRDM2),
   transcript variant 2, aka RIZI, MTB-ZF, KMT8, HUMHOXYl, RIZ2, RIZ, ACCESSION
   NUMBER NM_015866.3; PROP paired-like homeobox 1 (PROPI), ACCESSION NUMBER
   NM_006261.2; prospero homeobox 1 (PROXI), ACCESSION NUMBER NM_002763.3; paired
30 related homeobox 1 (PRRX1), transcript variant pmx-la, aka PRX1, PMX1, PHOX1, ACCESSION
   NUMBER NM_006902.3; paired related homeobox 1 (PRRX1), transcript variant pmx-la, aka
   PRX1, PMX1, PHOXI, ACCESSION NUMBER NM_006902.3; paired related homeobox 2
   (PRRX2), aka PMX2, MGC19843, PRX2, ACCESSION NUMBER NM_016307.3; pituitary tumor
   transforming 1 (PTTGI), aka PTTG, MGC126883, HPTTG, SECURIN, MGC138276, EAPI,
35 TUTRI, ACCESSION NUMBER NM_004219.2; purine-rich element binding protein A (PURA),
   aka PURALPHA, PUR-ALPHA, PUR1, ACCESSION NUMBER NM_005859.3; purine-rich
   element binding protein B (PURB), aka MGC126786, MGC126784, PURBETA, ACCESSION
                                                      42

   NUMBER NM_033224.3; retinoic acid receptor, alpha (RARA), transcript variant 2, aka NR1B1,
   RAR, ACCESSION NUMBER NM_001024809.2; retinoic acid receptor, alpha (RARA), transcript
   variant 1, aka NR1B1, RAR, ACCESSION NUMBER NM_000964.2; retinoic acid receptor, alpha
   (RARA), transcript variant 1, aka NR1B 1, RAR, ACCESSION NUMBER NM_000964.2; retinoic
 5 acid receptor, beta (RARB), transcript variant 1, aka RRB2, NR1B2, HAP, ACCESSION NUMBER
   NM_000965.2; retinoic acid receptor, beta (RARB), transcript variant 1, aka RRB2, NR1B2, HAP,
   ACCESSION NUMBER NM_000965.2; retinoic acid receptor, beta (RARB), transcript variant 2,
   aka RRB2, NR1B2, HAP, ACCESSION NUMBER NM_016152.2; retinoic acid receptor, gamma
   (RARG), aka RARC, NR1B3, ACCESSION NUMBER NM_000966.3; retina and anterior neural
10 fold homeobox (RAX), aka RX, ACCESSION NUMBER NM_013435.2; retina and anterior neural
   fold homeobox like 1 (RAXL1), aka QRX, MGC15631, ARMD6, CORD11, ACCESSION
   NUMBER NM_032753.2; retinoblastoma 1 (RB 1), aka RB, OSRC, ACCESSION NUMBER
   NM_000321.2; recombination signal binding protein for immunoglobulin kappa J region (RBPJ),
   transcript variant 3, aka SUH, KBF2, RBP-J, IGKJRB1, IGKJRB, RBPJK, CBF1, RBPSUH, csl,
15 MGC61669, ACCESSION NUMBER NM_203283.1; recombination signal binding protein for
   immunoglobulin kappa J region (RBPJ), transcript variant 1, aka SUH, RBP-J, RBPJK, csl, KBF2,
   IGKJRB1, IGKJRB, CBF1, RBPSUH, MGC61669, ACCESSION NUMBER NM_005349.2;
   recombination signal binding protein for immunoglobulin kappa J region (RBPJ), transcript variant
   4, aka SUH, RBP-J, RBPJK, csl, KBF2, IGKJRB1, IGKJRB, CBF1, RBPSUH, MGC61669,
20 ACCESSION NUMBER NM_203284.1; recombination signal binding protein for immunoglobulin
   kappa J region-like (RBPJL), aka SUHL, RBPSUHL, SUH, RBP-L, ACCESSION NUMBER
   NM_014276.2; regulator of calcineurin 1 (RCAN1), transcript variant 3, aka ADAPT78, MCIP1,
   DSC1, CSP1, DSCR1, RCN1, ACCESSION NUMBER NM_203418.1; regulator of calcineurin 1
   (RCAN1), transcript variant 2, aka ADAPT78, MCIP1, DSC1, CSP1, DSCR1, RCN1, ACCESSION
25 NUMBER NM_203417.1; regulator of calcineurin 1 (RCAN1), transcript variant 1, aka ADAPT78,
   MCIP1, DSC1, CSP1, DSCR1, RCN1, ACCESSION NUMBER NM_004414.5; REST corepressor 2
   (RCOR2), ACCESSION NUMBER NM_173587.2; v-rel reticuloendotheliosis viral oncogene
   homolog (avian) (REL), aka C-Rel, ACCESSION NUMBER NM_002908.2; v-rel
   reticuloendotheliosis viral oncogene homolog A (avian) (RELA), aka NFKB3, MGC131774,
30 ACCESSION NUMBER NM_021975.2; v-rel reticuloendotheliosis viral oncogene homolog B
   (RELB), aka I-REL, ACCESSION NUMBER NM_006509.2; arginine-glutamic acid dipeptide (RE)
   repeats (RERE), transcript variant 3, aka ARP, ATNIL, ARG, KIAA0458, DNB1, FLJ38775,
   ACCESSION NUMBER NM_001042682.1; arginine-glutamic acid dipeptide (RE) repeats (RERE),
   transcript variant 1, aka ARP, ATNIL, ARG, KIAA0458, DNB1, FLJ38775, ACCESSION
35 NUMBER NM_012102.3; arginine-glutamic acid dipeptide (RE) repeats (RERE), transcript variant
   1, aka ARP, ATNIL, ARG, KIAA0458, DNB1, FLJ38775, ACCESSION NUMBER NM_012102.3;
   REX4, RNA exonuclease 4 homolog (S. cerevisiae) (REXO4), aka XPMC2, XPMC2H,
                                                      43

   ACCESSION NUMBER NM_020385.2; regulatory factor X, 1 (influences HLA class II expression)
   (RFXI), aka EF-C, ACCESSION NUMBER NM_002918.3; regulatory factor X, 3 (influences HLA
   class II expression) (RFX3), transcript variant 1, aka bA32F11.1, MGC87155, ACCESSION
   NUMBER NM_002919.2; regulatory factor X, 3 (influences HLA class II expression) (RFX3),
 5 transcript variant 2, aka bA32F11.1, MGC87155, ACCESSION NUMBER NM_134428.1;
   regulatory factor X, 3 (influences HLA class II expression) (RFX3), transcript variant 2, aka
   bA32F11.1, MGC87155, ACCESSION NUMBER NM_134428.1; regulatory factor X, 5 (influences
   HLA class II expression) (RFX5), transcript variant 1, ACCESSION NUMBER NM_000449.3;
   regulatory factor X, 5 (influences HLA class II expression) (RFX5), transcript variant 2,
10 ACCESSION NUMBER NM_001025603.1; regulatory factor X-associated ankyrin-containing
   protein (RFXANK), transcript variant 1, aka BLS, RFX-B, MGC138628, F14150 1, ANKRA1,
   ACCESSION NUMBER NM_003721.2; regulatory factor X-associated ankyrin-containing protein
   (RFXANK), transcript variant 1, aka BLS, RFX-B, MGC138628, F14150_1, ANKRA1,
   ACCESSION NUMBER NM_003721.2; regulatory factor X-associated ankyrin-containing protein
15 (RFXANK), transcript variant 2, aka BLS, RFX-B, MGC138628, F14150_1, ANKRA1,
   ACCESSION NUMBER NM_134440.1; regulatory factor X-associated protein (RFXAP),
   ACCESSION NUMBER NM_000538.2; Rhox homeobox family, member 1 (RHOXF1), aka
   MGC1 19030, MGC1 19033, OTEX, PEPPI, ACCESSION NUMBER NM_139282.1; rearranged L
   myc fusion (RLF), aka ZNF292L, Zn-15L, MGC142226, ACCESSION NUMBER NM_012421.2;
20 ring finger protein 20 (RNF20), aka FLJ20382, KIAA2779, FLJ1 1189, BRE1A, MGC129667,
   MGC129668, ACCESSION NUMBER NM_019592.5; ring finger protein 4 (RNF4), aka RES4-26,
   SNURF, ACCESSION NUMBER NM_002938.2; RAR-related orphan receptor A (RORA),
   transcript variant 2, aka NR1F1, MGC119326, ROR2, RZRA, RORI, MGC1 19329, ROR3,
   ACCESSION NUMBER NM_134260.1; RAR-related orphan receptor A (RORA), transcript variant
25 1, aka NRIF1, MGC119326, ROR2, RZRA, RORI, MGC119329, ROR3, ACCESSION NUMBER
   NM_134261.1; RAR-related orphan receptor A (RORA), transcript variant 4, aka NR1F1,
   MGC1 19326, ROR2, RZRA, RORI, MGC1 19329, ROR3, ACCESSION NUMBER NM_134262.1;
   RAR-related orphan receptor A (RORA), transcript variant 3, aka NR1F1, MGC1 19326, ROR2,
   RZRA, RORI, MGC1 19329, ROR3, ACCESSION NUMBER NM_002943.2; RAR-related orphan
30 receptor A (RORA), transcript variant 3, aka NR1F1, MGC1 19326, ROR2, RZRA, RORI,
   MGC1 19329, ROR3, ACCESSION NUMBER NM_002943.2; RAR-related orphan receptor A
   (RORA), transcript variant 3, aka NR1F1, MGC1 19326, ROR2, RZRA, RORI, MGC1 19329,
   ROR3, ACCESSION NUMBER NM_002943.2; RAR-related orphan receptor B (RORB), aka
   NR1F2, RZRB, bA133M9.1, ROR-BETA, ACCESSION NUMBER NM_006914.3; RAR-related
35 orphan receptor C (RORC), transcript variant 2, aka MGC129539, RORG, RZRG, NR1F3, TOR,
   ACCESSION NUMBER NM_001001523.1; RAR-related orphan receptor C (RORC), transcript
   variant 2, aka MGC129539, RORG, RZRG, NR1F3, TOR, ACCESSION NUMBER
                                                      44

   NM_001001523.1; RAR-related orphan receptor C (RORC), transcript variant 2, aka MGC129539,
   RORG, RZRG, NR1F3, TOR, ACCESSION NUMBER NM_001001523.1; RAR-related orphan
   receptor C (RORC), transcript variant 1, aka MGC129539, RZRG, NR1F3, RORG, TOR,
   ACCESSION NUMBER NM_005060.3; runt-related transcription factor 1 (acute myeloid leukemia
 5 1, aml1 oncogene) (RUNX1), transcript variant 2, aka AMLCR1, PEBP2aB, PEBP2A2, EVI-1,
   CBFA2, AMLI, AML1-EVI-1, ACCESSION NUMBER NM_001001890.1; runt-related
   transcription factor 1 (acute myeloid leukemia 1, amlI oncogene) (RUNX 1), transcript variant 1, aka
   AMLCR1, PEBP2aB, EVI-1, CBFA2, AMLI, AML1-EVI-1, ACCESSION NUMBER
   NM_001754.3; runt-related transcription factor 1 (acute myeloid leukemia 1, aml 1 oncogene)
10 (RUNX1), transcript variant 1, aka AMLCR1, PEBP2aB, EVI-1, CBFA2, AMLI, AML1-EVI-1,
   ACCESSION NUMBER NM_001754.3; runt-related transcription factor 1, translocated to, 1 (cyclin
   D-related) (RUNX1T1), transcript variant 4, aka ZMYND2, MTG8b, AMLIT1, MGC2796,
   CBFA2T1, CDR, MTG8, ETO, ACCESSION NUMBER NM_175636.1; runt-related transcription
   factor 1, translocated to, 1 (cyclin D-related) (RUNX1T1), transcript variant 3, aka ZMYND2,
15 MTG8b, AMLIT1, MGC2796, CBFA2T1, CDR, MTG8, ETO, ACCESSION NUMBER
   NM_175635.1; runt-related transcription factor 1, translocated to, 1 (cyclin D-related) (RUNX1T1),
   transcript variant 2, aka ZMYND2, MTG8b, AMLIT1, MGC2796, CBFA2T1, CDR, MTG8, ETO,
   ACCESSION NUMBER NM_175634.1; runt-related transcription factor 1, translocated to, 1 (cyclin
   D-related) (RUNX1T1), transcript variant 1, aka ZMYND2, MTG8b, AMLIT1, MGC2796,
20 CBFA2T1, CDR, MTG8, ETO, ACCESSION NUMBER NM_004349.2; runt-related transcription
   factor 1, translocated to, 1 (cyclin D-related) (RUNX1T1), transcript variant 1, aka ZMYND2,
   MTG8b, AMLIT1, MGC2796, CBFA2T1, CDR, MTG8, ETO, ACCESSION NUMBER
   NM_004349.2; runt-related transcription factor 2 (RUNX2), transcript variant 3, aka PEBP2A2,
   MGC120023, PEA2aA, CBFA1, MGC120022, AML3, OSF2, PEBP2aA1, PEBP2A1, PEBP2aA,
25 CCD1, CCD, ACCESSION NUMBER NM_004348.3; runt-related transcription factor 2 (RUNX2),
   transcript variant 2, aka PEBP2A2, MGC120023, PEA2aA, CBFA1, MGC120022, AML3, OSF2,
   PEBP2aA1, PEBP2A1, PEBP2aA, CCD1, CCD, ACCESSION NUMBER NM_001015051.2; runt
   related transcription factor 2 (RUNX2), transcript variant 1, aka PEBP2A2, MGC120023, PEA2aA,
   CBFA1, MGC120022, AML3, OSF2, PEBP2aA1, PEBP2A1, PEBP2aA, CCD1, CCD,
30 ACCESSION NUMBER NM_001024630.2; runt-related transcription factor 3 (RUNX3), transcript
   variant 2, aka FLJ34510, MGC16070, PEBP2aC, CBFA3, AML2, ACCESSION NUMBER
   NM_004350.2; runt-related transcription factor 3 (RUNX3), transcript variant 1, aka FLJ345 10,
   MGC16070, PEBP2aC, CBFA3, AML2, ACCESSION NUMBER NM_001031680.2; retinoid X
   receptor, alpha (RXRA), aka MGC102720, FLJ16020, FLJ16733, NR2B1, ACCESSION NUMBER
35 NM_002957.3; retinoid X receptor, beta (RXRB), aka NR2B2, MGC1831, RCoR-1, H-2RIIBP,
   DAUDI6, ACCESSION NUMBER NM_021976.3; retinoid X receptor, gamma (RXRG), transcript
   variant 1, aka NR2B3, RXRC, ACCESSION NUMBER NM_006917.3; retinoid X receptor, gamma
                                                      45

   (RXRG), transcript variant 2, aka RXRC, NR2B3, ACCESSION NUMBER NM_001009598.1;
   retinoid X receptor, gamma (RXRG), transcript variant 2, aka RXRC, NR2B3, ACCESSION
   NUMBER NM_001009598.1; sal-like 1 (Drosophila) (SALLI), transcript variant 1, aka TBS,
   HSAL1, ZNF794; ACCESSION NUMBER NM_002968.2; sal-like 2 (Drosophila) (SALL2), aka
 5 FLJ10414, KIAA0360, ZNF795, HSAL2, p150(Sal2), ACCESSION NUMBER NM_005407.1;
   SATB homeobox 1 (SATB 1), ACCESSION NUMBER NM_002971.2; SATB homeobox 2
   (SATB2), aka MGC1 19474, MGC119477, KIAA1034, FLJ21474, FLJ32076, ACCESSION
   NUMBER NM_015265.1; SCAN domain containing 1 (SCANDI), transcript variant 2, aka RAZI,
   SDP1, ACCESSION NUMBER NM_033630.1; SCAN domain containing 1 (SCAND1), transcript
10 variant 1, aka RAZ1, SDP1, ACCESSION NUMBER NM_016558.2; SCAN domain containing 1
   (SCAND1), transcript variant 1, aka RAZI, SDP1, ACCESSION NUMBER NM_016558.2; sex
   comb on midleg homolog 1 (Drosophila) (SCMH1), transcript variant 2, aka Scml3, ACCESSION
   NUMBER NM_012236.2; sex comb on midleg homolog 1 (Drosophila) (SCMH1), transcript variant
   1, aka Scm13, ACCESSION NUMBER NM_001031694.1; sex comb on midleg homolog 1
15 (Drosophila) (SCMH1), transcript variant 1, aka Scml3, ACCESSION NUMBER NM_001031694.1;
   sex comb on midleg homolog 1 (Drosophila) (SCMH1), transcript variant 1, aka Scml3,
   ACCESSION NUMBER NM_001031694.1; sex comb on midleg-like 1 (Drosophila) (SCML1),
   transcript variant 1, ACCESSION NUMBER NM_001037540.1; sex comb on midleg-like 1
   (Drosophila) (SCML1), transcript variant 1, ACCESSION NUMBER NM_001037540.1; sex comb
20 on midleg-like 1 (Drosophila) (SCML1), transcript variant 1, ACCESSION NUMBER
   NM_001037540.1; sex comb on midleg-like 2 (Drosophila) (SCML2), ACCESSION NUMBER
   NM_006089.1; scratch homolog 1, zinc finger protein (Drosophila) (SCRT1), aka DKFZp547FO72,
   SCRT, ACCESSION NUMBER NM_031309.4; scratch homolog 1, zinc finger protein (Drosophila)
   (SCRTI), aka DKFZp547FO72, SCRT, ACCESSION NUMBER NM_031309.3; SEBOX homeobox
25 (SEBOX), transcript variant 1, aka OG-9, OG9X, OG9, ACCESSION NUMBER NM_001080837.1;
   SEBOX homeobox (SEBOX), transcript variant 1, aka OG-9, OG9X, OG9, ACCESSION NUMBER
   NM_001080837.1; short stature homeobox (SHOX), transcript variant 2, aka GCFX, SHOXY, SS,
   PHOG, ACCESSION NUMBER NM_006883.2; short stature homeobox (SHOX), transcript variant
   2, aka GCFX, SHOXY, SS, PHOG, ACCESSION NUMBER NM_006883.2; short stature homeobox
30 2 (SHOX2), transcript variant SHOX2a, aka OG12X, SHOT, OG12, OGI2X, ACCESSION
   NUMBER NM_006884.2; short stature homeobox 2 (SHOX2), transcript variant SHOX2a, aka
   OG12X, SHOT, OG12, OGI2X, ACCESSION NUMBER NM_006884.2; single-minded homolog 1
   (Drosophila) (SIMI), ACCESSION NUMBER NM_005068.2; single-minded homolog 2
   (Drosophila) (SIM2), transcript variant SIM2, aka MGC1 19447, SIM, ACCESSION NUMBER
35 NM_005069.2; single-minded homolog 2 (Drosophila) (SIM2), transcript variant SIM2, aka
   MGC1 19447, SIM, ACCESSION NUMBER NM_005069.2; SIX homeobox 1 (SIXI), aka BOS3,
   TIP39, DFNA23, ACCESSION NUMBER NM_005982.2; SIX homeobox 2 (SIX2), ACCESSION
                                                    46

   NUMBER NM_016932.3; sine oculis homeobox homolog 3 (Drosophila) (SIX3), aka HPE2,
   ACCESSION NUMBER NM_005413.1; SIX homeobox 4 (SIX4), aka MGC119452, MGC119453,
   MGC1 19450, AREC3, ACCESSION NUMBER NM_017420.3; SIX homeobox 5 (SIX5), aka
   DMAHP, BOR2, ACCESSION NUMBER NM_175875.3; SIX homeobox 6 (SIX6), aka
 5 MCOPCT2, OPTX2, Six9, ACCESSION NUMBER NM_007374.1; solute carrier family 26,
   member 3 (SLC26A3), aka CLD, DRA, ACCESSION NUMBER NM_000111.1; SLC2A4 regulator
   (SLC2A4RG), aka GEF, Si-1-2, Si-1-2-19, HDBP1, ACCESSION NUMBER NM_020062.3; solute
   carrier family 30 (zinc transporter), member 9 (SLC30A9), aka C4orf 1, HUEL, ZNT9, GAC63,
   ACCESSION NUMBER NM_006345.3; SMAD family member 1 (SMAD 1), transcript variant 1,
10 aka MADRI, BSP1, JV41, JV4-1, MADHI, ACCESSION NUMBER NM_005900.2; SMAD family
   member 1 (SMAD1), transcript variant 2, aka MADRI, JV41, JV4-1, MADHI, BSP1, ACCESSION
   NUMBER NM_001003688.1; SMAD family member 2 (SMAD2), transcript variant 2, aka hMAD
   2, JV18, hSMAD2, MGC22139, MGC34440, MADH2, MADR2, JV18-1, ACCESSION NUMBER
   NM_001003652.2; SMAD family member 2 (SMAD2), transcript variant 1, aka hMAD-2, JV18,
15 hSMAD2, MGC22139, MGC34440, MADH2, MADR2, JV18-1, ACCESSION NUMBER
   NM_005901.4; SMAD family member 3 (SMAD3), aka MADH3, JV15-2, HSPC193, MGC60396,
   Smad 3, HsT17436, DKFZp686J10186, DKFZP586NO721, ACCESSION NUMBER NM_005902.3;
   SMAD family member 4 (SMAD4), aka DPC4, MADH4, JIP, ACCESSION NUMBER
   NM_005359.3; SMAD family member 5 (SMAD5), transcript variant 1, aka Dwfc,
20 DKFZp78101323, MADH5, JV5-1, DKFZp781C1895, ACCESSION NUMBER NM_005903.5;
   SMAD family member 5 (SMAD5), transcript variant 1, aka Dwfc, DKFZp78101323, MADH5,
   JV5-1, DKFZp781C1895, ACCESSION NUMBER NM_005903.5; SMAD family member 5
   (SMAD5), transcript variant 2, aka Dwfc, DKFZp78101323, MADH5, JV5-1, DKFZp781C1895,
   ACCESSION NUMBER NM_001001419.1; SMAD family member 6 (SMAD6), aka MADH6,
25 HsT17432, MADH7, ACCESSION NUMBER NM_005585.3; SMAD family member 7 (SMAD7),
   aka MADH8, MADH7, FLJ16482, ACCESSION NUMBER NM_005904.2; SMAD family member
   9 (SMAD9), aka SMAD8B, MADH9, MADH6, SMAD8A, ACCESSION NUMBER NM_005905.3;
   SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
   (SMARCA4), aka SNF2L4, BRG1, SW12, SNF2, hSNF2b, BAF190, FLJ39786, SNF2-BETA,
30 SNF2LB, ACCESSION NUMBER NM_003072.2; snail homolog 3 (Drosophila) (SNAI3), aka
   SNAIL3, MGC129606, Zfp293, SMUC, ZNF293, ACCESSION NUMBER NM_178310.1; small
   nuclear RNA activating complex, polypeptide 2, 45kDa (SNAPC2), aka PTFdelta, SNAP45,
   ACCESSION NUMBER NM_003083.2; small nuclear RNA activating complex, polypeptide 5,
   l9kDa (SNAPC5), aka SNAP19, ACCESSION NUMBER NM_006049.2; small optic lobes
35 homolog (Drosophila) (SOLH), aka MGC131491, CAPN15, ACCESSION NUMBER
   NM_005632.2; SRY (sex determining region Y)-box 1 (SOXI), ACCESSION NUMBER
   NM_005986.2; SRY (sex determining region Y)-box 10 (SOX1O), aka WS4, DOM, WS2E,
                                                     47

   MGC15649, ACCESSION NUMBER NM_006941.3; SRY (sex determining region Y)-box 11
   (SOXI 1), ACCESSION NUMBER NM_003108.3; SRY (sex determining region Y)-box 13
   (SOX13), aka ICA12, MGC117216, Sox-13, SRY-box 13, ACCESSION NUMBER NM_005686.2;
   SRY (sex determining region Y)-box 14 (SOX14), aka SOX28, MGC1 19898, MGC1 19899, SRY
 5 box 14, ACCESSION NUMBER NM_004189.2; SRY (sex determining region Y)-box 15 (SOX15),
   aka SOX27, SOX26, SOX20, ACCESSION NUMBER NM_006942.1; SRY (sex determining region
   Y)-box 18 (SOX18), aka HLTS, ACCESSION NUMBER NM_018419.2; SRY (sex determining
   region Y)-box 2 (SOX2), aka ANOP3, MGC2413, MCOPS3, ACCESSION NUMBER
   NM_003106.2; SRY (sex determining region Y)-box 21 (SOX21), aka SOX25, ACCESSION
10 NUMBER NM_007084.2; SRY (sex determining region Y)-box 4 (SOX4), aka EVI16,
   ACCESSION NUMBER NM_003107.2; SRY (sex determining region Y)-box 5 (SOX5), transcript
   variant 2, aka MGC35153, L-SOX5, ACCESSION NUMBER NM_152989.2; SRY (sex determining
   region Y)-box 5 (SOX5), transcript variant 2, aka MGC35153, L-SOX5, ACCESSION NUMBER
   NM_152989.2; SRY (sex determining region Y)-box 5 (SOX5), transcript variant 1, aka MGC35153,
15 L-SOX5, ACCESSION NUMBER NM_006940.4; SRY (sex determining region Y)-box 6 (SOX6),
   transcript variant 2, aka HSSOX6, ACCESSION NUMBER NM_033326.2; SRY (sex determining
   region Y)-box 6 (SOX6), transcript variant 1, aka HSSOX6, ACCESSION NUMBER
   NM_017508.1; SRY (sex determining region Y)-box 6 (SOX6), transcript variant 1, aka HSSOX6,
   ACCESSION NUMBER NM_017508.1; SRY (sex determining region Y)-box 6 (SOX6), transcript
20 variant 1, aka HSSOX6, ACCESSION NUMBER NM_017508.1; SRY (sex determining region Y)
   box 7 (SOX7), aka MGC10895, ACCESSION NUMBER NM_031439.2; SRY (sex determining
   region Y)-box 8 (SOX8), aka MGC24837, ACCESSION NUMBER NM_014587.2; SRY (sex
   determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal) (SOX9), aka CMPD 1,
   CMD1, SRA1, ACCESSION NUMBER NM_000346.2; SpI transcription factor (SPI),
25 ACCESSION NUMBER NM_138473.2; SP140 nuclear body protein (SP140), transcript variant 1,
   aka MGC126440, LYSP100-B, LYSP100-A, ACCESSION NUMBER NM_007237.3; SP140
   nuclear body protein (SP140), transcript variant 2, aka MGC126440, LYSP100-B, LYSP100-A,
   ACCESSION NUMBER NM_001005176.1; SP140 nuclear body protein (SP140), transcript variant
   2, aka MGC126440, LYSP100-B, LYSP100-A, ACCESSION NUMBER NM_001005176.1; Sp4
30 transcription factor (SP4), aka MGC130009, SPR-1, HFIB, MGC130008, ACCESSION NUMBER
   NM_003112.3; SAM pointed domain containing ets transcription factor (SPDEF), aka bA375E1.3,
   PDEF, RP11-375E1__A.3, ACCESSION NUMBER NM_012391.1; spleen focus forming virus
   (SFFV) proviral integration oncogene spil (SPIl), transcript variant 2, aka SPI-A, SFPIl, PU.1, OF,
   SPI-1, ACCESSION NUMBER NM_003120.2; spleen focus forming virus (SFFV) proviral
35 integration oncogene spil (SPIl), transcript variant 1, aka SPI-A, SFPIl, PU.1, OF, SPI-1,
   ACCESSION NUMBER NM_001080547.1; Spi-B transcription factor (Spi-1/PU.1 related) (SPIB),
   aka SPI-B, ACCESSION NUMBER NM_003121.2; Spi-C transcription factor (Spi-1/PU.1 related)
                                                     48

   (SPIC), aka SPI-C, MGC40611, ACCESSION NUMBER NM_152323.1; sterol regulatory element
   binding transcription factor 1 (SREBF1), transcript variant 2, aka SREBP1, ACCESSION NUMBER
   NM_004176.3; sterol regulatory element binding transcription factor 1 (SREBF1), transcript variant
   1, aka SREBP1, ACCESSION NUMBER NM_001005291.1; sterol regulatory element binding
 5 transcription factor 1 (SREBF1), transcript variant 1, aka SREBP1, ACCESSION NUMBER
   NM_001005291.1; serum response factor (c-fos serum response element-binding transcription factor)
   (SRF), aka MCM1, ACCESSION NUMBER NM_003131.2; sex determining region Y (SRY), aka
   TDF, TDY, ACCESSION NUMBER NM_003140.1; suppression of tumorigenicity 18 (breast
   carcinoma) (zinc finger protein) (ST18), aka KIAA0535, ZNF387, ACCESSION NUMBER
10 NM_014682.1; signal transducer and activator of transcription 1, 91kDa (STAT1), transcript variant
   alpha, aka ISGF-3, STAT91, DKFZp686BO4100, ACCESSION NUMBER NM_007315.2; signal
   transducer and activator of transcription 1, 91kDa (STAT1), transcript variant alpha, aka ISGF-3,
   STAT91, DKFZp686BO4100, ACCESSION NUMBER NM_007315.2; signal transducer and
   activator of transcription 1, 91kDa (STAT1), transcript variant beta, aka ISGF-3, STAT91,
15 DKFZp686BO4100, ACCESSION NUMBER NM_139266.1; signal transducer and activator of
   transcription 2, 113kDa (STAT2), aka ISGF-3, STAT113, MGC59816, P113, ACCESSION
   NUMBER NM_005419.2; signal transducer and activator of transcription 3 (acute-phase response
   factor) (STAT3), transcript variant 3, aka APRF, FLJ20882, MGC16063, ACCESSION NUMBER
   NM_213662.1; signal transducer and activator of transcription 4 (STAT4), ACCESSION NUMBER
20 NM_003151.2; signal transducer and activator of transcription 5A (STAT5A), aka MGF, STAT5,
   ACCESSION NUMBER NM_003152.2; signal transducer and activator of transcription 5B
   (STAT5B), aka STAT5, ACCESSION NUMBER NM_012448.3; signal transducer and activator of
   transcription 6, interleukin-4 induced (STAT6), aka STAT6C, D12S1644, STAT6B, IL-4-STAT,
   ACCESSION NUMBER NM_003153.3; striatin, calmodulin binding protein 3 (STRN3), transcript
25 variant 2, aka SG2NA, ACCESSION NUMBER NM_014574.3; suppressor of Ty 6 homolog (S.
   cerevisiae) (SUPT6H), aka MGC87943, SPT6H, KIAA0162, SPT6, emb-5, ACCESSION NUMBER
   NM_003170.3; T, brachyury homolog (mouse) (T), aka TFT, MGC104817, ACCESSION NUMBER
   NM_003181.2; transcriptional adaptor 2 (ADA2 homolog, yeast)-like (TADA2L), transcript variant
   2, aka KLO4P, FLJ12705, ADA2, hADA2, ACCESSION NUMBER NM_133439.2; transcriptional
30 adaptor 2 (ADA2 homolog, yeast)-like (TADA2L), transcript variant 1, aka KLO4P, FLJ12705,
   ADA2, hADA2, ACCESSION NUMBER NM_001488.3; transcriptional adaptor 2 (ADA2 homolog,
   yeast)-like (TADA2L), transcript variant 1, aka KLO4P, FLJ12705, ADA2, hADA2, ACCESSION
   NUMBER NM_001488.3; transcriptional adaptor 3 (NGG1 homolog, yeast)-like (TADA3L),
   transcript variant 1, aka hADA3, FLJ20221, FLJ21329, ADA3, ACCESSION NUMBER
35 NM_006354.2; transcriptional adaptor 3 (NGG1 homolog, yeast)-like (TADA3L), transcript variant
   2, aka hADA3, FLJ20221, FLJ21329, ADA3, ACCESSION NUMBER NM_133480.1; TAF1O
   RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa (TAF1O), aka
                                                     49

   TAF2H, TAF2A, TAF1130, ACCESSION NUMBER NM_006284.2; TAF13 RNA polymerase II,
   TATA box binding protein (TBP)-associated factor, l8kDa (TAF13), aka TAFII18, MGC22425,
   TAF2K, ACCESSION NUMBER NM_005645.3; TATA box binding protein (TBP)-associated
   factor, RNA polymerase I, B, 63kDa (TAF1B), aka RAF1B, SLI, RAFI63, TAFI63, MGC:9349,
 5 ACCESSION NUMBER NM_005680.1; TAF4 RNA polymerase II, TATA box binding protein
   (TBP)-associated factor, 135kDa (TAF4), aka TAFII135, TAF2C1, TAF4A, TAF11130, FLJ41943,
   TAF2C, ACCESSION NUMBER NM_003185.3; TAF5 RNA polymerase II, TATA box binding
   protein (TBP)-associated factor, 100kDa (TAF5), aka TAFII100, TAF2D, ACCESSION NUMBER
   NM_006951.3; TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated
10 factor, 65kDa (TAF5L), transcript variant 1, mRNA aka PAF65B, ACCESSION NUMBER
   NM_0144093; TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated
   factor, 65kDa (TAF5L), transcript variant 2, mRNA aka PAF65B, ACCESSION NUMBER
   NM_0010252471; TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor,
   80kDa (TAF6), transcript variant 2, mRNA aka MGC:8964, DKFZp781E21155, TAF2E, TAFII80,
15 TAFII85, TAFII70, ACCESSION NUMBER NM_1393151; TAF6 RNA polymerase II, TATA box
   binding protein (TBP)-associated factor, 8OkDa (TAF6), transcript variant 1, mRNA aka MGC:8964,
   DKFZp781E21155, TAF2E, TAFII80, TAFII85, TAFII70, ACCESSION NUMBER NM_0056412;
   TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa (TAF7) aka
   TAFII55, TAF2F, ACCESSION NUMBER NM_0056422; TAF7-like RNA polymerase II, TATA
20 box binding protein (TBP)-associated factor, 50kDa (TAF7L) aka TAF2Q, dJ738A131, FLJ23157,
   ACCESSION NUMBER NM_0248852; T-cell acute lymphocytic leukemia 1 (TALl) aka tal-1,
   SCL, TCL5, ACCESSION NUMBER NM_0031891; TAR DNA binding protein (TARDBP) aka
   TDP-43, ACCESSION NUMBER NM_0073753; TATA box binding protein (TBP) aka
   MGC126055, SCA17, MGC117320, MGC126054, TFIID, GTF2D1, GTF2D, ACCESSION
25 NUMBER NM_0031943; TATA box binding protein like 2 (TBPL2) aka TRF3, TBP2,
   ACCESSION NUMBER NM_1990472; T-box, brain, 1 (TBRI) aka TES-56, MGC141978,
   ACCESSION NUMBER NM_0065932; T-box 1 (TBX1), transcript variant A aka VCFS, TGA,
   DORV, CTHM, TBX1C, DGS, CAFS, DGCR, ACCESSION NUMBER NM_0806461; T-box 1
   (TBX1), transcript variant B aka VCFS, TGA, DORV, CTHM, TBX1C, DGS, CAFS, DGCR,
30 ACCESSION NUMBER NM_0059921; T-box 1 (TBX1), transcript variant B aka VCFS, TGA,
   DORV, CTHM, TBX1C, DGS, CAFS, DGCR, ACCESSION NUMBER NM_0059921; T-box 1
   (TBX1), transcript variant C aka VCFS, TGA, DORV, CTHM, TBX1C, DGS; CAFS; DGCR,
   ACCESSION NUMBER NM_0806471; T-box 10 (TBX1O), mRNA aka TBX7; TBX13,
   ACCESSION NUMBER NM_0059952; T-box 15 (TBX15), mRNA aka TBX14, ACCESSION
35 NUMBER NM_1523802; T-box 18 (TBX18), ACCESSION NUMBER NM_0010805081; T-box 18
   (TBX18), ACCESSION NUMBER NM_0010805081; T-box 19 (TBX19), aka TBS 19, FLJ26302,
   TPIT, FLJ34543, dJ747L41, TBS19, ACCESSION NUMBER NM_0051491; T-box 2 (TBX2) aka
                                                   50

   FLJ10169, ACCESSION NUMBER NM_0059943; T-box 20 (TBX20), transcript variant 2 aka
   ASD4, ACCESSION NUMBER NM_0204171; T-box 20 (TBX20), transcript variant 1 aka ASD4,
   ACCESSION NUMBER NM_0010776531; T-box 21 (TBX21) aka TBLYM, TBET, T-PET, T-bet,
   ACCESSION NUMBER NM_0133511; T-box 22 (TBX22), transcript variant 2 aka TBXX,
 5 dJ795G231, CLPA, ACCESSION NUMBER NM_0169542; T-box 3 (ulnar mammary syndrome)
   (TBX3), transcript variant 2 aka UMS, XHL, TBX3-ISO, ACCESSION NUMBER NM_0165693; T
   box 3 (TBX3), transcript variant 1 aka    UMS, XHL, TBX3-ISO, ACCESSION NUMBER
   NM_0059963; T-box 4 (TBX4) aka SPS, ACCESSION NUMBER NM_0184882; T-box 5 (TBX5),
   transcript variant 4 aka HOS, ACCESSION NUMBER NM_1814861; T-box 5 (TBX5), transcript
10 variant 1 aka HOS, ACCESSION NUMBER NM_0001923; T-box 5 (TBX5), transcript variant 3 aka
   HOS, ACCESSION NUMBER NM_0807172; T-box 6 (TBX6), transcript variant 2 aka DFNB67,
   ACCESSION NUMBER NM_0807581; T-box 6 (TBX6), transcript variant 1 aka DFNB67,
   ACCESSION NUMBER NM_0046082; T-box 6 (TBX6), transcript variant 1 aka DFNB67,
   ACCESSION NUMBER NM_0046082; transcription elongation factor A (SII)-like 1 (TCEAL1),
15 transcript variant 2 aka SIIR; p21, pp2l, ACCESSION NUMBER NM_0010066391; transcription
   elongation factor A (SII)-like 1 (TCEAL1), transcript variant 3 aka SIIR; p21, pp2l, ACCESSION
   NUMBER NM_0010066401; transcription factor 1, hepatic; LF-B1, hepatic nuclear factor (HNF1),
   albumin proximal factor (TCF1) aka MODY3, HNF1, HNF1A, LFBI, ACCESSION NUMBER
   NM_0005453; transcription factor 15 (basic helix-loop-helix) (TCF15) aka EC2, PARAXIS,
20 ACCESSION NUMBER NM_0046093; transcription factor 19 (SCI) (TCF19), transcript variant 1
   aka SCI, SC1-1, ACCESSION NUMBER NM_0071092; transcription factor 19 (SCI) (TCF19),
   transcript variant 2 aka SCI, SC1-1, ACCESSION NUMBER NM_0010775111; transcription factor
   2, hepatic; LF-B3, variant hepatic nuclear factor (TCF2), transcript variant b, aka VHNF1, MODY5,
   HNF2, HNFIB, FJHN, HNFlbeta, LFB3, ACCESSION NUMBER NM_0064811; transcription
25 factor 2, hepatic, LF-B3; variant hepatic nuclear factor (TCF2), transcript variant a aka VHNF1,
   MODY5, HNF2, HNFIB, FJHN, HNFlbeta, LFB3, ACCESSION NUMBER NM_0004581;
   transcription factor 2, hepatic, LF-B3, variant hepatic nuclear factor (TCF2), transcript variant a aka
   VHNF1, MODY5, HNF2, HNFIB, FJHN, HNFlbeta, LFB3, ACCESSION NUMBER
   NM_0004581; transcription factor 21 (TCF21), transcript variant 1 aka PODI, ACCESSION
30 NUMBER NM_1983921; transcription factor 21 (TCF21), transcript variant 1 aka PODI,
   ACCESSION NUMBER NM_1983921; transcription factor 21 (TCF21), transcript variant 2 aka
   POD1, ACCESSION NUMBER NM_0032062; transcription factor 25 (basic helix-loop-helix)
   (TCF25) aka hKIAA1049, NULPI, PR02620, Hulp1, FKSG26, KIAA1049, ACCESSION
   NUMBER NM_0149721; transcription factor 3 (E2A immunoglobulin enhancer binding factors
35 E12/E47) (TCF3) aka MGC129648, MGC129647, ITFI,            E2A, ACCESSION NUMBER
   NM_0032001; transcription factor 7-like 1 (T-cell specific, HMG-box) (TCF7L1) aka TCF-3, TCF3,
   ACCESSION NUMBER NM_0312831; transcription factor 7-like 2 (T-cell specific, HMG-box)
                                                      51

   (TCF7L2) aka TCF-4, TCF4, ACCESSION NUMBER NM_0307562; transcription factor-like 5
   (basic helix-loop-helix) (TCFL5) aka MGC46135, E2BP-1, CHA, Figlb, ACCESSION NUMBER
   NM_0066022; TEA domain family member 1 (SV40 transcriptional enhancer factor) (TEAD 1) aka
   AA, REF1, TCF13, TEF-i, ACCESSION NUMBER NM_0219614; TEA domain family member 1
 5 (SV40 transcriptional enhancer factor) (TEADi) aka AA, REF1, TCF13, TEF-i, ACCESSION
   NUMBER NM_0219614; TEA domain family member 2 (TEAD2) aka ETF, TEF-4, TEF4,
   ACCESSION NUMBER NM_0035981; TEA domain family member 3 (TEAD3) aka TEF-5,
   DTEF-1, TEF5, TEAD5, ETFR-1, ACCESSION NUMBER NM_0032143; TEA domain family
   member 4 (TEAD4), transcript variant 1 aka RTEF-1, MGC9014, TEF-3, TEFR-1, EFTR-2,
10 TCF13L1, hRTEF-1B, RTEF1, ACCESSION NUMBER NM_0032132; TEA domain family
   member 4 (TEAD4), transcript variant 3 aka RTEF-1, MGC9014, TEF-3, TEFR-1, EFTR-2,
   TCF13L1, hRTEF-1B, RTEF1, ACCESSION NUMBER NM_2014431; TEA domain family
   member 4 (TEAD4), transcript variant 3 aka RTEF-1, MGC9014, TEF-3, TEFR-1, EFTR-2,
   TCF13L1, hRTEF-1B, RTEF1, ACCESSION NUMBER NM_2014431; thyrotrophic embryonic
15 factor (TEF) aka ACCESSION NUMBER NM_0032162; transcription factor A, mitochondrial
   (TFAM), nuclear gene encoding mitochondrial protein aka MtTF1, mtTFA, TCF6, TCF6L2,
   ACCESSION NUMBER NM_0032011; transcription factor AP-2 alpha (activating enhancer binding
   protein 2 alpha) (TFAP2A), transcript variant 2 aka TFAP2, AP-2, AP2TF, AP-2alpha, ACCESSION
   NUMBER NM_0010322802; transcription factor AP-2 alpha (activating enhancer binding protein 2
20 alpha) (TFAP2A), transcript variant 2 aka TFAP2, AP-2, AP2TF, AP-2alpha, ACCESSION
   NUMBER NM_0010322802; transcription factor AP-2 alpha (activating enhancer binding protein 2
   alpha) (TFAP2A), transcript variant 3 aka TFAP2, AP-2, AP2TF, AP-2alpha, ACCESSION
   NUMBER NM_0010424251; transcription factor AP-2 alpha (activating enhancer binding protein 2
   alpha) (TFAP2A), transcript variant 1 aka TFAP2, AP-2, AP2TF, AP-2alpha, ACCESSION
25 NUMBER NM_0032202; transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
   (TFAP2B) aka MGC21381, AP-2B, AP2-B, ACCESSION NUMBER NM_0032213; transcription
   factor AP-2 gamma (activating enhancer binding protein 2 gamma) (TFAP2C) aka AP2-GAMMA,
   TFAP2G, hAP-2g, ERF1, ACCESSION NUMBER NM_0032223; transcription factor AP-2 delta
   (activating enhancer binding protein 2 delta) (TFAP2D) aka TFAP2BL1, ACCESSION NUMBER
30 NM_1722383; transcription factor AP-2 epsilon (activating enhancer binding protein 2 epsilon)
   (TFAP2E) aka MGC49007, AP2E, ACCESSION NUMBER NM_1785482; transcription factor AP
   4 (activating enhancer binding protein 4) (TFAP4) aka AP-4, ACCESSION NUMBER
   NM_0032231; transcription factor CP2 (TFCP2) aka LBP-1C, LSF, CP2, TFCP2C, SEF,
   ACCESSION NUMBER NM_0056533; transcription factor CP2-like 1 (TFCP2L1) aka LBP-9,
35 LBP9, CRTR1, ACCESSION NUMBER NM_0145531; transcription factor Dp-1 (TFDP1) aka DPI,
   DRTF1, Dp-1, ACCESSION NUMBER NM_0071113; transcription factor Dp-2 (E2F dimerization
   partner 2) (TFDP2) aka Dp-2, DP2, ACCESSION NUMBER NM_0062861; transcription factor Dp
                                                    52

   family, member 3 (TFDP3) aka E2F-like, MGC161639, HCA661, CT30, ACCESSION NUMBER
   NM_0165212; transcription factor binding to IGHM enhancer 3 (TFE3) aka RCCP2, TFEA,
   ACCESSION NUMBER NM_0065213; transcription factor EB (TFEB) aka AlphaTFEB, TCFEB,
   ACCESSION NUMBER NM_0071621; transcription factor EC (TFEC), transcript variant 1 aka
 5 TCFEC, TFECL, ACCESSION NUMBER NM_0122522; transcription factor EC (TFEC), transcript
   variant 1 aka TCFEC, TFECL, ACCESSION NUMBER NM_0122522; TGFB-induced factor
   homeobox 1 (TGIF1), transcript variant 4 aka HPE4, MGC5066, MGC39747, TGIF, ACCESSION
   NUMBER NM_0032442; TGFB-induced factor homeobox 1 (TGIF1), transcript variant 5 aka
   HPE4, MGC5066, MGC39747, TGIF, ACCESSION NUMBER NM_1732091; TGFB-induced
10 factor homeobox 1 (TGIF1), transcript variant 1 aka HPE4, MGC5066, MGC39747, TGIF,
   ACCESSION NUMBER NM_1706952; TGFB-induced factor homeobox 1 (TGIF1), transcript
   variant 1 aka HPE4, MGC5066, MGC39747, TGIF, ACCESSION NUMBER NM_1706952; TGFB
   induced factor homeobox 1 (TGIF1), transcript variant 8 aka HPE4, MGC5066, MGC39747, TGIF,
   ACCESSION NUMBER NM_1748861; TGFB-induced factor homeobox 1 (TGIF1), transcript
15 variant 2 aka HPE4, MGC5066, MGC39747, TGIF, ACCESSION NUMBER NM_1732071; TGFB
   induced factor homeobox 2 (TGIF2), ACCESSION NUMBER NM_0218095; thyroid hormone
   receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) (THRA), transcript
   variant 1 aka NR1A1, THRA1, THRA2, ERB-T-1, ERBA, ERBA1, c-ERBA-1, AR7, MGC43240,
   MGCO00261, EAR7, ACCESSION NUMBER NM_1993342; thyroid hormone receptor, alpha
20 (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) (THRA), transcript variant 2 aka
   NR1A1, THRA, THRA2, ERB-T-1, ERBA, ERBA1, c-ERBA-1, AR7, MGC43240, MGCO00261,
   EAR7, ACCESSION NUMBER NM_0032504; thyroid hormone receptor, alpha (erythroblastic
   leukemia viral (v-erb-a) oncogene homolog, avian) (THRA), transcript variant 2 aka NR1A1,
   THRA1, THRA2, ERB-T-1, ERBA, ERBA1, c-ERBA-1, AR7, MGC43240, MGCO00261, EAR7,
25 ACCESSION NUMBER NM_0032504; thyroid hormone receptor, beta (erythroblastic leukemia
   viral (v-erb-a) oncogene homolog 2, avian) (THRB) aka MGC126110, THRI, THRB1, GRTH,
   ERBA-BETA, MGC126109, ERBA2, THRB2, NR1A2, ACCESSION NUMBER NM_0004613; T
   cell leukemia homeobox 1 (TLX1) aka MGC163402, TCL3, HOX 11, ACCESSION NUMBER
   NM_0055212; T-cell leukemia homeobox 2 (TLX2) aka HOXI ILl, NCX, Enx, ACCESSION
30 NUMBER NM_0161703; T-cell leukemia homeobox 2 (TLX2) aka HOX1IL1, NCX, Enx,
   ACCESSION NUMBER NM_0161703; T-cell leukemia homeobox 3 (TLX3), aka RNX,
   MGC29804, HOX 1L2, ACCESSION NUMBER NM_0210252; trinucleotide repeat containing 4
   (TNRC4), aka MGC57297, CAGH4, BRUNOL1, CELF3, ERDA4, ACCESSION NUMBER
   NM_0071853; tumor protein p73 (TP73), aka P73, ACCESSION NUMBER NM_0054271; tumor
35 protein p73-like (TP73L), aka TP63, EEC3, p63, B(p51B), p73H, p51, SHFM4, OFC8, RHS, KET,
   B(p51A), LMS, p73L, ACCESSION NUMBER NM_0037223; tetra-peptide repeat homeobox 1
   (TPRX1), aka FLJ40321, TPRX, ACCESSION NUMBER NM_1984792; transcriptional regulating
                                                      53

   factor 1 (TRERF1), aka RP1-139D85, dJ139D85, HSA277276, RAPA, TReP-132, BCAR2,
   ACCESSION NUMBER NM_0335021; transcriptional regulating factor 1 (TRERF1), aka RP1
   139D85, dJ139D85, HSA277276, RAPA, TReP-132, BCAR2, ACCESSION NUMBER
   NM_0335021; transcriptional regulating factor 1 (TRERF1), aka RP1-139D85, dJ139D85,
 5 HSA277276, RAPA, TReP-132, BCAR2, ACCESSION NUMBER NM_0335021; tripartite motif
   containing 15 (TRIM15), transcript variant 2, aka ZNF178, ZNFB7, RNF93, ACCESSION
   NUMBER NM_0528121; tripartite motif-containing 15 (TRIM15), transcript variant 1, aka ZNF178,
   ZNFB7, RNF93, ACCESSION NUMBER NM_0332291; tripartite motif-containing 15 (TRIM15),
   aka ZNF178, ZNFB7, RNF93, ACCESSION NUMBER NM_0332292; tripartite motif-containing 16
10 (TRIM16), aka EBBP, ACCESSION NUMBER NM_0064703; tripartite motif-containing 22
   (TRIM22), aka STAF50, RNF94, GPSTAF50, ACCESSION NUMBER NM_0060743; tripartite
   motif-containing 25 (TRIM25), aka Z147, ZNF147, EFP, RNF147, ACCESSION NUMBER
   NM_0050824; tripartite motif-containing 28 (TRIM28), aka FLJ29029, TIFIB, RNF96, TFIB,
   KAPI, ACCESSION NUMBER NM_0057622; tripartite motif-containing 29 (TRIM29), aka
15 FLJ36085, ATDC, ACCESSION NUMBER NM_0121013; tripartite motif-containing 29 (TRIM29),
   aka FLJ36085, ATDC, ACCESSION NUMBER NM_0121013; trichorhinophalangeal syndrome I
   (TRPS1), aka MGC134928, GC79, ACCESSION NUMBER NM_0141122; TSC22 domain family,
   member 1 (TSC22D1), transcript variant 2, aka TSC22, TGFB 114, RP11-269C232,
   DKFZp686019206, MGC17597, ACCESSION NUMBER NM_0060222; TSC22 domain family,
20 member 1 (TSC22D1), transcript variant 1, aka TSC22, RP11-269C232, DKFZp686019206,
   TGFB1I4, MGC17597, ACCESSION NUMBER NM_1834221; TSC22 domain family, member 1
   (TSC22D1), transcript variant 1, aka TSC22, RP11-269C232, DKFZp686019206, TGFB1I4,
   MGC17597, ACCESSION NUMBER NM_1834221; TSC22 domain family, member 2 (TSC22D2),
   aka KIAA0669, TILZ4a, TILZ4c, TILZ4b, ACCESSION NUMBER NM_0147792; TSC22 domain
25 family, member 3 (TSC22D3), transcript variant 2, aka hDIP, DIP, DKFZp313A1 123, DSIPI, TSC
   22R, GILZ, ACCESSION NUMBER NM_0040893; TSC22 domain family, member 3 (TSC22D3),
   transcript variant 2, aka hDIP, DIP, DKFZp313A1 123, DSIPI, TSC-22R, GILZ, ACCESSION
   NUMBER NM_0040893; TSC22 domain family, member 3 (TSC22D3), transcript variant 3, aka
   hDIP, DIP, DKFZp313A1123, DSIPI, TSC-22R, GILZ, ACCESSION NUMBER NM_0010158811;
30 TSC22 domain family, member 3 (TSC22D3), transcript variant 1, aka hDIP, DIP,
   DKFZp313A1 123, DSIPI, TSC-22R, GILZ, ACCESSION NUMBER NM_1980572; TSC22 domain
   family, member 3 (TSC22D3), transcript variant 1, aka hDIP, DIP, DKFZp313A1 123, DSIPI, TSC
   22R, GILZ, ACCESSION NUMBER NM_1980572; TSC22 domain family, member 4 (TSC22D4),
   aka THG-1, ACCESSION NUMBER NM_0309353; teashirt zinc finger homeobox 1 (TSHZ1), aka
35 TSH1, SDCCAG33, NY-CO-33, ACCESSION NUMBER NM_0057864; teashirt zinc finger
   homeobox 2 (TSHZ2), aka C20orfl7, OVC10-2, TSH2, ZNF218, FLJ33887, DKFZp686K2480,
   ZABC2, ACCESSION NUMBER NM_1734854; teashirt zinc finger homeobox 3 (TSHZ3), aka
                                                    54

   ZNF537, TSH3, KIAA1474, ACCESSION NUMBER NM_0208562; tubby like protein 4 (TULP4),
   transcript variant 2, aka TUSP, RP3-442A171, KIAA1397, ACCESSION NUMBER
   NM_0010074661; tubby like protein 4 (TULP4), transcript variant 1, aka TUSP, RP3-442A171,
   KIAA1397, ACCESSION NUMBER NM_0202453; tubby like protein 4 (TULP4), transcript variant
 5 1, aka TUSP, RP3-442A171, KIAA1397, ACCESSION NUMBER NM_0202453; ubinuclein 1
   (UBN1), transcript variant 2, aka VT4, VT, ACCESSION NUMBER NM_0010795141; ubinuclein 1
   (UBN1), transcript variant 2, aka VT4, VT, ACCESSION NUMBER NM_0010795141; upstream
   binding protein 1 (LBP-la) (UBP1), aka LBP-1B, LBPlA, LBPlB, LBP-la, DKFZp686L1745,
   ACCESSION NUMBER NM_0145173; ubiquitin-like with PHD and ring finger domains 1
10 (UHRF1), transcript variant 2, aka Np95, hNP95, MGC138707, ICBP90, RNF106, FLJ21925,
   ACCESSION NUMBER NM_0132823; UNC homeobox (UNCX), aka UNCX41, ACCESSION
   NUMBER NM_0010804611; upstream transcription factor 1 (USF1), transcript variant 2, aka
   HYPLIPI, FCHLI, MLTF, FCHL, UEF, MLTFI, ACCESSION NUMBER NM_2070051; upstream
   transcription factor 1 (USF1), transcript variant 1, aka HYPLIPI, FCHLI, MLTF, FCHL, UEF,
15 MLTFI, ACCESSION NUMBER NM_0071223; upstream transcription factor 2, c-fos interacting
   (USF2), transcript variant 2, aka FIP, ACCESSION NUMBER NM_2072911; upstream transcription
   factor 2, c-fos interacting (USF2), transcript variant 2, aka FIP, ACCESSION NUMBER
   NM_2072911; upstream transcription factor 2, c-fos interacting (USF2), transcript variant 1, aka FIP,
   ACCESSION NUMBER NM_0033672; vav 1 guanine nucleotide exchange factor (VAVI), aka
20 VAV, ACCESSION NUMBER NM_0054282; ventral anterior homeobox 1 (VAX1) aka
   MGC126745, MGC126743, ACCESSION NUMBER NM_1991311; ventral anterior homeobox 2
   (VAX2) aka DRES93, ACCESSION NUMBER NM_0124761; vitamin D (1,25- dihydroxyvitamin
   D3) receptor (VDR), transcript variant 2 aka NR1Il, ACCESSION NUMBER NM_0010175351;
   vitamin D (1,25- dihydroxyvitamin D3) receptor (VDR), transcript variant 1 aka NR1Il,
25 ACCESSION NUMBER NM_0003762; VENT homeobox homolog (Xenopus laevis) (VENTX) aka
   HPX42B, MGC119910, MGC119911, VENTX2, NA88A, ACCESSION NUMBER NM_0144682;
   vacuolar protein sorting 72 homolog (S aka cerevisiae) (VPS72) aka TCFL1, Swc2, YL1, CFLl, YL
   1, ACCESSION NUMBER NM_0059971; visual system homeobox 1 (VSX1), transcript variant 1
   aka RINX, PPD, KTCN, PPCD, ACCESSION NUMBER NM_0145884; visual system homeobox 1
30 (VSX1), transcript variant 1 aka RINX, PPD, KTCN, PPCD, ACCESSION NUMBER
   NM_0145884; visual system homeobox 1 (VSX1), transcript variant 2 aka RINX, PPD, KTCN,
   PPCD, ACCESSION NUMBER NM_1994251; Wilms tumor 1 (WTI), transcript variant A aka
   GUD, WT33, WAGR, WIT-2, ACCESSION NUMBER NM_0003783; Wilms tumor 1 (WT1),
   transcript variant D aka GUD, WT33, WAGR, WIT-2, ACCESSION NUMBER NM_0244263; X
35 box binding protein 1 (XBP1), transcript variant 1 aka TREB5, XBP2, ACCESSION NUMBER
   NM_0050802; X-box binding protein 1 (XBP1), transcript variant 2 aka TREB5, XBP2,
   ACCESSION NUMBER NM_0010795391; YEATS domain containing 4 (YEATS4) aka
                                                       55

   B230215MIORik, GAS41, NUBI-I, YAF9, 4930573H17Rik, ACCESSION NUMBER
   NM_0065302; YY1 transcription factor (YY1) aka UCRBP, YIN-YANG-1, DELTA, NF-El,
   ACCESSION NUMBER NM_0034033; zinc finger and BTB domain containing 17 (ZBTB17) aka
   ZNF60, pHZ-67, ZNF151, MIZ-1, ACCESSION NUMBER NM_0034431; zinc finger and BTB
 5 domain containing 25 (ZBTB25) aka KUP, ZNF46, ACCESSION NUMBER NM_0069772; zinc
   finger and BTB domain containing 38 (ZBTB38) aka FLJ31131, FLJ22332, FLJ35036,
   ACCESSION NUMBER NM_0010804121; zinc finger and BTB domain containing 48 (ZBTB48)
   aka pp9964, HKR3, ACCESSION NUMBER NM_0053411; zinc finger CCCH-type containing 8
   (ZC3H8) aka Flizi, ZC3HDC8, ACCESSION NUMBER NM_0324941; zinc finger E-box binding
10 homeobox 1 (ZEB1) aka NIL-2A, ZFHEP, ZEB, BZP, NIL-2-A, AREB6, MGC133261, TCF8,
   ZFHXIA, ACCESSION NUMBER NM_0307513; zinc finger E-box binding homeobox 2 (ZEB2)
   aka KIAA0569, SMADIPI, ZFHXIB, SIPI, SIP-1, ACCESSION NUMBER NM_0147952; zinc
   finger homeobox 3 (ZFHX3) aka ATBF1, ZFHX3, ATBT, ACCESSION NUMBER NM_0068853;
   zinc finger homeobox 4 (ZFHX4) aka ZHF4, ZFH4, ZFH-4, FLJ20980, FLJ16514, ACCESSION
15 NUMBER NM_0247213; zinc finger protein 36, C3H type-like 1 (ZFP36LI) aka TIS11B, Berg36,
   cMGI, ERF1, BRF1, RNF162B, ERF-I, ACCESSION NUMBER NM_0049262; zinc finger protein
   36, C3H type-like 2 (ZFP36L2) aka ERF2, ERF-2, TISI1D, RNF162C, BRF2, ACCESSION
   NUMBER NM_0068873; zinc finger protein 37 homolog (mouse) (ZFP37) aka FLJ38524,
   ACCESSION NUMBER NM_0034081; zinc finger protein 42 homolog (mouse) (ZFP42) aka
20 REX1, ZNF754, ACCESSION NUMBER NM_1749003; zinc finger protein 95 homolog (mouse)
   (ZFP95), transcript variant 1 aka MGC33710, KIAA1015, ACCESSION NUMBER NM_0145692;
   zinc finger, CCCH-type with G patch domain (ZGPAT), transcript variant 3, aka RP4-583P153,
   GPATC6, ZC3H9, ZC3HDC9, MGC44880, KIAA1847, GPATCH6, ACCESSION NUMBER
   NM_1814851; zinc finger, CCCH-type with G patch domain (ZGPAT), transcript variant 2 aka RP4
25 583P153, GPATC6, ZC3H9, ZC3HDC9, MGC44880, KIAA1847, GPATCH6, ACCESSION
   NUMBER NM_1814841; zinc finger, CCCH-type with G patch domain (ZGPAT), transcript variant
   1 aka RP4-583P153, GPATC6, ZC3H9, ZC3HDC9, MGC44880, KIAA1847, GPATCH6,
   ACCESSION NUMBER NM_0325272; zinc finger, CCCH-type with G patch domain (ZGPAT),
   transcript variant 1 aka RP4-583P153, GPATC6, ZC3H9, ZC3HDC9, MGC44880, KIAA1847,
30 GPATCH6, ACCESSION NUMBER NM_0325273; zinc fingers and homeoboxes 1 (ZHX1),
   transcript variant 2, ACCESSION NUMBER NM_0072223; zinc fingers and homeoboxes 1 (ZHX 1),
   transcript variant 2, ACCESSION NUMBER NM_0072223; zinc fingers and homeoboxes 1 (ZHX 1),
   transcript variant 1, ACCESSION NUMBER NM_0010179261; zinc fingers and homeoboxes 2
   (ZHX2) aka KIAA0854, ACCESSION NUMBER NM_0149433; zinc fingers and homeoboxes 3
35 (ZHX3) aka KIAA0395, TIXI, ACCESSION NUMBER NM_0150353; Zic family member 1 (odd
   paired homolog, Drosophila) (ZICI) aka ZNF201, ZIC, ACCESSION NUMBER NM_0034123; Zic
   family member 3 heterotaxy 1 (odd-paired homolog, Drosophila) (ZIC3) aka      HTXI, ZNF203,
                                                 56

   HTX, ACCESSION NUMBER NM_0034132; zinc finger with KRAB and SCAN domains 1
   (ZKSCAN1) aka MGC138429, 9130423L19Rik, KOX18, ZNF139, PHZ-37, ZNF36, ACCESSION
   NUMBER NM_0034391; zinc finger with KRAB and SCAN domains 2 (ZKSCAN2) aka ZNF694,
   ZSCAN31, FLJ23199, ACCESSION NUMBER NM_0010129813; zinc finger with KRAB and
 5 SCAN domains 3 (ZKSCAN3) aka ZSCAN13, ZF47, dJ874C201, ZFP306, KIAA0426, Zfp47,
   ZNF309, FLJ33906, ZNF306, ACCESSION NUMBER NM_024491; zinc finger with KRAB and
   SCAN domains 4 (ZKSCAN4) aka FLJ32136, ZNF307, p373c61, P1P373C6, ACCESSION
   NUMBER NM_0191103; zinc finger with KRAB and SCAN domains 5 (ZKSCAN5), transcript
   variant 2 aka ZFP95, FLJ39233, MGC33710, KIAA1015, ACCESSION NUMBER NM_1451022;
10 zinc finger with KRAB and SCAN domains 5 (ZKSCAN5), transcript variant 2 aka ZFP95,
   FLJ39233, MGC33710, KIAA1015, ACCESSION NUMBER NM_1451022; zinc finger protein 117
   (ZNF1 17) aka HPF9, ACCESSION NUMBER NM_0244981; zinc finger protein 117 (ZNF1 17) aka
   H-plk, MGC22613, HPF9, ACCESSION NUMBER NM_0158523; zinc finger protein 131
   (ZNF131) aka pHZ-10, ACCESSION NUMBER NM_0034321; zinc finger protein 132 (ZNF132)
15 aka MGC126390, pHZ-12, MGC126391, ACCESSION NUMBER NM_0034332; zinc finger
   protein 133 (ZNF133) aka ZNF150, pHZ-13, pHZ-66, ACCESSION NUMBER NM_0034343; zinc
   finger protein 134 (ZNF134) aka MGC141970, pHZ-15, MGC138499, ACCESSION NUMBER
   NM_0034352; zinc finger protein 135 (ZNF135) aka ZNF61, pT3, pHZ-17, ZNF78L1, ACCESSION
   NUMBER NM_0034362; zinc finger protein 137 (ZNF137) aka pHZ-30, MGC 119991,
20 MGC1 19990, ACCESSION NUMBER NM_0034382; zinc finger protein 140 (ZNF140) aka pHZ
   39, ACCESSION NUMBER NM_0034402; zinc finger protein 142 (ZNF142), transcript variant 2
   aka pHZ-49, ACCESSION NUMBER NM_0050812; zinc finger protein 155 (ZNF155), transcript
   variant 1 aka MGC161655, pHZ-96, ACCESSION NUMBER NM_0034452; zinc finger protein 155
   (ZNF155), transcript variant 1 aka MGC161655, pHZ-96, ACCESSION NUMBER NM_0034452;
25 zinc finger protein 155 (ZNF155), transcript variant 2 aka MGC161655, pHZ-96, ACCESSION
   NUMBER NM_1980891; zinc finger protein 157 (ZNF157) aka HZF22, ACCESSION NUMBER
   NM_0034463; zinc finger protein 165 (ZNF165) aka ZSCAN7, LD65, ACCESSION NUMBER
   NM_0034472; zinc finger protein 167 (ZNF167), transcript variant 2 aka FLJ12738, ZNF64, ZFP,
   ZNF448, ZKSCAN7, ACCESSION NUMBER NM_0251691; zinc finger protein 167 (ZNF167),
30 transcript variant 1 aka FLJ12738, ZNF64, ZFP, ZNF448, ZKSCAN7, ACCESSION NUMBER
   NM_0186512; zinc finger protein 167 (ZNF167), transcript variant 1 aka FLJ12738, ZNF64, ZFP,
   ZNF448, ZKSCAN7, ACCESSION NUMBER NM_0186512; zinc finger protein 169 (ZNF169) aka
   MGC51961, ACCESSION NUMBER NM_1943202; zinc finger protein 174 (ZNF174), transcript
   variant 2 aka ZSCAN8, ACCESSION NUMBER NM_0010322921; zinc finger protein 174
35 (ZNF174), transcript variant 2, aka ZSCAN8, ACCESSION NUMBER NM_0010322921; zinc
   finger protein 174 (ZNF174), transcript variant 1, aka ZSCAN8, ACCESSION NUMBER
   NM_0034501; zinc finger protein 175 (ZNF175), aka OTK18, ACCESSION NUMBER
                                                     57

   NM_0071472; zinc finger protein 18 (ZNF18), aka KOXI1, ZKSCAN6, HDSG1, ZNF535, Zfp535,
   ACCESSION NUMBER NM_1446802; zinc finger protein 187 (ZNF187), transcript variant 1, aka
   ZSCAN26, MGC2815, SRE-ZBP, ACCESSION NUMBER NM_0071511; zinc finger protein 187
   (ZNF187), transcript variant 1, aka ZSCAN26, MGC2815, SRE-ZBP, ACCESSION NUMBER
 5 NM_0071511; zinc finger protein 189 (ZNF189), transcript variant 2, ACCESSION NUMBER
   NM_1979771; zinc finger protein 189 (ZNF189), transcript variant 1, ACCESSION NUMBER
   NM_0034522; zinc finger protein 19 (ZNF19), aka KOX12, MGC51021, ACCESSION NUMBER
   NM_0069613; zinc finger protein 192 (ZNF192), aka LD5-1, ZKSCAN8, ACCESSION NUMBER
   NM_0062982; zinc finger protein 193 (ZNF193), aka ZSCAN9, PRD51, ACCESSION NUMBER
10 NM_0062993; zinc finger protein 197 (ZNF197), transcript variant 2, aka ZNF20, D3S1363E,
   VHLaK, P18, ZKSCAN9, ZNF166, ACCESSION NUMBER NM_0010248551; zinc finger protein
   197 (ZNF197), transcript variant 1, aka ZNF20, D3S1363E, VHLaK, P18, ZKSCAN9, ZNF166,
   ACCESSION NUMBER NM_0069913; zinc finger protein 197 (ZNF197), transcript variant 1, aka
   ZNF20, D3S1363E, VHLaK, P18, ZKSCAN9, ZNF166, ACCESSION NUMBER NM_0069913;
15 zinc finger protein 202 (ZNF202), aka ZKSCAN1O, ACCESSION NUMBER NM_0034552; zinc
   finger protein 207 (ZNF207), transcript variant 2, aka DKFZp761N202, ACCESSION NUMBER
   NM_0010322932; zinc finger protein 207 (ZNF207), transcript variant 2, aka DKFZp761N202,
   ACCESSION NUMBER NM_0010322932; zinc finger protein 211 (ZNF21 1), transcript variant 1,
   aka C2H2-25, ZNF-25, ZNFC25, MGC131841, CH2H2-25, ACCESSION NUMBER NM_0063852;
20 zinc finger protein 213 (ZNF213), aka ZKSCAN21, CR53, ACCESSION NUMBER NM_0042201;
   zinc finger protein 215 (ZNF215), aka BAZ2, ACCESSION NUMBER NM_0132501; zinc finger
   protein 217 (ZNF217), aka ZABC1, ACCESSION NUMBER NM_0065262; zinc finger protein 219
   (ZNF219), aka ZFP219, ACCESSION NUMBER NM_0164231; zinc finger protein 232 (ZNF232),
   aka ZSCAN11, ACCESSION NUMBER NM_0145192; zinc finger protein 236 (ZNF236), aka
25 ZNF236B, ZNF236A, ACCESSION NUMBER NM_0073451; zinc finger protein 238 (ZNF238),
   transcript variant 1, aka RP58, ZBTB18, TAZ-1, C2H2-171, ACCESSION NUMBER NM_2057681;
   zinc finger protein 238 (ZNF238), transcript variant 1, aka RP58, ZBTB18, TAZ-1, C2H2-171,
   ACCESSION NUMBER NM_2057681; zinc finger protein 238 (ZNF238), transcript variant 2, aka
   RP58, ZBTB18, TAZ-1, C2H2-171, ACCESSION NUMBER NM_0063523; zinc finger protein 24
30 (ZNF24), aka KOX17, ZSCAN3, RSG-A, ZNF191, Zfpl9l, ACCESSION NUMBER NM_0069651;
   zinc finger protein 256 (ZNF256), aka BMZF-3, BMZF3, ACCESSION NUMBER NM_0057732;
   zinc finger protein 263 (ZNF263), aka ZKSCAN12, FPM315, ACCESSION NUMBER
   NM_0057413; zinc finger protein 268 (ZNF268), aka HZF3, MGC126498, ACCESSION NUMBER
   NM_0034151; zinc finger protein 268 (ZNF268), aka HZF3, MGC126498, ACCESSION NUMBER
35 NM_0034151; zinc finger protein 274 (ZNF274), transcript variant ZNF274c, aka ZKSCAN19,
   DKFZp686K08243, FLJ37843, HFB101, ZF2, ACCESSION NUMBER NM_1335021; zinc finger
   protein 274 (ZNF274), transcript variant ZNF274b, aka ZKSCAN19, DKFZp686K08243, FLJ37843,
                                                     58

   HFB101, ZF2, ACCESSION NUMBER NM_0163242; zinc finger protein 274 (ZNF274), transcript
   variant ZNF274b, aka ZKSCAN19, DKFZp686K08243, FLJ37843, HFB 101, ZF2, ACCESSION
   NUMBER NM_0163242; zinc finger protein 277 (ZNF277), aka ZNF277P, ZNF277, NRIF4,
   ACCESSION NUMBER NM_0219942; zinc finger protein 287 (ZNF287), aka MGC126536,
 5 ZKSCAN13, MGC141923 ACCESSION NUMBER NM_0206531; zinc finger protein 3 (ZNF3),
   transcript variant 2, aka HF12, KOX25, PP838, Zfp1 13, FLJ20216, A8-51, ACCESSION NUMBER
   NM_0329243; zinc finger protein 3 (ZNF3), transcript variant 2, aka HF12, KOX25, PP838, Zfp1 13,
   FLJ20216, A8-51, ACCESSION NUMBER NM_0329243; zinc finger protein 3 (ZNF3), transcript
   variant 1, aka HF12, KOX25, PP838, Zfp113, FLJ20216, A8-51, ACCESSION NUMBER
10 NM_0177152; zinc finger protein 3 (ZNF3), transcript variant 1, aka HF aka12, KOX25, PP838,
   Zfp113, FLJ20216, A8-51, ACCESSION NUMBER NM0177152; zinc finger protein 323
   (ZNF323), transcript variant 1, aka ZNF20-Lp, dJ874C202, ZNF310P, FLJ23407, ACCESSION
   NUMBER NM_0308992; zinc finger protein 323 (ZNF323), transcript variant 2, aka ZNF20-Lp,
   dJ874C202, ZNF310P, FLJ23407, ACCESSION NUMBER NM_1459092; zinc finger protein 33A
15 (ZNF33A), transcript variant 2, aka ZNF11 A, KOX5, FLJ23404, KIAA0065, KOX2, NF1IA,
   ZNF1 1, ZZAPK, ZNF33, KOX31, ACCESSION NUMBER NM_0069742; zinc finger protein 33A
   (ZNF33A), transcript variant 2, aka ZNF11 A, KOX5, FLJ23404, KIAA0065, KOX2, NF1IA,
   ZNF1 1, ZZAPK, ZNF33, KOX31, ACCESSION NUMBER NM_0069742; zinc finger protein 33B
   (ZNF33B), aka FLJ23327, MGC129696, KOX2, ZNF11B, KOX31, ACCESSION NUMBER
20 NM_0069551; zinc finger protein 35 (ZNF35), aka Zfp105, HF aka10, HF1O, ACCESSION
   NUMBER NM_0034203; zinc finger protein 367 (ZNF367), aka ZFF29, CDC14B, FLJ33970,
   ACCESSION NUMBER NM_1536952; zinc finger protein 37A (ZNF37A), transcript variant 1, aka
   KOX21, FLJ3472, ZNF37, ACCESSION NUMBER NM_0010070941; zinc finger protein 37A
   (ZNF37A), transcript variant 2, aka KOX21, FLJ3472, ZNF37, ACCESSION NUMBER
25 NM_0034211; zinc finger protein 37A (ZNF37A), transcript variant 2, aka KOX21, FLJ3472,
   ZNF37, ACCESSION NUMBER NM_0034211; zinc finger protein 394 (ZNF394), aka FLJ 12298,
   ZKSCAN14, ACCESSION NUMBER NM_0321642; zinc finger protein 396 (ZNF396), aka
   FLJ31213, ZSCAN14, ACCESSION NUMBER NM_1457561; zinc finger protein 397 (ZNF397),
   transcript variant 2, aka ZNF47, ZSCAN15, MGC13250, ACCESSION NUMBER NM_0323471;
30 zinc finger protein 41 (ZNF41), transcript variant 2, aka MRX89, MGC8941, ACCESSION
   NUMBER NM_1533801; zinc finger protein 41 (ZNF41), transcript variant 1, aka MRX89;
   MGC8941, ACCESSION NUMBER NM_0071301; zinc finger protein 41 (ZNF41), transcript
   variant 1, aka MRX89, MGC8941, ACCESSION NUMBER NM_0071301; zinc finger protein 434
   (ZNF434), aka FLJ20417, FLJ31901, MGC4179, ACCESSION NUMBER NM_0178102; zinc
35 finger protein 444 (ZNF444), aka FLJ 11137, EZF-2, EZF2, ZSCAN17, ACCESSION NUMBER
   NM_0183372; zinc finger protein 445 (ZNF445), aka ZNF168, MGC126535, ZKSCAN15,
   ACCESSION NUMBER NM_1814895; zinc finger protein 446 (ZNF446), aka ZKSCAN20,
                                                     59

   FLJ20626, ZSCAN30, ACCESSION NUMBER NM_0179082; zinc finger protein 449 (ZNF449),
   aka FLJ23614, ZSCAN19, ACCESSION NUMBER NM_1526954; zinc finger protein 45 (ZNF45),
   aka KOX5, ZNF13, ACCESSION NUMBER NM_0034252; zinc finger protein 483 (ZNF483),
   transcript variant 1, aka ZKSCAN16, ACCESSION NUMBER NM_1334641; zinc finger protein
 5 483 (ZNF483), transcript variant 2, aka ZKSCAN16, ACCESSION NUMBER NM_0010071691;
   zinc finger protein 483 (ZNF483), transcript variant 2, aka ZKSCAN16, ACCESSION NUMBER
   NM_0010071691; zinc finger protein 496 (ZNF496), aka ZKSCAN17, MGC15548, NIZP1,
   ACCESSION NUMBER NM_0327521; zinc finger protein 498 (ZNF498), aka ZSCAN25,
   ACCESSION NUMBER NM_1451152; zinc finger protein 500 (ZNF500), aka ZKSCAN18,
10 ACCESSION NUMBER NM_0216461; zinc finger protein 69 (ZNF69), aka MGC59928, Cos5,
   ACCESSION NUMBER NM_0219151; zinc finger protein 70 (ZNF70), aka Cos17, MGC48959,
   ACCESSION NUMBER NM_0219162; zinc finger protein 71 (ZNF71), aka EZFIT, ACCESSION
   NUMBER NM_0212163; zinc finger protein 80 (ZNF80), aka pT17, ACCESSION NUMBER
   NM_0071362; zinc finger protein 81 (ZNF81), aka FLJ44367, HFZ20, MRX45, ACCESSION
15 NUMBER NM_0071372; zinc finger protein 83 (ZNF83), aka MGC33853, FLJ90585, HPF1,
   FLJ1 1015, ZNF816B, FLJ14876, ACCESSION NUMBER NM_0183002; zinc finger protein 85
   (ZNF85), aka HTFI, MGC78566, HPF4, ACCESSION NUMBER NM_0034292; zinc finger protein
   91 (ZNF91), aka HTFIO, HPF7, ACCESSION NUMBER NM_0034302; zinc finger protein 92
   (ZNF92), transcript variant 1, aka HPF12, HTF12, TF12, ACCESSION NUMBER NM_0071392;
20 zinc finger protein 92 (ZNF92), transcript variant 2, aka HPF12, TF12, ACCESSION NUMBER
   NM_1526262; zinc finger protein 93 (ZNF93), aka ZNF505, HTF34, HPF34, TF34, ACCESSION
   NUMBER NM_0312182; zinc finger protein 93 (ZNF93), aka ZNF505, HTF34, HPF34, TF34,
   ACCESSION NUMBER NM_0312182; zinc finger, NFXI-type containing 1 (ZNFX1), aka
   MGC131926, FLJ39275, ACCESSION NUMBER NM_0210352; zinc finger, RAN-binding domain
25 containing 2 (ZRANB2), transcript variant 2, aka DKFZp686J1831, ZIS1, FLJ41119, ZIS,
   DKFZp686NO9117, ZNF265, ZIS2, ACCESSION NUMBER NM_0054553; zinc finger, RAN
   binding domain containing 2 (ZRANB2), transcript variant 2, aka DKFZp686J1831, ZISI,
   FLJ41119, ZIS, DKFZp686NO9117, ZNF265, ZIS2, ACCESSION NUMBER NM_0054553; zinc
   finger and SCAN domain containing 1 (ZSCAN1), aka MGC104472, MZF-1, FLJ33779,
30 ACCESSION NUMBER NM_1825723; zinc finger and SCAN domain containing 10 (ZSCAN1O),
   aka ZNF206, FLJ14549, ACCESSION NUMBER NM_0328051; zinc finger and SCAN domain
   containing 12 (ZSCAN12), aka ZNF305, ZNF29K1, KIAA0426, dJ29K12, ZNF96, ZFP96,
   ACCESSION NUMBER NM_0010396431; zinc finger and SCAN domain containing 16
   (ZSCAN16), aka ZNF392, ZNF435, FLJ22191, dJ265C243, ACCESSION NUMBER NM_0252311;
35 zinc finger and SCAN domain containing 18 (ZSCAN18), aka ZNF447, DKFZp586B 1122,
   FLJ44152, MGC2427, MGC8682, MGC4074, FLJ12895, ACCESSION NUMBER NM_0239263;
   zinc finger and SCAN domain containing 2 (ZSCAN2), transcript variant 2, aka FLJ20595, ZFP29,
                                                     60

   ACCESSION NUMBER NM_0178944; zinc finger and SCAN domain containing 2 (ZSCAN2),
   transcript variant 3, aka FLJ20595, ZFP29, ACCESSION NUMBER NM_0010070721; zinc finger
   and SCAN domain containing 2 (ZSCAN2), transcript variant 3, aka FLJ20595, ZFP29,
   ACCESSION NUMBER NM_0010070721; zinc finger and SCAN domain containing 2 (ZSCAN2),
 5 transcript variant 1, aka FLJ20595, ZFP2, ACCESSION NUMBER NM_1818773; zinc finger and
   SCAN domain containing 20 (ZSCAN20), aka ZFP-31, ZNF31, KOX29, ZNF360, ACCESSION
   NUMBER NM_1452383; zinc finger and SCAN domain containing 22 (ZSCAN22), aka ZNF50,
   MGC126679, MGC138482, HKR2, ACCESSION NUMBER NM_1818461; zinc finger and SCAN
   domain containing 29 (ZSCAN29), aka MGC129895, MGC129894, FLJ35867, Zfp690, ZNF690,
10 ACCESSION NUMBER NM_1524553; zinc finger and SCAN domain containing 4 (ZSCAN4), aka
   FLJ35105, ZNF494, MGC126789, MGC126787, ACCESSION NUMBER NM_1526771; zinc
   finger, X-linked, duplicated A (ZXDA), ACCESSION NUMBER NM_0071563; zinc finger, X
   linked, duplicated A (ZXDA), ACCESSION NUMBER NM_0071563; ZXD family zinc finger C
   (ZXDC), aka FLJ13861, DKFZp547NO24, ZXDL, MGC1 1349, ACCESSION NUMBER
15 NM_0251123; ZXD family zinc finger C (ZXDC), transcript variant 2, aka DKFZp547NO24,
   FLJ13861, ZXDL, MGC1 1349, ACCESSION NUMBER NM_0010406531. Additional genes with
   DNA binding domains that are useful in modifying the gene expression profiles of the cells of the
   present invention include: ADAMTS17, ADAMTS19, ADAR, AEBP2, AFF3, AHCTF], AHDC],
   AKAP8, AKAP8L, AKNA, ALX1, ANAPC2, ANKZF], APTX, ARID2, ARID5B, ASCL3, ASCL4,
20 ASHiL, ATMIN, ATOH7, ATOH8, ATXN7, BAZ2A, BAZ2B, BBX, BCL]]A, BCL]]B, BCL6B,
   BCLAF1, BDP], BHLHB4, BHLHB5, BHLHB8, BMP2, BNC2, BOLA], BOLA3, BPNT], BRD9,
   BRPF], BSX, C10orf]40, C]2orf28, C4orf]06,C4orf43, C]7orf49, Clor25, C20orf]94,
   CAMTA], CAMTA2, CARHSP], CASP8AP2, CASZ], CBLL], CBX2, CCDC71, CCDC79, CD36,
   CDC5L, CEBPZ, CENPB, CENPT, CHD], CHD2, CHD6, CHD7, CHD9, CHRAC], CIC, CIZi,
25 COPS2, COPS3, COPS4, CPSF4, CPSF4L, CPXCR], CRAMPIL, CSDC2, CSDE], CTCFL, CULl,
   CUL2, CUL3, CUL4A, CUL4B, CUL5, CXXC], DACH2, DEAF], DEK, DEPDC], DEPDCB,
   DEPDC2, DEPDC4,DEPDC5, DEPDC6, DEPDC7, DHX34, DHX57, DMAP], DMC], DMRTA2,
   DNAJC], DNAJC2, DNAJC2], DOTiL, DPF], DPF2, DPF3,DR], DSP, DUS3L, DUSP12, DVL],
   DVL2, DVL3, DZIP], DZIP]L, EBF1, EBF3, EBF4, EEA], EIF3K, EMX2, EP400, ETV7, EWSR],
30 EXOC2, EZH], EZH2, FAM170A, FAM]71B, FAM44A, FARSA, FARSB, FBN1, FBXO41, FERD3L,
   FEZF], FEZF2,FGD], FIGLA, FIZi, FOXD4L5, FOXD4L6, FOXO6, GABPB], GBX1, GCM2,
   GFI], GFI]B, GLIS], GLIS2, GMEB2, GON4L, GPATCH8, GPR]23, GPR]55, GRHL], GRHL2,
   GRHL3, GRLF], GRM6, GTF2E2, GTF2F], GTF2F2, GTF2IRD2, GTF2IRD2B, GTF3A, GZF1,
   HiFO, H]FOO, H]FX, HBP], HELZ, HES], HES2, HES3, HES4, HES5, HES7, HIC2, HILS],
35 HISTiHiA, HISTiHiB, HISTiH]C,HISTiHiD, HISTiHiE, HISTiHiT,HIVEP], HIVEP2,
   HIVEP3, HKR], HLA-DQB], HLA-DQB2, HLA-DRB3, HMG]L, HMG2L], HMGA2, HMGB],
   HMGB3, HMGB4, HMX3, HNFA, HNF]B, HP]BP3, ID], ID2, ID3, ID4, IFI16,IGHM, IKZF2,
                                                  61

   IKZF5, INF2, INSM], INSM2, ISLi, JAZF], JRKL, KAT5, KCMF], KIAA0415, KIAA1549,
   KIAA1618, KIAA1683, KIAA2018, KIN, KLF13, KLF14, KLF8, KRTAP5-9, LARPi, LARP2, LARP4,
   LARP5, LARP6, LARP7, LBXCOR], LCORL, LENG9, LEUTX, LGR4, LIN28, LIN28B, LYL],
   MACF], MAEL, MATR3, MAZ, MBD2, MBD3, MBD4, MBNL], MBNL2, MBNL3, MECP2, MEIS],
 5 MESP2, MET, MGMT, MIERi, MIER2, MIER3, MINK], MIZF, MKRNi, MKRN2, MKRN3, MLL2,
   MLL3, MLLT], MLLT3, MLXIP, MLXIPL, MNX], MRPL28, MRRF, MSGN], MST]R, MXD3,
   MXD4, MXIl, MYB, MYBLi, MYCL2, MYSM], MYST], MYST3, MYST4, NCOAl, NCOA2, NCOA3,
   NCORi, NCOR2, NEUROD], NEUROD4, NEUROD6, NEUROG2, NEUROG3, NFRKB, NHLHi,
   NHLH2, NKRF, NKX2-4, NKX2-6, NKX3-2, NKX6-3, NOC3L, NOC4L, NOTO, NPAS3, NPAS4,
10 NUFIPi,NUPL2, OLIG], OLIG3, OSRi, OSR2, OTOP3, OVOL2, PARP12, PATZi, PAWR, PAX],
   PAX2, PAX9, PBRMi, PCSK6, PDS5B, PDXi, PHB2, PHF20,PHF21A, PIP5K3, PKHDi,
   PKHDiLi, PLAGLi, PLEK, PLEK2, PLEKHA4, PLXNA], PLXNA2, PLXNA3, PLXNA4, PLXNBi,
   PLXNB2, PLXNB3, PLXNC], PLXNDi, PMSi, POGK,POGZ,POLE3, POLE4, POLR2L,
   PPPiRiO,PPPiR13L,PPP2R3B,PRB3, PRB4, PRDMiO, PRDM12, PRDM13, PRDM14,
15 PRDMi5, PRDM4, PRDM5, PRDM6, PRDM7, PRDM8, PRDM9, PREB, PRKRIR, PRMT3,
   PROX2, PRR12, PRR3, PSMDll, PSMD12, PTCHD2,PTFiA, RAD5], RAG], RAPGEF3,
   RAPGEF4, RAPGEF5, RAX2, RBAK, RBMiO, RBM20, RBM22, RBM26, RBM27, RBM5, RBM6,
   RC3Hi, RC3H2, RCORi, RCOR3, RELL2, REPIN], REST, RFX2, RFX4, RFX6, RFX7, RGSii,
   RGS6, RGS7, RGS9, RHOXF2, RHOXF2B, RIOK2, RNASE2, RNFii3A, RNFii3B, RNFii4,
20 RNF125, RNF138, RNFi66, RPA2, RPA4, RREBi, SALL3, SALL4, SCAPER, SCML4, SCRT2,
   SEMA4A, SETBPi, SETDBi, SETDB2, SF3A2, SF3A3, SHPRH, SKI, SKIL, SLC22A4, SLC26AO,
   SLC39A]O, SLC4AiO, SMARCAl, SMARCA5, SMARCC], SMARCC2, SMARCE], SNAIl, SNAI2,
   SNAPC4, SOHLHi, SOHLH2, SORBS2, SOX12, SOX17, SOX3, SOX30, SP100, SPilO, SP2, SP3,
   SP5, SP6, SP7, SP8, SRCAP, SREBF2, SSB, SSHi, SSH2, SSH3, SSRPi, SUZi2, TAL2, TAXiBPi,
25 TCEAL8, TCF12, TCF20, TCF23, TCF24, TCF4, TCF7, TERFi, TERF2, TERF2IP, TGIF2LX,
   TGIF2LY, THAP], THAPlO, THAP]], THAP2, THAP3, THAP4, THAP5, THAP6, THAP7, THAP8,
   THAP9, TIGD2, TIGD3, TIGD4, TIGD5, TIGD6, TIGD7, TIPARP, TOE], TOX, TOX2, TOX3,
   TOX4, TP53, TP63, TRAFD], TRIM23, TRIM3, TRIM32, TRIT], TRMT1, 7TF, TUB, TUT],
   TWIST], U2AFi, U2AF]L4, UBE2K, UBR4, UBTF, UNK, UNKL, USP39, VEZFi, VSX2, WDHDi,
30 WHSCi, WIZ, WNT8B, XPA, YBXi, YBX2, YEATS2, YODi, YY2, ZBEDi, ZBED2, ZBED3, ZBED4,
   ZBPi, ZBTBi, ZBTBiO, ZBTBil, ZBTB12, ZBTB16, ZBTB2, ZBTB20, ZBTB22, ZBTB24, ZBTB26,
   ZBTB3, ZBTB32, ZBTB33, ZBTB34, ZBTB37, ZBTB39, ZBTB4, ZBTB40, ZBTB41, ZBTB43,
   ZBTB44, ZBTB45, ZBTB46, ZBTB47, ZBTB5, ZBTB6, ZBTB7A, ZBTB7B, ZBTB7C, ZBTB9,
   ZC3HiO, ZC3HiiA, ZC3H13, ZC3H14, ZC3Hi5, ZC3Hi8, ZC3H3, ZC3H4, ZC3H6, ZC3H7A,
35 ZC3H7B, ZC3HAVi, ZCCHCil, ZCCHC6, ZDHHCii, ZDHHCi9, ZFAT, ZFHX2, ZFPi, ZFP106,
   ZFPii2,ZFP4, ZFP161, ZFP2, ZFP28, ZFP3, ZFP30, ZFP36,ZFP41, ZFP57,ZFP62, ZFP64,
   ZFP82, ZFP90,ZFP91, ZFP92, ZFPM], ZFPM2, ZFR, ZFR2, ZFX, ZFY, ZFYVE20, ZFYVE26,
                                              62

   ZIC2, ZIC4, ZIC5, ZIK], ZIM2, ZIM3, ZMATi, ZMAT2, ZMAT3, ZMAT4, ZMAT5, ZNF]0, ZNF]00,
   ZNF]0], ZNF]07, ZNF]]4, ZNF12, ZNF121, ZNF]24, ZNF]36, ZNF]38, ZNF14, ZNF]41,
   ZNF]43, ZNF]46, ZNF]48, ZNF]54, ZNF16, ZNF]60, ZNF17, ZNF]77, ZNF]80, ZNF]81,
   ZNF]82, ZNF]84, ZNF]95, ZNF2, ZNF20, ZNF200, ZNF205, ZNF208, ZNF212, ZNF214, ZNF22,
 5 ZNF221, ZNF222, ZNF223, ZNF224, ZNF225, ZNF226, ZNF227, ZNF229, ZNF23, ZNF230,
   ZNF233, ZNF234, ZNF235, ZNF239, ZNF248, ZNF25, ZNF250, ZNF251, ZNF252, ZNF253,
   ZNF254, ZNF257, ZNF26, ZNF260, ZNF264, ZNF266, ZNF267, ZNF271, ZNF273, ZNF275,
   ZNF276, ZNF28, ZNF280A, ZNF280B, ZNF280C, ZNF280D, ZNF281, ZNF282, ZNF283, ZNF284,
   ZNF285A, ZNF286A, ZNF292, ZNF295, ZNF296, ZNF30, ZNF300, ZNF302, ZNF304, ZNF311,
10 ZNF316, ZNF317, ZNF318, ZNF319, ZNF32, ZNF320, ZNF321, ZNF322A, ZNF322B, ZNF324,
   ZNF326, ZNF329, ZNF331, ZNF333, ZNF334, ZNF335, ZNF337, ZNF34, ZNF341, ZNF343,
   ZNF345, ZNF346, ZNF347, ZNF350, ZNF354A, ZNF354B, ZNF354C, ZNF358, ZNF362, ZNF365,
   ZNF366, ZNF382, ZNF383, ZNF384, ZNF385A, ZNF385B, ZNF385C, ZNF385D, ZNF391, ZNF395,
   ZNF398, ZNF404, ZNF407, ZNF408, ZNF409, ZNF410, ZNF414, ZNF415, ZNF416, ZNF417,
15 ZNF418, ZNF419, ZNF420, ZNF423, ZNF425, ZNF426, ZNF428, ZNF429, ZNF43, ZNF430,
   ZNF431, ZNF432, ZNF433, ZNF436, ZNF438, ZNF439, ZNF44, ZNF440, ZNF441, ZNF442,
   ZNF443, ZNF451, ZNF454, ZNF460, ZNF461, ZNF462, ZNF467, ZNF468, ZNF470, ZNF471,
   ZNF473, ZNF474, ZNF479, ZNF48, ZNF480, ZNF484, ZNF485, ZNF486, ZNF487, ZNF488,
   ZNF490, ZNF491, ZNF493, ZNF497, ZNF501, ZNF502, ZNF503, ZNF506, ZNF507, ZNF509,
20 ZNF510, ZNF511, ZNF512, ZNF512B, ZNF513, ZNF514, ZNF516, ZNF517, ZNF518A, ZNF518B,
   ZNF519, ZNF521, ZNF524, ZNF526, ZNF527, ZNF528, ZNF529, ZNF530, ZNF532, ZNF536,
   ZNF540, ZNF541, ZNF542, ZNF543, ZNF544, ZNF546, ZNF547, ZNF548, ZNF549, ZNF550,
   ZNF551, ZNF552, ZNF554, ZNF555, ZNF556, ZNF557, ZNF558, ZNF559, ZNF56, ZNF560,
   ZNF561, ZNF562, ZNF563, ZNF564, ZNF565, ZNF566, ZNF567, ZNF568, ZNF569, ZNF57,
25 ZNF570, ZNF571, ZNF572, ZNF573, ZNF574, ZNF575, ZNF576, ZNF577, ZNF578, ZNF579,
   ZNF580, ZNF581, ZNF582, ZNF583, ZNF584, ZNF585A, ZNF585B, ZNF586, ZNF587, ZNF589,
   ZNF592, ZNF593, ZNF594, ZNF595, ZNF596, ZNF597, ZNF598, ZNF599, ZNF600, ZNF605,
   ZNF606, ZNF607, ZNF608, ZNF609, ZNF610, ZNF611, ZNF613, ZNF615, ZNF616, ZNF618,
   ZNF619, ZNF620, ZNF621, ZNF622, ZNF623, ZNF624, ZNF625, ZNF626, ZNF627, ZNF628,
30 ZNF629, ZNF638, ZNF639, ZNF641, ZNF642, ZNF643, ZNF644, ZNF645, ZNF646, ZNF648,
   ZNF649, ZNF652, ZNF653, ZNF654, ZNF655, ZNF658, ZNF660, ZNF662, ZNF663, ZNF664,
   ZNF665, ZNF667, ZNF668, ZNF669, ZNF670, ZNF671, ZNF672, ZNF674, ZNF675, ZNF676,
   ZNF677, ZNF678, ZNF679, ZNF680, ZNF681, ZNF682, ZNF683, ZNF684, ZNF687, ZNF688,
   ZNF689, ZNF691, ZNF692, ZNF695, ZNF696, ZNF697, ZNF699, ZNF7, ZNF700, ZNF701,
35 ZNF703, ZNF704, ZNF705A, ZNF705D, ZNF705F, ZNF706, ZNF707, ZNF708, ZNF709, ZNF710,
   ZNF711, ZNF713, ZNF714, ZNF716, ZNF717, ZNF718, ZNF720, ZNF721, ZNF725, ZNF733,
   ZNF734, ZNF738, ZNF74, ZNF740, ZNF746, ZNF747, ZNF749, ZNF750, ZNF75A, ZNF75D,
                                               63

   ZNF76, ZNF761, ZNF763, ZNF764, ZNF765, ZNF766, ZNF768, ZNF77, ZNF770, ZNF771,
   ZNF772, ZNF773, ZNF774, ZNF775, ZNF776, ZNF777, ZNF778, ZNF780A, ZNF780B, ZNF781,
   ZNF782, ZNF783, ZNF784, ZNF786, ZNF787, ZNF788, ZNF789, ZNF79, ZNF790, ZNF791,
   ZNF792, ZNF793, ZNF799, ZNF8, ZNF800, ZNF804A, ZNF804B, ZNF805, ZNF808, ZNF821,
 5 ZNF823, ZNF826, ZNF827, ZNF828, ZNF829, ZNF830, ZNF831, ZNF833, ZNF834, ZNF835,
   ZNF836, ZNF837, ZNF839, ZNF84, ZNF841, ZNF843, ZNF845, ZNF846, ZNF90, ZNF98, ZNF99,
   ZRSR], ZRSR2, ZSCAN21, ZSCAN23, ZSCAN5A, ZSCAN5B, ZSCAN5C, ZUFSP, ZXDB, and ZZZ3.
   All of these genes capable of modulating differentiated gene expression in a trans manner can include
   their splice variants and their analogs in other animal species many of which are readily found in the
10 scientific literature or in online databases such as http://www.ihop-net.org/UniPub/iHOP/.
   Chromatin-modifying molecules include but are not limited to: K-demethylases including: KDM1,
   KDM2, KDM2A, KDM2B, KDM3A, KDM3B, KDM4, KDM4A, KDM4B, KDM4C, KDM4D, KDM5,
   KDM5A, KDM5B, KDM5C, KDM5D, KDM6A, and KDM6B; K-acetlytransferases including: KAT1,
   KAT2, KAT2A, KAT2B, KAT3, KAT3A, KAT3B, Kat4, KAT5, KAT6, KAT6A, KAT6B, KAT7, KAT8,
15 KAT9, KAT0, KATI], KAT]2, KAT]3A, KAT]3B, KAT]3C, and KAT]3D; K-methyltransferases
   including: KMT1, KMT]A, KMT]B, KMT]C, KMT]D, KMT]E, KMT]F, KMT2, KMT2A, KMT2B,
   KMT2C, KMT2D, KMT2E, KMT2F, KMT2G, KMT2H, KMT3, KMT3A, KMT3B, KMT3C, KMT4,
   KMT5, KMT5A, KMT5B, KMT5C, KMT6, KMT7, and KMT8; members of the histone deacetylase
   (HDAC) family including: HDAC], HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8,
20 HDA C9, HDA C10, and HDA C11; members of the protein arginine methyltransferase (PRMT) family
   including: PRMT1, PRMT2, PRMT3, PRMT5, PRMT6, PRMT7, and PRMT8.
   III.      Driving cell proliferation
             In addition to the expression of transrciption factors (as described above), clonal or
   oligoclonal cells isolated according to the present invention may further be modified to artificially
25 inhibit cell cycle inhibitory factors or to otherwise stimulate the cells to replicate. Any convenient
   modification for inducing cell replication may be employed, including those described in U.S. Patent
   Application Serial No. 12/504,630, filed on July 16, 2009 (US Patent Pub. No. 2010/0184033)
   entitled "Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells
   obtained thereby" (incorporated herein by reference in its entirety). The artificial stimulation of the
30 cell cycle may be made reversible through any convenient means, many of which are known in the
   art, including but not limited to, the use of inducible promoters, temperature sensitive promoters,
   RNAi, transient delivery of transcript as described in Transient Expression Vector Methods below, or
   the ddlivery of proteins into the cells (e.g., cell permeable proteins/peptides, e.g., as described in US
   Patent 7,928,186 entitiled "Cell permeable bioactive peptide conjugates", incorporated herein by
35 reference in its entirety), or by other means known in the art whereby factors are modulated that lead
   to an increase in cell proliferation, more preferably, in a bypass of cell cycle checkpoints. In certain
   embodiments, the means of overcoming cell cycle inhibition is specific to cell cycle control with
                                                         64

   relatively little effect on the differentiated state of the cell. By way of nonlimiting example, the
   retinoblastoma and p53 pathways may be inhibited, such as by the use of SV40 T-antigen, the
   adenovirus proteins ElA and ELiB, or the papillomavirus proteins E6 and E7 or the cell cycle can be
   induced by other means such as by the up-regulation of CDK4 as is known in the art to override p16
 5 cell cycle checkpoint. In certain embodiments, protein agents may be modified with protein
   transduction domains as described herein. By way of nonlimiting example, pluripotent stem cells
   such as ES, EG, EC, iPS or ED cells, including pluripotent stem cells not derived from a human
   embryo, are modified to transiently express CDK4 to facilitate expansion, that is to say proliferation
   of the cells before, during, or after the cells have been similarly modified to alter transcriptional
10 regulators as described herein. Vectors used to introduce such agents to increase the proliferation rate
   of the cells can be in various forms known in the art and as described herein under the heading
   "Means of altering the expression of transcriptional regulators or cell cycle drivers" below.
   IV.      Means of altering the expression of transcriptional regulators or cell cycle drivers:
15          Coding sequences for transcriptional regulators or cell cycle drivers may be transfected via a
   construct that leads to an inducible transcriptional regulator as described herein or cell cycle driver
   including but not limited to SV40 T-antigen or CDK4. Said vector may be designed to allow
   regulated expression such as a temperature or tetracycline in a tet-on or tet-off system as is known in
   the art. As a result, cells can be allowed to differentiate into an initial heterogeneity of cell types and
20 then clonally or oligoclonally expanded under conditions wherein the transcriptional regulator and/or
   SV40 T-antigen or CDK4 genes are induced to stimulate the proliferation of the cells. When
   sufficient numbers of cells are obtained, the expression of the transcriptional regulator or SV40 T
   antigen or CDK4 may be downregulated by reversing the steps that led to the activation of the gene,
   or by the physical removal of the gene or genes using recombinase technology as is well known in
25 the art, such as through the use of the CRE recombinase system or the use of FLP recombinase.
            In certain embodiments, the transcriptional regulator or SV40 T-antigen or CDK4 may be
   added during the first differentiation step or at the beginning of the clonal or oligoclonal
   expansion/propagation step. In certain embodiments, the import of the transcriptional regulator or
   SV40 T-antigen or CDK4 may be improved by delivery with liposomes, electroporation, or by
30 permeabilization (see U.S. Patent Application No.2005/0014258, incorporated by reference herein).
   For example, cells may be permeabilized using any standard procedure, such as permeabilization
   with digitonin or Streptolysin 0. Briefly, cells are harvested using standard procedures and washed
   with PBS. For digitonin permeabilization, cells are resuspended in culture medium containing
   digitonin at a concentration of approximately 0.001-0.1% and incubated on ice for 10 minutes. For
35 permeabilization with Streptolysin 0, cells are incubated in Streptolysin 0 solution (see, for example,
   Maghazachi et al., FASEB J. 1997 Aug; 11(10):765-74) for 15-30 minutes at room temperature. After
   either incubation, the cells are washed by centrifugation at 400xg for 10 minutes. This washing step
                                                          65

   is repeated twice by resuspension and sedimentation in PBS. Cells are kept in PBS at room
   temperature until use. Alternatively, the cells can be permeabilized while placed on coverslips to
   minimize the handling of the cells and to eliminate the centrifugation of the cells, thereby
   maximizing the viability of the cells.
 5          Delivery of the transcriptional regulator, T-antigen, CDK4, or other proteins may be
   accomplished indirectly by transfecting transcriptionally active DNA into living cells (such as the
   cells of this invention) where the gene is expressed and the protein is made by cellular machinery.
   Similarly, only the RNA for these proteins may be expressed to reduce the likelihood of integration
   of the DNA. Several methods are known to one of skill in the art to effectively transfect plasmid
10 DNA including calcium phosphate coprecipitation, DEAE dextran facilitated transfection,
   electroporation, microinjection, cationic liposomes and retroviruses, including, by way of nonlimiting
   example, Transfection Protocol 1 and Expression Vector Protocol 1 shown in Table I. Any method
   known in the art may be used with this invention to deliver the transcriptional regulator or T-antigen
   or CDK4 or other proteins into cells.
15          In certain embodiments, protein is delivered directly into cells of this invention, thereby
   bypassing the DNA transfection step. Several methods are known to one of skill in the art to
   effectively deliver proteins into cells including microinjection, electroporation, the construction of
   viral fusion proteins, and the use of cationic lipids.
            Electroporation may be used to introduce foreign DNA into mammalian (Neumann, E. et al.
20 (1982) EMBO J. 1, 841-845), plant and bacterial cells, and may also be used to introduce proteins
   (Marrero, M.B. et al. (1995) J. Biol. Chem. 270, 15734-15738; Nolkrantz, K. et al. (2002) Anal.
   Chem. 74, 4300-4305; Rui, M. et al. (2002) Life Sci. 71, 1771-1778). Cells (such as the cells of this
   invention) suspended in a buffered solution of the purified protein of interest are placed in a pulsed
   electrical field. Briefly, high-voltage electric pulses result in the formation of small (nanometer
25 sized) pores in the cell membrane. Proteins enter the cell via these small pores or during the process
   of membrane reorganization as the pores close and the cell returns to its normal state. The efficiency
   of delivery is dependent upon the strength of the applied electrical field, the length of the pulses,
   temperature and the composition of the buffered medium. Electroporation is successful with a variety
   of cell types, even some cell lines that are resistant to other delivery methods, although the overall
30 efficiency is often quite low. Some cell lines remain refractory even to electroporation unless
   partially activated.
            Microinjection was first used to introduce femtoliter volumes of DNA directly into the
   nucleus of a cell (Capecchi, M.R. (1980) Cell 22, 470-488) where it can be integrated directly into
   the host cell genome, thus creating an established cell line bearing the sequence of interest. Proteins
35 such as antibodies (Abarzua, P. et al. (1995) CancerRes. 55, 3490-3494; Theiss, C. and Meller, K.
   (2002) Exp. Cell Res. 281, 197-204) and mutant proteins (Naryanan, A. et al. (2003) J. Cell Sci.
   116, 177-186) can also be directly delivered into cells via microinjection to determine their effects on
                                                        66

   cellular processes first hand. Microinjection has the advantage of introducing macromolecules
   directly into the cell, thereby bypassing exposure to potentially undesirable cellular compartments
   such as low-pH endosomes. All of these techniques can be used on the cells of this invention or the
   parent pluripotent cells.
 5          Several proteins and small peptides have the ability to transduce or travel through biological
   membranes independent of classical receptor- or endocytosis-mediated pathways. Examples of these
   proteins include the HIV- 1 TAT protein, the herpes simplex virus 1 (HSV-1) DNA-binding protein
   VP22, and the Drosophila Antennapedia (Antp) homeotic transcription factor. The small protein
   transduction domains (PTDs) from these proteins can be fused to other macromolecules, peptides or
10 proteins to successfully transport them into a cell (Schwarze, S.R. et al. (2000) Trends Cell Biol. 10,
   290-295). Sequence alignments of the transduction domains from these proteins show a high basic
   amino acid content (Lys and Arg) which may facilitate interaction of these regions with negatively
   charged lipids in the membrane. Secondary structure analyses show no consistent structure between
   all three domains. The advantages of using fusions of these transduction domains is that protein
15 entry is rapid, concentration-dependent and appears to work with difficult cell types (Fenton, M. et
   al. (1998) J. Immunol. Methods 212, 41-48.). All of these techniques can be used on the cells of
   this invention or the parent pluripotent cells.
            Liposomes have been rigorously investigated as vehicles to deliver oligonucleotides, DNA
   (gene) constructs and small drug molecules into cells (Zabner, J. et al. (1995) J. Biol. Chem. 270,
20 18997-19007; Felgner, P.L. et al. (1987) Proc.NatL. Acad. Sci. USA 84, 7413-7417). Certain lipids,
   when placed in an aqueous solution and sonicated, form closed vesicles consisting of a circularized
   lipid bilayer surrounding an aqueous compartment. These vesicles or liposomes can be formed in a
   solution containing the molecule to be delivered. In addition to encapsulating DNA in an aqueous
   solution, cationic liposomes can spontaneously and efficiently form complexes with DNA, with the
25 positively charged head groups on the lipids interacting with the negatively charged backbone of the
   DNA. The exact composition and/or mixture of cationic lipids used can be altered, depending upon
   the macromolecule of interest and the cell type used (Felgner, J.H. et al. (1994) J. Biol. Chem. 269,
   2550-2561). The cationic liposome strategy has also been applied successfully to protein delivery
   (Zelphati, 0. et al. (2001) J. Biol. Chem. 276, 35103-35110). Because proteins are more
30 heterogeneous than DNA, the physical characteristics of the protein such as its charge and
   hydrophobicity will influence the extent of its interaction with the cationic lipids. All of these
   techniques can be used on the cells of this invention or the parent pluripotent cells.
            In certain embodiments Pro-Ject Protein Transfection Reagent may be used. Pro-Ject Protein
   Transfection Reagent utilizes a unique cationic lipid formulation that is noncytotoxic and is capable
35 of delivering a variety of proteins into numerous cell types. The protein being studied is mixed with
   the liposome reagent and is overlayed onto cultured cells. The liposome:protein complex fuses with
   the cell membrane or is internalized via an endosome. The protein or macromolecule of interest is
                                                       67

   released from the complex into the cytoplasm free of lipids (Zelphati, 0. and Szoka, Jr., F.C. (1996)
   Proc.Natl. Acad. Sci. USA 93, 11493-11498) and escaping lysosomal degradation. The noncovalent
   nature of these complexes is a major advantage of the liposome strategy as the delivered protein is
   not modified and therefore is less likely to lose its activity. All of these techniques can be used on
 5 the cells of this invention or the parent pluripotent cells.
            In certain embodiments, the nuclear localization sequence of SV40 T-antigen may be
   modified. Protein transduction domains (PTD), covalently or non-covalently linked to the
   transcriptional regulator or T-antigen, allow the translocation of T-antigen across the cell membranes
   so the protein may ultimately reach the nuclear compartments of the cells. PTDs that may be fused
10 with a Tag protein include the PTD of the HIV transactivating protein (TAT) (Tat 47-57) (Schwarze
   and Dowdy (2000) Trends Pharmacol.Sci. 21: 45-48; Krosl et al. (2003) Nature Medicine 9: 1428
   1432). For the HIV TAT protein, the amino acid sequence conferring membrane translocation
   activity 5 corresponds to residues 47-57 (YGRKKRRQRRR) (SEQ ID NO: 1) (Ho et al. (2001)
   CancerResearch 61: 473-477; Vives et al. (1997) J. Biol Chem. 272: 16010-16017). This sequence
15 alone can confer protein translocation activity. The TAT PTD may also be the nine amino acids
   peptide sequence RKKRRQRRR (SEQ ID NO: 2) (Pauk et al. Mol Cells (2002) 30 :202-8). The
   TAT PTD sequences may be any of the peptide sequences disclosed in Ho et al. (2001) Cancer
   Research 61: 473-477, including YARKARRQARR (SEQ ID NO: 3), YARZLAARQARA (SEQ ID
   NO: 4), YARAARRAARR (SEQ ID NO: 5), and RARAARRAARA (SEQ ID NO: 6). Other
20 proteins that contain PTDs that may be fused with Tag include the herpes simplex virus 1 (HSV-1)
   DNA-binding protein VP22 and the Drosophila Antennapedia (Antp) transcription factor (Schwarze
   et al. (2000) Trends Cell Biol 10: 290-295). For Antp, amino acids 43-58
   (RQIKIWFQNRRMKWM) (SEQ ID NO: 7) represent the protein transduction domain, and for HSV
   VP22 the PTD is represented by the residues DAATATRGRSAASRPTERPRAPARSASRPRRPVE
25 (SEQ ID NO: 8). Alternatively, HeptaARG (RRRRRRR) (SEQ ID NO: 9) or artificial peptides that
   confer transduction activity may be used as a PTD. The PTD may be a PTD peptide that is duplicated
   or multimerized; including one or more of the TAT PTD peptide YARAAARQARA (SEQ ID NO:
   10), or a multimer consisting of three of the TAT PTD peptide YARARARQARA (SEQ ID NO: 11).
   Techniques for making fusion genes encoding fusion proteins are well known in the art. The joining
30 of various DNA fragments coding for different polypeptide sequences may be performed in
   accordance with conventional techniques. The fusion gene can be synthesized by conventional
   techniques including automated DNA synthesizers. Alternatively, PCR amplification of gene
   fragments can be carried out using anchor primers which give rise to complementary overhangs
   between two consecutive gene fragments which can subsequently be annealed to generate a chimeric
35 gene sequence (see, for example, Current Protocols in Molecular Biology, eds. Ausubel et al., John
   Wiley & 20 Sons: 1992). A fusion gene coding for a purification leader sequence, such as a poly
   (His) sequence, may be linked to the N-terminus or C-terminus of the desired portion of the Tag
                                                        68

   polypeptide or Tag-fusion protein allowing the fusion protein be purified by affinity chromatography
   using a metal resin. The purification leader sequence can then be subsequently removed by treatment
   with enterokinase to provide the purified Tag polypeptide (e.g., see Hochuli, E., et al (1987) J.
   Chromatog. 411:177-184). T antigen that is provided in the media may be excreted by another cell
 5 type. The other cell type may be a feeder layer, such as a mouse stromal cell layer transduced to
   express secretable T antigen. For example, T antigen may be fused to or engineered to comprise a
   signal peptide, or a hydrophobic sequence that facilitates export and secretion of the protein.
   Alternatively, T antigen, as a fusion protein covalently or linked to a PTD or as a protein or a fusion
   protein non-covalently linked to a PTD, may be added directly to the media. In certain embodiments,
10 cell lines are created that secrete the TAT-T antigen fusion protein (see Derer, W. et al. (2001) The
   FASEB Journal,Published online). Conditioned medium from TAT-T antigen secreting cell lines is
   subsequently added to recipient cell lines to promote cell growth.
   TransientExpression Vector Methods
15          The transcriptional regulator genes and/or cell cycle drivers of the present invention may be
   introduced into cells using vectors for transient expression known in the art. These include, without
   limitation, those described in Yu, J et al, 2009 Science 324: 797-801. In brief, Epstein-Barr virus,
   oriP/UBNAi vectors are utilized for introducing reprogrammingfactors into human somatic cells,
   hES cells, iPS cells, or other pluripotent stem cells not derived from a human embryo. Efficiency can
20 be improved through the use of linkers to coexpress combinations of transcriptional regulators or cell
   cycle drivers with the use of internal ribosome entry site 2 (IRES2).
   V.       Use of oligonucleotide transcription factor binding site decoys
            The moduclation of transcription factor activity in cells can be achieved in a number of ways.
25 One method for repressing or blocking the activity of a transcription factor is through the use of a
   transcription factor ODN decoys, which floods the cell with competing synthetic, transcription
   factor-specific consensus sequences. These synthetic decoys "compete" for binding of the
   transcription factor with consensus sequences in target genes. If delivered into the cell in sufficient
   concentrations these "decoys" thus have the potential to attenuate the binding of the transcription
30 factor to promoter regions of target genes and thus attenuate the function of the transcription factor to
   regulate the expression of its target gene(s). Transfected at high concentrations these decoys have
   been reported in the literature to completely block transcription factor function and thus represent
   powerful research tools for studying gene regulation in the cells of the present invention.
            ODN decoys are generally double-stranded synthetic phosphorothioate deoyxynucleotides
35 which range in length from 20-28 base pairs. The transcription factor consensus sequence occurs
   within the middle of the decoy sequence and is flanked by carefully selected base-pairs that allow for
   "optimized" transcription factor binding. ODN decoys may be labeled to allow imaging of the
                                                       69

   passage of the decoy into the cell (for example by fluorescence microscopy). ODN decoys may be
   produced using any convenient method and may be highly pruified (e.g., by HPLC). In certain
   emodobeiments, matching mutant decoys are employed for each transcription factor, where the
   mutant decoys have the same flanking sequences but contain a disrupted consensus sequence in
 5 comparison with the (wild type) ODN decoy. Such controls may be employed to determine the
   specificity of the activity of the wild type ODN in affecting the growth, proliferation and/or
   differentiation of progenitor cells according to the persent invention.
            In certain embodiments, naked ODN decoys are added directly into the cell culture media
   along with the cells of interest, whereby the cells uptake the ODN decoys where they can have their
10 transcription factor repressing effect. In other embodiments, ODN decoys are introduced into cells
   via transfection protocols as known in the art, e.g., using a cationic lipid to form a liposome complex
   before adding the ODN decoy/liposome mixture directly to the media (e.g., OligofectAMINE
   reagent, InVitrogen). Other transfection reagents and processes may also be employed (e.g., FuGene
   6 from Roche Diagnostics and Superfect Transfection Reagent from Qiagen).
15          Cells are contacted to the ODN decoys for a time sufficient for repression of the specific
   transcription factor being targetted. This time may vary, where in cerain embodiments the time
   ranges from hours to days or even weeks. Such parameters may be determined empirically. It may
   be necessary to re-apply the ODN decoys one or more additional time during the incubation period to
   achieve the desired effect. ODN decoy concentrations used may very, ranging from 0.1 ptM to 5mM
20 or more.
            References describing the use of ODN decoys include the following, which are incorporated
   herein byb reference: Morishita, R., Higaki, J., Tomita N. and Ogihara T. (1998) Application of
   transcription factor "decoy" strategy as means of gene therapy and study of gene expression in
   cardiovascular disease. Circ Res 82, 1023-1028; and Mann, M.J. and Dzau, V.J. (2000) Therapeutic
25 applications of transcription factor decoy oligonucleotides. J. Clin. Invest. 106, 1071-1075.
   VI.      Cells and Methods
            Human embryo-derived (hED) cells are cells that are derived from human embryos such as
   human preimplantation embryos, postimplantation embryos (such as aborted embryonic tissue) or
30 pluripotent cell lines such as ES cell lines derived from human preimplantation embryos wherein the
   embryo may be destroyed in the process of producing the cells. Human zygotes, 2 or more cell
   premorula stage such as blastomeres, morula stage, compacting morula, blastocyst embryo inner cell
   masses, or cells from developing embryos all contain pluripotent cells. Such cells may be
   differentiated using techniques described herein to yield the initial heterogeneous population of cells
35 of the first step. Because such culture conditions may induce the direct differentiation of the ED cells
   without allowing the propagation of a hES cell line, the probability of a hES cell contaminating the
   resulting clonal or oligoclonal cultures is reduced.
                                                       70

            Human somatic cells reprogrammed to pluripotency such as hiPS cells are cells that have the
   properties of hES cells including the presence of pluripotency markers such as OCT4, SOX2, CDH2,
   NANOG, are capable of differentiating into the three primary germ layers, but which do not require
   the use of cells from a human embryo that was destroyed.
 5          The clonal, oligoclonal, or polyclonal cells of this invention (made by the methods of this
   invention) may be used as the starting point for deriving various differentiated cell types. The single
   cells of this invention may be the precursors of any cell or tissue lineage.
            There have been numerous attempts in the prior art to differentiate embryonic stem cells,
   embryonal carcinoma cells, iPS cells, and embryonic germ cells into various cell types. These
10 methods have been only marginally successful due to problems with culturing and characterizing the
   complex mixture of cell types originating out of differentiating ES, EC, iPS and EG cell cultures in
   vitro. It has not been possible to preserve a pure culture of the differentiated cell type without having
   the culture overgrown with fibroblastic or other contaminating cell types. See, Ian Freshney, Culture
   of Animal Cells: A Manual of Basic Technique (5th Ed.), New York: Wiley Publishing, 2005, p.
15 217. The methods of the present application can overcome those difficulties due in part to the
   unexpected clonogenicity of ES, EC, EG, iPS and ED cell-derived cells.
            In one embodiment of the application, any methods of differentiating, propagating,
   identifying, isolating, or using stem cells known in the art (for example, U.S. patent nos: 6,953,799,
   7,029,915, 7,101,546, 7,129,034, 6,887,706, 7,033,831, 6,989,271, 7,132,286, 7,132,287, 6,844,312,
20 6,841,386, 6,565,843, 6,908,732, 6,902,881, 6,602,680, 6,719,970, 7,112,437, 6,897,061, 6,506,574,
   6,458,589, 6,774,120, 6,673,606, 6,602,711, 6,770,478, 6,610,535, 7,045,353, 6,903,073, 6,613,568,
   6,878,543, 6,670,397, 6,555,374, 6,261,841, 6,815,203, 6,967,019, 7,022,666, 6,423,681, 6,638,765,
   7,041,507, 6,949,380, 6,087,168, 6,919,209, 6,676,655, 6,761,887, 6,548,299, 6,280,718, 6,656,708,
   6,255,112, 6,413,773, 6,225,119, 6,056,777, 6,962,698, 6,936,254, 6,942,995, 6,924,142, 6,165,783,
25 6,093,531, 6,379,953, 6,022,540, 6,586,243, 6,093,557, 5,968,546, 6,562,619, 5,914,121, 6,251,665,
   6,228,640, 5,948,623, 5,766,944, 6,783,775, 6,372,262, 6,147,052, 5,928,945, 6,096,540, 6,709,864,
   6,322,784, 5,827,740, 6,040,180, 6,613,565, 5,908,784, 5,854,292, 6,790,826, 5,677,139, 5,942,225,
   5,736,396, 5,648,248, 5,610,056, 5,695,995, 6,248,791, 6,051,415, 5,939,529, 5,922,572, 6,610,656,
   6,607,913, 5,844,079, 6,686,198, 6,033,906, 6,340,668, 6,020,197, 5,766,948, 5,369,030, 6,001,654,
30 5,955,357, 5,700,691, 5,498,698, 5,733,878, 5,384,331, 5,981,165, 6,464,983, 6,531,445, 5,849,686,
   5,197,985, 5,246,699, 6,177,402, 5,488,040, 6,667,034, 5,635,386, 5,126,325, 5,994,518, 5,032,507,
   5,847,078, 6,004,548, 5,529,982, 4,342,828, 7,105,344, 7,078,230, 7,074,911, 7,053,187, 7,041,438,
   7,030,292, 7,015,037, 7,011,828, 6,995,011, 6,969,608, 6,967,102, 6,960,444, 6,929,948, 6,878,542,
   6,867,035, 6,866,843, 6,833,269, 6,828,144, 6,818,210, 6,800,480, 6,787,355, 6,777,231, 6,777,230,
35 6,749,847, 6,737,054, 6,706,867, 6,677,306, 6,667,391, 6,642,048, 6,638,501, 6,607,720, 6,576,464,
   6,555,318, 6,545,199, 6,534,052, RE37,978, 6,461,865, 6,432,711, 6,399,300, 6,372,958, 6,369,294,
   6,342,356, 6,337,184, 6,331,406, 6,271,436, 6,245,566, 6,235,970, 6,235,969, 6,215,041, 6,204,364,
                                                      71

   6,194,635, 6,171,824, 6,090,622, 6,015,671, 5,955,290, 5,945,577, 5,914,268, 5,874,301, 5,866,759,
   5,865,744, 5,843,422, 5,830,510, 5,795,569, 5,766,581, 5,733,727, 5,725,851, 5,712,156, 5,688,692,
   5,656,479, 5,602,301, 5,370,870, 5,366,888, and 5,332,672, and U.S. patent publication nos.
   20060251642,20060217301,20060216820,20060193769,20060161996,20060134784,
 5 20060134782,20060110828,20060104961,20060088890,20060079488,20060078989,
   20060068496,20060062769,20060024280,20060015961,20060009433,20050244969,
   20050244386,20050233447,20050221483,20050164377,20050153425,20050149998,
   20050142102,20050130147,20050118228,20050106211,20050054102,20050032207,
   20040260079,20040228899,20040193274,20040152189,20040151701,20040141946,
10 20040121464,20040110287,20040052768,20040028660,20040028655,20040018178,
   20040009595,20030203003,20030175680,20030161819,20030148510,20030082155,
   20030040111,20030040023,20030036799,20030032187,20030032183,20030031657,
   20020197240,20020164307,20020098584,20020098582,20020090714,20020022259,
   20020019018, 20010046489, 20010024824, and 20010016203) are used in combination with the
15 methods of the present application in differentiating, propagating, identifying, isolating, or using
   directly differentiated derivatives of pluripotent stem cells such as ES, iPS, or embryo-derived cells
   (i.e., substituting ED cells for ES cells and directly differentiating the ED cells). In certain
   embodiments, only the initial differentiation procedure from the prior art is used in combination with
   the present methods. In certain embodiments, pluripotent stem cells such as ES, iPS, ED cells are
20 directly differentiated in the manner disclosed in the art for ES cells, and following differentiation,
   cells are plated resulting in isolating a number of individual clonal cultures of cells or a number of
   individual clonal cultures of cells that are subsequently combined (oligoclonal), or a large number of
   individual clonal cultures of cells that are subsequently combined (polyclonal), wherein one or more
   of said cultures comprise cells with reduced differentiation potential than the starting pluripotent
25 stem cells and wherein each of said individual cultures having only one cell may be propagated into a
   pure clonal culture of cells and wherein each of said individual cultures of cells having cells that are
   oligoclonal may be propagated into a larger number of cells, and one or more (or all) of said
   individual cultures of cells is propagated. To summarize, pluripotent stem cells such as ES, iPS, or
   ED cells are differentiated in step 1 of this invention according to the methods in the art and then the
30 heterogenous population of cells so generated are cultured and propagated according to step 2 of this
   invention.
             In another aspect of the invention, the methods of this invention result in the derivation of
   endodermal cells from a single cell differentiated or in the process of differentiating from pluripotent
   stem cells such as, but not limited to, hES, hEG, hiPS, hEC or hED cells, including pluripotent stem
35 cells not derived from a human embryo.
             In another aspect of the invention, the methods of this invention result in the derivation of
   mesodermal cells from a single cell differentiated or in the process of differentiating from pluripotent
                                                        72

   stem cells such as, but not limited to, hES, hEG, hiPS, hEC or hED cells, including pluripotent stem
   cells not derived from a human embryo.
            In another aspect of the invention, the methods of this invention result in the derivation of
   ectodermal cells from a single cell differentiated or in the process of differentiating from pluripotent
 5 stem cells such as, but not limited to, hES, hEG, hiPS, hEC or hED cells, including pluripotent stem
   cells not derived from a human embryo.
            In another aspect of the invention, the methods of this invention result in the derivation of
   neuroglial precursor cells from a single cell differentiated or in the process of differentiating from
   pluripotent stem cells such as, but not limited to, hES, hEG, hiPS, hEC or hED cells, including
10 pluripotent stem cells not derived from a human embryo.
            In another aspect of the invention, the methods of this invention result in the derivation of
   hepatic cells or hepatic precursor cells from a single cell differentiated or in the process of
   differentiating from pluripotent stem cells such as, but not limited to, hES, hEG, hiPS, hEC or hED
   cells, including pluripotent stem cells not derived from a human embryo.
15          In another aspect of the invention, the methods of this invention result in the derivation of
   chondrocyte or chondrocyte precursor cells from a single cell differentiated or in the process of
   differentiating from pluripotent stem cells such as, but not limited to, hES, hEG, hiPS, hEC or hED
   cells, including pluripotent stem cells not derived from a human embryo.
            In another aspect of the invention, the methods of this invention result in the derivation of
20 myocardial or myocardial precursor cells from a single cell differentiated or in the process of
   differentiating from pluripotent stem cells such as, but not limited to, hES, hEG, hiPS, hEC or hED
   cells, including pluripotent stem cells not derived from a human embryo.
            In another aspect of the invention, the methods of this invention result in the derivation of
   gingival fibroblast or gingival fibroblast precursor cells from a single cell differentiated or in the
25 process of differentiating from pluripotent stem cells such as, but not limited to, hES, hEG, hiPS,
   hEC or hED cells, including pluripotent stem cells not derived from a human embryo.
            In another aspect of the invention, the methods of this invention result in the derivation of
   pancreatic beta cells or pancreatic beta precursor cells from a single cell differentiated or in the
   process of differentiating from pluripotent stem cells such as, but not limited to, hES, hEG, hiPS,
30 hEC or hED cells, including pluripotent stem cells not derived from a human embryo.
            In another aspect of the invention, the methods of this invention result in the derivation of
   retinal precursor cells with from a single cell differentiated or in the process of differentiating from
   pluripotent stem cells such as, but not limited to, hES, hEG, hiPS, hEC or hED cells, including
   pluripotent stem cells not derived from a human embryo.
35          In another aspect of the invention, the methods of this invention result in the derivation of
   hemangioblasts from a single cell differentiated or in the process of differentiating from pluripotent
   stem cells such as, but not limited to, hES, hEG, hiPS, hEC or hED cells, including pluripotent stem
                                                        73

   cells not derived from a human embryo.
            In another aspect of the invention, the methods of this invention result in the derivation of
   dermal fibroblasts with prenatal patterns of gene expression from a single cell differentiated or in the
   process of differentiating from pluripotent stem cells such as, but not limited to, hES, hEG, hiPS,
 5 hEC or hED cells, including pluripotent stem cells not derived from a human embryo.
            Dermal fibroblasts derived according to the invention can be grown on a biocompatible
   substratum and engrafted on the neodermis of artificial skin covering a wound. Autologous
   keratinocytes may also be cultivated on a commercially available membrane such as LaserskinTM
   using the methods provided in this invention.
10          In another embodiment of the present invention, it is possible to simplify burn treatment
   further and to save lives of patients having extensive burns where sufficient autologous skin grafts
   cannot be repeatedly harvested in a short period of time. The dead skin tissue of a patient with
   extensive burns can be excised within about three to seven days after injury. The wound can be
   covered with any artificial skin, for example Integra TM , or any dermal equivalent thereof, and dermal
15 keratinocytes or dermal fibroblasts produced according to the methods of this invention or derived
   from said cells may thereafter be engrafted on the neodermis of the artificial skin, with resultant
   lower rejection and infection incidences.
   VII.     Isolation of Cells
20          In certain embodiments of the invention, specific cell binding moieties are employed to
   isolate one or more cell of interest from a heterogenous population of cells and/or for re-deriving
   clonal or oligo clonal cell lines from a population after one or more culturing steps. Any convenient
   method for using specific cell binding moieties to isolate one or more cell may be employed, where
   in many embodiments the specific cell binding moiety is an antibody that recognizes a specific cell
25 surface molecule (e.g., a receptor, CD antigen, etc.). The isolation of cells can be achieved using any
   convenient method, including but not milited to, fluorescence activated cell sorting (FACS), solid
   phase isolation processes using substrate-bound antibodies (e.g., on plates, columns, beads, and the
   like). Exemplary bead based sorting reagents include para-magnetic beads coated with antigen
   specific antibodies, e.g., as provided by Miltenyi Biotech. In certain embodiments, the cells are
30 isolated based on the presence or absence of multiple cell surface molecules (e.g., multiple CD
   antigens). For example, in FACS applications, the cells may be sorted according to the cell surface
   expression level of multiple different cell surface antigens to make clonal cell lines, e.g., by use of an
   automated cell deposition device (ACDU). The ability to isolate cells by virtue of their cell surface
   antigen profile can be very useful in many steps of the subject invention, for example in re-deriving
35 clonal cell lines after prolonged culture periods.
                                                       74

   VIII.    Methods of network analysis.
            A Bayesian network is a graphical model that encodes probabilistic relationships among
   variables of interest. When used in conjunction with statistical techniques, the graphical model has
   several advantages for data analysis. One, because the model encodes dependencies among all
 5 variables, it readily handles situations where some data entries are missing. Two, a Bayesian network
   can be used to learn causal relationships, and hence can be used to gain understanding about a
   problem domain and to predict the consequences of intervention. Three, because the model has both
   a causal and probabilistic semantics, it is an ideal representation for combining prior knowledge
   (which often comes in causal form) and data. Four, Bayesian statistical methods in conjunction with
10 bayesian networks offer an efficient and principled approach for avoiding the overfitting of data.
   IX.      Exemplary Uses of the cell lines of the present Invention
            Uses in making novel cells for therapy and research and embedded in gels are provided.
   Secreted Protein Isolation Protocol 1 - Conditioned medium
15          Cells are grown in either their normal propagation medium (West et al., 2008, Regen Med
   vol. 3(3) pp. 287-308) or the differentiation conditions described herein. To obtain conditioned
   medium on a smaller scale (typically 1-2 L or less), the cells are grown in monolayer cultures in
   T150, T175 or T225 flasks (Corning or BD Falcon) in a 37 0 C. incubator with 10% CO 2 atmosphere.
   For larger volume medium collections, the cells are typically grown either in 2 L roller bottles, on
20 microcarrier suspensions (porous such as Cytodex varieties from Sigma-Aldrich, St. Louis, MO, or
   non-porous such as from SoloHill Engineering, Ann Arbor, MI) in spinner flasks or other
   bioreactors, or in hollow fiber cartridge bioreactors (GE Healthcare, Piscataway, NJ). Prior to
   conditioned medium collection, the cultures are rinsed twice with PBS and then incubated for 2 hours
   at 37 0C in the presence of serum-free medium (e.g., the same basal medium as described herein for
25 the propagation or differentiation of the cells) in order to remove fetal serum proteins. The serum
   free medium is then removed and replaced with fresh medium, followed by continued culture at 37 0 C
   for 24-48 hours.
            The culture-conditioned medium is then collected by separation from the cell-bound vessel
   surface or matrix (e.g., by pouring off directly or after sedimentation) and processed further for
30 secreted protein concentration, enrichment or purification. As deemed appropriate for the collection
   volume, the culture medium is first centrifuged at 500 to 10,000 xg to remove residual cells and
   cellular debris in 15 or 50 ml centrifuge tubes or 250 ml bottles. It is then passaged through
   successive 1 pm or 0.45 pm and 0.2 pm filter units (Corning) to remove additional debris, and then
   concentrated using 10,000 MW cutoff ultrafiltration in a stirred cell or Centricon centrifuge filter
35 (Amicon-Millipore) for smaller volumes, or using a tangential flow ultrafiltration unit (Amicon
   Millipore) for larger volumes. The retained protein concentrate is then dialyzed into an appropriate
   buffer for subsequent purification of specific proteins, and further purified using a combination of
                                                        75

   isoelectric focusing, size exclusion chromatography, ion exchange chromatography, hydrophobic or
   reverse phase chromatography, antibody affinity chromatography or other well-known methods
   appropriate for the specific proteins. During the various steps in the purification process, collection
   fractions are tested for the presence and quantity of the specific secreted protein by ELISA. The
 5 purified proteins are then kept in solution or lyophilized and then stored at 4 or minus 20-80C.
   Secreted Protein Isolation Protocol 2 - Urea-mediated protein extraction
            In the case of some secreted proteins, interactions with the cell or ECM components may
   reduce the simple diffusion of factors into the medium as described above in Secreted Protein
10 Isolation Protocol 1. A simple comparison of the yield in the two protocols will suffice to determine
   which protocol provides the highest yield of the desired factors. In the case of Secreted Protein
   Isolation Protocol 2, a low concentration of urea is added to facilitate the removal of factors. Urea
   extractions can be performed two days subsequent to feeding. On the second day, cell monolayers in
   T-150 cell culture flasks are rinsed twice with CMF-PBS and then incubated for two hours at 37 0 C in
15 the presence of serum-free medium. The rinse with CMF-PBS and the incubation in serum-free
   medium together aid in the removal of fetal serum proteins from the surface of the cells. The serum
   free medium is then removed and 10 ml /T150 of freshly made 200 mM urea in CMF-PBS is added.
   The flasks are then placed on a rocker at 37 0 C for 6.0 hours. The urea solution is then removed and
   immediately frozen at -70C.
20
   Extracellular Matrix Isolation Protocol 1 - DOC-Mediated Preparation
            Extracellular matrix proteins can be extracted using the method of Hedman et al, 1979
   (Isolation of the pericellular matrix of human fibroblast cultures. J. Cell Biol. 81: 83-91). Cell layers
   are rinsed three times with CMF-PBS buffer at ambient temperature and then washed with 30 mL of
25 0.5% sodium deoxycholate (DOC), 1 mM phenylmethylsulfonylfluride (PMSF, from 0.4M solution
   in EtOH), CMF-PBS buffer 3 X 10 min. on ice while on a rocking platform. The flasks are then
   washed in the same manner with 2mM Tris-HCI, pH 8.0 and 1 mM PMSF 3 X 5 min. The protein
   remaining attached to the flask is then removed in 2 mL of gel loading buffer with a rubber
   policeman.
30
   Cellular and Acellular Formulations
            In certain aspects, the rpesent invention includes the production and use of cellular and
   acellular formulations that find use in therapeutic applicaitons, where the formulations include one or
   more cell according to the subejct invention and/or one or more cellular product produced from one
35 or more cell according to the subejct invention. Any convenient method for generating cellular or
   acellular formulations, e.g., for therapeutic use (e.g., either topically or internally) may be employed.
            Exemplary formulations include cellular and acellular formulations that provide for the slow
                                                       76

   release of components in a subject or patient, e.g., at a specific site where the components can
   provide a therapeutic benefit. Such formulations are described, for example, in US Patent
   Publications 20090105193 (entitled "Crosslinked compounds and methods of making and using
   therof"), 20090117078 (entitled "Crosslinked compounds and methods of making and using therof"),
 5 and 20080025950 (entitled "Modified macromolecules and associated methods of synthesis and
   use"), each of which is incorporated herein by reference. These patent publications describe
   macromolecular compounds that have been modified in order to facilitate crosslinking by
   introduction of at least one hydrazide-reactive group and/or aminooxy-reactive group, and methods
   of making and using in therapeutic applciaitons (e.g., for scar-free wound healing, for delivering
10 bioactive agents or living cells to a subject, for preventing adhesion after a surgical procedure or for
   bone and cartilage repair). The macromolecule can be an oligonucleotide, a necleic acid, a
   polypeptide, a lipid, a glycoprotein, a glycolipid, a polysaccharide, a protein or a synthetic polymer
   (e.g., a glycosaminoglycan like hyaluronan). Natural extracellular matrix proteins and chemically
   modified versions thereof are used in many embodiments.
15           Any of the macromolecular compounds and compositions described in the above patent
   applications can include one or more pharmaceutically-active agent. The resulting pharmaceutical
   composition can provide a system for sustained, continuous delivery of biologically-active agents,
   including those produced by the cells of the present invention, to tissues adjacent to or distant from
   the application site. The biologically-active agent is capable of providing a local or systemic
20 biological, physiological or therapeutic effect in the biological system to which it is applied. For
   example, the agent can act to enhance cell growth and tissue regeneration, control tumor growth, and
   enhance bone or cartilage growth, among other functions. Exemplary substances or metabolic
   precursosr derived from the cells of the present invention that are capable of promoting growth and
   survival of cells and tissues, or augmenting the functioning of cells, include but are not limited to: a
25 nerve growth promoting substance such as a nerve growth factor, and the like; a hard or soft tissue
   growth promoting agent such as fibronectin (FN), human growth hormone (HGH), a colony
   stimulating factor, bone morphogenic protein (BMP), platelet-derived growth factor (PDGF), insulin
   derived growth factor (IGF-I, IGF-II), transforming growth factor-alpha (TGF-alpha), transforming
   growth factor-beta (TGF-beta), epidermal growth factor (EGF), fibroblast growth factor (FGF),
30 interleukin- 1 (IL-1), vascular endothelial growth factor (VEGF) and keratinocyte growth factor
   (KGF). Additional non-cell derived components may also be present in the formulations, for
   example: dried bone material, and the like; antineoplastic agents such as methotrexate, 5-fluorouracil,
   adriamycin, vinblastine, cisplatin, tumor-specific antibodies conjugated to toxins, tumor necrosis
   factor, and the like.
35           The formulations can contain one or a combination of cells according to the present
   invention and/or products from one or a combination of cells according to the present invention, e.g.,
   secreted factors present in culture supernatants. In certain embodiments, therapeutic formulations,
                                                        77

   e.g., slow release formulations, are prepared by combining the macromolecular compositions
   described in this section with the cellular factors and components isolated according to the Secreted
   Protein Isolation Protocol 1 (Conditioned medium), Secreted Protein Isolation Protocol 2 (Urea
   mediated protein extraction) and Extracellular Matrix Isolation Protocol 1 (DOC-Mediated
 5 Preparation) detailed above.
   SYSTEMS AND KITS
            Also provided by the subject invention are systems and kits that include the cells of the
   invention for use in various applications, as described herein. The systems and kits may further
10 include reagents and materials for the propagation and use of the cells for research and/or therapeutic
   applications as described herein.
   COMBINATIONS
            It is appreciated that certain features of the invention, which are, for clarity, described in the
15 context of separate embodiments, may also be provided in combination in a single embodiment.
    Conversely, various features of the invention, which are, for brevity, described in the context of a
   single embodiment, may also be provided separately or in any suitable sub-combination. All
   combinations of the embodiments pertaining to the cells and method for producing the same are
   specifically embraced by the present invention and are disclosed herein just as if each and every
20 combination was individually and explicitly disclosed. In addition, all sub-combinations of the
   factors (e.g., transcription factors) listed in the embodiments describing such variables are also
   specifically embraced by the present invention and are disclosed herein just as if each and every such
   sub-combination of factors was individually and explicitly disclosed herein.
25 EXAMPLES
            The following examples are put forth so as to provide those of ordinary skill in the art with a
   complete disclosure and description of how to make and use the present invention, and are not
   intended to limit the scope of what the inventors regard as their invention nor are they intended to
   represent that the experiments below are all or the only experiments performed. Efforts have been
30 made to ensure accuracy with respect to numbers used (e.g. amounts, temperature, etc.) but some
   experimental errors and deviations should be accounted for. Unless indicated otherwise, parts are
   parts by weight, molecular weight is weight average molecular weight, temperature is in degrees
   Centigrade, and pressure is at or near atmospheric.
35
                                                         78

   Example 1. Novel clonal human progenitors derived from hES cells that constitutively express the
   transcription factor OCT4.
            Clonal progenitor lines from iPS cells constitutively expressing POU class 5 homeobox 1
   (POU5F1), transcript variant 1, aka OTF4, OCT3, OCT4, MGC22487, OTF3, ACCESSION
 5 NUMBER NM_002701.4 were created using Reprogramming Protocol 1 described herein (See Table
   I). An iPS clone that did not silence OCT4 following differentiation was identified and used to
   generate clonal progenitors as described herein. In incubators using 5% oxygen, the iPS colonies
   were grown to confluence, then differentiated in DMEM supplemented with 10% FBS or endothelial
   MV2 media (Promocell) for seven days. The cells were then replated and expanded in four different
10 media on gelatin coated plates. The latter four media used were: DMEM supplemented with 10%
   FBS, Promocell MV2 endothelial media, Promocell smooth muscle cell media, and Promocell
   skeletal muscle media. As the cells approached confluence, they were designated candidate cultures,
   and were plated at clonal densities or 500-2,500 cells/15cm tissue culture plates coated with gelatin
   and incubated in 5% oxygen. After 14 days, visibly distinct colonies were identified and isolated
15 using cloning cylinders with trypsin and scaled up in 24, 12, 6 well and subsequently larger flasks.
   After 6 passages, the cells were synchronized for five days in confluence in media with 10% of the
   normal mitogens and RNA was isolated for use in gene expression microarray analysis using
   Illumina bead arrays. The cell lines subjected to microarray analysis where the initial iPS cells were
   differentiated in DMEM supplemented with 10% FBS and later isolated from candidate cultures
20 cultured in Promocell skeletal muscle medium were: 14SKEL7X, and 14SKEL18X. The cell lines
   subjected to microarray analysis where the initial iPS cells were differentiated in Promocell MV2
   endothelial media and later isolated from candidate cultures cultured in Promocell skeletal muscle
   medium were: 14SKEL12Z, 14SKEL14Z, 14SKEL15Z, 14SKEL20Z, and 14SKEL24Z. The cell
   lines subjected to microarray analysis where the initial iPS cells were differentiated in DMEM
25 supplemented with 10% FBS and later isolated from candidate cultures cultured in Promocell MV2
   endothelial media were: 14PEND2X, 14PEND1 1X, 14PEND12X, 14PEND14X, 14PEND20X,
   14PEND23X and 14PEND24X. The cell lines subjected to microarray analysis where the initial iPS
   cells were differentiated in DMEM supplemented with 10% FBS and later isolated from candidate
   cultures cultured in Promocell smooth muscle media were: 14SMOO2X and 14SMOO8X. The cell
30 line subjected to microarray analysis where the initial iPS cells were differentiated in DMEM
   supplemented with 10% FBS and later isolated from candidate cultures cultured in Promocell MV2
   endothelial media was: 14PEND 17Z.
            As can be seen in Figure 1, all of these clonal progenitor cell lines continued to constitutively
   express OCT4 at levels comparable to hES and hiPS cell lines. As can be seen in Table II, where
35 relative fluorescence units (RFUs) of greater than 100 are considered positive, and where genes are
   ranked with highest differential expression listed first, the clonal progenitors expressed a diverse
                                                       79

   array of differentiated patterns of gene expression and showed that many unique phenotypes were
   captured using the present invention.
            It is noted here that the progenitor cell lines described herein have the unique gene
   expression patterns markers shown in Table II. These clonal progenitor cell lines can thus be
 5 identified and distinguished from other clonal progenitors in their unique pattern of most
   infrequently-expressed genes, that is with high filter scores as shown in Table II. For example, such
   progenitor cell lines can be identified from other cell types by using the top 5, top 6, top 7, top 8, top
   9, top 10, up to the top 20 or more genes listed for each cell line. Thus, one aspect of the subject
   invention includes progenitor cell lines having the unique patern of gene expression for the top 5 to
10 top 20 or more genes as shown in Table II.
            By way of example, the cell line 14SKEL12Z can be seen in Table II to have the gene LHX3
   (Accession number NM_178138.2) expressed at 1716 RFUs which is 29-fold higher than the average
   of 253 other lines, and a filter score of 252 indicating that it was the only line in 253 lines expressing
   the gene. This can be seen in Figure 2. The line 14SKEL12Z also expressed the relatively rare
15 transcript RESP18 (Accession number NM_001007089.2). The expression of both LHX3 and
   RESP18 as well as PITX1 and PITX2 is consistent with progenitors of the anterior and intermediate
   lobes of the pituitary. Such purified pituitary cells have not been previously produced from
   pluripotent stem cells and are useful in research and therapy wherein said cells are transplanted to
   restore pituitary function impaired by disease.
20          In addition, other useful cell types include those expressing IL19 as shown in Figure 3 and
   Table II. Microarray gene expression analysis of the expression of IL19 (Accession
   number NM_013371.2) in diverse normal cultured cell types, diverse normal clonal progenitor cell
   lines derived from hES cells, hES and iPS cells, and select cell lines of the present invention showed
   that pluripotent rarely if ever express IL19, but that the clonal cell lines of the present invention
25 14SMOO8X, 14PEND1IX, and 14PEND20X express the rare gene. Cells expressing the gene can be
   used to manufacture the protein in vivo for therapeutic effect such as to provide a function normally
   provided by monocytes. It can bind the IL20 receptor complex and lead to the activation of the signal
   transducer and activator of transcription 3 (STAT3). It can be used to up-regulate the expression of
   IL6 and TNF-alpha and induce apoptosis, or used to manufacture the secreted protein as described in
30 the sections above titled Secreted Protein Isolation Protocol 1 or Secreted Protein Isolation Protocol.
            In addition, other useful cell types include those expressing gastrin-releasing peptide RNA as
   shown in Figure 4 and Table II. Microarray gene expression analysis of the expression of Gastrin
   releasing peptide (GRP) (Accession number NM_001012513.1) in diverse normal cultured cell types,
   diverse normal clonal progenitor cell lines derived from hES cells, hES and iPS cells rarely showed
35 expression of the gene, while select cell lines of the present invention including 14SKEL14Z,
   14SKEL15Z, 14SKEL20Z, 14SKEL24Z, and 14PEND20X expressed abundant levels of the
   transcript (>1,000 RFUs). Cells expressing the gene can be used to manufacture the protein in vivo
                                                         80

   for therapeutic effect such as to regulate numerous functions of the gastrointestinal and central
   nervous systems, including release of gastrointestinal hormones, smooth muscle cell contraction, and
   epithelial cell proliferation as is known in the art for the normal protein, or used to manufacture the
   secreted protein as described in the sections above titled Secreted Protein Isolation Protocol 1 or
 5 Secreted Protein Isolation Protocol.
            In addition, another useful cell type includes one expressing paraoxonase 3 RNA (PON3) as
   shown in Figure 5 and Table II. Microarray gene expression analysis of paraoxonase 3 (PON3)
   (Accession number NM_000940.1) in diverse normal cultured cell types, diverse normal clonal
   progenitor cell lines derived from hES cells, hES and iPS cells, and the select cell lines of the present
10 invention shows rare and low expression of the gene, while the line 14PEND2X expressed abundant
   levels of the gene. Cells expressing the gene can be used to manufacture the protein in vivo for
   therapeutic effect such as when it is secreted into the blood as a protein and associates with high
   density lipoprotein (HDL). The protein also rapidly hydrolyzes lactones and can inhibit the oxidation
   of low-density lipoprotein (LDL), a function that is believed to slow the initiation and progression of
15 atherosclerosis, or used to manufacture the secreted protein as described in the sections above titled
   Secreted Protein Isolation Protocol 1 or Secreted Protein Isolation Protocol.
   Example 2. Novel clonal human progenitors derived from hES cells with inducible expression of the
   transcription factors SIXI and SIX2 are generated in hES and hiPS cells as described herein. Clonal
20 progenitor lines are assayed for their capacity to undergo chondrogenesis in micromass conditions in
   the presence of TGFB3, e.g., as described in PCT Patent Applicaiton Serial No.
   PCT/US2010/042369 filed on July 16, 2010, entitled "Methods and Compositions for In Vitro and In
   Vivo Chondrogenesis", incorporated herein by reference.
25 Example 3. Novel clonal human progenitors are isolated, expanded, and microarray analysis is
   performed from hES and somatic cells reprogrammed to a pluripotent stem cell state (hiPS
   cells)overexpressing each of the CNS transcription factors SOX2, SOX21, and PAX6 introduced by
   an expression plasmid as described herein. hES cells are also isolated where there is separately
   inducible expression of the genes for the pair of factors SOX2/SOX21, and PAX6/SOX21. In the case
30 where separately-inducible pairs of factors are introduced, SOX21 is induced only after expansion of
   the clonal progenitors to induce terminal neuronal differentiation which is assayed by microarray
   analysis.
   Example 4. Novel clonal human progenitors are isolated, expanded, and microarray analysis is
35 performed from hES cells and somatic cells reprogrammed to a pluripotent stem cell state (hiPS
   cells) overexpressing each of the endoderm transcription factors FOXA 1, and SOX] 7 introduced by
   an expression plasmid as described herein. hES and hiPS cells are also isolated where there is
                                                        81

   separately-inducible expression of the genes for the pair of factors FOXA], and SOX] 7. The resulting
   clonal, oligoclonal, or pooled polyclonal progenitor cell lines are useful in the treatment of diseases
   associated with dysfunctional endoderm-derived cells including pancreatic beta cells for the
   treatment of diabetes, lung epithelial cells for the treatment of lung disease, intestinal epithelium for
 5 the treatment of digestive disorders, and so on.
   Example 5. Novel clonal human progenitors are isolated, expanded, and microarray analysis is
   performed from hES cells and somatic cells reprogrammed to a pluripotent stem cell state (hiPS
   cells) overexpressing cardiac field transcription factor NKX2.5 introduced by an expression plasmid
10 as described herein. hES and hiPS cells are also isolated where there is inducible expression of the
   gene. The resulting clonal, oligoclonal, or pooled polyclonal progenitor cell lines are useful in the
   treatment of diseases associated with dysfunctional myocardium such as heart failure or acute
   myocardial infarction wherein the resulting cells are injected into the heart tissue by means of a
   catheter or other means known in the art, together with matrix such as HyStem hydrogel
15 (www.biotimeinc.com) to promote engraftment.
            Although the foregoing invention has been described in some detail by way of illustration
   and example for purposes of clarity of understanding, it is readily apparent to those of ordinary skill
   in the art in light of the teachings of this invention that certain changes and modifications may be
20 made thereto without departing from the spirit or scope of the appended claims.
            Accordingly, the preceding merely illustrates the principles of the invention. It will be
   appreciated that those skilled in the art will be able to devise various arrangements which, although
   not explicitly described or shown herein, embody the principles of the invention and are included
25 within its spirit and scope. Furthermore, all examples and conditional language recited herein are
   principally intended to aid the reader in understanding the principles of the invention and the
   concepts contributed by the inventors to furthering the art, and are to be construed as being without
   limitation to such specifically recited examples and conditions. Moreover, all statements herein
   reciting principles, aspects, and embodiments of the invention as well as specific examples thereof,
30 are intended to encompass both structural and functional equivalents thereof. Additionally, it is
   intended that such equivalents include both currently known equivalents and equivalents developed
   in the future, i.e., any elements developed that perform the same function, regardless of structure.
   The scope of the present invention, therefore, is not intended to be limited to the exemplary
   embodiments shown and described herein. Rather, the scope and spirit of present invention is
35 embodied by the appended claims.
                                                         82

TABLES
Table I: Protocols
                                         Transfection Protocol 1
By way on nonlimiting example, for stable transfections, plasmids are linearized by restriction digest
such that 0.2 microgram of DNA is contained within 1 microliter of the restriction digest mixture,
and such that approximately 1 microgram of DNA per 5 square centimeters of the tissue culture
dish/plate/flask into which cells are seeded during the transfection process can be used. Linearized
plasmids are diluted in mTeSR1 Basal Medium (STEMCELL Technologies Inc.), and supplemented
with FuGENE HD (Roche) such that the ratio of DNA (in microgram) : FuGENE HD (in microliter)
: mTeSR1 Basal Medium (in milliliter) is 1 : 3: 0.25. The DNA/FuGENE HD mixture is incubated
at room temperature (RT) for 30 minutes - 2 hours. In the meantime, pluripotent stem cells such as
hES cells or hiPS cells are grown on Matrigel (BD Biosciences)-coated tissue culture ware are
detached with Accutase, and an aliquot of the single cell suspension used for cell counting. Cells are
spun at 200 x g for 5 minutes at RT and suspended to 1.5 x 10e6 cells per milliliter in mTeSR1
complete medium supplemented with 10 micromolar Y27632 (ROCK inhibitor). Approximately 0.75
x 10e6 cells per 1 microgram of DNA are combined with the DNA/FuGENE HD mixture, then
plated on Matrigel-coated tissue culture ware, and incubated at 37 centigrades/5% oxygen/10%
carbon dioxide. 3 hours later, 1 volume of mTeSR1 complete medium supplemented with 2X
Penicillin/Streptomycin and 10 micromolar Y27632 is added. The next day, medium is replaced by
mTeSR1 complete medium containing Penicillin/Streptomycin and 10 micromolar Y27632.
Selection for hES cells or iPS cells with stably integrated transgenes is carried out 2 days or later
after transfection. For transient transfections, a similar procedure is carried out also relying on a ratio
of DNA: FuGENE HD: mTeSR1 Basal Medium = 1: 3: 0.25.
                                       Reprogramming Protocol 1:
Somatic cells are reprogrammed using retroviral-mediated expression of OCT4, SOX2, and KLF4
(pMx-OCT4/pMx-SOX2/pMx-KLF4 viruses) as described in PCT Application Serial No.
PCT/US2011/025316, published as WO 2011/103343 and entitled "METHODS FOR TELOMERE
LENGTH AND GENOMIC DNA QUALITY CONTROL ANALYSIS IN PLURIPOTENT STEM
CELLS", incorporated herein by reference in its entirety. The somatic cells (including those
genetically modified to display altered transcriptional regulators as described herein) are infected
with the SOK (SOX2, OCT4 and KLF4) viruses for 20 hours in presence of 8 pg/ml of polybrene.
After infection, media is changed and cells are plated onto irradiated feeders (12 Gy). Co-cultures
are then switched to knock-out DMEM hES media (Invitrogen, cat# 10829-018) containing 16%
KOSR media (Invitrogen); IX Glutamax (Invitrogen); pen/strep (Invitrogen); non-essential amino
acids (Invitrogen); 0.6ml P-Mercaptoethanol (Invitrogen) per 500 ml of media and 50ng/mI of bFGF
                                                     83

(Millipore, cat#GF003). Media is changed daily until iPS colonies appear. The colonies are
manually picked with a pipette tip (p200) or by using plastic cloning rings, washed in PBS and
manually removed to 24 well dishes containing radiated feeders. The hES media is changed
completely everyday. The cells are subsequently transferred to six well dishes and eventually moved
to feeder free 10 cm 2 dishes (Corning). Matrigel (BD Bioscience) is thawed at 40 C and diluted 1:12
with cold DMEM (Invitrogen). A final concentration of 1OOng/ml of bFGF (Millipore) is added to
mTESR1 media (Stem Cell Technologies, Vancouver). Media is changed every day and the
differentiated or near differentiated colonies are removed. Cell lines are subcultured on average once
per week.
 Table II
                                               14PEND11X P6
                             Symbol     Definition             Synonyms    RFUs          Fold over Ave. Filter
 ProbelD    RefSeq_ID
                                                                                                        Score
                                        Homo sapiens           NG.1; IL
  3180068  NM 013371.2       IL19       interleukin 19 (1119),      AC;      888.5502538   15.96168331   247
                                        transcript variant 2,  ZMDA1;
                                        mRNA.                  MDA1
                                        Homo sapiens CSAG
  5860504  NM_001080848.1    CSAG3B     family, member 3B      CSAG2         274.1073604   3.806242927   247
                                        (CSAG3B), mRNA.
                                        Homo sapiens
                                        tripartite motif-      RBCC; terf;
  6350682  NM_016102.2       TRIM17     containing 17          RNF16         241.0488156    3.04374161   247
                                        (TRIM17), transcript
                                        variant 1, mRNA.
                                        Homo sapiens CSAG
  4010095  NM_203311.1       CSAG3A     family, member 3A      MGC17065      708.1494078   8.825421693   246
                                        (CSAG3A), mRNA.
                                        Homo sapiens CSAG
  6900377  NM_001080848.1    CSAG3B     family, member 3B      CSAG2           444.11489    5.81561537   246
                                        (CSAG3B), mRNA.
                                        Homo sapiens           HPA; HSE1;
   630619  NM_006665.3       HPSE       heparanase (HPSE),     HPSE1;         326.830203   3.839238782   246
                                        mRNA.                  HPR1
                                        Homo sapiens
                                        transcobalamin I
  1770603  NM_001062.3       TCN1       (vitamin B12 binding   TCI; TCl      30460.03096   145.1865227   244
                      _                ~~~~~~~protein,
                                                  R binder     TI    C        06.39         4.852         4
                                        family) (TCN1),
                                        mRNA.
                                        Homo sapiens solute
                                        carrier family 17
                                        (sodium-dependent
  7160192  NM 139319.1       SLC17A8    inorganic phosphate    VGLUT3       483.2905245    7.840373688   244
                                        cotransporter),
                                        member 8
                                        (SLC17A8), mRNA.
                                        Homo sapiens
                                        potassium voltage-     KV2.; h
                                        gated channel, Shab-   KV.1
  6900196  NM004975.2        KCNB1      related subfamily,     DRK1;         1279.524365   17.97978203   243
                                        member 1 (KCNB 1),     DRK1
                                        mRNA.
                                        Homo sapiens
  3450544  NM_138569.2       C6orfl42   chromosome 6 open      MGC18257      188.5175973   2.228827544   243
                                        reading frame 142
                                        (C6orfl42), mRNA.
                                                          84

                                                        DKFZp434P
                                                        2350;
                                                        USH1H;
                               Homo sapiens             KIAA1774;
6510274 NM_022124.3    CDH23   cadherin-like 23         FLJC02331   213.8431472 2.220053223 242
                               (CDH23), transcript      MGC102761
                               variant 1, mRNA.         ; FLJ36499;
                                                        DFNB 12;
                                                        USHID;
                                                        KIAA1812
                               Homo sapiens             D2S69E;
         M_0248.1
        536064          NLY    granulysin (GNLY),       519; LAG2;
5360064 NM 012483.1    GNLY    granuysc    iant    )    NKG5;       215.1233503 2.422329434 241
                               transcript variant 519   LAG-2;
                               mRNA.                    TLA519
                                                .       HSD26;
                               Homo sapiens             LL37;
                               cathelicidin               L7
5860075 NM 004345.3    CAMP     atheicidin              FALL39;     187.4673435 2.075440453 241
                  --           antimicrobial peptide    FALL-39'
                               (CAMP), mRNA.            CAP18
                               Homo sapiens
                               vasoactive intestinal    MGC13587;
 360379 NM 194435.1    VIP     peptide (VIP),           PHM27       259.2274112 3.052114612 240
                               transcript variant 2,
                               mRNA.
                               Homo sapiens
6270022 NM 002110.2    HCK     hemopoietic cell         JTK9        610.5037225 7.680844729 239
                               kinase (HCK),
                               mRNA.
                               Homo sapiens myosin
                               binding protein C,       slow-type;
 840017 NM 206819.1    MYBPCl  slow type (MYBPC1),      MYBPCS;     305.5191201 3.198362009 239
                               transcript variant 2,    MYBPCC
                               mRNA.
                               Homo sapiens myosin
                               binding protein C,       slow-type;
5910056 NM_206821.1    MYBPCl  slow type (MYBPC1),      MYBPCS;     236.6600677 2.283355152 239
                               transcript variant 4,    MYBPCC
                               mRNA.
                               Homo sapiens sterile
3390523 NM_001010971.1 SAMD13  alpha motif domain       RP11-       227.2099831 2.282533933 239
                               containing 13            376N17.1
                               (S AMD 13), mRNA.
                               Homo sapiens NK2         NKX2B;
7610441 NM 002509.2    NKX2-2  homeobox 2 (NKX2-        NKX2.2      5979.623181 34.51368017 238
                               2), mRNA.
                                                        HsT17226;
                               Homo sapiens solute      FATP2;
                               carrier family 27 (fatty FACVL1;
4670138 NM_003645.2    SLC27A2 acid transporter),       hFACVL1;    258.8497462  2.27246929 238
                               member 2                 VLACS;
                               (SLC27A2), mRNA.         VLCS;
                                                        ACSVL1
                               Homo sapiens Fas
5270520 NM_005449.3    FAIM3   apoptotic inhibitory     TOSO        796.8850254 10.50369487 237
                               molecule 3 (FAIM3),
                               mRNA.
                               Homo sapiens Src
                               homology 2 domain
 730093 NM 020209.2    SHD     containing                           270.9575296 2.750523803 237
                               transforming protein
                               D (SHD), mRNA.
                               Homo sapiens             HBGR;
                               glutamate receptor,      GLURA;
1190592 NM_000827.2    GRIAl   gtrceptor'               GLUHI;      233.2972927 2.357055576 237
                               ionotropic, AMPA 1       GLURI;
                               (GRIA1), mRNA.           MGC133252
                                                        SCYB 13;
                               Homo sapiens             ANGIE;
                               chemokine (C-X-C         BCAl;
1110564 NM 006419.1    CXCL13  motif) ligand 13 (B-     ANGIE2;     5015.168866  41.6397734 236
                               cell chemoattractant)    BCA-1;
                               (CXCL13), mRNA.          BLR1L;
                                                        BLC
                                                  85

                               Homo sapiens            Erk4;
4860403 NM 002747.3    MAPK4   mitogen-activated       p63MAPK;   681.5299492 9.892172042  236
                               protein kinase 4        ERK3;
                               (MAPK4), mRNA.          PRKM4
                               Homo sapiens            NG.1; IL
6330070 NM 013371.2    IL19    interleukin 19 (IL19),  1OC;       698.1584602 8.432367471  235
                               transcript variant 2,   ZMDA1;
                               mRNA.                   MDA1
                               Homo sapiens solute
                               carrier family 10
7000176 NM 152679.2    SLC10A4 (sodium/bile acid       MGC29802;  627.2695431 7.965185955  235
                               cotransporter family),  P4
                               member 4
                               (SLC1OA4), mRNA.
                               Homo sapiens SH2        NSP3;
 270487 NM_170600.1    SH2D3C  domain containing 3C    PR034088;  296.3759729 3.171074362  235
                               (SH2D3C), transcript    CHAT;
                               variant 2, mRNA.        FLJ39664
                               Homo sapiens solute
                               carrier family 7
                                                       CAT-3;
                               (cationic amino acid    ATRC3;
  60278 NM_001048164.1 SLC7A3  transporter, y+         FLJ1451:   707.6612521   5.26365107 234
                               system), member 3       MGC20687
                               (SLC7A3), transcript
                               variant 2, mRNA.
                               Homo sapiens
6020224 NM 000507.2    FBP1    fructose-1,6-           FBP         277.680203 3.741121248  234
                               bisphosphatase 1
                               (FBP1), mRNA.
                               Homo sapiens NEL
7550358 NM 006159.1    NELL2   like 2 (chicken)        NRP2       741.8240271 4.338251013  233
                               (NELL2), mRNA.
                               Homo sapiens eyes
                               absent homolog 4        CMD1J;
1260180 NM 004100.3    EYA4    (Drosophila) (EYA4),    DFNA1      389.3572758 2.833686856  233
                               transcript variant 1,
                               mRNA.
                               Homo sapiens            KIAA1263;
1070162 NM_020116.2    FSTL5   follistatin-like 5      DKFZp566D  378.9091371 4.110594619  232
                               (FSTL5), mRNA.          234
                               Homo sapiens
 580187 NM001029851.1  PDE8B   phosphodiesterase8B     FLJ11212   351.5852792 3.117135307  232
                               (PDE8B), transcript
                               variant 3, mRNA.
                               Homo sapiens ST8        MGC116857
                               alpha-N-acetyl-         ;HsT19690;
 150066 NM_006011.3    ST8SIA2 neuraminide alpha-      ST8SA- I;   268.872758 2.751244758  232
                               2,8-sialyltransferase 2 MGC116854
                               (ST8SIA2), mRNA.        ; STX
                               Homo sapiens GTP        DYT5; GTP
1010360 NM 001024070.1 GCH1    cyclohydrolase 1        CH-1;      287.9126058 3.574011669  230
                               (GCH1), transcript      GTPCH1;
                               variant 3, mRNA.        GCH
                               Homo sapiens fragile    FRA3B;
 510452 NM_002012.1    FHIT    histidine triad gene    AP3Aase    228.7604061 2.317346033  230
                               (FHIT), mRNA.
                               Homo sapiens SRY
3310037 NM 005634.2    SOX3    (sex determining        SOXB;      1479.767174   10.8216027 229
                               region Y)-box 3         MRGH
                               (SOX3), mRNA.
                               Homo sapiens            GTH1;
1090561 NM_145740.2    GSTA1   glutathione S-          GST2;      556.5102369 5.787657576  229
                               transferase Al          MGC13 1939
                               (GSTA1), mRNA.          ; GSTAl-1
                               Homo sapiens
                               neurotrophic tyrosine
                                                       GP145
3870246 NM_001007097.1 NTRK2   kinase, receptor, type  TrkB; TRKB 847.2759729 6.532092112  228
                               2 (NTRK2), transcript
                               variant b, mRNA.
                               Homo sapiens
                               neurotrophic tyrosine   GP145
 430102 NM_001018065.1 NTRK2   kinase, receptor, type  TrkB; TRKB 961.9575296 6.967734817  227
                               2 (NTRK2), transcript
                               variant d, mRNA.
                                                 86

                                        Homo sapiens ankyrin    MGC26087;
                                        repeat and sterile      EB-1;
 2350201 NM_181670.2           ANKS1B   alpha motif domain      ANKS2;       285.6676819   3.125722047   227
            -                           containing lB           AIDA-1;
                                        (ANKS IB), transcript   AIDA;
                                        variant 2, mRNA.        cajalin-2
                                        Homo sapiens            LIECG3;
                                        tubulointerstitial      LCN7
 1450634 NM_022164.1           TINAGL1  nephritis antigen-like  TNARP        270.9575296   2.631481406   227
                                        1 (TINAGL1),            ARG1
                                        mRNA.
                                        Homo sapiens solute
                                        carrier family 8
 2320369 NM_015063.1           SLC8A2   (sodium/calcium         NCX2         1108.214552   8.081731657   226
                                        exchanger), member 2
                                        (SLC8A2), mRNA.
                                                                OTF4
                                        Homo sapiens POU        OCT3;
  770615 NM_002701.4           POU5F1   cU5F ) tranript            GOCT4;    9900.403892   14.71166303   225
                                        variant 1, mRNA.        OTF3
                                        Homo sapiens MOB 1,     FLJ13204;
                               MOBKL2   Mps One Binder          FLJ23916;
  940630 NM_024761.3           B        kinase activator-like   MOB3B;       343.5135364   3.171424587   224
                                        2B (yeast)              MC26
                                        (MOBKL2B), mRNA.        MGC32960
                                        Homo sapiens calcium
                                        channel, voltage-       CACNLB2;
 2850458 NM_201572.1           CACNB2   dependent, b2                   43   277.0624365   3.125835177   224
                      _subunit                   (CACNB32),     FLJ23743
                                        transcript variant 8,
                                        mRNA.
                                        Homo sapiens POU
                                        class 5 homeobox 1      POU5FLC8;
 6450746 NR_002304.1           POU5F1Pi pseudogene 1            OTF3C;       11585.36311   19.28453406   223
                                        (POU5F1Pi), non-        OTF3P1
                                        coding RNA.
                                                 14PEND12X P6
                               Symbol   Definition              Synonyms   RFUs          Fold over Ave. Filter
ProbelD  RefSeq_ID
                                                                ngn-2;
                                        Homo sapiens            NGN2;
                               NEUROG
 7610746 NM 024019.2           2        neurogenin 2            MGC46562;    297.4715736     3.41521657  250
                                        (NEUROG2), mRNA.        Math4A;
                                                                Atoh4
                                        Homo sapiens uridine    UPASE2;
 2360743 NM_173355.2           UPP2     phosphorylase 2         UDRPASE2;     209.841286   2.786979154   250
                                        (UPP2), mRNA.           UP2
                                        Homo sapiens
                                        ribonuclease, RNase
 2640068 NM_002934.2           RNASE2   A family, 2 (liver      EDN; RNS2    1769.958037     26.4030724  245
                                        eosinophil-derive
                                        neurotoxin)
                                        (RNASE2), mRNA.
                                        Homo sapiens serum      MGC111216
 2600424 NM 000331.3           SAAl     amyloid Al (SAA1),      ; SAA;       902.0096447   10.77448424   245
                                        transcript variant 1,   PIG4;
                                        mRNA.                   TP5314
                                        Homo sapiens            HBGR2;
 6220750 NM 000826.2           GRIA2    glutamate receptor,     GLURB;      431.6473773    3.605401705   245
             -0ionotropic,                           AMPA 2     GLUR2
                                        (GRIA2), mRNA.
                                        Homo sapiens
                                        transcobalamin I
 1770603 NM 001062.3           TCN1     (vitamin B12 binding    TCI; TC 1    11220.49662   52.85041744   244
            -                           protein, R binder
                                        family) (TCNl),
                                        mRNA.
                                        Homo sapiens solute     MGC126299
 1010097 NM_021815.2           SLC5A7   carrier family p                     247.5932318   3.254269838   244
                      _                 ~~~~~(choline
                                                  transporter), MGC126300    275331         .S293         4
                                        member 7 (SLC5A7),        CHT1;
                                                          87

                               mRNA.                  hCHT; CHT
                               Homo sapiens
                               transcription factor
                               AP-2 beta (activating  MGC21381;
7320471 NM_003221.3    TFAP2B  enhancer binding       AP-2B;    438.5033841 5.285112768  243
                               protein 2 beta)        AP2-B
                               (TFAP2B), mRNA.
                               Homo sapiens family
                               with sequence
                               similarity 19          TAFA-1
2230088 NM_213609.2    FAM19A1 (chemokine (C-C        TAFA1     230.4490694 2.471180495  243
                               motif)-like), member
                               Al (FAM19A1),
                               mRNA.
                               Homo sapiens
4810487 NM 018712.2    ELMODI  ELMO/CED-12            DKFZp547C 423.9783418 4.891351541  242
                               domain containing 1    176
                               (ELMOD 1),mRNA.
                               Homo sapiens gastrin-  proGRP;
 160500 NM 001012513.1 GRP     releasing peptide      GRP-10;    390.171912   3.35811555 242
                               (GRP), transcript      BN;
                               variant 3, mRNA.       preproGRP
                               Homo sapiens ciliary
                               neurotrophic factor
6560487 NM_001842.3    CNTFR   receptor (CNTFR),      MGC1774    235.391709 2.429155916  242
                               transcript variant 2,
                               mRNA.
                               Homo sapiens
3390372 NM 001843.2    CNTN1   contactin 1 (CNTN1)    GP135; F3 682.6843486 8.726416526  241
                               transcript variant 1,
                               mRNA.
                               Homo sapiens
4880138 NM 000905.2    NPY     neuropeptide Y         PYY4      1095.820812 8.509567707  241
                               (NPY), mRNA.
                               Homo sapiens
6270022 NM 002110.2    HCK     hemopoietic cell       JTK9      263.4060914 2.745411036  239
                               kinase (HCK),
                               mRNA.
                               Homo sapiens NK2       NKX2B;
7610441 NM 002509.2    NKX2-2  homeobox 2 (NKX2-      NKX2.2    1223.904569 6.268912118  238
                               2), mRNA.
                               Homo sapiens
                               glutamate
                               decarboxylase 1        SCP;
3840192 NM_000817.2    GADI    (brain, 67kDa)         FLJ45882; 284.7027073 3.402376455  238
                               (GAD1), transcript     GAD
                               variant GAD67,
                               mRNA.
                               Homo sapiens           HBGR;
1190592 NM_000827.2    GRIAl   glutamate receptor'    GLUH1;    289.4909475 3.165659996  237
                               ionotropic, AMPA 1
                                                      GLURI;
                               (GRIA1), mRNA.         MGC133252
                                                      CSDD1;
                               Homo sapiens lin-28    LIN28A;
1340551 NM_024674.4    LIN28   homolog (C. elegans)   FLJ12457; 2479.402538 2.210091192  237
                               (LIN28), mRNA.         LIN-28;
                                                      ZCCHC1
                               Homo sapiens           PRO1155;
 840291 NM 013251.2    TAC3    tachykinin 3 (TAC3),   NB;       298.9903553 2.009165335  237
                               transcript variant 2,  ZNIEUROK1
                               mRNA.                  ;NKNB
                               Homo sapiens heparan
5870435 NM 006043.1    HS3ST2  sulfate (glucosamine)  30ST2;    273.9906937 2.977575504  236
                               3-0-sulfotransferase 2 30ST2
                               (HS3ST2), mRNA.
                               Homo sapiens SRY
2570538 NM 007084.2    SOX21   (sex determining       SOX25     1192.648308   7.92266175 235
                               region Y)-box 21
                               (SOX21), mRNA.
                                                88

                                 Homo sapiens eyes
                                 absent homolog 4        CMD1J
2350139 NM 004100.3      EYA4    (Drosophila) (EYA4),    DFNA1       373.3384095 4.344035695 235
                                 transcript variant 1,
                                 mRNA.
                                 Homo sapiens
                                 reprimo, TP53           FLJ90327
5550414 NM 019845.2      RPRM    dependent G2 arrest     REPRIMO     594.4890017 3.325358686 234
                                 mediator candidate
                                 (RPRM), mRNA.
                                 Homo sapiens cyclic
                                 AMP-regulated
7160437 NM_001025068.1   ARPP-21 phosphoprotein, 21      FLJ32997    228.1532149 2.224344891 234
                                 kD (ARPP-21),
                                 transcript variant 3,
                                 mRNA.
                                 Homo sapiens SRY        ANOP3;
5130156 NM 003106.2      SOX2    (sex determining        MGC2413;    815.6978003 1.950260059 234
                                 region Y)-box 2         MCOPS3
                                 (SOX2), mRNA.
                                 Homo sapiens eyes
                                 absent homolog 4        CMD1J
1260180 NM 004100.3      EYA4    (Drosophila) (EYA4),    DFNA1       787.1558376 6.750488243 233
                                 transcript variant 1,
                                 mRNA.
                                 Homo sapiens solute
                                 carrier family 22
                                                         EMT;
6200333 NM 021977.2      SLC22A3 (extraneuronal          OCT3;       402.0670051 4.584713555 233
                  --             monoammne               EMTH
                                 transporter), member
                                 3 (SLC22A3), mRNA.
                                                         HSPOX2;
                                 Homo sapiens proline    MGC148078
                                 dehydrogenase            PIG6;
5860689 NM_016335.2      PRODH   (oxidase) 1 (PRODH),    SCZD4;
              58069 M 16352ROH     ucea gneenodng        FLJ33744;   378.1150592 2.479178716 233
                                 nuclear gene encoding   PRODH1
                                 mitochondrial protein,  TP53I6;
                                 mRNA.                   MGC148079
                                                         ;PRODH2
                                 Homo sapiens            BCH;
3190246 NM_004067.2      CHN2    chimerin (chimaerin)    ARHGAP3;    226.9649746 2.379830339 233
          M 0406.2
         19046             HN2   2 (CHN2), transcript    RHOGAP3;
                                 variant 2, mRNA.        MGC138360
                                                         MGC1934;
                                 Homo sapiens            HOX1.7;
2810673 NM 152739.3      HOXA9   homeobox A9             HOXIG;      446.3071066 1.957145588 233
                                 (HOXA9), mRNA.          HOXI;
                                                         ABD-B
                                 Homo sapiens C-type
7320348 NM 016511.2      CLEC1A  lectin domain family    CLECI;      613.7247885 7.363051918 232
                                 1, member A             MGC34328
                                 (CLEC1A), mRNA.
                                 Homo sapiens Zic
                                 family member 3
                                                         HTX1;
 670414 NM_003413.2      ZIC3    heterotaxy (odd-        ZNF203;     1096.337563 4.255659158 232
                                 paired homolog'         HTX
                                 Drosophila) (ZIC3),
                                 mRNA.
                                                         MGC1 16857
                                 Homo sapiens ST8         HsT19690;
                                 alpha-N-acetyl-           sTSIA-I
 150066 NM_006011.3      ST8SIA2 neuraminide alpha-      ST8SA- I;   367.6824027 4.129811944 232
                                 2,8-sialyltransferase 2 MGC116854
                                 (ST8SIA2), mRNA.             1STX
                                 Homo sapiens ADP
7040497 NM 001179.3      ART3    ribosyltransferase 3                401.8192893 3.053793795 232
                                 (ART3), mRNA.
                                 Homo sapiens zona       ZBP: ZPB
7400392 NM_021186.2      ZP4     pellucida glycoprotein  ZP1;      ' 162.1536379 1.916272182 232
                                 4 (ZP4), mRNA.
                                                  89

                                               .       BNC1;
                                Homo sapiens           hBNaC1;
                                amiloride-sensitive    MDEG;
                                cation channel 1,      BMaC1;
  240592 NM_001094.4    ACCN1   neuronal (ACCN1),      ASIC2;       270.8832487   2.445203911   231
                                transcript variant 2,  ACCN;
                                mRNA.                  ASIC2
                                Homo sapiens           GTH1;
 1090561 NM_145740.2    GSTA1     tanferase              GC331939   1261.548562   14.38688614   229
                                (GSTA1), mRNA.           GSTAl-1
                                Homo sapiens SRY
 3310037 NM 005634.2    SOX3    (sex determining       SOXB;       428.3458545    2.421980564   229
                                region Y)-box 3        MRGH
                                (SOX3), mRNA.
                                Homo sapiens
                                neurotrophic tyrosine  GP145
 3870246 NM_001007097.1 NTRK2   kinase, receptor, type TrkB; TRKB   805.6666667   6.162194773   228
                                2 (NTRK2), transcript
                                variant b, mRNA.
                                Homo sapiens           MGC126406
                                engulfment and cell    ; CED12;
 2750154 NM 014800.9    ELMO1   motility 1 (ELMO1),    CED-12;      217.5994924   2.081154468   228
                                transcript variant 1,  KIAA0281;
                                mRNA.                  ELMO-1
                                Homo sapiens
                                neurotrophic tyrosine  GP145
  430102 NM_001018065.1 NTRK2   kinase, receptor, type TrkB; TRKB   786.8602369   5.517432956   227
                                2 (NTRK2), transcript
                                variant d, mRNA.
                                Homo sapiens solute
                                carrier family 8
 2320369 NM_015063.1    SLC8A2  (sodium/calcium        NCX2         934.3940778   6.657286456   226
                                exchanger), member 2
                                (SLC8A2), mRNA.
                                Homo sapiens           FMR2;
 2030445 NM 002025.2    AFF2    AF4/FMR2 family,       MRX2;        327.9978003   3.313605756   226
                                member 2 (AEF2),       OX 19;
                                mRNA.                  FRAXE
                                Homo sapiens v-myc
                                myelocytomatosis       ODED;
  430204 NM_005378.4    MYCN    neruroblatoma de ive    MDE; N-     941.0628596   2.503281932   226
                                (avian) (MYCN),        myc
                                mRNA.
                                Homo sapiens cyclic
                                AMP-regulated
 7210554 NM_016300.4    ARPP-21 phosphoprotein, 21     FLJ32997     258.5707276   2.320790506   226
                   _            kD (ARPP-21),
                                transcript variant 1,
                                mRNA.
                                                       OTF4;
                                Homo sapiens POU       OCT3
  770615 NM_002701.4    POU5F1  cU5F ) tranript           GOCT4;    9406.515059   13.92787532   225
                                variant 1, mRNA.       OTF3
                                Homo sapiens
                                complement
 4920047 NM_001008223.1 C1QL4   component 1, q         MGC131708   432.9840948    4.255154143   225
                                subcomponent-like 4
                                (C1QL4), mRNA.
                                         14PEND12X P6
                        Symbol  Definition             Synonyms   RFUs          Fold over Ave. Filter
ProbelD  RefSeq_ID
                                Homo sapiens
                                transcobalamin I
 1770603 NM 001062.3    TCN1    (vitamin B12 binding   TCI; TC 1    11101.23858   52.27806354   244
            -                   protein, R binder
                                family) (TCN1),
                                mRNA.
                                                 90

                                Homo sapiens
                                ribonuclease, RNase
2640068 NM_002934.2    RNASE2   A family, 2 (liver      EDN; RNS2  1819.413367 27.16875608 245
                                eosinophil-derive
                                neurotoxin)
                                (RNASE2), mRNA.
                                Homo sapiens serum      MGC111216
1690563 NM 199161.1    SAAl     amyloid Al (SAA1),      ; SAA;     3500.000677 21.66993608 212
                                transcript variant 2,   PIG4;
                                mRNA.                   TP5314
                                Homo sapiens cellular   RBP5;
2510132 NM 004378.1    CRABP1   retinoic acid binding   CRABPI;     6268.61709 18.92144854 212
                                protein 1 (CRABP1),     CRABP;
                                mRNA.                   CRABP-I
                                Homo sapiens POU
                                class 5 homeobox 1      POU5FLC8;
6450746 NR_002304.1    POU5F1Pi pseudogene 1            OTF3C;     10441.29577 17.28141402 223
                                (POU5F1Pi), non-        OTF3P1
                                coding RNA.
                                PREDICTED: Homo
1780273 XM 001127464.1 ALOX5    sapiens arachidonate               3381.302876 16.67848822 134
                                5-lipoxygenase
                                (ALOX5), mRNA.
                                Homo sapiens            CRISP1O;
                                cysteine-rich secretary DKFZp762F
1430750 NM_031461.3    CRISPLD1 protein LCCL domain     133:       2605.396785 16.48430171 146
                                containing 1            LCRISP1
                                (CRISPLD1), mRNA.
                                Homo sapiens            GTH1;
1090561 NM_145740.2    GSTA1    glutathione -           GST2;      1349.498139 15.45959168 229
                                transferase Al          MGC13 1939
                                (GSTA1), mRNA.            GSTAl-1
                                Homo sapiens ADAM
                       ADAMTS   metallopeptidase with   KIAA1312
1570382 NM 182920.1             thrombospondin type     FLJ42955   3201.370558 14.36094098 123
                                1 motif, 9
                                (ADAMTS9), mRNA.
                                                        OTF4;
                                Homo sapiens POU        OCT3;
 770615 NM_002701.4    POU5F1   cU5F ) tranript            GOCT4;  9064.077834 13.38443706 225
                                variant 1, mRNA.        OTF3
                                Homo sapiens
                                carbamoyl-phosphate
6110044 NM_001875.2    CPS1     synthetase 1,                      10310.73926 12.85053084  17
                                mitochondrial (CPS 1),
                                mRNA.
                                Homo sapiens serum      MGC111216
2600424 NM 000331.3    SAAl     amyloid Al (SAA1),      ; SAA;     976.8588832 11.75153719 245
                                transcript variant 1,   PIG4;
                                mRNA.                   TP5314
                                Homo sapiens
                                dachshund homolog 1
                                                        DACH;
6510554 NM_080760.3    DACHI    (Drosophila)            FLJ10138   1421.217259 10.37859753 197
                                (DACHI), transcript
                                variant 2, mRNA.
                                Homo sapiens            RP11
6580626 NM 018015.4    CXorf57  chromosome X open       647M7.1;   2530.088663 10.13675566 146
                                reading frame 57        FLJ1O178;
                                (CXorf57), mRNA.        FLJ14191
                                Homo sapiens
                                fibroblast growth
7380239 NM_004114.2    FGF13    factor 13 (FGF13),      FGF2; FHF2 1914.284941 9.747040198 197
                                transcript variant 1A,
                                mRNA.
                                Homo sapiens
3930424 NM 053277.1    CLIC6    chloride intracellular  CLICIL     1425.501692  9.24057445 195
                                channel 6 (CLIC6),
                                mRNA.
                                Homo sapiens            MGC138845
                                neuronal cell adhesion
2750092 NM_005010.3    NRCAM    molecule (NRCAM)                   1556.537902 9.101003472 194
                                transcript variant 2,   MGC138846
                                mRNA.                     KIAA0343
                                                 91

                                 Homo sapiens
6520064 NM_152390.1      TMEM178 transmembrane          MGC33926   3950.689509   8.83406618  41
                                 protein 178
                                 (TMEM178), mRNA.
                                 Homo sapiens
                                 adenomatosis           DRAPC1;
4280739 NM_153000.3      APCDD1  polyposis coli down-   B7323;     3228.213536   8.42766302 195
                                 regulated 1            FP7019
                                 (APCDD 1), mRNA.
                                 Homo sapiens
        339032 NM00183.2  NTN1   contactin 1 (CNTN1),
3390372 NM 001843.2      CNTN1     tact     1a(Cnt1)    GP135; F3  652.6756345 8.298873032  241
                                 mRNA.
                                 Homo sapiens Norrie
2320598 NM 000266.1      NDP     disease                ND; EVR2;  2015.200508 8.108560783  112
                                 (pseudoglioma)         FEVR
                                 (NDP), mRNA.
                                 Homo sapiens
4880138 NM 000905.2      NPY     neuropeptide Y         PYY4        1008.01489 7.747585134  241
                                 (NPY), mRNA.
                                 Homo sapiens renin
5810678 NM 002910.4      RENBP   binding protein        RNBP; RBP  1564.592386 7.643734819  192
                                 (RENBP), mRNA.
                                 Homo sapiens           NF68;
                                 neurofilament, light   CMT2E;7
3140139 NM 006158.2      NEFL    polypeptide 68kDa      NTFL;      733.3238579 7.460258344  220
                                 (NEFEL), mRNA.         L
                                 Homo sapiens SRY
2570538 NM 007084.2      SOX21   (sex determining       SOX25      1089.118274 7.148113657  235
                                 region Y)-box 21
                                 (SOX21), mRNA.
                                 Homo sapiens protein
                                 phosphatase 1,
                                 regulatory (inhibitor)
                                 subunit lB (dopamine   DARPP-32;
1940747 NM_181505.1      PPP1R1B and cAMP regulated     FLJ20940;  974.3307107 7.112562778  215
                                 phosphoprotein,        DARPP32
                                 DARPP-32)
                                 (PPP1R1B), transcript
                                 variant 2, mRNA.
                                                        PR2AB
                                                        BETA;
                                                        PR52B;
                                 Homo sapiens protein   PR2APR55
                                 phosphatase 2          BETA;
                                 (formerly 2A),         PR2AB55
6020523 NM_181676.1      PPP2R2B regulatory subunit B,  BETA;      4083.244332 7.054715728    1
                                 beta isoform           MGC24888;
                                 (PPP2R2B), transcript  PR55
                                 variant 4, mRNA.       BETA;
                                                        PP2A
                                                        PR55B;
                                                        SCA12
                                 Homo sapiens solute
                                 carrier family 8
2320369 NM_015063.1      SLC8A2  (sodium/calcium        NCX2       974.3307107 6.984564041  226
                                 exchanger), member 2
                                 (SLC8A2), mRNA.
                                 Homo sapiens C-type
7320348 NM 016511.2      CLEC1A  lectin domain family   CLECI;     583.3066836 6.948553114  232
                                 1, member A            MGC34328
                                 (CLEC1A), mRNA.
                                 Homo sapiens
                                 neurotrophic tyrosine  GP145
3870246 NM_001007097.1   NTRK2   kinase, receptor, type TrkB; TRKB 882.4951777 6.845182891  228
                                 2 (NTRK2), transcript
                                 variant b, mRNA.
                                                        SCYB14;
                                 Homo sapiens           KS1; Kec;
                                 chemokine (C-X-C       bolekine;
3520246 NM_004887.3      CXCL14    mokin (X             MGC10687;   1439.55753 6.784666288  204
                                 motif) hgand 14        NJAC; MIP
                                 (CXCL14), mRNA.        2g; BRAK;
                                                        BMAC
                                                  92

                                  Homo sapiens eyes
                                  absent homolog 4        CMD1J
1260180 NM 004100.3       EYA4    (Drosophila) (EYA4),    DFNA1      781.6235195 6.696015971 233
                                  transcript variant 1,
                                  mRNA.
                                  Homo sapiens            NRXN4;
                                  contactin associated    CDFE;
1400520 NM 014141.4       CNTNAP2 protein-like 2          DKFZp781D  2559.152792 6.560386834 224
                       --         poten-lie 21846;
                                  (CNTNAP2), mRNA.        CASPR2
                                  Homo sapiens
                                  transcription factor
                                  AP-2 beta (activating   MGC21381;
7320471 NM_003221.3       TFAP2B  enhancer binding        AP-2B;     512.0135364 6.338741117 243
                                  protein 2 beta)         AP2-B
                                  (TFAP2B), mRNA.
                                                          DKFZp686B
                                                          2470;
                                                          DKFZp781I
                                                          1455;
                                                          DKFZp781C
                                                          1754;
                                                          LMO7B:
                                  Homo sapiens LIM        DKFZp686G
          M 14881
        17074              TMH1   and calponin              K p6G
1770754 NM014988.1        LIMCH   homology domains 1      18243;     2178.018105 6.025738134 143
                                  homology dmas         1 DKFZp686G
                                  (LIMCH1), mRNA.         2094;
                                                          MGC72127;
                                                          DKFZp434I
                                                          0312;
                                                          DKFZp686A
                                                          01247;
                                                          LIMCH1A
                                  Homo sapiens            MGC1274;
                                  hairy/enhancer-of-      CHF2;
3840753 NM_001040708.1    HEY1    split related with      HERP2;      3693.71912 5.946625326  22
                                  YRPW motif 1            HRT-1;
                                  (HEYl), transcript      HESRI;
                                  variant 2, mRNA.        OAF1
                                  Homo sapiens
                                  neurotrophic tyrosine
                                                          GP145
 430102 NM_001018065.1    NTRK2   kinase, receptor, type  TrkB; TRKB 835.6263959 5.921354971 227
                                  2 (NTRK2), transcript
                                  variant d, mRNA.
                                  Homo sapiens eyes
                                  absent homolog 4        CMD1J
2350139 NM 004100.3       EYA4    (Drosophila) (EYA4),    DFNA1      475.4637902 5.805877462 235
                                  transcript variant 1,
                                  mRNA.
                                  Homo sapiens            MGC138845
                                  neuronal cell adhesion
6980301 NM_005010.3       NRCAM   molecule (NRCAM)'       MGC138846  1029.687986 5.590344651 164
                                  transcript variant 2,   ;GIA343
                                  mRNA.                    KIAA0343
                                  Homo sapiens
                                  fibronectin leucine
2320626 NM_198391.1       FLRT3   rich transmembrane                 1876.306599 5.521362941 108
                                  protein 3 (FLRT3),
                                  transcript variant 2,
                                  mRNA.
                                  Homo sapiens NK2        NKX2B;
7610441 NM_002509.2       NKX2-2  homeobox 2 (NKX2-       NKX2.2      1080.23198  5.41562384 238
                                  2), mRNA.
                                  Homo sapiens
                                  pregnancy upregulated   MGC45419;
  10543 NM 001039582.1    PNCK    non-ubiquitously        CaMK1b;    1640.675635 5.316271349  69
                                  expressed CaM kinase    BSTK3
                                  (PNCK), mRNA.
                                  Homo sapiens solute
                                  carrier family 22
                                                          EMT;
6200333 NM 021977.2       SLC22A3 (extraneuronal          OCT3;      452.1553299 5.280440743 233
                                  monoamine               EMTH
                                  transporter), member
                                  3 (SLC22A3), mRNA.
                                                   93

                               Homo sapiens heparan
                               sulfate 6-0-           MGC130022
  830491 NM_001077188.1 HS6ST2 sulfotransferase 2                  536.6374788   5.175125686   213
                               (HS6ST2), transcript   MGC130023
                               variant L, mRNA.
                               Homo sapiens
                               oculocutaneous         D15S12;
 4250463 NM_000275.1    OCA2   albinism II (pink-eye  EYCL3;       633.0969543   5.162611074   214
                               dilution homolog,      PED; P;
                               mouse) (OCA2),         BOCA
                               mRNA.
                                                      ZNF32;
                               Homo sapiens           ALPHA2AA
 5720523 NM_000681.2    ADRA2A adrenergic, alpha-2A-, R;           567.8824027   4.983295682   164
                               receptor (ADRA2A),     ADRA2R;     568247         493962        14
                               mRNA.                  ADRA2;
                                                      ADRAR
                               Homo sapiens claudin
  840324 NM 006984.3    CLDN1O 10 (CLDN1O),           CPETRL3;     985.0699662   4.972328566   214
                               transcript variant 2,  OSP-L
                               mRNA.
                               Homo sapiens solute    MGC126299
                               carrier family 5
 1010097 NM_021815.2    SLC5A7 (choline transporter), MGC126300    346.5666667   4.954880535   244
                               member 7 (SLC5A7),     ; CHT1;
                               mRNA.                  hCHT; CHT
                                        14PEND14X P6
                        Symbol Definition             Synonyms   RFUs          Fold over Ave. Filter
ProbelD  RefSeqID
                               Homo sapiens
 4010040 NM_000184.2    HBG2   hemoglobin, gamma                   313.7634518   4.211275238   251
                               G (HBG2), mRNA.
                               Homo sapiens fibulin
  430088 NM_006487.2    FBLN1  1 (FBLN1), transcript  FBLN          316.600423   4.041834655   251
                               variant A, mRNA.
                               Homo sapiens glia      MGC126867
 3370452 NM_004877.1    GMFG   maturation factor,     : GMF-        628.971066   7.266782539   241
                               gamma (GMFG),          GAMMA
                               mRNA.
                               Homo sapiens CD19
                                                      B4;
 7210136 NM_001770.4    CD19   molecule (CD19),       MGC12802     164.8480541   1.723527702   241
                               mRNA.
                               Homo sapiens NK2
                                                      NKX2B
 7610441 NM 002509.2    NKX2-2 homeobox 2 (NKX2-      NKX2.2       8958.460406   52.20534222   238
                               2), mRNA.
                               Homo sapiens eyes
                               absent homolog 4       CMD1J
 6760725 NM 172105.2    EYA4   (Drosophila) (EYA4)'   DFNA1O       296.6160745   3.231332733   237
                               transcript variant 4,
                               mRNA.
                                                      SCYB13;
                               Homo sapiens           ANGIE;
                               chemokine (C-X-C       BCAl;
 1110564 NM 006419.1    CXCL13 motif) ligand 13 (B-   ANGIE2;      1235.339255   9.503053304   236
                               cell chemoattractant)  BCA-1;
                               (CXCL13), mRNA.        BLR1L;
                                                      BLC
                               Homo sapiens
                               carcinoembryonic
                               antigen-related cell
 5700753 NM_001024912.1 CEACAM adhesion molecule 1    BGPI; BGP;   189.4456853      1.8757467  236
                        1      (biliary glycoprotein) BGP1
                               (CEACAM1),
                               transcript variant 2,
                               mRNA.
                               Homo sapiens eyes
                               absent homolog 4       CMD1J
 2350139 NM 004100.3    EYA4   (Drosophila) (EYA4),   DFNA1         696.336379   8.967488935   235
                               transcript variant 1,
                               mRNA.
                                                94

                                Homo sapiens gremlin
                                2, cysteine knot        DAND3;
3440068 NM 022469.3    GREM2    superfamily, homolog    PRDC;       415.1347716 4.635949325 235
                                (Xenopus laevis)        CKTSF1B2
                                (GREM2), mRNA.
                                                        SV31;
                                Homo sapiens            DC29;
1980639 NM_030923.3    TMEM163  transmembrane           DKFZP566N   277.7566836 3.054668594 235
                                protein 163             034;
                                (TMEM163), mRNA.        DKFZp666J
                                                        217
                                Homo sapiens
4220674 NM 152709.3    STOXI    storkhead box 1         PEE4;       247.1394247 2.622790499 234
                                (STOXI), transcript     Cl~orf24
                                variant 1, mRNA.
                                Homo sapiens eyes
                                absent homolog 4        CMD1J;
1260180 NM 004100.3    EYA4     (Drosophila) (EYA4),    DFNA1       1038.350761 9.223801926 233
                                transcript variant 1,
                                mRNA.
                                Homo sapiens family
                                with sequence           FLJ30158;
                                similarity 107,
                                                        DRR1;
5390463 NM_001076778.1 FAM107A  member A                TU3A-       237.4274958 1.720487646 233
                                (FAM107A),              FLJ45473
                                transcript variant 2,
                                mRNA.
                                                        FTF: B1F2;
                                Homo sapiens nuclear    FTZ-FEbeta;
                                receptor subfamily 5,   hB1F: hB1E
4120408 NM_003822.3    NR5A2    group A, member 2       2; LRH-1-   525.6414552 6.760066797 231
                                (NR5A2), transcript     BF; :TZ
                                variant 2, mRNA.          F; CPF
                                Homo sapiens            CD122; P70
3170152 NM_000878.2    IIL2RB   interleukin 2 receptor, 75          335.7822335 3.395880134 230
                                beta (IL2RB), mRNA.
                                Homo sapiens SH3        ProSAPI;
                                and multiple ankyrin    CTTNBPl;
4220209 NM 012309.1    SHANK2   repeat domains 2        CORTBP1;    291.9580372 2.668218497 229
                                (SHANK2), transcript    SPANK-3;
                                variant 1, mRNA.        SHANK
                                Homo sapiens retinol    MGC70641;
3850112 NM_052960.1    RBP7     binding protein 7,      CRBPIV;     306.2944162 3.090247686 227
                                cellular (RBP7),          RP
                                mRNA.
                                                        OTF4;
                                Homo sapiens POU
                                                        OCT3;
 770615 NM_002701.4    POU5F1   cU5F ) tranript            GOCT4;   4508.640609 6.155086072 225
                                variant 1, mRNA.        OTF3
                                Homo sapiens
                                aldehyde                MGC26444;
                                dehydrogenase 1         RALDH(II);
 510687 NM_170697.1    ALDH1A2  family, member A2       RALDH2;     299.6906091 2.700072881 225
                                (ALDH1A2),              RALDH2-T
                                transcript variant 3,
                                mRNA.
                                Homo sapiens solute
                                carrier family 2
                                (facilitated glucose    GLUTX
3930546 NM 001001290.1 SLC2A9   transporter), member    GLUT9       498.1417936 4.834247907 224
                                9 (SLC2A9),
                                transcript variant 2,
                                mRNA.
                                Homo sapiens POU
                                class 5 homeobox 1      POU5FLC8;
6450746 NR_002304.1    POU5F1Pi pseudogene 1            OTF3C;      4465.328088 6.818235718 223
                                (POU5F1Pi), non-        OTF3P1
                                coding RNA.
                                Homo sapiens
                                Cbp/p300-interacting
5290711 NM004143.2     CITD1    transactivator, with    MSG1         528.443824 5.473851143 222
                                Glu/Asp-rich carboxy
                                terminal domain, 1
                                (CITED 1), mRNA.
                                                 95

                                Homo sapiens             MGC54284
                                glycoprotein M6B1           GC424
2760228 NM_001001994.1 GPM6B    (GPM6B), transcript      M61;        660.5593909 6.510212216 221
                                variant 4, mRNA.         MGC17150
                                Homo sapiens
1450358 NM 000519.3    HBD      hemoglobin, delta                     270.141286 2.855395504 221
                                (HBD), mRNA.
                                Homo sapiens             CDA019;
                                sclerostin domain        USAGI;
4810273 NM 015464.2    SOSTDC1   clerosin       I        ECTODIN;    1933.582403 17.29690634 219
                                (SOSTDC 1), mRNA.         0IFZp564D
                                Homo sapiens CD1d        MGC34622
6400358 NM_001766.3    CD1D     molecule (CD1D),         R3; CD1A    1065.026058 9.934318891 217
                                mRNA.
                                Homo sapiens zinc
                                finger, CCHC domain      SUZN;
2690279 NM_173798.2    ZCCHC12  containing 12            FLJ16123;   707.9072758 8.633550582 217
                                (ZCCHC12), mRNA.         SIZN1
                                                         FTF: B1F2;
                                Homo sapiens nuclear     FTZ-FEbeta;
                                receptor subfamily 5,     BEF lBE
7330639 NM_003822.3    NR5A2    group A, member 2        2; LRH-1-   668.3686971  7.66113023 217
                                (NR5A2), transcript      BF; :TZ
                                variant 2, mRNA.           F; CPF
                                Homo sapiens
5720075 NM_003638.1    ITGA8    integrin, alpha 8                    329.7620981 3.642052083 217
                                (ITGA8), mRNA.
                                Homo sapiens
                                collectin sub-family     MGC118794
4590129 NM_006438.2    COLEC1O  member 10 (C-type        ; CLL1;     317.2076142 2.295375699 216
                                lectin) (COLEC1O),       MGC118795
                                mRNA.
                                Homo sapiens brain
5690301 NM 001704.1    BAI3          i   anggenesis      KIGC1331    302.9328257  2.80249768 213
                                inhibitor 3 (BAI3),      MGC133100
                                mRNA.
                                                         PGY3;
                                Homo sapiens ATP-
                                                         PFIC-3
                                binding cassette, sub-   MDR2/3
1070594 NM_018850.2    ABCB4       i   B 4               MDR3;       214.2930626 2.022388164 210
                  _            ~member    4 (ABCB34),    MD2
                                transcript variant C,    ABC21;
                                mRNA.                    GBD1
                                Homo sapiens             MGC54284;
2630279 NM_001001995.1 GPM6B     Gc               script
                                          )roteinra      M61;        2439.674788 9.540605397 205
                                variant 1, mRNA.
                                Homo sapiens 5
6940037 NM 000867.3    HTR2B    hydroxytryptamine        5-HT2B; 5-  304.8783418 2.079311279 205
                                (serotonin) receptor     HT(2B)
                                2B (HTR2B), mRNA.
                                Homo sapiens Ca++
                                dependent secretion      KIAA1591     8.
7160102 NM_017954.9    CADPS2   activator 2 (CADPS2),     LJ481       819.379357 6.295499352 199
                                transcript variant 1,
                                mRNA.
                                Homo sapiens             MGC54284;
3870202 NM_001001995.1 GPM6B     Gc       )roteinra
                                                  script M61;        2486.648393 5.998064449 199
                                variant 1, mRNA.
                                Homo sapiens
                                NIEDD4 binding
 620112 NM 001079691.1 N4BP2L1  protein 2-like 1         CGO18        353.541709 3.406839005 198
                                (N4BP2L1), transcript
                                variant 2, mRNA.
                                Homo sapiens
                                fibroblast growth
7380239 NM_004114.2    FGF13    factor 13 (FGF13),       FGF2; FHF2  1352.223689 6.591556528 197
                                transcript variant 1A,
                                mRNA.
                                                   96

                                                         VCFS; TGA;
                                                         DORV;
                                  Homo sapiens T-box 1   CTH
  460575 NM 080647.1    TBX1      (TBX1), transcri T     CTHM;        268.2879865   1.904340449   197
                                  variant C, mRNA.       DGS; CAS;
                                                         DGCR
                                  Homo sapiens calpain
 3710253 NM 144691.3    CAPN12    12 (CAPN12),           MGC20576    404.0658206    3.489635797   196
                                  mRNA.
                                  Homo sapiens
                                  NIEDD4 binding
 6550133 NM 001079691.1 N4BP2L1   protein 2-like 1       CGO18        337.4719966   3.235131775   196
                                  (N4BP2L1), transcript
                                  variant 2, mRNA.
                                                 .       MGC13 1800
                                  Homo sapiens           :FI125475
                                  NADPH oxidase            F-245
  630181 NM_006647.1    NOXA1           1 H o(lA1)'      SDCCAG31;    252.3011844   2.035903839   195
                   ~
                   _    ~       ~    Racttr1(O.)
                                  mRNA.
                                                         p~iNOX;
                                                         NY-CO-31
                                  Homo sapiens renin
 5810678 NM 002910.4    RENBP     binding protein        RNBP; RBP    1070.759898   4.915511734   192
                                  (RENBP), mRNA.
                                              m          BPES1;
 4230750 NM 023067.2    FOXL2     forehead box L2        PINTO;       254.4526227   1.947051692   191
                                  (FOXL2), mRNA.         PERK; POF3
                                                         ARL-1;
                                  Homo sapiens aldo-     AKR1B11;
                                  keto reductase family  HSI;
 5310646 NM 020299.3    AKR1B1O   1, member B10          AKR1B12;     361.3534687   2.790458805   186
                                  (aldose reductase)     ALDRLn;
                                  (AKR1B10), mRNA.       MGC14103;
                                                         HIS; ARLI
                                  Homo sapiens
                                  sparc/osteonectin,
 3840554 NM_014767.1    SPOCK2    cwcv and kazal-like    testican-2   565.0042301   3.698112666   179
                                  domains proteoglycan
                                  (testican) 2
                                  (SPOCK2), mRNA.
                                  Homo sapiens RNA
                                  binding protein with
 2510369 NM_006867.2    RBPMS     multiple splicing      HERMES       366.4856176   3.304611272   179
                                  (RBPMS), transcript
                                  variant 4, mRNA.
                                           14PEND17Z P6
                        Symbol    Definition             Synonyms   RFUs          Fold over Ave. Filter
ProbelD  RefSeqID
                                  Homo sapiens           RP11
 7400280 NM 033069.2    C6orfl 14 chromosome 6 open      501119.1;    284.8199662   3.970829122   247
                                  reading frame 114      ADG-90;
                                  (C6orfl 14), mRNA.     FLJ20330
                                  Homo sapiens sodium
 4210274 NM_002976.2    SCN7A     channel, voltage-      SCN6A        324.3121827   3.784997675   247
                                  gated, type VII, alpha
                                  (SCN7A), mRNA.
                                  Homo sapiens LIM
 6860762 NM 020204.2    LHX9      homeobox 9 (LHX9),                   221.878511   3.038891353   247
                                  transcript variant 1,
                                  mRNA.
                                  Homo sapiens 4-        4HPPD;
  670736 NM 002150.2    HPD       hydroxyphenylpyruvat   GLOD3;       314.7539763   3.523995488   246
                                  e dioxygenase (HPD),   PPD; 4
                                  mRNA.                  HPPD
                                  Homo sapiens paired-   PMX2B;
 6940400 NM_003924.2    PHOX2B3   like homeobox 2b       NBPhox        2477.42132   35.40956947   245
                                  (PHOX2B), mRNA.
                                  Homo sapiens
 6420113 NM_080723.3    NRSN1     neurensin 1 (NRSN1),   p24; VMP     338.6403553   4.466916441   245
                                  mRNA.
                                                    97

                                   Homo sapiens
                                   ribonuclease, RNase
2640068 NM_002934.2        RNASE2  A family, 2 (liver     EDN; RNS2  269.6680203 3.175088973  245
                                   eosinophil-derive
                                   neurotoxin)
                                   (RNASE2), mRNA.
                                   Homo sapiens           HBGR2;
6220750 NM 000826.2        GRIA2   glutamate receptor,    GLURB;     380.2961929 3.057517379  245
           -0ionotropic,                        AMPA 2    GLUR2
                                   (GRIA2), mRNA.
                                   Homo sapiens solute    MGC126299
                                   carrier family 5
1010097 NM_021815.2        SLC5A7  (choline transporter), MGC126300  440.9554992 6.576716319  244
                                   member 7 (SLC5A7),     ; CHT1;
                                   mRNA.                  hCHT; CHT
                                   Homo sapiens
                                                          LEC3;
1170739 NM_015236.3        LPHN3   latrophilin 3          CIRL3      311.1620981 4.228710899  244
                                   (LPHN3), mRNA.
                                   Homo sapiens family
                                   with sequence
                                   similarity 19          TAFA-1
2230088 NM_213609.2        FAM19A1 (chemokine (C-C        TAFA-1I    2621.940609 38.49345131  243
                                   motif)-like), member
                                   Al (FAM19A1),
                                   mRNA.
                                   Homo sapiens
                                   transcription factor
7320471 NM_003221.3        TFAP2B  AP-2 beta (activating  MGC21381;
              73041NM0021. TA21    ehncr       idig       AP-2B3;     719.314044 9.309999981  243
                                   enhancer binding       AP2-B
                                   protein 2 beta)
                                   (TFAP2B), mRNA.
                                   Homo sapiens matrix    MGC138506
4760626 NM 002426.2        MMP12   metallopeptidase 12     MME;        477.83511 7.099577237  243
                                   (macrophage elastase)
                                   (MMP12), mRNA.
                                   Homo sapiens
                                   potassium voltage-     KV2.; h
                                   gated channel, Shab-   KV.1
6900196 NM_004975.2        KCNB1   related subfamily,     DRK1;      373.3384095 4.537902853  243
                                   member 1 (KCNB 1),     DRK1
                                   mRNA.
                                   Homo sapiens unc-13
1660152 NM 001080534.1     UNC13C  homolog C (C.          DKFZp547H  877.1373942 13.19629982  242
                                   elegans) (UNC13C),     074
                                   mRNA.
                                   Homo sapiens major
                           HLA-    histocompatibility
6370315 NM_002125.3        DRB5    complex, class II, DR  HLA-DRB1   641.5165821 4.660709429  242
                                   beta 5 (HLA-DRB5),
                                   mRNA.
                                   Homo sapiens gastrin-  proGRP;
 160500 NM 001012513.1     GRP     releasing peptide      GRP-10;    428.8714044 3.790378495  242
                                   (GRP), transcript      BN;
                                   variant 3, mRNA.       preproGRP
                                   Homo sapiens solute
                                   carrier family 6
                                   (neurotransmitter      BGT-1;
6220332 NM_003044.2        SLC6A12 transporter,           BGT1;      269.6680203   2.80365914 240
                                   betaine/GABA),         FLJ38727
                                   member 12
                                   (SLC6A12), mRNA.
                                   Homo sapiens myosin
                                   binding protein C,     slow-type;
 840017 NM 206819.1        MYBPCl  slow type (MYBPC1),    MYBPCS;    1449.060914 18.91260739  239
                                   transcript variant 2,  MYBPCC
                                   mRNA.
                                   Homo sapiens myosin
                                   binding protein C,     slow-type;
5910056 NM_206821.1        MYBPCl  slow type (MYBPC1),    MYBPCS;    948.8686971 12.16433717  239
                                   transcript variant 4,  MYBPCC
                                   mRNA.
                                                    98

                               Homo sapiens CD36      GPIV; FAT;
                               molecule
                                                      GP3B
1010592 NM_001001548.1 CD36    (thrombospondin        CHDS7;      1243.074027 12.92549177  238
                               receptor) (CD36),      SCARB3;
                               transcript variant 1,  PASIV; GP4
                               mRNA.
                               Homo sapiens
                                                      LEC3;
6620369 NM_015236.3    LPHN3   latrophilin 3          CIRL        700.2458545 9.729724226  238
                               (LPHN3), mRNA.
                               Homo sapiens NK2       NKX2B;
7610441 NM_002509.2    NKX2-2  homeobox 2 (NKX2-      NKX2.2      1796.867005   9.67180292 238
                               2), mRNA.
                               Homo sapiens
5130471 NM 000922.2    PDE3B   phosphiterase 3,       HcGIP1;     806.7043147 11.36131335  237
                               (PDE3B), mRNA.
                               Homo sapiens eyes
                               absent homolog 4       CMD1J
6760725 NM 172105.2    EYA4    (Drosophila) (EYA4)    DFNA1O      333.1470389 3.752459802  237
                               transcript variant 4,
                               mRNA.
                                                      SCYB 13;
                               Homo sapiens           ANGIE;
                               chemokine (C-X-C       BCAl;
1110564 NM 006419.1    CXCL13  motif) ligand 13 (B-   ANGIE2;     493.3796954   3.19479363 236
                               cell chemoattractant)  BCA-1;
                               (CXCL13), mRNA.        BLR1L;
                                                      BLC
                               Homo sapiens glycine
                               amidinotransferase (L
                               arginine:glycine
3940292 NM_001482.2    GATM    amidinotransferase)    AT; AGAT    281.8204738   3.07380463 236
                               (GATM), nuclear
                               gene encoding
                               mitochondrial protein,
                               mRNA.
                               Homo sapiens solute
                               carrier family 10
7000176 NM_152679.2    SLC1OA4 (sodium/bile acid      MGC29802;   523.5020305 6.482099366  235
                               cotransporter family), P4
                               member 4
                               (SLC1OA4), mRNA.
                               Homo sapiens eyes
                               absent homolog 4       CMD1J
2350139 NM 004100.3    EYA4    (Drosophila) (EYA4),   DFNA1       493.8817259 6.069515232  235
                               transcript variant 1,
                               mRNA.
                                                      RP4
                               Homo sapiens           647M16.2;
2640348 NM_021146.2    ANGPTL7 angiopoietin-like 7    dJ647M16.1;  1412.57445 6.571285458  234
                               (ANGPTL7), mRNA.       AngX;
                                                      CDT6
                               Homo sapiens
4220674 NM 152709.3    STOXI   storkhead box 1        PEE4;       349.6734349 4.125825631  234
                               (STOXI), transcript    ClOorf24
                               variant 1, mRNA.
                               Homo sapiens solute
                               carrier family 16,
3520255 NM_004731.3    SLC16A7 member 7               MCT2        326.5969543 3.555242703  234
                               (monocarboxylic acid
                               transporter 2)
                               (SLC16A7), mRNA.
                               Homo sapiens cyclic
                               AMP-regulated
7160437 NM_001025068.1 ARPP-21 phosphoprotein, 21     FLJ32997    322.0407783 3.551198363  234
                               kD (ARPP-21),
                               transcript variant 3,
                               mRNA.
                               Homo sapiens eyes
                               absent homolog 4       CMD1J
1260180 NM 004100.3    EYA4    (Drosophila) (EYA4),   DFNA1       1359.628257 12.38716213  233
                               transcript variant 1,
                               mRNA.
                                                99

                                Homo sapiens NEL-      FLJ45906;
1990731 NM_006157.2    NELLI    like 1 (chicken)       IDH3GL;     587.851269 6.119205435  233
                                (NELLI), mRNA.         NRP1
                                Homo sapiens solute
                                carrier family 22
                                                       EMT;
6200333 NM 021977.2    SLC22A3  (extraneuronal         OCT3;      398.2453469 4.531630695  233
                                monoamine              EMTH
                                transporter), member
                                3 (SLC22A3), mRNA.
                                Homo sapiens C-type
7320348 NM 016511.2    CLEC1A   lectin domain family   CLECI;     673.8399323 8.182223765  232
                                1, member A            MGC34328
                                (CLEC1A), mRNA.
                                Homo sapiens
                                neurotrophic tyrosine  GP145
 620349 NM_006180.3    NTRK2    kinase, receptor, type TrkB; TRKB 470.8583756 5.477254002  232
                                2 (NTRK2), transcript
                                variant a, mRNA.
                                Homo sapiens CD36      GPIV; FAT;
                                molecule
                                                       GP3B
3310538 NM_000072.2    CD36     (thrombospondin        CHDS7;     2198.552961 18.19294729  229
                                receptor) (CD36)'      SCARB3;
                                transcript variant 3,  PASIV; GP4
                                mRNA.
                                Homo sapiens
                                neurotrophic tyrosine
                                                       GP145
3870246 NM_001007097.1 NTRK2    kinase, receptor, type TrkB; TRKB 1484.388494 12.19587859  228
                                2 (NTRK2), transcript
                                variant b, mRNA.
                                Homo sapiens           ABCDS;
                                endothelin receptor    HSCR2;
3840465 NM_003991.1    EDNRB    type B (EDNRB)'        ETRB;      326.9213198 2.735607746  228
                                transcript variant 2,  HSCR; ETB
                                mRNA.
                                Homo sapiens
                                neurotrophic tyrosine
                                                       GP145
 430102 NM_001018065.1 NTRK2    kinase, receptor, type TrkB; TRKB 1612.340102 12.35474589  227
                                2 (NTRK2), transcript
                                variant d, mRNA.
                                Homo sapiens cyclic
                                AMP-regulated
7210554 NM_016300.4    ARPP-21  phosphoprotein, 21     FLJ32997   364.6739425   3.68346041 226
                                kD (ARPP-21),
                                transcript variant 1,
                                mRNA.
                                                       OTF4;
                                Homo sapiens POU       OCT3
 770615 NM_002701.4    POU51    class 5 homeobox 1     OCT4;      9463.014721   14.0175387 225
                                (POU5F1), transcript   MGC22487;
                                variant 1, mRNA.
                                                       OTF3
                                Homo sapiens major     HLA
                       HLA-     histocompatibility     DRB1*;
5260484 NM_002124.1    DRB1     complex, class II, DR  HLA-DR1B;  835.7881557 5.665449167  225
                                beta 1 (HLA-DRB1),     HLA DRB1;
                                mRNA.                  DRB1
                                Homo sapiens
                                phosphatidic acid
7000181 NM_001037317.1 PAP2D    phosphatase type 2     PAP2        488.528511   5.88468091 224
                                (PAP2D), transcript
                                variant 1, mRNA.
                                Homo sapiens solute
                                carrier family 2
                                (facilitated glucose   GLUTX;
3930546 NM 001001290.1 SLC2A9   transporter), member   GLUT9      570.7226734 5.684316806  224
                                9 (SLC2A9),
                                transcript variant 2,
                                mRNA.
                                Homo sapiens POU
                                class 5 homeobox 1     POU5FLC8;
6450746 NR_002304.1    POU5F1Pi pseudogene 1           OTF3C;     12076.53553 20.14451606  223
                                (POU5F1Pi), non-       OTF3P1
                                coding RNA.
                                        14PEND20X P6
                                                 100

                        Symbol  Definition             Synonyms    RFUs          Fold over Ave. Filter
ProbelD  RefSeq_ID
                                                                                                Score
                                Homo sapiens ATP-      DKFZp313D
                                binding cassette, sub- 2411;
 1780537 NM_152701.2    ABCA13  family A (ABC1),       FLJ33951;     323.0055838   5.357087727   250
                                member 13              FLJ33876;
                                (ABCA13), mRNA.        FLJ16398
                                                       OTF7
                                Homo sapiens POU
                                                       OCT7;
 2490551 NM_005604.2    POU3F 2 class 3 homeobox 2     BRN2-         370.4913706   4.261487952   250
                                (POU3F2), mRNA.        POUF3
                                Homo sapiens
 1050040 NM 004925.3    AQP3    aquaporin 3 (Gill      GIL           311.0724196     3.69052413  248
                                blood group) (AQP3),
                                mRNA.
                                Homo sapiens           GLUR5;
                                glutamate receptor,
                                                       EEA3;
 1260370 NM_175611.2    GRIKI   ionotropic, kainate 1  GLR5;         289.4507614     3.52290451  248
                                (GRIKI), transcript
                                                       EAA3
                                variant 2, mRNA.
                                Homo sapiens CUB
 1010189 NM 033225.3    CSMD1   domains 1 (CMD 1),     KIAA1890      191.4615905   2.820872145   248
                                mRNA.
                                Homo sapiens LIM
 6860762 NM 020204.2    LHX9    homeobox 9 (LHX9),                   269.1796954   3.899922662   247
                                transcript variant 1,
                                mRNA.
                                Homo sapiens
                                tripartite motif-      RBCC; terf;
 6350682 NM_016102.2    TRIM17  containing 17          RNF16         256.5441624   3.303685551   247
                                (TRIM17), transcript
                                variant 1, mRNA.
                                Homo sapiens           NG.1; IL
 3180068 NM 013371.2    IL19    interleukin 19 (IL19), 1OC;           190.142132   2.629654724   247
                                transcript variant 2,  ZMDA1;
                                mRNA.                  MDA1
                                Homo sapiens gastrin-  proGRP;
 1400053 NM 001012513.1 GRP     releasing peptide      GRP-10;       1112.613029   15.26540634   245
                                (GRP), transcript      BN;
                                variant 3, mRNA.       preproGRP
                                Homo sapiens           HBGR2;
 6220750 NM 000826.2    GRIA2   glutamate receptor'    GLURB;        1194.494755   11.74449578   245
                                ionotropic, AMPA 2
                                                       GLUR2
                                (GRIA2), mRNA.
                                Homo sapiens
                                roundabout, axon
 7650168 NM_002942.2    ROBO2   guidance receptor,     KIAA1568;     253.7025381   3.197433272   245
                                homolog 2              SAX3
                                (Drosophila)
                                (ROBO2), mRNA.
                                Homo sapiens
                                cytochrome P450,       CYP24
                                family 24, subfamily   P450-CC24;
 6400131 NM_000782.3    CYP24A1 A, polypeptide 1       MGC126274     206.1935702   2.725350393   245
                                (CYP24A), nuclear
                                                          P24
                                gene encoding          MGC126273
                                mitochondrial protein,
                                mRNA.
                                Homo sapiens solute    MGC126299
                                carrier family 5
 1010097 NM_021815.2    SLC5A7  (choline transporter), MGC126300     918.8030457   14.78733011   244
                                member 7 (SLC5A7),     ; CHT1;
                                mRNA.                  hCHT; CHT
                                Homo sapiens solute
                                carrier family 17
                                (sodium-dependent
 7160192 NM 139319.1    SLC17A8 inorganic phosphate    VGLUT3        705.6516074   11.90781339   244
                                cotransporter),
                                member 8
                                (SLC17A8), mRNA.
                                                 101

                              Homo sapiens
                              potassium voltage-        KV2.1 h
6900196 NM_004975.2    KCNB1  related ubfal y,a-        DRK;        1022.349915 14.16499339  243
                              member 1 (KCNB 1),
                              mRNA.
                              Homo sapiens
                              transcription factor      MGC21381;
7320471 NM_003221.3    TFAP2B AP2 beta (activating      AP-2B;      760.6098139 9.901896372  243
                              enhancer binding          AP
                              protein 2 beta)           AP2-B
                              (TFAP2B), mRNA.
                                          m      sMGC12301;
4570639 NM 003063.2    SLN    sarcolipin (SLN),         MGC125854   868.8908629   5.60439611 243
                              mRNA.
                                                        MGC125855
                              Homo sapiens gastrin-     proGRP;
 160500 NM 001012513.1 GRP    releasing peptide         GRP-10;     4223.607614  46.1765636  242
                              (GRP), transcript         BN;
                              variant 3, mRNA.          preproGRP
                              Homo sapiens
4810487 NM 018712.2    ELMODI ELMO/CED-12               DKFZp547C   1332.051269 17.50939429  242
                              domain containing 1       176
                              (ELMOD 1), mRNA.
                              Homo sapiens unc-13
1660152 NM 001080534.1 UNC13C homolog C (C.             DKFZp547H   479.4463621 6.759747045  242
                              elegans) (UNC13C),        074
                              mRNA.
                              Homo sapiens major
                       HLA-   histocompatibility
6370315 NM_002125.3    DRB5   complex, class II, DR     HLA-DRB1    597.7241963 4.274287662  242
                              beta 5 (HLA-DRB5),
                              mRNA.
                              Homo sapiens ankyrin      MGC26087;
                              repeat and sterile        ANKS2;
6660463 NM 020140.2    ANKS1B alpha motif domain        AIDA;        326.001269 3.806471071  242
                              containing lB             cajalin-2;
                              (ANKS1B), transcript      EB-1;
                              variant 3, mRNA.          AIDA-1
                                                        DKFZp434P
                                                        2350;
                                                        USH1H;
                              Homo sapiens              KIAA1774;
6510274 NM_022124.3    CDH23  cadherin-like23           FLJ02331    257.7777496 2.881621105  242
                              (CDH23), transcript       MGC102761
                              variant 1, mRNA.          ; FLJ36499;
                                                        DFNB 12;
                                                        USHID;
                                                        KIAA1812
                              Homo sapiens
                              transglutaminase 3 (E     MGC126249
4920075 NM_003245.2    TGM3   polypeptide, protem-      ; TGE;      622.6956007 5.779798736  240
                              glutamine-gamma ,         MGC126250
                              glutamyltransferase)
                              (TGM3), mRNA.
                              Homo sapiens
6270022 NM 002110.2    HCK    hemopoietic cell          JTK9        1388.537733 18.74382795  239
                              kinase (HCK),
                              mRNA.
                              Homo sapiens myosin
                              binding protein C,        slow-type;
 840017 NM 206819.1    MYBPCl slow type (MYBPC1),       MYBPCS;     297.1455161 3.083294182  239
                              transcript variant 2,     MYBPCC
                              mRNA.
                              Homo sapiens sterile
3390523 NM 001010971.1 SAMD13 alpha motif domain        RP11-       242.1697124 2.498659203  239
                              containing 13             376N17.1
                              (SAMD13), mRNA.
                              Homo sapiens NK2          NKX2B;
7610441 NM 002509.2    NKX2-2 homeobox 2 (NKX2-         NKX2.2        5085.8978 29.20574079  238
                              2), mRNA.
                                              102

                              Homo sapiens
                              calcium/calmodulin-    CAMKB;
                              dependent protein
                                                     CAM2-     2234.6614213
1710131 NM_172078.1   CAMK2B  kinase (CaM kinase)    MGC29528;              2.900738101 238
                              II beta (CAMK2B),      CAMK2
                              transcript variant 2,
                              mRNA.
                              Homo sapiens Fas
5270520 NM_005449.3   FAIM3   amolpetotic inh        TOSO      418.2686971  5.038054817 237
                              mRNA.
                              Homo sapiens eyes
                              absent homolog 4       CMD1J
6760725 NM 172105.2   EYA4    (Drosophila) (EYA4)    DFNA1O     291.1939086 3.153983628 237
                              transcript variant 4,
                              mRNA.
                              Homo sapiens Src
                              homology 2 domain
 730093 NM 020209.2   SHD     containing                        247.6580372 2.428018276 237
                              transforming protein
                              D (SHD), mRNA.
                                                     SCYB 13;
                              Homo sapiens           ANGIE;
                              chemokine (C-X-C       BCAl;
1110564 NM 006419.1   CXCL13  motif) ligand 13 (B-   ANGIE2;    920.6203046 6.827262097 236
                              cell chemoattractant)  BCA-1;
                              (CXCL13), mRNA.        BLR1L;
                                                     BLC
                              Homo sapiens           Erk4;
4860403 NM 002747.3   MAPK4   mitogen-activated      p63MAPK;   206.8522843 2.305901186 236
                              protein kinase 4       ERK3;
                              (MAPK4), mRNA.         PRKM4
                              Homo sapiens solute
                              carrier family 10
7000176 NM_152679.2   SLC1OA4 (sodium/bile acid      MGC29802;  2764.305584 38.50855556 235
                              cotransporter family), P4
                              member 4
                              (SLC1OA4), mRNA.
                              Homo sapiens eyes
                              absent homolog 4       CMD1J;
2350139 NM 004100.3   EYA4    (Drosophila) (EYA4),   DFNA1      348.5341794 3.988983315 235
                              transcript variant 1,
                              mRNA.
                              Homo sapiens
6020224 NM 000507.2   FBP1    fructose-1,6-          FBP        250.6651438 3.279865206 234
                              bisphosphatase 1
                              (FBP1), mRNA.
                              Homo sapiens eyes
                              absent homolog 4
                                                     CMD1J
1260180 NM 004100.3   EYA4    (Drosophila) (EYA4),   DFNA1      1071.213113 9.547370984 233
                              transcript variant 1,
                              mRNA.
                              Homo sapiens
1230477 NM 005853.4   IRX5    iroquois homeobox      IRX-2a     924.7071066 8.927866096 233
                              protein 5 (IRXS),
                              mRNA.
                              Homo sapiens NEL
7550358 NM 006159.1   NELL2   like 2 (chicken)       NRP2       517.2309645 2.722053505 233
                              (NELL2), mRNA.
                              Homo sapiens           KIAA1263;
1070162 NM_020116.2   FSTL5   follistatin-like 5     DKFZp566D  1344.380541 17.13253704 232
                              (FSTL5), mRNA.         234
                              Homo sapiens
 580187 NM001029851.1 PDE8B   phosphodiesterase 8B   FLJ11212   554.7313029 5.496016666 232
                              (PDE8B), transcript
                              variant 3, mRNA.
                              PREDICTED: Homo
5860093 XM 940314.2   NLF2    sapiens facte2                    322.1834179  3.42630665 230
                              localized factor 2               321319        34606       3
                              (NLF2), mRNA.
                              Homo sapiens fragile   FRA3B;
 510452 NM_002012.1   FHIT    histidine triad gene   AP3Aase    251.7199662 2.650291786 230
                              (FHIT), mRNA.
                                               103

                              Homo sapiens leucine   KIAA1580;
 2940189 NM_020929.1  LRRC4C  rich repeat training   NGL1;         273.0175973   2.546513329   230
                              mRNA.
                              Homo sapiens           GTH1;
 1090561 NM_145740.2  GSTA1     tanferase              GC331939   495.3754653    5.042007509   229
                              (GSTA1), mRNA.           GSTAl-1
                              Homo sapiens SRY
 3310037 NM 005634.2  SOX3    (sex determining       SOXB;          561.513621   3.485834699   229
                              region Y)-box 3        MRGH
                              (SOX3), mRNA.
                                                     DKFZp434P
                                                     2350;
                                                     USH1H;
                              Homo sapiens           KIAA1774;
  360014 NM_052836.1  CDH23   cadherin-like 23       FLJ00233;     257.0951777   2.527703313   229
                              (CDH23), transcript    MGC102761
                              variant 2, mRNA.       ;FLJ36499;
                                                     DFNB 12;
                                                     USHID;
                                                     KIAA1812
                                       14PEND23X P6
                      Symbol  Definition             Synonyms    RFUs          Fold over Ave. Filter
ProbelD  RefSeqID
                              Homo sapiens
 4010040 NM_000184.2  HBG2    hemoglobin, gamma                    269.1013536   3.469485572   251
                              G (HBG2), mRNA.
                              Homo sapiens EF-       DK Zp686
                              hand calcium binding   0638;
 6380328 NM198529.2   EFCAB5  domain     (EFCAI5)    FLJ46247;     155.8787648   1.861978037   248
                              mRNA.mRNA.DKEZp434G
                                                     2420
                              Homo sapiens paired-   PMX2B;
 6940400 NM_003924.2  PHOX2B3 like homeobox 2b       NBPhox        296.7730964   3.361543426   245
                              (PHOX2B), mRNA.
                              Homo sapiens solute    MGC126299
                              carrier family 5
 1010097 NM_021815.2  SLC5A7  (choline transporter), MGC126300     155.6969543   1.675262372   244
                              member 7 (SLC5A7),     ; CHT1;
                              mRNA.                  hCHT; CHT
                              Homo sapiens proline-  Ps 1; PMF;
                              rich protein BstNI     PRB1L; Ps
 4010224 NM 199353.1  PRB1    subfamily 1 (PRB1)'    2; PM; PMS;   190.9407783   1.731192933   243
                              transcript variant 2,  PRB1M
                              mRNA.
                              Homo sapiens proline
 6370189 NM 006248.2  PRB2    rich protein BstNI     cP7; Ps;      240.0468697   2.376676938   242
                              subfamily 2 (PRB32),   PRPPRB1
                              mRNA.
                              Homo sapiens glia      MGC126867
 3370452 NM 004877.1  GMFG    maturation factor,     : GMF-        554.7313029   6.291023858   241
                              gamma (GMFG),          GAMMA
                              mRNA.
                                          .i         HSD26;
                              Homo sapiens           LL37;
 5860075 NM 004345.3  CAMP    cathelicidin           FALL39;       205.6200508   2.373239362   241
                   --         antimicrobial peptide  FALL-39'
                              (CAMP), mRNA.          CAP18
                              Homo sapiens NK2
                                                     NKX2B;
 7610441 NM 002509.2  NKX2-2  homeobox 2 (NKX2-      NKX2.2        6656.180372   38.53183231   238
                              2), mRNA.
                              Homo sapiens eyes
                              absent homolog 4       CMD1J
 6760725 NM 172105.2  EYA4    (Drosophila) (EYA4)'   DFNA1O        324.8649746   3.634313239   237
                              transcript variant 4,
                              mRNA.
                              Homo sapiens Src
                              homology 2 domain
  730093 NM 020209.2  SHD     containing                           199.1903553   1.757141202   237
                              transforming protein
                              D (SHD), mRNA.
                                              104

                                                       SCYB13;
                               Homo sapiens            ANGIE;
                               chemokine (C-X-C        BCAl;
1110564 NM 006419.1    CXCL13  motif) ligand 13 (B-    ANGIE2;     989.5116751 7.412987625  236
                               cell chemoattractant)   BCA-1;
                               (CXCL13), mRNA.         BLR1L;
                                                       BLC
                               Homo sapiens heparan
5870435 NM 006043.1    HS3ST2  sulfate (glucosamine)   30ST2;       244.043824 2.542831047  236
                               3-0-sulfotransferase 2  30ST2
                               (HS3ST2), mRNA.
                               Homo sapiens eyes
                               absent homolog 4        CMD1J
2350139 NM 004100.3    EYA4    (Drosophila) (EYA4),    DFNA1       584.2120135 7.362519834  235
                               transcript variant 1,
                               mRNA.
                               Homo sapiens
4220674 NM 152709.3    STOXI   storkhead box 1         PEE4;        481.828511 6.063072814  234
                               (STOXI), transcript     ClOorf24
                               variant 1, mRNA.
                               Homo sapiens family
                               with sequence           FLJ30158;
                               similarity 107,
                                                       DRR1;
5390463 NM_001076778.1 FAM107A member A                TU3A-       951.3730118 9.901005872  233
                               (FAM107A),              FLJ45473
                               transcript variant 2,
                               mRNA.
                               Homo sapiens eyes
                               absent homolog 4
                                                       CMD1J
1260180 NM 004100.3    EYA4    (Drosophila) (EYA4),    DFNA1       1059.589002 9.432917738  233
                               transcript variant 1,
                               mRNA.
                               Homo sapiens            KIAA1263;
1070162 NM_020116.2    FSTL5   follistatin-like 5      DKFZp566D   403.7604061  4.44577989  232
                               (FSTL5), mRNA.          234
                               Homo sapiens C-type
7320348 NM 016511.2    CLEC1A  lectin domain family    CLECI;       357.271912   3.86844202 232
                               1, member A             MGC34328
                               (CLEC1A), mRNA.
                                                       FTF: B1F2;
                               Homo sapiens nuclear    FTZ-FEbeta;
                               receptor subfamily 5,   hB1F: hB1E
4120408 NM_003822.3    NR5A2   group A, member 2       2; LRH-1-   808.8181895 10.94061677  231
                               (NR5A2), transcript     BF; :TZ
                               variant 2, mRNA.          F; CPF
                               Homo sapiens            CD122; P70
3170152 NM_000878.2    IIL2RB  interleukin 2 receptor, 75          235.0103215 2.076628542  230
                               beta (IL2RB), mRNA.
                               Homo sapiens SH3        ProSAPI;
                               and multiple ankyrin    CTTNBPl;
4220209 NM 012309.1    SHANK2  repeat domains 2        CORTBP1;    204.2963621 1.566819881  229
                               (SHANK2), transcript    SPANK-3;
                               variant 1, mRNA.        SHANK
                               Homo sapiens solute
                               carrier family 8
2320369 NM_015063.1    SLC8A2  (sodium/calcium         NCX2        458.9714044 2.761234796  226
                               exchanger), member 2
                               (SLC8A2), mRNA.
                                                       OTF4
                               Homo sapiens POU        OCT3
                               class 5 homeobox 1        CT
 770615 NM_002701.4    POU5F1       U5F) transcript    OCT4;       5102.421658 7.097399927  225
                               variant 1, mRNA.        OTF3
                               Homo sapiens solute
                               carrier family 2
                               (facilitated glucose    GLUTX;
3930546 NM 001001290.1 SLC2A9  transporter), member    GLUT9        511.514044 4.990864005  224
                               9 (SLC2A9),
                               transcript variant 2,
                               mRNA.
                               Homo sapiens MOB 1,     FLJ13204;
                       MOBKL2  Mps One Binder          FLJ23916;     1.67S     1.4782        2
 940630 NM_024761.3       BK   kinase activator-like   MOB3B;       217.462775 1.640738923  224
         M_246.3
         9463          B2B          (yeast)              MC26
                               (MOBKL2B), mRNA.        MGC32960
                                                105

                                Homo sapiens POU
                                class 5 homeobox 1       POU5FLC8;
6450746 NR_002304.1    POU5F1P1 pseudogene 1             OTF3C;      5565.606091  8.744686051 223
                                (POU5F1P1), non-         OTF3P1
                                coding RNA.
                                Homo sapiens family
                                with sequence
                                similarity 184,
4490333 NM_024581.4    FAM184A  member A                 FLJ13942    262.1167513  1.847581012 223
                                (FAM184A),
                                transcript variant 1,
                                mRNA.
                                Homo sapiens
                                Cbp/p300-interacting
5290711 NM004143.2     C I      transactivator, with     MSG1        405.5830795  3.968710701 222
         M_001432
        529011         CLE~i    Glu/Asp-rich carboxy
                                terminal domain, 1
                                (CITED 1), mRNA.
                                Homo sapiens             MGC54284;
                                glycoprotein M6B1           GC424
2760228 NM_001001994.1 GPM6B    (GPM6B), transcript      M6B;          405.100846 3.605783166 221
                                variant 4, mRNA.         MGC17150
                                Homo sapiens
1450358 NM 000519.3    HBD      hemoglobin, delta                      233.172335 2.327782975 221
                                (HBD), mRNA.
                                Homo sapiens             CDA 19;
4810273 NM 015464.2    SOSTDC1  sclerostni domain        ECTODIN;    2865.606768  26.11637144 219
                                (SOSTDC 1), mRNA.          0IFZp564D
                                                         FTF: B1F2;
                                Homo sapiens nuclear     FTZ-FEbeta;
                                receptor subfamily 5,    hB1F: hB1E
7330639 NM_003822.3    NR5A2    group A, member 2        2LRH-1-     1121.432487  13.53220783 217
                                (NR5A2), transcript      BF; :TZ
                                variant 2, mRNA.           F; CPF
                                Homo sapiens zinc
                                finger, CCHC domain      SUZN;
2690279 NM_173798.2    ZCCHC12  containing 12            FLJ16123;   834.3165821  10.35379063 217
                                (ZCCHC 12), mRNA.        SIZN1
                                Homo sapiens CD1d        MGC34622
6400358 NM_001766.3    CD1D     molecule (CD1D),         R3; CD1A    752.6918782  6.727672919 217
                                mRNA.
                                Homo sapiens
5720075 NM_003638.1    ITGA8    integrin, alpha 8                    276.5741117  2.893326245 217
                                (ITGA8), mRNA.
                                Homo sapiens mal, T
                                cell differentiation
4040398 NM_022440.1    MAL      protein (MAL),                         1193.45313 2.345562437 216
                                transcript variant d,
                                mRNA.
                                Homo sapiens             bA56H7.1;
 380561 NM 006393.1    N-EBL    nebulette (NE-BL),       MGC 119746  283.8456007  1.924644406 215
                                transcript variant 1,    ; LNEBL;
                                mRNA.                    MGC 119747
                                                         LIM-1;
                                Homo sapiens LIM         LIMI;
 630452 NM_005568.2    LHX1     homeobox 1 (LHX1),       MGC138141   259.5757191  1.757318091 215
                                mRNA.
                                                         MGC126723
                                Homo sapiens brain
5690301 NM 001704.1    BAI3     specific angiogenesis    KIAAO33O;   573.1351946  6.194153497 213
                                inhibitor 3 (BAI3),      MGC133100
                                mRNA.
                                Homo sapiens
                                wingless-type MMTV
                                integration site family, WNT13-
4640386 NM 024494.1    WNT2B    member 2B                XWNT2       3342.0128596  2.97194221 213
                                (WNT2B), transcript
                                variant WNT-2B2,
                                mRNA.
                                Homo sapiens actinin,    MGC 117002
 830348 NM_001104.1    ACTN3    alpha 3 (ACTN3),         ;            394.3165821 2.318724864 208
                                mRNA.                    MGC117005
                                                 106

                                Homo sapiens           MGC54284;
                                glycoprotein M6B       MG524
 2630279 NM_001001995.1 GPM6B   (GPM6B), transcript    M6B;              1635.314044   6.065367942   205
                                variant 1, mRNA.       MGC17150
                                Homo sapiens bone
 2000471 NM_021073.2    BMP5    morphogenetic protein  MGC34244           670.784264   6.188059646   204
                                5 (BMP5), mRNA.
                                Homo sapiens ATP
                                binding cassette, sub- FLJ43498
 5810209 NM_080284.2    ABCA6   family A (ABC1),       EST155051         264.3340102     1.65136103  200
                                member 6 (ABCA6),
                                mRNA.
                                Homo sapiens Ca++
                                dependent secretion    KIAA1591          17
 7160102 NM_017954.9    CADPS2  activator 2 (CADPS2),  FLJ40851          1047.691201   8.328317116   199
                                transcript variant 1,
                                mRNA.
                                Homo sapiens           MGC54284;
 3870202 NM_001001995.1 GPM6B    Gcrotei anscipt                 5M6B;   1569.374619   3.416621491   199
                                variant 1, mRNA.
                                Homo sapiens
                                NIEDD4 binding
  620112 NM 001079691.1 N4BP2L1 protein 2-like 1       CG018             302.4654822   2.770182275   198
                                (N4BP2L1), transcript
                                variant 2, mRNA.
                                         14PEND24X P6
                        Symbol  Definition             Synonyms        RFUs          Fold over Ave. Filter
ProbelD  RefSeq_ID
                                                                                                    Score
                                Homo sapiens EF-       DKFZp686
                                hand calcium binding   0638;
 6380328 NM_198529.2    EFCAB5  domain (EFCAB5),       FLJ46247;         874.0688663   15.04815063   248
                                mRNA.mRNA.DKFZp434G
                                                       2420
                                Homo sapiens chronic
                                lymphocytic leukemia
  650669 NM_001025232.1 CLLUlOS up-regulated 1                           298.8708122   3.682272662   248
                                opposite strand
                                (CLLUlOS), mRNA.
                                Homo sapiens
 2470184 NM 014479.2    ADAMDE  ADAM-like, decysin     M12.219            356.441709   4.958405482   246
                        Cl      1 (ADAMDEC1),
                                mRNA.
                                Homo sapiens CSAG
 4010095 NM_203311.1    CSAG3A  family, member 3A      MGC17065          285.7824873   2.965170936   246
                                (CSAG3A), mRNA.
                                Homo sapiens
                                cytochrome P450,       CYP24;
                                family 24, subfamily   P450-CC24;
 6400131 NM_000782.3    CYP24A1 A,polypeptide 1        MGC126274         254.3592217   3.595571168   245
                                (CYP24A), nuclear
                                                         CP24
                                gene encoding          MGC126273
                                mitochondrial protein,
                                mRNA.
                                Homo sapiens
                                transcobalamin I
 1770603 NM 001062.3    TCN1    (vitamin B12 binding   TCI; TC 1         30460.03096   145.1865227   244
                                protein, R binder
                                family) (TCN1),
                                mRNA.
                                Homo sapiens solute    MGC126299
                                carrier family 5
 1010097 NM_021815.2    SLC5A7  (choline transporter), MGC126300         829.8722504   13.25927703   244
                                member 7 (SLC5A7),     ; CHT1;
                                mRNA.                  hCHT; CHT
                                Homo sapiens
                                transcription factor
                                AP-2 beta (activating  MGC21381;
 7320471 NM_003221.3    TFAP2B  enhancer binding       AP-2B;            885.4104907   11.69067693   243
                                protein 2 beta)        AP2-B
                                (TFAP2B), mRNA.
                                                107

                               Homo sapiens
                               potassium voltage-    KV2.1 h
6900196 NM004975.2     KCNB1   related ubfal y,a-    DRK;        500.2368866 6.420247184  243
                               member 1 (KCNB 1),
                               mRNA.
                               Homo sapiens proline- Ps 1; PMF;
                               rich protein BstNI    PRB1L: Ps
4010224 NM_199353.1    PRB1    subfamily 1 (PRB1),   2; PM; PMS; 273.3172589 2.909495773  243
                               transcript variant 2, PRB1M
                               mRNA.
                               Homo sapiens
4810487 NM 018712.2    ELMODI  ELMO/CED-12           DKFZp547C   400.5093063 4.565239745  242
                               domain containing 1   176
                               (ELMOD 1), mRNA.
                               Homo sapiens proline
6370189 NM 006248.2    PRB2    rich protein BstNI    cP7; Ps;    377.4169205 4.309025745  242
                               subfamily 2 (PRB2),   PRPPRB1
                               mRNA.
                               Homo sapiens ataxia
                                                     SCKI1;
4040286 NM 001184.2    ATR     telangiectasia and    MECI;       284.2343486 3.022407115  242
                               Rad3 related (ATR),   ERPI; SCKI
                               mRNA.
                               Homo sapiens ankyrin  MGC26087;
                               repeat and sterile    ANKS2;
6660463 NM 020140.2    ANKS lB alpha motif domain    AIDA;       225.6940778 2.327570041  242
          -                    containing lB         cajalin-2;
                               (ANKS1B), transcript  EB-1;
                               variant 3, mRNA.      AIDA-1
                               Homo sapiens
4880138 NM 000905.2    NPY     neuropeptide Y        PYY4          5085.8978 43.13558215  241
                               (NPY), mRNA.
                               Homo sapiens          LGMD1A;
1400392 NM 006790.1    MYOT    myotilin (MYOT),      LGMD1;      363.1686971 4.418465629  241
                               mRNA.                 TTID
                               Homo sapiens
6270022 NM 002110.2    HCK     hemopoietic cell      JTK9        599.1159052 7.518919634  239
                               kinase (HCK),
                               mRNA.
                               Homo sapiens NK2
                                                     NKX2B;
7610441 NM_002509.2    NKX2-2  homeobox 2 (NKX2-     NKX2.2      6605.236887    38.229273 238
                               2), mRNA.
                               Homo sapiens CD36     GPIV; FAT;
                               molecule
                                                     GP3B
1010592 NM_001001548.1 CD36    (thrombospondin       CHDS7;      1040.994416 10.66170225  238
                               receptor) (CD36),     SCARB3;
                               transcript variant 1, PASIV; GP4
                               mRNA.
                               Homo sapiens Src
                               homology 2 domain
 730093 NM 020209.2    SHD     containing                        799.1094755 10.06106597  237
                               transforming protein
                               D (SHD), mRNA.
                               Homo sapiens          MGC87867;
                               secretoglobin, family PnSP-2;
2000292 NM_052863.2    SCGB3A1 secre       bin I     HIN1; HIN-  591.5932318 8.643090782  237
                               3A, member 1          1; UGRP2;
                               (SCGB3A1), mRNA.      LU105
                               Homo sapiens eyes
                               absent homolog 4      CMD1J;
6760725 NM 172105.2    EYA4    (Drosophila) (EYA4)'  DFNA1O      366.4281726 4.227226892  237
                               transcript variant 4,
                               mRNA.
                               Homo sapiens Fas
5270520 NM005449.3     FAIM3   amolpetotic inh       TOSO        283.4650592 3.092052735  237
                               mRNA.
                               Homo sapiens          HBGR;
                               glutamate receptor,   GLURA;
1190592 NM_000827.2    GRIAl   glutrceptor'          GLUHI;      274.6204738 2.951679773  237
                               ionotropic, AMPA 1    GLURI;
                               (GRIA1), mRNA.        MGC133252
                                               108

                               Homo sapiens A
                               kinase (PRKA) anchor
6380689 NM_004842.2    AKAP7   protein 7 (AKAP7),      AKAP18     241.7647208 2.655316984  237
                               transcript variant
                               alpha, mRNA.
                               Homo sapiens heparan
5870435 NM 006043.1    HS3ST2  sulfate (glucosamine)   30ST2;     1421.217259   19.6320838 236
                               3-0-sulfotransferase 2  30ST2
                               (HS3ST2), mRNA.
                                                       SCYB 13;
                               Homo sapiens            ANGIE;
                               chemokine (C-X-C        BCAl;
1110564 NM 006419.1    CXCL13  motif) ligand 13 (B-    ANGIE2;    681.3115059  4.79262015  236
                               cell chemoattractant)   BCA-1;
                               (CXCL13), mRNA.         BLR1L;
                                                       BLC
                               Homo sapiens            Erk4;
4860403 NM 002747.3    MAPK4   mitogen-activated       p63MAPK;   289.0861252 3.620157653  236
                               protein kinase 4        ERK3;
                               (MAPK4), mRNA.          PRKM4
                               Homo sapiens eyes
                               absent homolog 4        CMD1J
2350139 NM 004100.3    EYA4    (Drosophila) (EYA4),    DFNA1      654.2714044 8.365363035  235
                               transcript variant 1,
                               mRNA.
                               Homo sapiens solute
                               carrier family 10
7000176 NM_152679.2    SLC1OA4 (sodium/bile acid       MGC29802;  302.4654822 3.322957049  235
                               cotransporter family),  P4
                               member 4
                               (SLC1OA4), mRNA.
                               Homo sapiens cyclic
                               AMP-regulated
7160437 NM_001025068.1 ARPP-21 phosphoprotein, 21      FLJ32997   601.7113367 7.503605242  234
                               kD (ARPP-21),
                               transcript variant 3,
                               mRNA.
                                                       DKFZp434C
                               Homo sapiens            1372;
5910521 NM 014996.1    PLCH1   phospholipase C, eta 1  PLCetal;   310.5576988 3.860094424  234
                               (PLCH1), mRNA.          PLCL3;
                                                       MGC117152
                               Homo sapiens eyes
                               absent homolog 4        CMD1J
1260180 NM 004100.3    EYA4    (Drosophila) (EYA4),    DFNA1      1302.621827 11.82586583  233
                               transcript variant 1,
                               mRNA.
                               Homo sapiens solute
                               carrier family 22
                                                       EMT;
6200333 NM 021977.2    SLC22A3 (extraneuronal          OCT3;       284.351269 2.949641146  233
                               monoamine
                                                       EMTH
                               transporter), member
                               3 (SLC22A3), mRNA.
                               Homo sapiens
 580187 NM_001029851.1 PDE8B   phosphodiesterase 8B    FLJ11212   679.4294416 6.956257297  232
                               (PDE8B), transcript
                               variant 3, mRNA.
                               Homo sapiens ST8        MGC116857
                               alpha-N-acetyl-         ;HsT19690;
 150066 NM_006011.3    ST8SIA2 neuraminide alpha-      SIAT8B-    372.3873096 4.195453617  232
                               2,8-sialyltransferase 2 MGC116854
                               (ST8SIA2), mRNA.        ; STX
                               Homo sapiens GTP        DYT5; GTP
1010360 NM 001024070.1 GCH1    cyclohydrolase 1        CH-1;      316.4216582 4.026929451  230
                               (GCH1), transcript      GTPCH1;
                               variant 3, mRNA.        GCH
                               Homo sapiens CD36       GPIV; FAT;
                               molecule
                                                       GP3B
3310538 NM_000072.2    CD36    (thrombospondin         CHDS7;     1115.056007 8.734225894  229
                               receptor) (CD36)'       SCARB3;
                               transcript variant 3,   PASIV; GP4
                               mRNA.
                                               109

                                         Homo sapiens           GTH1;
 1090561 NM_145740.2             GSTA1   glutathione 5-         GST2;         311.9514382     2.80481688  229
                                         transferase Al
                                                                MGC13 193 9
                                         (GSTA1), mRNA.         ; GSTAl-1
                                         Homo sapiens           MGC126406
                                         engulfment and cell    ; CED12;
 2750154 NM 014800.9             ELMO1   motility 1 (ELMO1),    CED-12;       294.8979695      3.1756816  228
                                         transcript variant 1,  KIAA0281;
                                         mRNA.                  ELMO-1
                                         Homo sapiens ankyrin   MGC26087;
                                         repeat and sterile     EB-1;
 2350201 NM_181670.2             ANKS1B  alpha motif domain     ANKS2;        879.8979695     11.7078234  227
            -                            containing lB          AIDA-1;
                                         (ANKS IB), transcript  AIDA;
                                         variant 2, mRNA.       cajalin-2
                                         Homo sapiens cyclic
                                         AMP-regulated
 7210554 NM_016300.4             ARPP-21 phosphoprotein, 21     FLJ32997      698.5147208   7.970934471   226
                   _                     kD (ARPP-21),
                                         transcript variant 1,
                                         mRNA.
                                         Homo sapiens solute
                                         carrier family 8
 2320369 NM_015063.1             SLC8A2  (sodium/calcium        NCX2          1094.461421   7.969025829   226
                                         exchanger), member 2
                                         (SLC8A2), mRNA.
                                         Homo sapiens           FMR2;
 2030445 NM 002025.2             AFF2    AF4/FMR2 family,       MRX2;         262.3605753     2.45038926  226
                                         member 2 (AEF2),       OX 19;
                                         mRNA.                  FRAXE
                                                                OTF4;
                                         Homo sapiens POU       OCT3;
  770615 NM_002701.4             POU5F1  cU5F ) tranript           GOCT4;     12941.20931   19.53733586   225
                                         variant 1, mRNA.       OTF3
                                         Homo sapiens solute
                                         carrier family 2
                                         (facilitated glucose   GLUTX
 3930546 NM 001001290.1          SLC2A9  transporter), member   GLUT9         1780.868697   19.85757429   224
                                         9 (SLC2A9),
                                         transcript variant 2,
                                         mRNA.
                                         Homo sapiens mal, T
                                         cell differentiation
 6330196 NM_002371.2             MAL     protein (MAL),                       1343.049746   8.160066235   224
                                         transcript variant a,
                                         mRNA.
                                         Homo sapiens calcium
                                         channel, voltage-      CACNLB2;
 2850458 NM_201572.1             CACNB2  depe     ent, aB2),    MYSB;         352.0490694   4.242487768   224
                                         transcript variant 8,
                                         mRNA.
                                                   14PEND2X P6
                                 Symbol  Definition             Synonyms    RFUs          Fold over Ave. Filter
ProbelD  RefSeq_ID
                                         Homo sapiens leucine   DKFZp434A
 5550035 NM 178452.3             LRRC50  rich repeat containing 119; 5        281.2668359   3.469960436   252
                                         50 (LRRCO),            FJ53
                                         mRNA.
                                         Homo sapiens
 4210228 NM 000940.1             PON3    paraoxonase 3                        387.3813875   5.771377998   252
                                         (PON3), mRNA.
                                         Homo sapiens ATP-      DKFZp313D
                                         binding cassette, sub- 2411;
 1780537 NM_152701.2             ABCA13  family A (ABC1),       FLJ33951;      162.742555   2.202943698   250
                                         member 13              FLJ33876;
                                         (ABCA13), mRNA.        FLJ16398
                                         Homo sapiens           SKALP;
 1050168 NM_002638.2             PI3     peptidase inhibitor 3, ESI; WAP3;   457.8076142    2.647403708   248
                   _skin-derived                        (SKALP) WFDCl4;
                                         (PI3), mRNA.           MGC13613
                                                          110

                               Homo sapiens
                               cytochrome P450,       CYP24
                               family 24, subfamily   P450-CC24;
6400131 NM_000782.3    CYP24A1 A, polypeptide 1       MGC126274   415.3350254 6.503960954  245
                               (CYP24A), nuclear
                                                        CP24
                               gene encoding          MGC126273
                               mitochondrial protein,
                               mRNA.
                               Homo sapiens
                               transcobalamin I
1770603 NM 001062.3    TCN1    (vitamin B12 binding   TCI; TC l   1603.025719 6.693385338  244
                               protein, R binder
                               family) (TCN1),
                               mRNA.
                               Homo sapiens
                               potassium voltage-     KV2.; h
                               gated channel, Shab-   KV.1l
6900196 NM_004975.2    KCNB1   related subfamily,     DRK1;       317.1188663 3.703972133  243
                               member 1 (KCNB 1),     DRK1
                               mRNA.
                                                      USHIB;
                               Homo sapiens myosin    DFNA1 1;
6860736 NM_000260.2    MYO7A   VIIA (MYO7A),          NSRD2;      185.2216582   2.03369506 243
                               mRNA.                  MYU7A;
                                                      DFNB2
                                                      DKFZp434P
                                                      2350;
                                                      USH1H;
                               Homo sapiens           KIAA1774;
6510274 NM_022124.3    CDH23   cadherin-like23        FLJ02331    352.7102369 4.311115881  242
                               (CDH23), transcript    MGC102761
                               variant 1, mRNA.       ; FLJ36499;
                                                      DFNB 12;
                                                      USHID;
                                                      KIAA1812
                               Homo sapiens
                               membrane metallo-      NIP;
                               endopeptidase (neutral MGC126681
2970170 NM 007289.1    MME     endopeptidase,         : CD10:     222.9884941 2.111541705  241
                               enkephahinase'         MGC126707
                               CALLA, CD10)
                                                        CALLA
                               (MME), transcript
                               variant 2b, mRNA.
                               Homo sapiens
6270022 NM 002110.2    HCK     hemopoietic cell       JTK9         993.442978   13.1259159 239
                               kinase (HCK),
                               mRNA.
                               Homo sapiens myosin
                               binding protein C,     slow-type;
5910056 NM_206821.1    MYBPCl  slow type (MYBPC1),    MYBPCS;      1139.82335 14.81358827  239
                               transcript variant 4,  MYBPCC
                               mRNA.
                               Homo sapiens
                               collagen, type IV,
4860554 NM_033641.1    COL4A6  alpha 6 (COL4A6),      MGC88184    194.3451777 2.095551883  239
                               transcript variant B,
                               mRNA.
                               Homo sapiens sterile
3390523 NM_001010971.1 SAMD13  alpha motif domain     RP11-       269.2588832 2.890020188  239
                               containing 13          376N17.1
                               (SAMD13), mRNA.
                               Homo sapiens myosin
                               binding protein C,     slow-type;
 840017 NM 206819.1    MYBPCl  slow type (MYBPC1),    MYBPCS;     1484.388494 19.39806955  239
                               transcript variant 2,  MYBPCC
                               mRNA.
                               Homo sapiens NK2       NKX2B;
7610441 NM_002509.2    NKX2-2  homeobox 2 (NKX2-      NKX2.2      682.2215736 3.051793572  238
                               2), mRNA.
                               Homo sapiens eyes
                               absent homolog 4       CMD1J
6760725 NM 172105.2    EYA4    (Drosophila) (EYA4)'   DFNA1O      615.8304569 7.785038284  237
                               transcript variant 4,
                               mRNA.
                                               111

                               Homo sapiens Fas
5270520 NM 005449.3    FAIM3   apoptotic inhibitory    TOSO         360.872758 4.209496933 237
                               molecule 3 (EATM3),
                               mRNA.
                               Homo sapiens            HBGRA;
1190592 NM_000827.2    GRIAl   glutamate receptor,     GLUH1;      358.9098139 4.164569969 237
                               ionotropic, AMPA 1      GLURI;
                               (GRIA1), mRNA.          MGC133252
                               Homo sapiens Src
                               homology 2 domain
 730093 NM 020209.2    SHD     containing                          367.9559222 4.093150379 237
                               transforming protein
                               D (SHD), mRNA.
                               Homo sapiens            Erk4;
4860403 NM 002747.3    MAPK4   mitogen-activated       p63MAPK;    671.6402707 9.734115774 236
                               protein kinase 4        ERK3;
                               (MAPK4), mRNA.          PRKM4
                               Homo sapiens solute
                               carrier family 10
7000176 NM_152679.2    SLC1OA4 (sodium/bile acid       MGC29802;   598.3299492 7.551569762 235
                               cotransporter family),  P4
                               member 4
                               (SLC1OA4), mRNA.
                               Homo sapiens eyes
                               absent homolog 4
                                                       CMD1J
2350139 NM 004100.3    EYA4    (Drosophila) (EYA4),    DFNA1       1123.959052 15.08855972 235
                               transcript variant 1,
                               mRNA.
                               Homo sapiens
4220674 NM 152709.3    STOXI   storkhead box 1         PEE4;       257.8137056 2.779263646 234
                               (STOXI), transcript     ClOorf24
                               variant 1, mRNA.
                               Homo sapiens eyes
                               absent homolog 4        CMD1J
1260180 NM 004100.3    EYA4    (Drosophila) (EYA4),    DFNA1       1881.794247 17.52850921 233
                               transcript variant 1,
                               mRNA.
                               Homo sapiens
 580187 NM_001029851.1 PDE8B   phosphodiesterase 8B    FLJ11212    603.5299492 6.067458765 232
                               (PDE8B), transcript
                               variant 3, mRNA.
                               Homo sapiens ST8        MGC116857
                               alpha-N-acetyl-           HsT19690;
 150066 NM_006011.3    ST8SIA2 neuraminide alpha-      ST8SA-1I;   434.1379019 5.056982271 232
                               2,8-sialyltransferase 2 MGC116854
                               (ST8SIA2), mRNA.              1STX
                               Homo sapiens GTP        DYT5; GTP
1010360 NM 001024070.1 GCH1    cyclohydrolase 1        CH-1;       234.7860406 2.730000243 230
                               (GCH1), transcript      GTPCH1;
                               variant 3, mRNA.        GCH
                               Homo sapiens fragile    FRA3B-8
 510452 NM_002012.1    FHIT    histidine triad gene    AP3Aase       325.31489 3.717521176 230
                               (FHIT), mRNA.
                               Homo sapiens SRY
3310037 NM 005634.2    SOX3    (sex determining        SOXB;       636.1100677 4.081772744 229
                               region Y)-box 3         MRGH
                               (SOX3), mRNA.
                               Homo sapiens            MGC126406
                               engulfment and cell     ; CED12;
2750154 NM 014800.9    ELMO1   motility 1 (ELMO1),     CED-12;      405.992132 4.748747195 228
                               transcript variant 1,   KIAA0281;
                               mRNA.                   ELMO-1
                               Homo sapiens solute     dJ230I3.1;
1850138 NM 001029858.2 SLC35F1 carrier family 35,      C6orfl69;    286.021489 2.510643626 228
                               member Fl               FLJ13018
                               (SLC35F1), mRNA.
                               Homo sapiens            FMR2;
2030445 NM 002025.2    AFF2    A     b4/FMR2 family,   MRX2;       363.8155668 3.784656853 226
                               member 2 (AEE2),        0X19;
                               mRNA.                   FRAXE
                               Homo sapiens WNT
5290753 NM 007191.2    WIF1    inhibitory factor 1     WIF-i       344.5483926 3.384810371 225
                               (WIF1), mRNA.
                                                112

                                                          OTF4
                                  Homo sapiens POU        OCT3;
 770615   NM_002701.4    POU5F1   class 5 homeobox 1      OCT4        6175.480203  8.800313713  225
                                  (POU5F1), transcript    MGC22487;
                                  variant 1, mRNA.        OTF3
                                  Homo sapiens solute
                                  carrier family 2
                                  (facilitated glucose    GLUTX
3930546   NM 001001290.1 SLC2A9   transporter), member    GLUT9       1241.419628  13.53953464  224
                                  9 (SLC2A9),
                                  transcript variant 2,
                                  mRNA.
                                  Homo sapiens MOB 1,     FLJ13204;
                         MOBKL2   Mps One Binder          FLJ23916;    0.637        .2755        2
 940630   NM_024761.3      BK     kinase activator-like   MOB3B;      307.0633672  2.728795357  224
           M_246.3
           9463          B2B          (yeast)               MC26
                                  (MOBKL2B), mRNA.        MGC32960
                                  Homo sapiens claudin
6650477   NM 006984.3    CLDN1O   10 (CLDN1O),            CPETRL3;    839.9659052  7.360713685  223
                                  transcript variant 2,   OSP-L
                                  mRNA.
                                  Homo sapiens POU
                                  class 5 homeobox 1      POU5FLC8;
6450746   NR_002304.1    POU5F1Pi pseudogene 1            OTF3C;      6747.353469  10.81377916  223
                                  (POU5F1Pi), non-        OTF3P1
                                  coding RNA.
                                  Homo sapiens
                                  Cbp/p300-interacting
5290711   NM_004143.2    CITEDi   transactivator, with    MSG1               386.8   3.73860325 222
                                  Glu/Asp-rich carboxy
                                  terminal domain, 1
                                  (CITED 1), mRNA.
                                  Homo sapiens
                                                          EPT;
4150068   NM_005097.1    LGIl      eucine-rich 1Li1)      IB1099;     285.4045685  2.902197226  222
                                  mRNA.
                                                          PR2AB
                                                          BETA;
                                                          PR52B;
                                  Homo sapiens protein    PR2APR55
                                  phosphatase 2           BETA;
                                  (formerly 2A),          PR2AB55
1990019   NM_181676.1    PPP2R2B  regulatory subunit B,   BETA;       425.4836717  3.638701943  218
                                  beta isoform            MGC24888;
                                  (PPP2R2B), transcript   PR55
                                  variant 4, mRNA.        BETA;
                                                          PP2A
                                                          PR55B;
                                                          SCA12
                                  Homo sapiens family
                                  with sequence           RP1-32F7.2;
2370646   NM 173698.1    FAM133A  similarity 133,         FLJ37659    788.9001692  7.657158909  217
                                  member A
                                  (FAM133A), mRNA.
1070343   NM_012464.3    TLL1     Homo sapiens tolloid-   TLL         698.1584602  8.078011573  217
                                  like 1 (TL1), mRNA.
                                  Homo sapiens
                                  oculocutaneous          D15S12;
4250463   NM_000275.1    OCA2     albinism II (pink-eye   EYCL3;      554.7313029  4.399794213  214
                                  dilution homolog,       PED; P;
                                  mouse) (OCA2),          BOCA
                                  mRNA.
                                  Homo sapiens claudin
 840324   NM 006984.3    CLDN1O   10 (CLDN1O),            CPETRL3;    1460.319628  7.853694588  214
                                  transcript variant 2,   OSP-L
                                  mRNA.
                                  Homo sapiens
                                  synuclein, gamma
7000669   NM_003087.1    SNCG     (breast cancer-specific BCSG1; SR   362.6211506  2.944794824  213
                                  protein 1) (SNCG),
                                  mRNA.
                                  Homo sapiens killer     CD159c;
     2614 NM 002260.3    KLRC2    cell lectin-like        NKG2C;       89980         .5966       0
                                  receptor subfamily C,   MGC138244    859.998308  7.658976864  209
                                  member 2 (KLRC2),       ; NKG2-C
                                                   113

                                mRNA.
                                         14SKEL12Z P6
                        Symbol  Definition              Synonyms   RFUs          Fold over Ave. Filter
ProbelD  RefSeq_ID
                                Homo sapiens LIM        M2-LHX3;
 7550056 NM 178138.2    LHX3    homeobox 3 (LHX3)'      DKFZp762A    1715.749408   28.92056157   252
                   --           transcript variant l'   2013
                                mRNA.
                                Homo sapiens
 6560440 NM 001007089.2 RESPI8  regulated endocrine-                  1416.78714    23.3987498   252
                                specific protein 18
                                (RESP18), mRNA.
                                Homo sapiens uridine    UPASE2;
 2360743 NM_173355.2    UPP2    phosphorylase 2         UDRPASE2;   427.8104907    6.720641831   250
                                (UPP2), mRNA.           UP2
                                Homo sapiens
 1050040 NM_004925.3    AQP3    aquaporin 3 (Gill       GIL         482.9805415    6.282651052   248
                                blood group) (AQP3),
                                mRNA.
                                Homo sapiens            ESR-BETA;
                                estrogen receptor 2     ESTRB;
 4010544 NM_001040275.1 ESR2    (ER beta) (ESR2),       ESRB; Erb;    283.658714   3.698811776   248
                                transcript variant b,   ER-BETA;
                                mRNA.                   NR3A2
                                Homo sapiens major
                        HLA-    histocompatibility      MGC117330
 1770504 NM_022555.3    DRB3    complex, class II, DR   ; HLA-      472.3668359    6.504149016   247
                                beta 3 (HLA-DRB3),      DR3B
                                mRNA.
                                Homo sapiens sodium
 4210274 NM 002976.2    SCN7A   channel, voltage-       SCN6A       432.6501692    5.383448306   247
                                gated, type VII, alpha
                                (SCN7A), mRNA.
                                Homo sapiens
                                                        HBGR2;
 6220750 NM 000826.2    GRIA2   glutamate receptor'     GLURB;       2105.021997   21.45923965   245
                                ionotropic, AMPA 2      GLUR2
                                (GRIA2), mRNA.
                                Homo sapiens
 6420113 NM_080723.3    NRSN1   neurensin 1 (NRSN1),    p24; VMP     650.2043993   9.496720384   245
                                mRNA.
 6940400 NMHomo                         sapiens paired- PMX2B;
         6940400
         NM_003924.2    PHOX2B  like homeobox 2b        NBPhox       338.2059222   3.970463408   245
                                (PHOX2B), mRNA.
                                Homo sapiens solute     MGC126299
                                carrier family 5
 1010097 NM_021815.2    SLC5A7  (choline transporter),  MGC126300    698.7585448   11.00641625   244
                                member 7 (SLC5A7),      ; CHT1;
                                mRNA.                   hCHT; CHT
                                Homo sapiens family
                                with sequence
                                similarity 19           TAFA-1;
 2230088 NM_213609.2    FAM19A1 (chemokine (C-C         TAFA1        3235.903976   47.74138479   243
                                motif)-like), member
                                Al (FAM19A1),
                                mRNA.
                                Homo sapiens
                                transcription factor
                                AP-2 beta (activating   MGC21381;
 7320471 NM_003221.3    TFAP2B  enhancer binding        AP-2B;      474.3918782    5.799506135   243
                                protein 2 beta)         AP2-B
                                (TFAP2B), mRNA.
                                Homo sapiens matrix     MGC138506
 4760626 NM 002426.2    MMP12   metallopeptidase 12      MME:        377.5335025    5.39940787   243
                                (macrophage elastase)
                                (MMP12), mRN .
                                Homo sapiens major
                        HLA-    histocompatibility
 6370315 NM_002125.3    DRB5    complex, class II, DR   HLA-DRB1     1682.866328    13.8495262   242
                                beta 5 (HLA-DRB5),
                                mRNA.
                                                114

                               Homo sapiens unc-13
1660152 NM 001080534.1 UNC13C  homolog C (C.         DKFZp547H  693.9843486 10.23200304  242
                               elegans) (UNC13C),    074
                               mRNA.
                               Homo sapiens
4880138 NM 000905.2    NPY     neuropeptide Y        PYY4       1080.668528 8.378075704  241
                               (NPY), mRNA.
                               Homo sapiens myosin
                               binding protein C,    slow-type;
 840017 NM 206819.1    MYBPCl  slow type (MYBPC1),   MYBPCS;    2533.879695 33.81989685  239
                               transcript variant 2, MYBPCC
                               mRNA.
                               Homo sapiens myosin
                               binding protein C,    slow-type;
5910056 NM_206821.1    MYBPCl  slow type (MYBPC1),   MYBPCS;    1800.997462 23.98653175  239
                               transcript variant 4, MYBPCC
                               mRNA.
                               Homo sapiens          BCH;
 830687 NM 004067.2    CHN2    chimerin (chimaerin)  ARHGAP3;   311.2939086 4.156162991  239
                               2 (CHN2), transcript  RHOGAP3;
                               variant 2, mRNA.      MGC138360
                               Homo sapiens NK2      NKX2B;
7610441 NM 002509.2    NKX2-2  homeobox 2 (NKX2-     NKX2.2     2063.805584   11.2571823 238
                               2), mRNA.
                               Homo sapiens CD36     GPIV; FAT;
                               molecule
                                                     GP3B
1010592 NM_001001548.1 CD36    (thrombospondin       CHDS7;     968.6395939 9.851149972  238
                               receptor) (CD36),     SCARB3;
                               transcript variant 1, PASIV; GP4
                               mRNA.
                               Homo sapiens
                                                     LEC3;
6620369 NM_015236.3    LPHN3   latrophilin 3         CIRL'      290.9576988    3.4582854 238
                               (LPHN3), mRNA.
                               Homo sapiens
                               RALBP1 associated
6040673 NM 004726.2    REPS2   Eps domain            POBI       309.1473773   3.31580158 238
          --                   containing 2 (REPS2),
                               transcript variant 1,
                               mRNA.
                               Homo sapiens
5130471 NM 000922.2    PDE3B   phosphiterase 3B,     HcGIP1;     881.636379 12.50951438  237
                               (PDE3B), mRNA.
                               Homo sapiens eyes
                               absent homolog 4      CMD1J
6760725 NM 172105.2    EYA4    (Drosophila) (EYA4)'  DFNA1O     294.8572758 3.206242851  237
                               transcript variant 4,
                               mRNA.
                                                     CNSA2;
                               Homo sapiens SH3-     SH3P4;
2600465 NM_003026.1    SH3GL2  domain GRB2-like 2    SH3D2A;    835.2967851 9.345269638  235
                               (SH3GL2), mRNA.       FLJ251;
                                                     FLJ20276
                               Homo sapiens eyes
                               absent homolog 4      CMD1J
2350139 NM 004100.3    EYA4    (Drosophila) (EYA4),  DFNA1      553.6543147 6.925111228  235
                               transcript variant 1,
                               mRNA.
                               Homo sapiens
                               reprimo, TP53         FLJ90327
5550414 NM_019845.2    RPRM    dependent G2 arrest   REPRIM964.7199662      6.019069947  234
                               mediator candidate
                               (RPRM), mRNA.
                               Homo sapiens cyclic
                               AMP-regulated
7160437 NM_001025068.1 ARPP-21 phosphoprotein, 21    FLJ32997   372.5032149  4.26435202  234
                  _            kD (ARPP-21),
                               transcript variant 3,
                               mRNA.
                                               115

                                                        TM4SF2;
                                                        MRX58;
                                                        MXS1;
                               Homo sapiens             DXS1692E;
 460010 NM_004615.2    TSPAN7  tetraspanin 7            CD231;     1098.523942 11.51349763 233
                               (TSPAN7), mRNA.          CCG-B7;
                                                        TALLA-1;
                                                        A15;
                                                        TM4SF2b
                               Homo sapiens             BCH;
3190246 NM 004067.2    CHN2    chimerin (chimaerin)     ARHGAP3;   718.3005076 9.696513205 233
                               2 (CHN2), transcript     RHOGAP3;
                               variant 2, mRNA.         MGC138360
                               Homo sapiens solute
                               carrier family 22
                                                        EMT;
6200333 NM 021977.2    SLC22A3 (extraneuronal           OCT3;      718.3005076  8.97719915 233
                               monoamine
                                                        EMTH
                               transporter), member
                               3 (SLC22A3), mRNA.
                               Homo sapiens eyes
                               absent homolog 4         CMD1J
1260180 NM 004100.3    EYA4    (Drosophila) (EYA4),     DFNA1       993.442978 8.781631227 233
                               transcript variant 1,
                               mRNA.
                               Homo sapiens major
                               histocompatibility
4200725 NR_001298.1    HLA-    complex, class II, DR               910.5795262 9.069933352 232
                       DRB6    beta 6 (pseudogene)
                               (HLA-DRB6), non
                               coding RNA.
                               Homo sapiens
                               neurotrophic tyrosine
                                                        GP145
 620349 NM_006180.3    NTRK2   kinase, receptor, type   TrkB; TRKB 391.6777496  4.38802409 232
                               2 (NTRK2), transcript
                               variant a, mRNA.
                               Homo sapiens C-type
7320348 NM 016511.2    CLEC1A  lectin domain family     CLECI;     313.5815567 3.273086061 232
                               1, member A              MGC34328
                               (CLEC1A), mRNA.
                               PREDICTED: Homo
5860093 XM 940314.2    NLF2    sapiens facte2                      360.5552453 3.953476782 230
                               localized factor 236.525                        393478      20
                               (NLF2), mRNA.
                               Homo sapiens CD36        GPIV; FAT;
                               molecule
                                                        GP3B
3310538 NM_000072.2    CD36    (thrombospondin          CHDS7;     1493.647208 12.03925475 229
                               receptor) (CD36)'        SCARB3;
                               transcript variant 3,    PASIV; GP4
                               mRNA.
                               Homo sapiens
                               neurotrophic tyrosine
                                                        GP145
3870246 NM 001007097.1 NTRK2   kinase, receptor, type   TrkB; TRKB 2332.756684 19.73768026 228
                               2 (NTRK2), transcript
                               variant b, mRNA.
                               Homo sapiens
                                                        ABCDS;
                               endothelin receptor      HSCR2;
3840465 NM_003991.1    EDNRB   type B (EDNRB)'          ETRB;      418.4676819 3.781673814 228
                               transcript variant 2,    HSCR; ETB
                               mRNA.
                               Homo sapiens             MGC126406
                               engulfment and cell      ; CED12;
2750154 NM 014800.9    ELMO1   motility 1 (ELMO1),      CED-12;    335.9739425 3.757307118 228
                               transcript variant 1,    KIAA0281;
                               mRNA.                    ELMO-1
                               Homo sapiens
                               neurotrophic tyrosine    GP145
 430102 NM_001018065.1 NTRK2   kinase, receptor, type   TrkB; TRKB  3018.60846 24.00263368 227
                               2 (NTRK2), transcript
                               variant d, mRNA.
                               Homo sapiens solute
                               carrier family 8
2320369 NM_015063.1    SLC8A2  (sodium/calcium          NCX2       1053.866328 7.636352213 226
                               exchanger), member 2
                               (SLC8A2), mRNA.
                                               116

                                Homo sapiens cyclic
                                AMP-regulated
 7210554 NM_016300.4    ARPP-21 phosphoprotein, 21     FLJ32997     469.9600677    5.035636538   226
                                kD (ARPP-21),
                                transcript variant 1,
                                mRNA.
                                Homo sapiens major     HLA
                        HLA-    histocompatibility     DRB1*;
 5260484 NM_002124.1    DRB1    complex, class II, DR  HLA-DR1B;     2762.059052   21.02754859   225
                                beta 1 (HLA-DRB1),     HLA DRB1;
                                mRNA.                  DRB1
                                                       OTF4
                                Homo sapiens POU       OCT3;
  770615 NM_002701.4    POU5F1  cU5F ) tranript           GOCT4;     13222.53147   19.98378624   225
                                variant 1, mRNA.       OTF3
                                                       RHOM3;
                                Homo sapiens LIM       Rhom-3;
                                domain only 3          RBTNL2;
 5360301 NM_018640.3    LMO3    (rhombotin-like 2)     RBTN3-;      431.6473773    3.570645215   225
                                (LMO3), transcript     DAT1;
                                variant 1, mRNA.       MGC26081
                                         14SKEL14Z P6
                        Symbol  Definition             Synonyms    RFUs          Fold over Ave. Filter
ProbelD  RefSeq_ID
                                Homo sapiens
 4390403 NM_004042.3    ARSF    arylsulfatase F        ASF           272.7984772   4.107960639   251
                                (ARSF), mRNA.
                                Homo sapiens toll-like
 7200753 NM_016562.3    TLR7    receptor 7 (TLR7),                   293.7142132   4.289026084   250
                                mRNA.
                                Homo sapiens EF-       DKFZp686
                                hand calcium binding   0638;
 6380328 NM_198529.2    EFCAB5  domainS (EFCAb5)       FLJ46247;     345.2602369   5.339075217   248
                                mRNA.mRNA.DKFZp434G
                                                       2420
                                Homo sapiens FYVE,
                                RhoGEF and PH          MGC 117260
 5270619 NM_033086.2    FGD3    domain containing 3    ; FLJ00004;   2567.253299   36.84135495   247
                                (FGD3), transcript     ZFYVE5
                                variant 2, mRNA.
                                Homo sapiens gastrin-  proGRP;
 1400053 NM 001012513.1 GRP     releasing peptide      GRP-10;       2049.811168   28.96640405   245
                                (GRP), transcript      BN;
                                variant 3, mRNA.       preproGRP
                                Homo sapiens
 6420113 NM_080723.3    NRSN1   neurensin 1 (NRSN1),   p24; VMP      1207.042301     18.4861578  245
                                mRNA.
                                Homo sapiens
                                ribonuclease, RNase
 2640068 NM_002934.2    RNASE2  A family, 2 (liver     EDN; RNS2     779.2021151   11.06386339   245
                                eosinophil-derive
                                neurotoxin)
                                (RNASE2), mRNA.
                                Homo sapiens
  670707 NM 182532.1    TMEM61  transmembrane                       422.2224196    5.791838821   245
                                protein 61
                                (TMEM61), mRNA.
                                Homo sapiens
                                                       LEC3
 1170739 NM_015236.3    LPHN3   latrophilin 3          CIRL3         196.6147208   2.303877753   244
                                (LPHN3), mRNA.
                                Homo sapiens matrix    MGC138506
 4760626 NM 002426.2    MMP12   metallopeptidase 12      MME:        706.0241963     10.9675122  243
                                (macrophage elastase)
                                (MMP12), mRNA
                                Homo sapiens family
                                with sequence
                                similarity 19          TAFA-1
 2230088 NM_213609.2    FAM19A1 (chemokine (C-C        TAFA-1I      409.9824873    5.175434846   243
                                motif)-like), member
                                Al (FAM19A1),
                                mRNA.
                                                117

                               Homo sapiens gastrin-  proGRP;
 160500 NM 001012513.1 GRP     releasing peptide      GRP-10;      6826.28308 75.24775009  242
                               (GRP), transcript      BN;
                               variant 3, mRNA.       preproGRP
                                              .       TAILl;
                               Homo sapiens           MGC119416
                               thrombospondin, type
2370056 NM 199296.1    THSD3   I, domain containing 3             338.0033841 4.087053364  242
                               (THSD3), transcript    0215;
                               variant 1, mRNA.       FLJ32147
                               Homo sapiens major
                       HLA-    histocompatibility
6370315 NM_002125.3    DRB5    complex, class II, DR  HLA-DRB1    453.5716582 3.002293057  242
                               beta 5 (HLA-DRB5),
                               mRNA.
                               Homo sapiens
4880138 NM 000905.2    NPY     neuropeptide Y         PYY4        1426.187479   11.3765001 241
                               (NPY), mRNA.
                               Homo sapiens           LGMD1A;
1400392 NM 006790.1    MYOT    myotilin (MYOT),       LGMD1;      269.7420474   3.02454293 241
                               mRNA.                  TTID
                                                      DKFZp434A
                               Homo sapiens elastin   2410;
2850075 NM_052846.1    EMILIN3 microfibril interfacer dJ620E11.4; 568.5527919 7.086278387  239
                               3 (EMILIN3), mRNA.     C20orf130;
                                                      EMILIN5
                                                      PSD-93;
                                                      DKFZp781E
                               Homo sapiens discs,    0954;
                               large homolog 2,       FLJ37266;
1170048 NM_001364.2    DLG2    chapsyn-110            MGC131811   264.0153976 3.025665964  239
                               (Drosophila) (DLG2),   ,
                               mRNA.
                                                      DKFZp781D
                                                      1854
                               Homo sapiens myosin
                               binding protein C,     slow-type;
 840017 NM 206819.1    MYBPCl  slow type (MYBPC1),    MYBPCS;     270.3671743 2.715313374  239
                               transcript variant 2,  MYBPCC
                               mRNA.
                               Homo sapiens NK2       NKX2B;
7610441 NM 002509.2    NKX2-2  homeobox 2 (NKX2-      NKX2.2      4647.176311 26.60012265  238
                               2), mRNA.
                               Homo sapiens
                                                      LEC3;
6620369 NM_015236.3    LPHN3   latrophilin 3          CIRL        308.6822335 3.729874826  238
                               (LPHN3), mRNA.
                               Homo sapiens           HBGR;
                               glutamate receptor,    GLURA;
1190592 NM_000827.2    GRIAl   glutrceptor'           GLUHI;      288.6207276 3.153137876  237
                               ionotropic, AMPA 1     GLURI;
                               (GRIA1), mRNA.         MGC133252
                               Homo sapiens eyes
                               absent homolog 4       CMD1J
6760725 NM 172105.2    EYA4    (Drosophila) (EYA4)'   DFNA1O      237.8099831 2.392443135  237
                               transcript variant 4,
                               mRNA.
                               Homo sapiens Fas
5270520 NM 005449.3    FAIM3   apoptotic inhibitory   TOSO        231.4650592 2.341389698  237
                               molecule 3 (FAIM3),
                               mRNA.
                                                      SCYB 13;
                               Homo sapiens           ANGIE;
                               chemokine (C-X-C       BCAl;
1110564 NM 006419.1    CXCL13  motif) ligand 13 (B-   ANGIE2;      1892.78731 15.09278254  236
                               cell chemoattractant)  BCA-1;
                               (CXCL13), mRNA.        BLR1L;
                                                      BLC
                               Homo sapiens
                               carcinoembryonic
                               antigen-related cell
5700753 NM 001024912.1 CEACAM  adhesion molecule 1    BGPI; BGP;  244.5307107 2.711926103  236
                       1       (biliary glycoprotein) BGP1
                               (CEACAMI),
                               transcript variant 2,
                               mRNA.
                                                118

                               Homo sapiens eyes
                               absent homolog 4       CMD1J
2350139 NM 004100.3    EYA4    (Drosophila) (EYA4),   DFNA1      313.7634518 3.491268628 235
                               transcript variant 1,
                               mRNA.
                               Homo sapiens solute
                               carrier family 22
                                                      EMT;
6200333 NM 021977.2    SLC22A3 (extraneuronal         OCT3;      575.5480541 6.994366558 233
                               monoamine
                                                      EMTH
                               transporter), member
                               3 (SLC22A3), mRNA.
                               Homo sapiens eyes
                               absent homolog 4       CMD1J
1260180 NM 004100.3    EYA4    (Drosophila) (EYA4),   DFNA1      588.1519459 4.791057531 233
                               transcript variant 1,
                               mRNA.
                               Homo sapiens           KIAA1263;
1070162 NM_020116.2    FSTL5   follistatin-like 5     DKFZp566D  253.8345178 2.423631667 232
                               (FSTL5), mRNA.         234
                                               .      BNC1;
                               Homo sapiens           hBNaC1;
                               amiloride-sensitive    MDEG;
 240592 NM 001094.4    ACCN1   cation channel ',      BNaC1;     289.3739425 2.680376114 231
                               neuronal (ACCN1)'      ASIC2a;
                               transcript variant 2,  ACCN;
                               mRNA.                  ASIC2
                               Homo sapiens GTP       DYT5; GTP
1010360 NM 001024070.1 GCH1    cyclohydrolase 1       CH-1;      206.8774112 2.286621266 230
                               (GCH 1), transcript    GTPCH1;
                               variant 3, mRNA.       GCH
                               Homo sapiens           GTH1;
1090561 NM_145740.2    GSTA1     tanferase              GC331939 976.4761421 10.90990793 229
                               (GSTA1), mRNA.          GSTAl-1
                               Homo sapiens
                               neurotrophic tyrosine
                                                      GP145
3870246 NM_001007097.1 NTRK2   kinase, receptor, type TrkB; TRKB  526.958291 3.684540237 228
                               2 (NTRK2), transcript
                               variant b, mRNA.
                               Homo sapiens           ABCDS;
                               endothelin receptor    HSCR2;
3840465 NM_003991.1    EDNRB   type B (EDNRB)'        ETRB;      288.1918782 2.293060891 228
                               transcript variant 2,  HSCR; ETB
                               mRNA.
                               Homo sapiens
                               neurotrophic tyrosine
                                                      GP145
 430102 NM_001018065.1 NTRK2   kinase, receptor, type TrkB; TRKB 582.5891709 3.825489565 227
                               2 (NTRK2), transcript
                               variant d, mRNA.
                               Homo sapiens solute
                               carrier family 8
2320369 NM_015063.1    SLC8A2  (sodium/calcium        NCX2       596.0085448 3.884243454 226
                               exchanger), member 2
                               (SLC8A2), mRNA.
                                                      OTF4;
                               Homo sapiens POU       OCT3
 770615 NM_002701.4    POU5F1  cU5F ) tranript          GOCT4;   14012.64179 21.23766914 225
                               variant 1, mRNA.       OTF3
                               Homo sapiens           Hox-2.4;
 870524 NM_024016.3    HOXB8   homeobox B8            HOX2;      2523.421997 13.98125023 225
                               (HOXB 8), mRNA.        HOX2D
                               Homo sapiens major     HLA
                       HLA-    histocompatibility     DRB1*;
5260484 NM_002124.1    DRB1    complex, class II, DR  HLA-DR1B;  610.6073604 3.869621918 225
                               beta 1 (HLA-DRB1),     HLA DRB1;
                               mRNA.                  DRB1
                               Homo sapiens calcium
                               channel, voltage-      CACNL2;
2850458 NM_201572.1    CACNB2  dep     dent, aB2),    MYSB;      498.4685279 6.422871945 224
                               transcript variant 8,
                               mRNA.
                                                 119

                                    Homo sapiens MOB 1,   FLJ13204
                               MOK2 Mps One Binder           J296
  940630 NM_024761.3    MOBK2       kinase activator-like   LJ23916;    393.0116751   3.772500617   224
                           B2B          (yeast)           MGC3296
                                    (MOBKL2B), mRNA.      MGC32960
                                    Homo sapiens POU
                                    class 5 homeobox 1    POU5FLC8;
 6450746 NR_002304.1    POU5FiPi    pseudogene 1          OTF3C;        13697.71506   22.98300036   223
                                    (POU5FiPi), non-      OTF3P1
                                    coding RNA.
                                    Homo sapiens claudin
 6650477 NM 006984.3    CLDN1O      10 (CLDN1O),          CPETRL3;      871.7714044   7.677294001   223
                                    transcript variant 2, OSP-L
                                    mRNA.
                                    Homo sapiens
                                    Cbp/p300-interacting
 5290711 NM_004143.2    CITED1      transactivator, with  MSG1          280.2225888   2.432946407   222
                                    Glu/Asp-rich carboxy
                                    terminal domain, 1
                                    (CITED 1), mRNA.
                                    Homo sapiens          MGC54284;
                                    glycoprotein M6B      MG524
 2760228 NM_001001994.1 GPM6B       (GPM6B), transcript   M6B;          501.0681895   4.696881295   221
                                    variant 4, mRNA.      MGC17150
                                                          MGC 111022
                                                          ; IGDS; RS;
                                                          IDG2;
                                                          RIEG;
                                    Homo sapiens paired-  PTX2;
 2450307 NM_000325.5    PITX2       like homeodomain 2    IGDS2;       445.4820643    4.071059972   221
                                    (PITX2), transcript   Brxl; ARPI;
                                    variant 3, mRNA.      RIEGI;
                                                          IHG2;
                                                          IRID2; RGS;
                                                          Otlx2;
                                                          MGC20144
                                    Homo sapiens
                                                          APC7;
                                    scavenger receptor
                                                          MSLR1;
 6250349 NM_182826.1    SCARA3      class A, member 3     MSRL1        433.1906937    2.811591852   221
                                    (SCARA3), transcript  CSR; CSR1
                                    variant 2, mRNA.
                                             14SKEL15Z P6
                        Symbol      Definition            Synonyms    RFUs          Fold over Ave. Filter
ProbelD  RefSeq_ID
                                                                                                   Score
                                    Homo sapiens
 2230241 NM_000129.3    F13A1       coagulation factor    F13A         440.5475465    6.112055101   250
                                    XIII, Al polypeptide
                                    (F13A1), mRNA.
                                    Homo sapiens LIM
 6860762 NM 020204.2    LHX9        homeobox 9 (LHX9),                 459.7507614    7.368919399   247
                                    transcript variant 1,
                                    mRNA.
                                    Homo sapiens FYVE,
                                    RhoGEF and PH         MGC 117260
 5270619 NM_033086.2    FGD3        domain containing 3   ; FLJ00004;   344.2062606    4.07360582   247
                                    (FGD3), transcript    ZFYVE5
                                    variant 2, mRNA.
                                    Homo sapiens paired-  PMX2B
 6940400 NM 003924.2    PHOX2B      like homeobox 2b      NBPhox        2197.065821   31.28930823   245
                                    (PHOX2B), mRNA.
                                    Homo sapiens
                                    ribonuclease, RNase
 2640068 NM_002934.2    RNASE2      A family, 2 (liver    EDN; RNS2     988.8883249   14.31029425   245
                                    eosinophil-derive
                                    neurotoxin)
                                    (RNASE2), mRNA.
                                    Homo sapiens gastrin- proGRP;
 1400053 NM 001012513.1 GRP         releasing peptide     GRP-10;       518.7756345     6.58403531  245
                                    (GRP), transcript     BN;
                                    variant 3, mRNA.      preproGRP
 6420113 NM080723       NRSN           uensin 1 NRSN1),   p24; VMP      266.6759729   3.305143312   245
                                                    120

                                mRNA.
                                Homo sapiens
                                                       LEC3
1170739 NM_015236.3     LPHN3   latrophilin 3          CIRL3       250.6325719 3.211583828  244
                                (LPHN3), mRNA.
                                Homo sapiens family
                                with sequence
                                similarity 19          TAFA-1;
2230088 NM_213609.2     FAM19A1 (chemokine (C-C        TAFAI       861.2979695 11.97345535  243
                                motif)-like), member
                                Al (FAM19A1),
                                mRNA.
                                Homo sapiens matrix    MGC138506
4760626 NM 002426.2     MMP12   metallopeptidase 12     MME;       252.8263113   3.28554996 243
                                (macrophage elastase)
                                (MMP12), mRNA.
                                Homo sapiens
                                transcription factor
7320471 NM_003221.3     TFAP2B  AP-2 beta (activating  MGC21381;
             73041 M 032.3
                        TFP23     nanerbidig           AP-2B3;     220.2191201 2.156422627  243
                                enhancer binding       AP2-B
                                protein 2 beta)
                                (TFAP2B), mRNA.
                                Homo sapiens gastrin-  proGRP;
 160500 NM 001012513.1  GRP     releasing peptide      GRP-10;     1784.910998 18.93697685  242
                                (GRP), transcript      BN;
                                variant 3, mRNA.       preproGRP
                                Homo sapiens           LGMD1A;
1400392 NM 006790.1     MYOT    myotilin (MYOT),       LGMD1;      456.4598985 5.810367443  241
                                mRNA.                  TTID
                                Homo sapiens
4880138 NM 000905.2     NPY     neuropeptide Y         PYY4        421.7678511 2.660114767  241
                                (NPY), mRNA.
                                                       DKFZp434A
                                Homo sapiens elastin   2410;
2850075 NM_052846.1     EMILIN3 microfibril interfacer dJ620E11.4; 810.0241963 10.52062085  239
                                3 (EMILIN3), mRNA.     C20orfl3O;
                                                       EMILIN5
                                Homo sapiens myosin
                                binding protein C,     slow-type;
 840017 NM 206819.1     MYBPCl  slow type (MYBPC1),    MYBPCS;     285.7054992   2.92608853 239
                                transcript variant 2,  MYBPCC
                                mRNA.
                                Homo sapiens myosin
                                binding protein C,     slow-type;
5910056 NM_206821.1     MYBPCl  slow type (MYBPC1),    MYBPCS;     254.1605753 2.526152268  239
                                transcript variant 4,  MYBPCC
                                mRNA.
                                Homo sapiens NK2       NKX2B;
7610441 NM_002509.2     NKX2-2  homeobox 2 (NKX2-      NKX2.2      3219.130795 18.11879361  238
                                2), mRNA.
                                Homo sapiens CD36      GPIV; FAT;
                                molecule
                                                       GP3B
1010592 NM_001001548.1  CD36    (thrombospondin        CHDS7;      635.4603215 6.118721239  238
                                receptor) (CD36),      SCARB3;
                                transcript variant 1,  PASIV; GP4
                                mRNA.
                                Homo sapiens
                                                       LEC3;
6620369 NM_015236.3     LPHN3   latrophilin 3          CIRL        305.8598985 3.686628763  238
                                (LPHN3), mRNA.
                                Homo sapiens eyes
                                absent homolog 4       CMD1J;
6760725 NM 172105.2     EYA4    (Drosophila) (EYA4)'   DFNA1O      339.2258037 3.839175522  237
                                transcript variant 4,
                                mRNA.
                                Homo sapiens           HBGR;
                                glutamate receptor,    GLURA;
1190592 NM_000827.2     GRIAl   glutrceptor'           GLUHI;      262.4681049 2.776812001  237
                                ionotropic, AMPA 1
                                                       GLURI;
                                (GRIA1), mRNA.         MGC133252
                                             m         SCYB 13;
                                Homo sapiens           ANGIE;
                                chemokine (C-X-C       BCAl;
1110564 NM 006419.1     CXCL13  motif) ligand 13 (B-   ANGI2;      4686.629611 38.84647974  236
                                cell chemoattractant)
                                                       BCA-1;
                                (CXCL13), mRNA.        BLR1L;
                                                121

                                                      BLC
                               Homo sapiens eyes
                               absent homolog 4       CMD1J
2350139 NM 004100.3    EYA4    (Drosophila) (EYA4),   DFNA1      548.1777496 6.846718652 235
                               transcript variant 1,
                               mRNA.
                               Homo sapiens solute
                               carrier family 10
7000176 NM_152679.2    SLC1OA4 (sodium/bile acid      MGC29802;  342.5005076 3.895153565 235
                               cotransporter family), P4
                               member 4
                               (SLC10A4), mRNA.
                               Homo sapiens cyclic
                               AMP-regulated
7160437 NM_001025068.1 ARPP-21 phosphoprotein, 21     FLJ32997   252.2692047 2.565160902 234
                               kD (ARPP-21),
                               transcript variant 3,
                               mRNA.
                               Homo sapiens eyes
                               absent homolog 4
                                                      CMD1J
1260180 NM 004100.3    EYA4    (Drosophila) (EYA4),   DFNA1      1118.943824 10.01733677 233
                               transcript variant 1,
                               mRNA.
                               Homo sapiens solute
                               carrier family 22
                                                      EMT;
6200333 NM 021977.2    SLC22A3 (extraneuronal         OCT3;       258.298308 2.587765331 233
                  --           monoamine              EMTH
                               transporter), member
                               3 (SLC22A3), mRNA.
                               Homo sapiens C-type
7320348 NM 016511.2    CLEC1A  lectin     main family CLEC328     958.858714 12.06609307 232
                               (CLEC1A), mRNA.
                               Homo sapiens ADP
7040497 NM 001179.3    ART3    ribosyltransferase 3              1167.680711 10.78026278 232
                               (ART3), mRNA.
                               Homo sapiens           KIAA1263;
1070162 NM_020116.2    FSTL5   follistatin-like 5     DKFZp566D  271.7681895 2.665514793 232
                               (FSTL5), mRNA.         234
                               Homo sapiens CD36      GPIV; FAT;
                               molecule
                                                      GP3B
3310538 NM_000072.2    CD36    (thrombospondin        CHDS7;      993.442978 7.672567389 229
                               receptor) (CD36)'      SCARB3;
                               transcript variant 3,  PASIV; GP4
                               mRNA.
                               Homo sapiens           GTH1;
1090561 NM_145740.2    GSTA1     tanferase              GC331939 404.4903553 3.933497792 229
                               (GSTA1), mRNA.           GSTAl-1
                               Homo sapiens
                               neurotrophic tyrosine  GP145
3870246 NM_001007097.1 NTRK2   kinase, receptor, type TrkB; TRKB 597.5196277  4.31181459 228
                               2 (NTRK2), transcript
                               variant b, mRNA.
                               Homo sapiens           ABCDS;
                               endothelin receptor    HSCR2;
3840465 NM_003991.1    EDNRB   type B (EDNRB)'        ETRB;      289.7688663 2.311080545 228
                               transcript variant 2,  HSCR; ETB
                               mRNA.
                               Homo sapiens
                               neurotrophic tyrosine  GP145
 430102 NM_001018065.1 NTRK2   kinase, receptor, type TrkB; TRKB 599.1159052 3.962377767 227
                               2 (NTRK2), transcript
                               variant d, mRNA.
                               Homo sapiens
                                                      KV4.2;
                               potassium voltage-     MGC119703
7210180 NM_012281.2    KCND2   gated channel, Shal-   : RK5:     310.3406091 3.197940639 226
                               related subfamily,     KIAA1044;
                               member 2 (KCND2),      MGC119702
                               mRNA.
                                                122

                                 Homo sapiens cyclic
                                 AMP-regulated
 7210554 NM_016300.4    ARPP-21  phosphoprotein, 21     FLJ32997    325.6401015   3.182153825   226
                                 kD (ARPP-21),
                                 transcript variant 1,
                                 mRNA.
                                 Homo sapiens           FMR2;
 2030445 NM 002025.2    AFF2     AF4/FMR2 family,       MRX2;       271.2492386   2.567286962   226
                                 member 2 (AFF2),       0X19;
                                 mRNA.                  FRAXE
                                                        OTF4;
                                 Homo sapiens POU       OCT3;
  770615 NM_002701.4    POU5F1   cU5F ) tranript          GOCT4;    7959.854484     11.6320656  225
                                 variant 1, mRNA.       OTF3
                                 Homo sapiens           Hox-2.4;
  870524 NM_024016.3    HOXB8    homeobox B8            HOX2;       1165.569543     5.91984496  225
                                 (HOXB 8), mRNA.        HOX2D
                                                        RHOM3;
                                 Homo sapiens LIM       Rhom-3;
                                 domain only 3          RBTNL2;
 5360301 NM_018640.3    LMO3     (rhombotin-like 2)     RBTN3-;     363.6567682   2.850703502   225
                                 (LMO3), transcript     DAT1;
                                 variant 1, mRNA.       MGC26081
                                 Homo sapiens major     HLA
                        HLA-     histocompatibility     DRB1*;
 5260484 NM_002124.1    DRB1     complex, class II, DR  HLA-DR1B;    451.157022      2.5979981  225
                                 beta 1 (HLA-DRB1),     HLA DRB1;
                                 mRNA.                  DRB1
                                 Homo sapiens calcium
                                 channel, voltage-      CACNLB2;
 2850458 NM_201572.1    CACNB2   dependent, aB2),       MYSB;       366.9722504   4.464714159   224
                                 transcript variant 8,
                                 mRNA.
                                 Homo sapiens solute
                                 carrier family 2
                                 (facilitated glucose   GLUTX
 3930546 NM 001001290.1 SLC2A9   transporter), member   GLUT9      463.7666667    4.431645646   224
                                 9 (SLC2A9),
                                 transcript variant 2,
                                 mRNA.
                                 Homo sapiens
                                 phosphatidic acid
 7000181 NM_001037317.1 PAP2D    phosphatase type 2     PAP2        277.1762267   2.906158666   224
                                 (PAP2D), transcript
                                 variant 1, mRNA.
                                 Homo sapiens POU
                                 class 5 homeobox 1     POU5FLC8;
 6450746 NR_002304.1    POU5FiPi pseudogene 1           OTF3C;      9294.629103   15.27374289   223
                                 (POU5FiPi), non-       OTF3P1
                                 coding RNA.
                                 Homo sapiens claudin
 6650477 NM 006984.3    CLDN1O   10 (CLDN1O),           CPETRL3;    1256.821151   11.50993847   223
                                 transcript variant 2,  OSP-L
                                 mRNA.
                                           14SKEL18X P6
                        Symbol   Definition             Synonyms  RFUs          Fold over Ave. Filter
ProbelD  RefSeqID
                                                                                               Score
                                 Homo sapiens ankyrin   FLJ36178
 2480040 NM_001010925.2 ANKRD19  repeat domain 19       bA526D8.2   359.6522843   5.188399301   251
                                 (ANKRD19), mRNA.
                                 Homo sapiens EGF
                                 like, fibronectin type AGRINL;
 5820402 NM_182801.1    EGFLAM   dII an   la(    LAM)'  AGRNL;      533.0456853   6.541888158   250
                                 transcript variant 4,
                                 mRNA.
                                 Homo sapiens           GLUR5;
 1260370 NM 175611.2    GRIKI    glutamate receptor,    EEA3;       199.6889171   2.120302394   248
                                 ionotropic, kainate 1  GLR5;
                                 (GRIKI), transcript    EAA3
                                                  123

                                variant 2, mRNA.
                                Homo sapiens
                                                      LEC3
1170739 NM_015236.3    LPHN3    latrophilin 3         CIRL3     202.4005922 2.401102476  244
                                (LPHN3), mRNA.
                                Homo sapiens copine   MGC15604;
2120064 NM_130808.1    CPNE4    IV (CPNE4), mRNA.     COPN4;    980.1950085 15.17169906  243
                                                      CPN4
                                Homo sapiens
3450544 NM_138569.2    C6orfl42 chromosome 6 open     MGC18257  546.9849408   8.36846251 243
                                reading frame 142
                                (C6orfl42), mRNA.
                                Homo sapiens matrix   MGC138506
4760626 NM 002426.2    MMP12    metallopeptidase 12    MME;     332.3773266 4.633984971  243
                                (macrophage elastase)
                                (MMP12), mRNA
                                Homo sapiens major
                       HLA-     histocompatibility    D6S221E7
4900731 NM_002118.3    DMB      complex, class II, DM RING7     669.7582064 7.661512105  241
                                beta (HLA-DMB),
                                mRNA.
                                Homo sapiens NK2      NKX2B;
7610441 NM 002509.2    NKX2-2   homeobox 2 (NKX2-     NKX2.2    3485.537394 19.70101351  238
                                2), mRNA.
                                Homo sapiens
                                                      LEC3
6620369 NM_015236.3    LPHN3    latrophilin 3         CIRL3     321.4711506 3.925836791  238
                                (LPHN3), mRNA.
                                                      SCYB 13;
                                Homo sapiens          ANGIE;
                                chemokine (C-X-C      BCAl;
1110564 NM 006419.1    CXCL13   motif) ligand 13 (B-  ANGIE2;   5484.610152 45.63103882  236
                                cell chemoattractant) BCA-1;
                                (CXCL13), mRNA.       BLR1L;
                                                      BLC
                                Homo sapiens eyes
                                absent homolog 4      CMD1J
2350139 NM 004100.3    EYA4     (Drosophila) (EYA4),  DFNA1     346.9730964 3.966637682  235
                                transcript variant 1,
                                mRNA.
                                Homo sapiens
4220674 NM 152709.3    STOXI    storkhead box 1       PEE4;     620.9840102 8.102938452  234
                                (STOXI), transcript   ClOorf24
                                variant 1, mRNA.
                                Homo sapiens family
                                with sequence         FLJ30158;
                                similarity 107,
                                                      DRR1;
5390463 NM_001076778.1 FAM107A  member A              TU3A-      1172.72775 12.43732892  233
                                (FAM107A),            FLJ45473
                                transcript variant 2,
                                mRNA.
                                Homo sapiens kelch
4060100 NM 006063.2    KBTBD1O  repeat and BTB (POZ)  SARCOSIN  746.1352792 7.630117274  233
                                domain containing 10
                                (KBTBD1O), mRNA.
                                Homo sapiens eyes
                                absent homolog 4      CMD1J
1260180 NM 004100.3    EYA4     (Drosophila) (EYA4),  DFNA1     703.8910321 5.930646904  233
                                transcript variant 1,
                                mRNA.
                                Homo sapiens solute
                                carrier family 22
                                                      EMT;
6200333 NM 021977.2    SLC22A3  (extraneuronal        OCT3;     496.9555838 5.902716586  233
                  --            monoamine             EMTH
                                transporter), member
                                3 (SLC22A3), mRNA.
                                                      C20orfl7;
                                                      OVC10-2;
                                                      TSH2;
                                Homo sapiens teashirt ZNF218
4890292 NM_173485.4    TSHZ2    zinc finger homeobox  FLJ33887- 449.3137056 3.151526978  233
                                2 (TSHZ2), mRNA.      DKFZp686K
                                                      2480;
                                                      ZABC2
                                                124

                                 Homo sapiens           KIAA1263;
1070162 NM_020116.2     FSTL5    follistatin-like 5     DKFZp566D   1038.350761 13.00491383 232
                                 (FSTL5), mRNA.         234
                                 Homo sapiens C-type
7320348 NM 016511.2     CLEC1A   lectin     main family CLEC328     407.8927242 4.558237329 232
                                 (CLEC1A), mRNA.
                                                        FTF: B1F2;
                                 Homo sapiens nuclear   FTZ-FEbeta;
                                 receptor subfamily 5,   BEF lBE
4120408 NM_003822.3     NR5A2    group A, member 2      2; LRH-1-   276.1617597 3.076987614 231
                                 (NR5A2), transcript    BF; :TZ
                                 variant 2, mRNA.         F; CPF
                                 Homo sapiens SRY
3310037 NM 005634.2     SOX3     (sex determining       SOXB;        523.942132 3.185682606 229
                                 region Y)-box 3        MRGH
                                 (SOX3), mRNA.
                                                        ASP;
                                 Homo sapiens agouti    MGC126092
                                 signaling protein,     ; SHEP9;
3460474 NM_001672.2     ASIP     nonagouti homolog      AGTIL;      298.8708122 3.121804793 229
                                 (mouse) (ASIP),        MGC126093
                                 mRNA.                  ; AGSW;
                                                        AGTI
                                 Homo sapiens LEM
3180615 NM_001001552.3  LEMD1    domain containing 1    LEMP-1      246.1758037 2.288059176 228
                                 (LEMD 1), mRNA.
                                 Homo sapiens
                                                        OPN1;
4810482 NM_002547.1     OPHN1    oligophrenin 1         MRX60       265.1473773 2.256012172 227
                                 (OPHN1), mRNA.
                                 Homo sapiens tumor
                                 necrosis factor        TAJ: TAJ
                        TNERSE1  receptor superfamily,  alpha
5860088 NM_018647.2              member 19                aI;        491.405753 6.185357859 226
                                 (TNFRSF19),            TRADE;
                                 transcript variant 1,  TROY
                                 mRNA.
                                                        OTF4
                                 Homo sapiens POU
                                                        OCT3;
 770615 NM_002701.4     POU5F1   cU5F ) tranript           GOCT4;   9603.588832 14.24062587 225
                                 variant 1, mRNA.       OTF3
                                 Homo sapiens calcium
                                 channel, voltage-      CACNLB2;
2850458 NM_201572.1     CACNB2   dependent, b2                  43  291.1939086 3.336271949 224
                                 subunit (CACNB32),     ELJ23743
                                 transcript variant 8,
                                 mRNA.
                                 Homo sapiens MOB 1,    FLJ13204;
                        MOBKL2   Mps One Binder         FLJ23916;     6.062     2.5434       2
 940630 NM_024761.3       BK     kinase activator-like  MOB3B;       268.001692 2.254453549 224
         94060 N_027613 B2B           (yeast)           MGC32960
                                 (MOBKL2B), mRNA.
                                 Homo sapiens POU
                                 class 5 homeobox 1     POU5FLC8;
6450746 NR_002304.1     POU5F1Pi pseudogene 1           OTF3C;       8934.08731 14.64247892 223
                                 (POU5F1Pi), non-       OTF3P1
                                 coding RNA.
                                 Homo sapiens           MGC54284;
                                 glycoprotein M6B1         GC424
2760228 NM 001001994.1  GPM6B     gycoproteinsM6B.t     M6B;        1369.750931 14.57334634 221
                                 (GPM6B), transcript    MGC17150
                                 variant 4, mRNA.
                                 Homo sapiens T-cell
3130110 NM_153355.2     TCBA1    lymphoma breakpoint    FAM771      351.7424704 4.463403314 220
                                 associated target 1    MGC41924
                                 (TCBA1), mRNA.
                                 Homo sapiens heat
                                 shock transcription
4180289 NM_001538.2     HSF4     factor 4 (HSF4),       CTM         318.9629442 3.015795147 219
                                 transcript variant 1,
                                 mRNA.
                                 Homo sapiens heat
4890274 NM 001040667.1  HSF4     shock transcription    CTM         301.9978003 2.750469569 219
                                 factor 4 (HSE4),
                                 transcript variant 2,
                                                  125

                                mRNA.
                                                      PMEL17;
                                Homo sapiens silver   D12S53E;
 2320373 NM 006928.3    SILV    homolog (mouse)       SIL; SI;      8583.009475     35.8241112  217
                                (SILV), mRNA.         ME20;
                                                      gplOO
                                                      FTF: B1F2;
                                Homo sapiens nuclear  FTZ-Flbeta;
                                receptor subfamily 5, hB1F; hB1F
 7330639 NM_003822.3    NR5A2   group A, member 2     2; LRH-1-     378.2843486   3.902039879   217
                                (NR5A2), transcript   B1;F FTZ
                                variant 2, mRNA.        F; CPF
                                Homo sapiens brain
 5690301 NM 001704.1    BAI3    specific angiogenesis KI1AA05501    2264.844839     27.4289668  213
                                inhibitor 3 (BAI3),   MGC133100
                                mRNA.
                                Homo sapiens
 2260424 NM 006727.2    CDH1O   cadherin 10, type 2                 737.2966159   6.321713796   213
                                (T2-cadherin)
                                (CDH1O), mRNA.
                                                      alpha 2M;
                                                      CPAMD5;
                                Homo sapiens alpha-   S863-7;
 2370438 NM_000014.4    A2M     2-macroglobulin       FWP07;          430.47022   2.947254375   212
                                (A2M), mRNA.          DKFZp779B
                                                      086
                                Homo sapiens          NARP; NP
 6420050 NM_002523.1    NPTX2   neuronal pentraxin II II; NP2       605.2751269   1.942645888   210
                                (NPTX2), mRNA.
                                Homo sapiens actinin, MGC 117002
  830348 NM_001104.1    ACTN3   alpha 3 (ACTN3),      ;             433.5448393   2.648885447   208
                                mRNA.                 MGC 117005
                                Homo sapiens          MGC54284;
                                glycoprotein M6B.     MGC58243
 2630279 NM 001001995.1 GPM6B3  (GPM6B), transcript   M61;         4741.316582    19.48483978   205
                                variant 1, mRNA.      MGC17150
                                Homo sapiens LIM      TTG2;
 3850059 NM 005574.2    LMO2    domain only 2         RBTN2;       4977.640102    34.52136268   204
                                (rhombotin-like 1)    RBTNL1;
                                (LMO2), mRNA.         RHOM2
                                Homo sapiens          SCG1O;
 2030026 NM 007029.2    STMN2   stathmin-like 2       SCGN1O;       1060.256007   3.899915903   204
                                (STMN2), mRNA.        SGC10
                                Homo sapiens family
                                with sequence
                                similarity 134,       FLJ22155;
  270114 NM_001034850.1 FAM134B member B              FLJ20152;     324.0881557   3.396395642   202
                                (FAM134B),            FLJ22179
                                transcript variant 1,
                                mRNA.
                                Homo sapiens          MGC54284;
 3870202 NM_001001995.1 GPM6B    Gc)rotei ansc ipt    M61;          3927.222843   10.05220933   199
                                variant 1, mRNA.
                                Homo sapiens Ca++
                                dependent secretion   KIAA1591
 7160102 NM_017954.9    CADPS2  activator 2 (CADPS2), FLJ481        80
                                                                    893.6523689   6.956803185   199
                                transcript variant 1,
                                mRNA.
                                                      MGC70561;
 1430521 NM 053276.2    VIT     Homo sapiens vitrin   DKFZp313L     310.6416244   2.046705424   198
                                (VLT), mRNA.          1517;
                                                      MGC149746
                                         14SKEL20Z P6
                        Symbol  Definition            Synonyms    RFUs          Fold over Ave. Filter
ProbelD  RefSeqID
                                Homo sapiens          MGC141907
 2640315 NM_004245.2    TGM5    transglutaminase 5    ; TGM6;       322.4014382   4.527626051   251
                                (TGM5), transcript    TGMX;
                                variant 2, mRNA.      TGX
                                                126

                               Homo sapiens
4390403 NM_004042.3    ARSF    arylsulfatase F            ASF         252.3662437 3.725381361  251
                               (ARSF), mRNA.
                               Homo sapiens
2230241 NM 000129.3    F13A1   coagulation factor         F13A        264.7620135   3.27423111 250
                               X111, Al polypeptide
                               (F13A1), mRNA.
                                              .           GPHa;
                               Homo sapiens               TSHA;
                               glycoprotein               FSHA;
2350730 NM_000735.2    CGA     hormones, alpha            LHA;        289.5708968 3.124125522  248
                               polypeptide (CGA),         GPHA1;
                               mRNA.                      CG-ALPHA
                               Homo sapiens FYVE,
                               RhoGEF and PH              MGC 117260
5270619 NM_033086.2    FGD3    domain containing 3        ; FLJ00004; 2125.546531 30.33059008  247
                               (FGD3), transcript         ZFYVE5
                               variant 2, mRNA.
                               Homo sapiens
6420113 NM_080723.3    NRSN1   neurensin 1 (NRSN1),       p24; VMP    2742.191709 43.26918618  245
                               mRNA.
                               Homo sapiens
 670707 NM 182532.1    TMEM61  transmembrane                          426.8898477 5.866918726  245
                               protein 61
                               (TMEM61), mRNA.
                               Homo sapiens gastrin-      proGRP;
1400053 NM 001012513.1 GRP     releasing peptide          GRP-10;     417.9384095 5.109885361  245
                               (GRP), transcript          BN;
                               variant 3, mRNA.           preproGRP
                               Homo sapiens
                                                          LEC3
1170739 NM_015236.3    LPHN3   latrophilin 3              CIRL3       214.8902707 2.610976746  244
                               (LPHN3), mRNA.
                               Homo sapiens matrix        MGC138506
4760626 NM 002426.2    MMP12   metallopeptidase 12          MME;      343.4598139 4.821839443  243
                               (macrophage elastase)      H
                               (MMP12), mRNA.               ME
                               Homo sapiens family
                               with sequence
                               similarity 19              TAFA-1
2230088 NM_213609.2    FAM19A1 (chemokine (C-C            TAFA-1I     377.1337563 4.680644936  243
                               motif)-like), member
                               Al (FAM19A1),
                               mRNA.
                               Homo sapiens gastrin-      proGRP;
 160500 NM 001012513.1 GRP     releasing peptide          GRP-10;     1558.146531 16.40407861  242
                               (GRP), transcript          BN;
                               variant 3, mRNA.           preproGRP
                               Homo sapiens unc-13
1660152 NM 001080534.1 UNC13C  homolog (C.                DKFZp547H   288.2288494 3.664928424  242
                               elegans) (UNC13C),         074
                               mRNA.
                                              .           TAILl;
                               Homo sapiens               MGC119416
                               thrombospondin, type
2370056 NM 199296.1    THSD3   I, domain containing 3                 241.4720812 2.634228001  242
                               (THSD3), transcript        0215;
                               variant 1, mRNA.           FLJ32147
                                                          SP-40;
                                                          MGC24903;
                                              .           CLI: APOJ;
                               Homo sapiens               S    P
                               clusterin (CLU),           SGP-2;
2120670 NM 203339.1    CLU     clusterin (CLU)'           TRPM-2;     194.7063452 2.075885335  242
                               transcript variant 2,
                                                          AAG4;
                               mRNA.
                                                          TRPM2;
                                                          KUB1;
                                                          SGP2
                               Homo sapiens
4880138 NM 000905.2    NPY     neuropeptide Y             PYY4        1119.913029 8.718640725  241
                               (NPY), mRNA.
                                          m       sHSD26;
                               Homo sapiens               LL37;
5860075 NM 004345.3    CAMP    cathelicidin               FALL39;     188.0182741 2.084478584  241
                 --            antimicrobial peptide      FALL-39'
                               (CAMP), mRNA.              CAP18
                                                127

                                                       DKFZp434A
                                Homo sapiens elastin   2410;
2850075 NM_052846.1     EMILIN3 microfibril interfacer dJ620E11.4; 330.1922166 3.696179884  239
                                3 (EMILIN3), mRNA.     C20orfl3O;
                                                       EMILIN5
                                                       PSD-93;
                                                       DKFZp781E
                                Homo sapiens discs,    0954;
                                large homolog 2,       FLJ37266
1170048 NM_001364.2     DLG2    chapsyn-110            MGC31811     262.294247 2.999422126  239
                                (Drosophila) (DLG2),   MGC13181
                                mRNA.
                                                       DKEZp781D
                                                       1854
                                Homo sapiens NK2       NKX2B;
7610441 NM_002509.2     NKX2-2  homeobox 2 (NKX2-      NKX2.2      5007.687986 28.74124358  238
                                2), mRNA.
                                Homo sapiens
                                                       LEC3
6620369 NM_015236.3     LPHN3   latrophilin 3          CIRL        281.5400169 3.313980184  238
                                (LPHN3), mRNA.
                                Homo sapiens CD36      GPIV; FAT;
                                molecule
                                                       GP3B
1010592 NM_001001548.1  CD36    (thrombospondin        CHDS7;      307.7571912 2.447638789  238
                                receptor) (CD36),      SCARB3;
                                transcript variant 1,  PASIV; GP4
                                mRNA.
                                Homo sapiens
                                RALBP1 associated
6040673 NM 004726.2     REPS2   Eps domain             POBI        213.0592217 1.974378542  238
                                containing 2 (REPS2),
                                transcript variant 1,
                                mRNA.
                                Homo sapiens
1820315 NM 178497.2     C4orf26 chromosome 4 open      FLJ23657    590.8124365 7.871936118  237
                                reading frame 26
                                (C4orf26), mRNA.
                                Homo sapiens eyes
                                absent homolog 4       CMD1J;
6760725 NM 172105.2     EYA4    (Drosophila) (EYA4)'   DFNA1O      275.4266497 2.929058129  237
                                transcript variant 4,
                                mRNA.
                                Homo sapiens Fas
5270520 NM005449.3      FAIM3   amolpetotic inh        TOSO        261.0450931 2.768401968  237
                                mRNA.
                                Homo sapiens           HBGR;
1190592 NM_000827.2     GRIAl   glutamate receptor     GLURA;
                        GRAI
             11052 M 002.2      iooroic APAl           GLUHI;       223.508714 2.216201808  237
                                ionotropic, AMPA 1     GLUR1
                                (GRIA1), mRNA.         MGC133252
                                                       SCYB 13;
                                Homo sapiens           ANGIE;
                                chemokine (C-X-C       BCAl;
1110564 NM 006419.1     CXCL13  motif) ligand 13 (B-   ANGIE2;     1855.520812 14.77593678  236
                                cell chemoattractant)  BCA-1;
                                (CXCL13), mRNA.        BLR1L;
                                                       BLC
                                Homo sapiens
                                carcinoembryonic
                                antigen-related cell
5700753 NM_001024912.1  CEACAM  adhesion molecule 1    BGPI; BGP;  321.3001692   3.87727076 236
                         1      (biliary glycoprotein) BGP1
                                (CEACAMI),
                                transcript variant 2,
                                mRNA.
                                Homo sapiens
5570170 NM 002686.2     PNMT    phenylethanolamine     PENT        291.4395939 2.965819489  236
                                N-methyltransferase
                                (PNMT), mRNA.
                                Homo sapiens eyes
                                absent homolog 4       CMD1J
2350139 NM 004100.3     EYA4    (Drosophila) (EYA4),   DFNA1       392.9013536 4.624063331  235
                                transcript variant 1,
                                mRNA.
                                                128

                                                           PSTS;
                                                           MGC116827
                                  Homo sapiens              ; KLK-L1;
5290707 NM_004917.3      KLK4     kallikrein-related       ARM1;        1017.200508 4.866990617 234
                                  peptidase 4 (KLK4),      PRSS17;
                                  mRNA.                    MGC116828
                                                            ; EMSP;
                                                           EMSP1
                                  Homo sapiens eyes
                                  absent homolog 4         CMD1J
1260180 NM 004100.3      EYA4     (Drosophila) (EYA4),     DFNA1        850.9565144 7.378682016 233
                                  transcript variant 1,
                                  mRNA.
                                  Homo sapiens             KIAA1263;
1070162 NM_020116.2      FSTL5    follistatin-like 5       DKFZp566D    227.3607445 2.066562624 232
                                  (FSTL5), mRNA.           234
                                  Homo sapiens GTP         DYT5; GTP
1010360 NM 001024070.1   GCH1     cyclohydrolase 1         CH-1;        275.8187817 3.381879435 230
                                  (GCH1), transcript       GTPCH1;
                                  variant 3, mRNA.         GCH
                                  Homo sapiens             GTH1;
1090561 NM_145740.2      GSTA1      tanferase                  GC331939 731.4600677 7.921489922 229
                                  (GSTA1), mRNA.            ; GSTAl-1
                                                            tendin;
                                               m     sCHM1L;
 290445 NM_022144.1      TNMD     tenomodulin              BRICD4;      434.3483926 3.253058383 229
                                  (TNMD), mRNA.             myodulin;
                                                            CHM1-LIKE
                                  Homo sapiens
                                  neurotrophic tyrosine
                                                           GP145
3870246 NM_001007097.1   NTRK2    kinase, receptor, type   TrkB; TRKB    425.414044 2.781834807 228
                                  2 (NTRK2), transcript
                                  variant b, mRNA.
                                  Homo sapiens
                                  neurotrophic tyrosine     GP145
 430102 NM_001018065.1   NTRK2    kinase, receptor, type    TrkB; TRKB  462.4351946 2.830274089 227
                                  2 (NTRK2), transcript
                                  variant d, mRNA.
                                                            OTF4;
                                  Homo sapiens POU          OCT3
 770615 NM_002701.4      POU5F1   cU5F ) tranript              GOCT4;    7939.72758 11.60012477 225
                                  variant 1, mRNA.         OTF3
                                  Homo sapiens              Hox-2.4;
 870524 NM_024016.3      HOXB8    homeobox B8               HOX2;       1959.584433 10.63381502 225
                                  (HOXB8), mRNA.            HOX2D
                                  Homo sapiens MOB 1,      FLJ13204;
                         MOBKL2   Mps One Binder           FLJ23916;     2.717       .9864       2
 940630 NM_024761.3        BK     kinase activator-like    MOB3B;       427.8771574 4.195886349 224
         94060  N_027613 B2B           (yeast)             MGC32960
                                  (MOBKL2B), mRNA.
                                  Homo sapiens calcium
                                  channel, voltage-        CACNLB2;
2850458 NM_201572.1      CACNB2   dep     dent, aB2),      MYSB;        293.2337563 3.366648046 224
                                  transcript variant 8,
                                  mRNA.
                                  Homo sapiens POU
                                  class 5 homeobox 1       POU5FLC8;
6450746 NR_002304.1      POU5F1P1 pseudogene 1             OTF3C;       8719.425381 14.26663251 223
                                  (POU5F1Pi), non-         OTF3P1
                                  coding RNA.
                                  Homo sapiens claudin
6650477 NM 006984.3      CLDN1O   10 (CLDN1O),             CPETRL3;     827.6888325 7.238512189 223
                                  transcript variant 2,    OSP-L
                                  mRNA.
                                                   129

                                                       MGC 111022
                                                       ; IGDS; RS;
                                                       IDG2;
                                                       RIEG;
                                Homo sapiens paired-   PTX2;
 2450307 NM_000325.5    PITX2   like homeodomain 2     IGDS2;         463.842555   4.280063111   221
                                (PITX2), transcript    Brxl; ARPI;
                                variant 3, mRNA.       RIEGI;
                                                       IHG2;
                                                       IRID2; RGS;
                                                       Otlx2;
                                                       MGC20144
                                Homo sapiens
                                                       APC7;
                                scavenger receptor     MSLR1;
 6250349 NM_182826.1    SCARA3  class A, member 3      MSRL1462.7282572            3.071489254   221
                                (SCARA3), transcript   CSR; CSR1
                                variant 2, mRNA.
                                Homo sapiens Rho
                        ARHGAP2 GTPase activating      KIAA1391;
 6480593 NM 020809.2    0       protein 20             RARHOGA         302.63511   2.853079344   219
                                (ARHGAP20),            P
                                mRNA.
                                         14SKEL24Z P6
                        Symbol  Definition             Synonyms    RFUs          Fold over Ave. Filter
ProbelD  RefSeq_ID
                                                                                                Score
                                Homo sapiens major
                                histocompatibility     MGC117330
                        HLA-
 1770504 NM_022555.3    DRB3    complex, class II, DR  ;HLA-          277.680203   3.411303809   247
                                beta 3 (HLA-DRB3),     DR3B
                                mRNA.
                                Homo sapiens gastrin-  proGRP;
 1400053 NM 001012513.1 GRP     releasing peptide      GRP-10;       1422.990948   19.80285363   245
                                (GRP), transcript      BN;
                                variant 3, mRNA.       preproGRP
                                Homo sapiens paired-   PMX2B;
 6940400 NM 003924.2    PHOX2B  like homeobox 2b       NBPhox        1270.518274   17.67224722   245
                                (PHOX2B), mRNA.
                                Homo sapiens
 6420113 NM_080723.3    NRSN1   neurensin 1 (NRSN1),   p24; VMP       348.634687   4.628262173   245
                                mRNA.
                                Homo sapiens
                                ribonuclease, RNase
 2640068 NM_002934.2    RNASE2  A family, 2 (liver     EDN; RNS2     311.5109983   3.822915719   245
                                eosinophil-derive
                                neurotoxin)
                                (RNASE2), mRNA.
                                Homo sapiens
  670707 NM 182532.1    TMEM61  transmembrane                        230.0771574   2.701004249   245
                                protein 61
                                (TMEM61), mRNA.
                                Homo sapiens solute    MGC126299
                                carrier family 5
 1010097 NM_021815.2    SLC5A7  (choline transporter), MGC126300     381.1639594   5.549348396   244
                                member 7 (SLC5A7),     ; CHT1;
                                mRNA.                  hCHT; CHT
                                Homo sapiens family
                                with sequence
                                similarity 19          TAFA-1;
 2230088 NM_213609.2    FAM19A1 (chemokine (C-C        TAFAI         797.6087986   11.01412578   243
                                motif)-like), member
                                Al (FAM19A1),
                                mRNA.
                                Homo sapiens matrix    MGC138506
 4760626 NM 002426.2    MMP12   metallopeptidase 12     MME;         677.6341794   10.48628525   243
                                (macrophage elastase)
                                (MMP12), mRNA.
                                Homo sapiens
                                transcription factor
                                AP-2 beta (activating  MGC21381;
 7320471 NM 003221.3    TFAP2B3 enhancer binding       AP-2B;       664.0813875    8.518344803   243
                                protein 2 beta)        AP2-B
                                (TFAP2B), mRNA.
                                                130

                               Homo sapiens gastrin-  proGRP;
 160500 NM 001012513.1 GRP     releasing peptide      GRP-10;    4490.035702 49.15249384  242
                               (GRP), transcript      BN;
                               variant 3, mRNA.       preproGRP
                               Homo sapiens major
                       HLA-    histocompatibility
6370315 NM_002125.3    DRB5    complex, class II, DR  HLA-DRB1   837.2664975 6.387996646  242
                               beta 5 (HLA-DRB5),
                               mRNA.
                               Homo sapiens unc-13
1660152 NM 001080534.1 UNC13C  homolog C (C.          DKFZp547H  326.5530457 4.285198161  242
                               elegans) (UNC13C),     074
                               mRNA.
                               Homo sapiens           LGMD1A;
1400392 NM 006790.1    MYOT    myotilin (MYOT),       LGMD1;     364.8820643 4.444029014  241
                               mRNA.                  TTID
                               Homo sapiens
4880138 NM 000905.2    NPY     neuropeptide Y         PYY4       622.9119289 4.405649444  241
                               (NPY), mRNA.
                               Homo sapiens myosin
                               binding protein C,     slow-type;
 840017 NM 206819.1    MYBPCl  slow type (MYBPC1),    MYBPCS;    519.6189509 6.140464602  239
                               transcript variant 2,  MYBPCC
                               mRNA.
                               Homo sapiens
6270022 NM 002110.2    HCK     hemop      C cell      JTK9       485.8601523   5.90851896 239
                               mRNA.
                               Homo sapiens myosin
                               binding protein C,     slow-type;
5910056 NM_206821.1    MYBPCl  slow type (MYBPC1),    MYBPCS;    364.4626058 4.056451585  239
                               transcript variant 4,  MYBPCC
                               mRNA.
                                                      PSD-93;
                                                      DKFZp781E
                                                      0954;
                               Homo sapiens discs,
                               large homolog 2,       FLJ37266;
1170048 NM_001364.2    DLG2    chapsyn-110            MGC31811    320.407868 3.885529634  239
                               (Drosophila) (DLG2),
                               mRNA.
                                                      DKFZp781D
                                                      1854
                               Homo sapiens NK2       NKX2B;
7610441 NM 002509.2    NKX2-2  homeobox 2 (NKX2-      NKX2.2     3226.681387 18.16363746  238
                               2), mRNA.
                               Homo sapiens
                                                      LEC3;
6620369 NM_015236.3    LPHN3   latrophilin 3          CIRL'      337.6656514  4.17398182  238
                               (LPHN3), mRNA.
                               Homo sapiens eyes
                               absent homolog 4       CMD1J
6760725 NM 172105.2    EYA4    (Drosophila) (EYA4)'   DFNA1O     518.1888325 6.392146136  237
                               transcript variant 4,
                               mRNA.
                               Homo sapiens           HBGR;
1190592 NM_000827.2    GRIAl   glutamate receptor'    GLUH1;     251.2527919 2.615428092  237
                               ionotropic, AMPA 1     GLURI;
                               (GRIA1), mRNA.         MGC133252
                                                      SCYB 13;
                               Homo sapiens           ANGIE;
                               chemokine (C-X-C       BCAl;
1110564 NM 006419.1    CXCL13  motif) ligand 13 (B-   ANGIE2;    1223.904569 9.405833754  236
                               cell chemoattractant)  BCA-1;
                               (CXCL13), mRNA.        BLR1L;
                                                      BLC
                               Homo sapiens heparan
5870435 NM 006043.1    HS3ST2  sulfate (glucosamine)  30ST2;       230.97022 2.353039027  236
                               3-0-sulfotransferase 2 30ST2
                               (HS3ST2), mRNA.
                               Homo sapiens solute
                               carrier family 10
7000176 NM_152679.2    SLC1OA4 (sodium/bile acid      MGC29802;  1430.703892 19.44818942  235
                               cotransporter family), P4
                               member 4
                               (SLC1OA4), mRNA.
                                               131

                                Homo sapiens eyes
                                absent homolog 4       CMD1J
2350139 NM 004100.3    EYA4     (Drosophila) (EYA4),   DFNA1       750.8103215 9.747239118  235
                                transcript variant 1,
                                mRNA.
                                Homo sapiens cyclic
                                AMP-regulated
7160437 NM_001025068.1 ARPP-21  phosphoprotein, 21     FLJ32997    589.5439932 7.331651883  234
                                kD (ARPP-21),
                                transcript variant 3,
                                mRNA.
                                Homo sapiens eyes
                                absent homolog 4       CMD1J
1260180 NM 004100.3    EYA4     (Drosophila) (EYA4),   DFNA1       1724.199831 15.97680418  233
                                transcript variant 1,
                                mRNA.
                                Homo sapiens
                                mesenchyme
3890332 NM_001040002.1 MEOXI    homeobox 1             MOXi        406.2896785 5.733233367  233
                                (MEOXI), transcript
                                variant 3, mRNA.
                                Homo sapiens major
                                histocompatibility
4200725 NR_001298.1    HLA-     complex, class II, DR              449.4566836 3.970459711  232
                       DRB6     beta 6 (pseudogene)
                                (HLA-DRB6), non
                                coding RNA.
                                Homo sapiens C-type
7320348 NM 016511.2    CLEClA   lectin domain family   CLECI;      302.2972927 3.119318628  232
                                1, member A            MGC34328
                                (CLEC1A), mRNA.
                                               ..      S HP-1L:
                                Homo sapiens protein   HCP; SH
                                tyrosine phosphatase,  PTP1; PTP
6400465 NM_080548.3    PTPN6    non-receptor type 6    1C; HCPH;    222.898308 2.054490235  232
                                (PTPN6), transcript    SHP1; SHP
                                variant 2, mRNA.       1; HPTP1C
                                                       FT; B1F2;
                                Homo sapiens nuclear   FTZ-FEbeta;
                                receptor subfamily 5,  hB1F; hB1F
4120408 NM_003822.3    NR5A2    group A, member 2      2; LRH-1;   406.8490694 5.006329835  231
                                (NR5A2), transcript    B1F; FTZ
                                variant 2, mRNA.         F; CPF
                                Homo sapiens
1990661 NM_001010940.1 C9orfl35 chromosome 9 open                  7735.538579 45.39909909  230
                                reading frame 135
                                (C9orf135), mRNA.
                                Homo sapiens           GTHi;
1090561 NM_145740.2    GSTA1    glutathione S-         GST2;       514.3737733 5.273726533  229
                                transferase Al         MGC131939
                                (GSTAi), mRNA.         ; GSTAI-I
                                Homo sapiens
                                neurotrophic tyrosine
                                                       GP145
3870246 NM_001007097.1 NTRK2    kinase, receptor, type TrkB; TRKB  516.8939086   3.59507015 228
                                2 (NTRK2), transcript
                                variant b, mRNA.
                                Homo sapiens
                                neurotrophic tyrosine
                                                       GP145
 430102 NM_001018065.1 NTRK2    kinase, receptor, type TrkB; TRKB  665.0204738 4.508254388  227
                                2 (NTRK2), transcript
                                variant d, mRNA.
                                Homo sapiens cyclic
                                AMP-regulated
7210554 NM_016300.4    ARPP-21  phosphoprotein, 21     FLJ32997    620.5603215 6.969776174  226
                                kD (ARPP-21),
                                transcript variant 1,
                                mRNA.
                                                       OTF4;
                                Homo sapiens POU       OCT3;
 770615 NM_002701.4    POU5F1   class 5 homeobox 1     OCT4;        8934.08731 13.17814575  225
                                (POUFi), transcript    MGC22487;
                                variant 1, mRNA.
                                                       OTF3
                                                 132

                                 Homo sapiens major     HLA
                                 histocompatibility     DRB1*;
                        HLA-
 5260484 NM_002124.1    DRB1     complex, class II, DR  HLA-DR1B;       1241.1511     8.89823738  225
                                 beta 1 (HLA-DRB1),     HLA DRB1;
                                 mRNA.                  DRB1
                                 Homo sapiens
                                 phosphatidic acid
 7000181 NM_001037317.1 PAP2D    phosphatase type 2     PAP2          527.9923858   6.440833067   224
                                 (PAP2D), transcript
                                 variant 1, mRNA.
                                 Homo sapiens calcium
                                 channel, voltage-      CACNLB2;
 2850458 NM_201572.1    CACNB2   dep    dent, aB2),     MYSB;         232.7450931     2.46588987  224
                                 transcript variant 8,
                                 mRNA.
                                 Homo sapiens POU
                                 class 5 homeobox 1     POU5FLC8;
 6450746 NR_002304.1    POU5FiP1 pseudogene 1           OTF3C;        10908.25076     18.0989943  223
                                 (POU5FiPi), non-       OTF3P1
                                 coding RNA.
                                 Homo sapiens claudin
 6650477 NM 006984.3    CLDN1O   10 (CLDN1O),           CPETRL3;      1775.710152   16.67476998   223
                                 transcript variant 2,  OSP-L
                                 mRNA.
                                 Homo sapiens
                                 Cbp/p300-interacting
 5290711 NM_004143.2    CTEDi    transactivator, with   MSG1          245.1505922   2.003286952   222
                                 Glu/Asp-rich carboxy
                                 terminal domain, 1
                                 (CITED 1), mRNA.
                                                        MGC 111022
                                                        ; IGDS; RS;
                                                        IDG2;
                                                        RIEG;
                                 Homo sapiens paired-   PTX2;
 2450307 NM_000325.5    PITX2    like homeodomain 2     IGDS2;         311.378511   2.544517793   221
                                 (PITX2), transcript    Brxl; ARPI;
                                 variant 3, mRNA.       RIEGI;
                                                        IHG2;
                                                        IRID2; RGS;
                                                        Otlx2;
                                                        MGC20144
                                 Homo sapiens           MGC54284;
 2760228 NM_001001994.1 GPM6B     Gc)rotei ansc ipt     M61;          300.6131134   2.417812702   221
                                 variant 4, mRNA.
                                           14SKEL7X P6
                        Symbol   Definition             Synonyms    RFUs          Fold over Ave. Filter
ProbelD  RefSeqID
                                                                                                 Score
                                 Homo sapiens FYVE,
                                 RhoGEF and PH          MGC 117260
 5270619 NM_033086.2    FGD3     domain containing 3    ; FLJ00004;    816.151692   11.03008908   247
                                 (FGD3), transcript     ZFYVE5
                                 variant 2, mRNA.
                                 Homo sapiens action    KIAA1808;
                                 binding LIM       ctin DKFZp761F
 2260471 NM_032432.3    ABLIM2   bidn protein           129;         494.6637902    6.010679852   245
                                 family, member 2       MGC141918
                                 (ABLIM2), mRNA.        ;FL39684
                                 Homo sapiens seizure
                                 related 6 homolog
 6940553 NM 001098635.1 SEZ6     (mouse) (SEZ6),                      2266.439594   29.92365216   244
                                 transcript variant 2,
                                 mRNA.
                                 Homo sapiens
 3450544 NM_138569.2    C6orfl42 chromosome 6 open      MGC18257      296.6964467   4.081656423   243
                                 reading frame 142
                                 (C6orfl42), mRNA.
                                 Homo sapiens           ASTN;
 1990333 NM 004319.1    ASTN1    astrotactin 1          KIAA1747;     339.8981387   4.062577922   239
                                 (ASTN1), transcript    ASTN1
                                                 133

                                variant 1, mRNA.
                                Homo sapiens NK2       NKX2B;
7610441 NM 002509.2    NKX2-2   homeobox 2 (NKX2-      NKX2.2      5631.113706 32.44384171  238
                                2), mRNA.
                                Homo sapiens eyes
                                absent homolog 4
                                                       CMD1J
6760725 NM 172105.2    EYA4     (Drosophila) (EYA4)    DFNA1       165.6005076 1.362349545  237
                                transcript variant 4,
                                mRNA.
                                Homo sapiens eyes
                                absent homolog 4       CMD1J;
2350139 NM 004100.3    EYA4     (Drosophila) (EYA4),   DFNA1       272.2874788 2.897573808  235
                                transcript variant 1,
                                mRNA.
                                Homo sapiens eyes
                                absent homolog 4       CMD1J
1260180 NM 004100.3    EYA4     (Drosophila) (EYA4),   DFNA1       493.6221658 3.860299079  233
                                transcript variant 1,
                                mRNA.
                                Homo sapiens           KIAA1263;
1070162 NM_020116.2    FSTL5    follistatin-like 5     DKFZp566D   2549.290355 33.38394142  232
                                (FSTL5), mRNA.         234
                                Homo sapiens C-type
7320348 NM 016511.2    CLEC1A   lectin     main family CLEC328     190.3830795 1.594295698  232
                                (CLEC1A), mRNA.
                                Homo sapiens low
                                density lipoprotein-   LRPDIT;
3120528 NM_018557.2    LRP1B    related protein lB     LRP-D       169.7130288 1.513481592  232
                                (deleted in tumors)
                                (LRP1B), mRNA.
                                                       FTF: B1F2;
                                Homo sapiens nuclear   FTZ-FEbeta;
                                receptor subfamily 5,  hB1F: hB1E
4120408 NM_003822.3    NR5A2    group A, member 2      2; LRH-1;   186.4107445 1.751989621  231
                                (NR5A2), transcript    Bl; :TZ
                                variant 2, mRNA.         F; CPF
                                Homo sapiens
  50626 NM_015715.3    PLA2G3   phospholipase A2,      GIII-SPLA2, 477.3011844 3.549175966  226
                                group III (PLA2G3),    SPLA2111
                                mRNA.
                                                       OTF4;
                                Homo sapiens POU       OCT3;
 770615 NM_002701.4    POU5F1   cU5F ) tranript           GOCT4;   3084.613029   3.89519428 225
                                variant 1, mRNA.       OTF3
                                Homo sapiens POU
                                class 5 homeobox 1     POU5FLC8;
6450746 NR_002304.1    POU5F1Pi pseudogene 1           OTF3C;      3316.217936 4.806286347  223
                                (POU5F1Pi), non-       OTF3P1
                                coding RNA.
                                Homo sapiens
1450358 NM 000519.3    HBD      hemoglobin, delta                  207.9585448 1.967937448  221
                                (HBD), mRNA.
                                Homo sapiens           LIVIN; ML
                                baculoviral IAP        IAP;
3450347 NM_022161.2    BIRC7    repeat-containing 7    MLIAP;      184.8456853 1.428790724  221
                                (BIRC7), transcript    RNF50;
                                variant 2, mRNA.       KIAP
                                Homo sapiens Rho
                       ARHGAP2  GTPase activating      KIAA1391;
6480593 NM 020809.2    0        protein 20             RARHOGA     355.1510998 3.521700628  219
                                (ARHGAP20),            P
                                mRNA.
                                Homo sapiens heat
                                shock transcription
4180289 NM_001538.2    HSF4     factor 4 (HSF4),       CTM         240.8184433   2.03194322 219
                                transcript variant 1,
                                mRNA.
                                Homo sapiens heat
4890274 NM 001040667.1 HSF4     shock transcription    CTM         191.5365482 1.378666317  219
                                factor 4 (HSE4),
                                transcript variant 2,
                                                 134

                            mRNA.
                                                    FTF; B1F2;
                            Homo sapiens nuclear    FTZ-Flbeta;
                            receptor subfamily 5,   hBiF hBiF
7330639 NM_003822.3 NR5A2   group A, member 2       2; LRH-1;   263.0874788 2.409248407 217
                            (NR5A2), transcript     B1F; FTZ
                            variant 2, mRNA.        F1; CPF
                            Homo sapiens
5720075 NM_003638.1 ITGA8   integrin, alpha 8                   228.4329949 2.215645054 217
                            (ITGA8), mRNA.
                                                    COLA1L;
                            Homo sapiens            MGC26619;
3440747 NM_030820.2 COL21A1 collagen, type XXI,     dJ708F5. 1  223.3902707 1.402853959 214
                            alpha 1 (COL21A1),      DKEZp564B
                            mRNA.                   052;
                                                    dJ682J15.1
                            Homo sapiens brain
5690301 NM 001704.1 BAI3    specific angiogenesis   KIAAO55O1;  342.8615905 3.303694719 213
                            inhibitor 3 (BAI3),     MGC133100
                            mRNA.
                            Homo sapiens
2260424 NM_006727.2 CDH1O   cadherin 10, type 2                 284.0367174 1.820622674 213
                            (T2-cadherin)
                            (CDH1O), mRNA.
                                                    FLJ13288;
                                                    ZC3HDC2;
                                                    FLB6421;
                            Homo sapiens zinc       ZAP;
                            finger CCCH-type,       DKFZp686H
3710243 NM_024625.3 ZC3HAV1 antiviral 1             1869;       321.5152284  2.67624495 212
                            (ZC3HAV1),              DKEZp686O
                            transcript variant 2,   19171;
                            mRNA.                   MGC48898;
                                                    DKFZp686F
                                                    2052;
                                                    ZC3H2
                            Homo sapiens GRB2
5270544 NM_006613.3 GRAP    related adaptor protein MGC64880    196.3899323 1.471251846 212
                            (GRAP), mRNA.
                            Homo sapiens
3400307 NM_015900.1 PLAlA   meosphol       LA),     PSPLA1      224.7513536  2.11003931 210
                            mRNA.
                            Homo sapiens actinin,   MGC 117002
 830348 NM_001104.1 ACTN3   alpha 3 (ACTN3),        ;           384.3610829 2.234935432 208
                            mRNA.                   MGC 117005
                            Homo sapiens            ERp27
 940639 NM_152321.1 ERP27   endoplasmic reticulum   FLJ32115;   596.8041455 6.309864839 206
                            protein 27 kDa          C 12orf46
                            (ERP27), mRNA.
                            Homo sapiens leucine    C14orfl46;
                            rich repeat and         DKFZp686G
 520673 NM_152447.2 LRFN5   fibronectin type III    0210;       447.0818105  3.88384487 205
                            domain containing 5     FIGLER8;
                            (LRFN5), mRNA.          FLJ30803
                            Homo sapiens
                            myxovirus (influenza
5490470 NM_002463.1 MX2     virus) resistance 2     MXB         326.8739425 1.564606019 205
                            (mouse) (MX2),
                            mRNA.
                            Homo sapiens
                            caspase-1 dominant
2030170 NM_052889.2 COP     negative inhibitor      PSEUDO-     270.9976311 2.365305724 202
                            pseudo-ICE (COPI),      ICE; COP
                            transcript variant 2,
                            mRNA.
                            Homo sapiens acid
7050082 NM 001611.2 ACP5    phosphatase 5, tartrate TRAP;       285.5532995 1.732972465 200
                            resistant (ACPS),       MGC117378
                            mRNA.
                                            135

                                Homo sapiens Ca++
                                dependent secretion    KIAA1591;
 7160102 NM_017954.9    CADPS2  activator 2 (CADPS2),  FLJ40851      934.2084602   7.317902029   199
                                transcript variant 1,
                                mRNA.
                                Homo sapiens
                                NIEDD4 binding
  620112 NM 001079691.1 N4BP2L1 protein 2-like 1       CGO18         368.3773266   3.591762528   198
                                (N4BP2L1), transcript
                                variant 2, mRNA.
                                Homo sapiens
                                fibroblast growth
 7380239 NM_004114.2    FGF13   factor 13 (FGF13),     FGF2; FHF2    1373.698646   6.712119684   197
                                transcript variant 1A,
                                mRNA.
                                                       VCFS; TGA;
                                                       DORV;
                                Homo sapiens T-box 1   CTHM
  460575 NM 080647.1    TBX1    (TBX1), transcript     TBX1C;        565.7820643   5.124850227   197
                                variant C, mRNA.       DGS; CAS;
                                                       DGCR
                                Homo sapiens
                                NIEDD4 binding
 6550133 NM 001079691.1 N4BP2L1 protein 2-like 1       CGO18         380.0730964     3.76975768  196
                                (N4BP2L1), transcript
                                variant 2, mRNA.
                                Homo sapiens           CD118
  430079 NM 002310.3    LIFR    leukemia inhibitory    STWS:         279.1923858   1.662480673   196
                                factor receptor alpha  SJS2; SWS
                                (LIFR), mRNA.
                                Homo sapiens           MGC138845
                                neuronal cell adhesion
 2750092 NM_005010.3    NRCAM   molecule (NRCAM)                     853.3400169   4.537668221   194
                                transcript variant 2,  MGC138846
                                mRNA.                   KIAA0343
                                Homo sapiens
                                phosphodiesterase 1A,  HSPDE1A;
 4180707 NM_001003683.1 PDE1A   calmodulin-dependent   MGC26303;     544.2763959   2.241179844   193
                                (PDE1A), transcript    HCAM1
                                variant 2, mRNA.
                                Homo sapiens renin
 5810678 NM 002910.4    RENBP   binding protein        RNBP; RBP     1975.214721   9.912255749   192
                                (RENBP), mRNA.
                                Homo sapiens EGF
                                like, fibronectin type AGRINL;
 6270372 NM_182801.1    EGFLAM  III and laminin G      AGRNL;         325.179357   1.635739588   192
                                domains (EGELAM),      FLJ39 155
                                transcript variant 4,
                                mRNA.
                                Homo sapiens ankyrin   ANKRD20A
                        ANKRD20 repeat domain 20
 6450661 NM_032250.1    Al      family, member Al        KFZp434A    212.1874788   1.504584993   186
                                (ANKRD20A1),
                                                       17    p
                                mRNA.
                                Homo sapiens
                                hydroxyprostaglandin   PGDH; 15
 4250364 NM_000860.3    HPGD    dehydrogenase 15-      PGDH;         703.4062606   2.505990181   184
                                (NAD) (HPGD),          PGDH1
                                mRNA.
                                Homo sapiens           MTSG1;
                                mitochondrial tumor    MP44;
                                suppressor 1           DKFZp586D
 3800017 NM 001001924.1 MTUS1   (MTUS1), nuclear       1519; ATIP;   350.5238579   1.878143913   183
                                gene encoding          FLJ14295;
                                mitochondrial protein, KIAA1288;
                                transcript variant 1,  DKFZp686F
                                mRNA.                  20243
                                         14SMOO2X P6
ProbelD  RefSeqID       Symbol  Definition             Synonyms    RFUs          Fold over Ave. Score
                                                 136

                            Homo sapiens RALY
                            RNA binding protein
7400356 NM_173848.5 RALYL   like (RALYL),         HNRPCL3     712.1052453 13.05313107 251
                            transcript variant 3,
                            mRNA.
                            Homo sapiens LIM      RBTN1;
6980543 NM 002315.1 LMO1    domain only 1         MGC116692   566.7424704 8.156794155 250
                            (rhombotin 1)         ;TTG1;
                            (LMO1), mRNA.         RHOMI
                                                  OTF7
                            Homo sapiens POU
                                                  OCT7;
2490551 NM_005604.2 POU3F 2 class 3 homeobox 2    BRN2-       516.5646362 6.335929595 250
                            (POU3F2), mRNA.       POUF3
                            Homo sapiens
                            apolipoprotein B
3890743 NM 006789.2 APOBEC2 mRNA editing          ARCD1;      308.3164129 4.080790747 250
                            enzyme, catalytic     ARPI
                            polypeptide-like 2
                            (APOBEC2), mRNA.
                            Homo sapiens ficolin
                            (collagen/fibrinogen  MGC22543;
1170274 NM_003665.2 FCN3    domain containing) 3  FCNH;       587.9492386 8.195514874 247
                            (Hakata antigen)      HAKA 1
                            (FCN3), transcript
                            variant 1, mRNA.
                            Homo sapiens
                            tripartite motif-     RBCC; terf;
6350682 NM_016102.2 TRIM17  containing 17         RNF16       363.9677665 5.105782345 247
                            (TRIM17), transcript
                            variant 1, mRNA.
                                                  DKFZp686H
                            Homo sapiens catenin
                                                  02198;
4610692 NM_004389.2 CTNNA2  (cadherin-associated  CAPR;       276.3861252 3.283049351 247
                            protein), alpha 2     CAP-R;
                            (CTNNA2), mRNA.       CTNR
                            Homo sapiens          HBGR2;
6220750 NM 000826.2 GRIA2   glutamate receptor,   GLURB;      6419.420981 67.49112003 245
                            ionotropic, AMPA 2    GLUR2
                            (GRIA2), mRNA.
                            Homo sapiens
                            roundabout, axon
7650168 NM_002942.2 ROBO2   guidance receptor,    KIAA1568;   494.7444162 7.185399681 245
                            homolog 2             SAX3
                            (Drosophila)
                            (ROBO2), mRNA.
                                                  DKFZp434P
                                                  2350;
                                                  USH1H;
                            Homo sapiens          KIAA1774;
3360187 NM_052836.1 CDH23   cadherin-like 23      FLJ02331    468.8033841 6.296863132 244
                            (CDH23), transcript   MGC102761
                            variant 2, mRNA.      ; FLJ36499;
                                                  DFNB 12;
                                                  USHID;
                                                  KIAA1812
                            Homo sapiens
                            transcobalamin I
1770603 NM 001062.3 TCN1    (vitamin B12 binding  TCI; TC 1   985.6319797 3.730333725 244
                            protein, R binder
                            family) (TCN1),
                            mRNA.
                            Homo sapiens
                            transcription factor
                            AP-2 beta (activating MGC21381;
7320471 NM_003221.3 TFAP2B  enhancer binding      AP-2B;      2764.305584 38.62106781 243
                            protein 2 beta)       AP2-B
                            (TFAP2B), mRNA.
                                                  USHIB;
                            Homo sapiens myosin   DFNA1 1;
6860736 NM_000260.2 MYO7A   VIIA (MYO7A),         NSRD2;      713.0751269 10.67926317 243
                            mRNA.                 MYU7A;
                                                  DFNB2
                                             137

                             Homo sapiens
                             calcium/calmodulin-    CAMKB;
                             dependent protein
                                                    CAM2-        4
6220484 NM_172081.1  CAMK2B  kinase (CaM kinase)    MGC29528;    422.8152284  5.620626163 243
                             II beta (CAMK2B),      CAMK2
                             transcript variant 5,
                             mRNA.
                             Homo sapiens
6660747 NM 004826.1  ECEL1   endotheh converting    XCE DI;      400.5661591  5.296765231 243
                             enzyme-like 1          ECEX
                             (ECEL1), mRNA.
                                                    DKFZp434P
                                                    2350;
                                                    USH1H;
                             Homo sapiens           KIAA1774;
6510274 NM_022124.3  CDH23   cadherin-like 23       FLJC02337    1654.861083  23.91892227 242
                             (CDH23), transcript    MGC102761
                             variant 1, mRNA.       ; FLJ36499;
                                                    DFNB 12;
                                                    USHID;
                                                    KIAA1812
                             Homo sapiens ataxia    SCKI1;
4040286 NM 001184.2  ATR     telangiectasia and     MECI;          645.500846 8.134952228 242
                             Rad3 related (ATR),    ERPI; SCKI
                             mRNA.
                             Homo sapiens
4810487 NM_018712.2  ELMOD1  ELMO/CED-12            DKFZp547C     456.806599   5.34751353 242
                             domain containing 1    176
                             (ELMOD 1), mRNA.
                             Homo sapiens ciliary
                             neurotrophic factor
6560487 NM_001842.3  CNTFR   receptor (CNTFR),      MGC1774      302.2123519  3.402590384 242
                             transcript variant 2,
                             mRNA.
                             Homo sapiens
  50176 NM 020373.1  TMEM16   rotsmembrane            0          274.1839255  3.014927177 242
                     B       protein 16B            102; Cl2orf3
                             (TMEM16B), mRNA.
                             Homo sapiens
1580037 NM 002152.2  HRC     histidine rich calcium MGC133236    304.4183587  2.771181143 242
                             binding protein
                             (HRC), mRNA.
                                             .      HSD26;
                             Homo sapiens           LL37;
                             cathelicidin             L7
5860075 NM 004345.3  CAMP     atheicidin            FALL39;      828.3456853  12.58918189 241
                  --         antimicrobial peptide  FALL-39;
                             (CAMP), mRNA.          CAP18
                             Homo sapiens
                             transglutaminase 3 (E  MGC126249
4920075 NM_003245.2  TGM3    polypeptide, protein-  : TGE        3202.826142  33.87180029 240
                             glutamine-gamma-       MGC126250
                             glutamyltransferase)
                             (TGM3), mRNA.
                             Homo sapiens protein
                             phosphatase 1,
2750563 NM_006741.2  PPP1R1A regulatory (inhibitor)              303.6515228  3.433098747 240
                             subunit 1A
                             (PPP1R1A), mRNA.
                             Homo sapiens           CROC4;
4890670 NM 006365.1  Clorf6l chromosome I open      RP1-         271.9483926   3.29450522 240
                             reading frame 61       139114.3;
                             (C l orf6l), mRNA.     FLJ38303
                             Homo sapiens
                             calcium/calmodulin-    CAMKB;
                             dependent protein
                                                    CAM2
1710131 NM_172078.1  CAMK2B  kinase (CaM kinase)    MGC29528;    367.1896785  5.103733461 238
                             II beta (CAMK2B),      CAMK2
                             transcript variant 2,
                             mRNA.
                             Homo sapiens SH3       24b2;
  70086 NM 198993.2  STAC2   and cysteine rich      24b2/STAC2   304.1529611  2.773641982 238
                             domain 2 (STAC2),
                             mRNA.                  MGC129694
                                               138

                               Homo sapiens Src
                               homology 2 domain
 730093 NM 020209.2    SHD     containing                       1929.630626  25.70944633  237
                               transforming protein
                               D (SHD), mRNA.
                               Homo sapiens A
                               kinase (PRKA) anchor
6380689 NM_004842.2    AKAP7   protein 7 (AKAP7),     AKAP18      413.02978  5.244727373  237
                               transcript variant
                               alpha, mRNA.
                               Homo sapiens Fas
5270520 NM_005449.3    FAIM3   apoptotic inhibitory   TOSO      345.6143824  3.989229652  237
                               molecule 3 (FATM3),
                               mRNA.
                               Homo sapiens solute
                               carrier family 10
7000176 NM 152679.2    SLC1OA4 (sodium/bile acid      MGC29802; 458.8385787  5.557903578  235
                               cotransporter family), P4
                               member 4
                               (SLC1OA4), mRNA.
                               Homo sapiens
                               reprimo, TP53          FLJ90327
5550414 NM_019845.2    RPRM    dependent G2 arrest    REPRIM    3607.350423    25.2462122 234
                               mediator candidate
                               (RPRM), mRNA.
                               Homo sapiens cyclic
                               AMP-regulated
7160437 NM_001025068.1 ARPP-21 phosphoprotein, 21     FLJ32997  326.4632826  3.613698815  234
                  _            kD (ARPP-21),
                               transcript variant 3,
                               mRNA.
                               Homo sapiens
 580561 NM 021116.1    ADCY1   adenylate cyclase 1              1862.033503  23.40775682  233
                               (brain) (ADCY1),
                               mRNA.
                                                      C20orfl7;
                                                      OVC10-2;
                                                      TSH2;
                               Homo sapiens teashirt  ZNF218
4890292 NM_173485.4    TSHZ2   zinc finger homeobox   FLJ33887- 1285.017936  10.87318918  233
                               2 (TSHZ2), mRNA.       DKFZp686K
                                                      2480;
                                                      ZABC2
                               Homo sapiens
1230477 NM 005853.4    IRX5    iroquois homeobox      IRX-2a    1015.143655  9.898813475  233
                               protein 5 (TRXS),
                               mRNA.
                               Homo sapiens NEL-      FLJ45906;
1990731 NM_006157.2    NELLI   like 1 (chicken)       IDH3GL;          602.1 6.291765482  233
                               (NELLI), mRNA.         NRP1
                               Homo sapiens protein
                               tyrosine phosphatase,  GLEPPI;
1660386 NM_030667.1    PTPRO   receptor type, 0       PTP-U2;     518.52022    6.07356951 233
                               (PTPRO), transcript    PTPU2
                               variant 1, mRNA.
                               Homo sapiens           BCH;
3190246 NM_004067.2    CHN2    chimerin (chimaerin)   ARHGAP3;  356.2817259  4.305540154  233
                               2 (CHN2), transcript   RHOGAP3;
                               variant 2, mRNA.       MGC138360
                               Homo sapiens NEL
7550358 NM 006159.1    NELL2   like 2 (chicken)       NRP2      621.7490694  3.474177808  233
                               (NELL2), mRNA.
                               Homo sapiens
                                                      TSC;
5050681 NM 017899.2    TESC    tescalcin (TESC),      FLJ20607   334.614044  3.076014713  232
                               mRNA.
                               Homo sapiens CUG
                               triplet repeat, RNA    BRUNOL3;
5390575 NM_006561.2    CUGBP2  binding protein 2      ETR-3;    341.5216582  3.850276727  230
                               (CUGBP2), transcript   NAPOR
                               variant 2, mRNA.
                                                139

                                                        DKFZp434P
                                                        2350;
                                                       USH1H;
                                Homo sapiens            KIAA1774;
  360014 NM_052836.1    CDH23   cadherin-like 23       FLJC02337       854.4878173   10.72476097   229
                                (CDH23), transcript    MGC102761
                                variant 2, mRNA.        ;FU36499;
                                                        DFNB 12;
                                                       USHID;
                                                        KIAA1812
                                Homo sapiens           HsT3226;
 7200341 NM_152721.3    DOK6    docking protein 6      DOK5L;          523.1500846   6.976167836   229
                                (DOK6), mRNA.          MGC20785
                                                       KIAA1916;
                                Homo sapiens           MGC126808
 5390128 NM_018176.2    LGI2    leucinerich repeat                     332.0390017   2.972012889   229
                                LGl family, member 2   MGC126810       32.901        297189        29
                                (LGI2), mRNA.           ; FU10675;
                                                       LGIL2
                                Homo sapiens           MGC126406
                                engulfment and cell     ; CED12;
 2750154 NM 014800.9    ELMO1   motility 1 (ELMO1),    CED-12;         578.9230964   7.197406463   228
                                transcript variant 1,  KIAA0281;
                                mRNA.                  ELMO-1
                                Homo sapiens LEM
 3180615 NM_001001552.3 LEMD1   domain containing 1    LEMP-1          422.2824027   4.640235588   228
                                (LEMD 1), mRNA.
                                Homo sapiens ankyrin   MGC26087;
                                repeat and sterile     EB-1;
 2350201 NM_181670.2    ANKS1B  alpha motif domain     ANKS2;           814.623181   10.76509991   227
                                containing lB          AIDA-1;
                                (ANKS IB), transcript  AIDA;
                                variant 2, mRNA.       cajalin-2
                                        14SMOO8X P6
                        Symbol  Definition             Synonyms      RFUs          Fold over Ave. Filter
ProbelD  RefSeqID
                                                                                                  Score
                                Homo sapiens RALY
                                RNA binding protein
 7400356 NM_173848.5    RALYL   like (RALYL),          HNRPCL3         1350.184433   25.64538554   251
                                transcript variant 3,
                                mRNA.
                                Homo sapiens           SEGN;
                                secretagogin, EF-hand  DJ501N12.8;
 3990278 NM 006998.3    SCGN    calcium binding        CALBL;          310.5986464   4.222983258   251
                                protein (SCGN),         setagin;
                                mRNA.                  SECRET
                                                       FLJ16031;
                                                       MGC119459
                                                        :GalNAc
                                Homo sapiens UDP-      T3
                                N-acetyl-alpha-D-      MG      19461
                                galactosamine:polype
                                ptide N
 6480575 NM 052917.2    GALNT13       NTGSC:H              Lt          268.8393401   3.761884681   251
                                acetylgalactosaminyltr NH172
                                ansferase 13           NH187G20
                                (GaIlNAc-T13)          .1;
                                (GALNT13), mRNA.       20 1;
                                                       FLJ41157;
                                                       KIAA1918
                                Homo sapiens LIM       RBTN1;
 6980543 NM 002315.1    LMO1    domain only            MGC116692       534.0829103   7.629117327   250
                                (rhombotin 1)           ; TTG1;
                                (LMO1), mRNA.          RHOMI
                                                       OTF7
                                Homo sapiens POU       OCT7;
 2490551 NM 005604.2    POU3F2  class 3 homeobox 2     BRN2;           584.7906937   7.304833618   250
                                (POU3F2), mRNA.        POUF3
                                                140

                                                        TAG-1;
                                                        TAX;
                                 Homo sapiens           DKFZp781D
4260471 NM_005076.2      CNTN2   contactin 2 (axonal)   102; TAXI;  387.7181049 5.843291823  250
                                 (CNTN2), mRNA.         MGC157722
                                                        ; FU42746;
                                                        AXT
                                 Homo sapiens
                                 phosphatidic acid
 840681 NM_001037317.1   PAP2D   phosphatase type 2     PAP2        280.1494924 4.318001407  249
                                 (PAP2D), transcript
                                 variant 1, mRNA.
                                 Homo sapiens CUB
1010189 NM 033225.3      CSMD1   and Sushi multiple     KIAA1890     330.048308   5.58655547 248
                                 domains 1 (CSMD1),
                                 mRNA.
                                 Homo sapiens ficolin
                                 (collagen/fibrinogen   MGC22543;
1170274 NM_003665.2      FCN3    domain containing) 3   FCNH;       573.0299492 7.962177473  247
                                 (Hakata antigen)       HAKA 1
                                 (FCN3), transcript
                                 variant 1, mRNA.
                                 Homo sapiens           NG.1; IL
3180068 NM 013371.2      IL19    interleukin 19 (1119), 1OC;         363.062775 5.930565585  247
                                 transcript variant 2,  ZMDA1;
                                 mRNA.                  MDA1
                                 Homo sapiens
                                 tripartite motif-      RBCC; terf;
6350682 NM_016102.2      TRIM17  containing 17          RNF16       352.8722504 4.919648262  247
                                 (TRIM17), transcript
                                 variant 1, mRNA.
                                 Homo sapiens
                                                        HBGR2;
6220750 NM 000826.2      GRIA2   glutamate receptor,    GLURB;      8741.622166 92.26752285  245
                                 ionotropic, AMPA 2     GLUR2
                                 (GRIA2), mRNA.
                                 Homo sapiens
                                 roundabout, axon
7650168 NM_002942.2      ROBO2   guidance receptor,     KIAA1568;   760.7395939 11.58621103  245
                                 homolog 2              SAX3
                                 (Drosophila)
                                 (ROBO2), mRNA.
                                                        DKFZp434P
                                                        2350;
                                                        USH1H;
                                 Homo sapiens           KIAA1774;
3360187 NM_052836.1      CDH23   cadherin-like 23       FLJ00233;   495.5326565 6.712900749  244
                                 (CDH23), transcript    MGC102761
                                 variant 2, mRNA.       ; FU136499;
                                                        DFNB 12;
                                                        USHID;
                                                        KIAA1812
                                 Homo sapiens solute
                                 carrier family 17
                                 (sodium-dependent
7160192 NM 139319.1      SLC17A8 inorganic phosphate    VGLUT3      234.1624365 3.283310633  244
                                 cotransporter),
                                 member 8
                                 (SLC17A8), mRNA.
                                 Homo sapiens
                                 transcription factor
        732471 NM_0321.3 TFA2B   AP-2 beta (activating  MGC21381;
7320471 NM_003221.3      TFAP2B  ena-2 b      ivg       AP-2B;      1913.046193 26.41988201  243
                                 enhancer binding       AP2-B
                                 protein 2 beta)
                                 (TFAP2B), mRNA.
                                                        USHiB;
                                 Homo sapiens myosin    DFNA1 1;
6860736 NM_000260.2      MYO7A   VIIA (MYO7A),          NSRD2;      618.9494078 9.137603664  243
                                 mRNA.                  MYU7A;
                                                        DFNB2
                                 Homo sapiens
                                 calcium/calmodulin-    CAMKB;
6220484 NM_172081.1      CAMK2B  dependent protein      CAM2;       575.7461929 8.015286233  243
                                 kinase (CaM kinase)    MGC29528;
                                 II beta (CAMK2B),      CAMK2
                                 transcript variant 5,
                                                  141

                                   mRNA.
                                   Homo sapiens
6660747 NM 004826.1        ECEL1   endothelin converting  XCE; DINE;  491.9045685 6.732574293  243
                                   enzyme-like 1          ECEX
                                   (ECEL1), mRNA.
                                   Homo sapiens
                                   fibroblast growth
                                                          FHF1;
3310068 NM_004113.3        FGF12   factor 12 (FGF12),     FGF12B       386.514467 5.033556556  243
                                   transcript variant 2,
                                   mRNA.
                                   Homo sapiens
                                                          VSIG3;
                                   immunoglobulin
                                                          Igsfl3
5270102 NM_001015887.1     IGSF11  superfamil, member     MGC35227;   325.0898477 3.411330596  243
                                           11 (GSFII),BT-IgSF;
                                   transcript variant 2,  CXADRL1
                                   mRNA.
                                   Homo sapiens
2340438 NM 001048209.1     HNT     neurotrimin (HNT),     NTM;        283.6207276 2.992407537  243
                                   transcript variant 2,  MGC60329
                                   mRNA.
                                                          DKFZp434P
                                                          2350;
                                                          USH1H;
                                   Homo sapiens           KIAA1774;
6510274 NM_022124.3        CDH23   cadherin-like 23       FLJC02337   1603.834856 23.15056861  242
                 _(CDH23),                     transcript MGC102761
                                   variant 1, mRNA.       ; FLJ36499;
                                                          DFNB 12;
                                                          USHID;
                                                          KIAA1812
                                   Homo sapiens
4810487 NM 018712.2        ELMODI  ELMO/CED-12            DKFZp547C   1255.341032 16.44347434  242
                                   domain containing 1    176
                                   (ELMOD 1), mRNA.
                                   Homo sapiens ataxia    SCKL1;
4040286 NM 001184.2        ATR     telangiectasia(and     MECI;       480.6663283 5.802259011  242
                                   Rad3 related (ATR),    ERPI; SCKI
                                   mRNA.
                                   Homo sapiens ciliary
                                   neurotrophic factor
6560487 NM_001842.3        CNTFR   receptor (CNTFR),      MGC1774     365.4590525 4.323960122  242
                                   transcript variant 2,
                                   mRNA.
                                   Homo sapiens ankyrin   MGC26087;
                                   repeat and sterile     ANKS2;
6660463 NM 020140.2        ANKS lB alpha motif domain     AIDA;        276.051692 3.070028549  242
          -                        containing lB          cajalin-2;
                                   (ANKS1B), transcript   EB-1;
                                   variant 3, mRNA.       AIDA-1
                                   Homo sapiens
1580037 NM 002152.2        HRC     histidine rich calcium MGC133236   325.0898477 3.027262707  242
                                   binding protein
                                   (HRC), mRNA.
                                                   .      HSD26;
                                   Homo sapiens
                                                          LL37;
5860075 NM 004345.3        CAMP    cathelicidin           FALL39;     389.4118443   5.38838166 241
          --                       antimicrobial peptide  FALL-39'
                                   (CAMP), mRNA.          CAP18
                                   Homo sapiens
                                   transglutaminase 3 (E  MGC126249
4920075 NM_003245.2        TGM3    polypeptide, protein-  : TGE       2657.075635 27.92976602  240
                                   glutamine-gamma-       MGC126250
                                   glutamyltransferase)
                                   (TGM3), mRNA.
                                   Homo sapiens           FLJ41177;
7550156 NM_032880.2        IGSF21  immunoglobin           RP11-       639.0837563 7.139008159  240
                                   superfamily, member    12 1A23. 1;
                                   21 (IGSF21), mRNA.     MGC15730
                                                     142

                               Homo sapiens protein
                               phosphatase 1,
2750563 NM_006741.2    PPP1R1A regulatory (inhibitor)            304.9199662 3.451617128 240
                               subunit 1A
                               (PPP1R1A), mRNA.
                               Homo sapiens           KIAA1342;
3180639 NM_020783.2    SYT4    synaptotagmin IV       HsT1192    272.0239425 2.947078494 239
                               (SYT4), mRNA.
                               Homo sapiens
                               calcium/calmodulin-    CAMKB;
                               dependent protein      CAM2-     5554.2815567
1710131 NM_172078.1    CAMK2B  kinase (CaM kinase)    MGC29528;              8.213730893 238
                               II beta (CAMK2B),      CAMK2
                               transcript variant 2,
                               mRNA.
                               Homo sapiens Src
                               homology 2 domain
 730093 NM 020209.2    SHD     containing                        1398.263452 18.35439981 237
                               transforming protein
                               D (SHD), mRNA.
                               Homo sapiens A
                               kinase (PRKA) anchor
6380689 NM_004842.2    AKAP7   protein 7 (AKAP7),     AKAP18     606.8905245 8.175769047 237
                               transcript variant
                               alpha, mRNA.
                               Homo sapiens Fas
5270520 NM_005449.3    FAIM3   apoptotic inhibitory   TOSO       573.0299492 7.272161577 237
                               molecule 3 (FATM3),
                               mRNA.
                               Homo sapiens solute
                               carrier family 10
7000176 NM_152679.2    SLC1OA4 (sodium/bile acid      MGC29802; 445.6170897  5.368936795 235
                               cotransporter family), P4
                               member 4
                               (SLC1OA4), mRNA.
                               Homo sapiens           NG.1; IL
6330070 NM 013371.2    IL19    interleukin 19 (IL19), 1OC;       290.8384095 2.929329671 235
                               transcript variant 2,  ZMDA1;
                               mRNA.                  MDA1
                               Homo sapiens
                               reprimo, TP53          FLJ90327
5550414 NM 019845.2    RPRM    dependent G2 arrest    REPRIMO    9603.588832 68.87339758 234
                               mediator candidate
                               (RPRM), mRNA.
                               Homo sapiens cyclic
                               AMP-regulated
7160437 NM_001025068.1 ARPP-21 phosphoprotein, 21     FLJ32997   362.5733503 4.124019532 234
                               kD (ARPP-21),
                               transcript variant 3,
                               mRNA.
                               Homo sapiens
 580561 NM 021116.1    ADCY1   adenylate cyclase 1               1274.147885 15.70168216 233
                               (brain) (ADCY1),
                               mRNA.
                               Homo sapiens NEL-      FLJ45906;
1990731 NM_006157.2    NELLI   like 1 (chicken)       IDH3GL;    779.0571912 8.434815372 233
                               (NELLI), mRNA.         NRP1
                               Homo sapiens protein
                               tyrosine phosphatase,  GLEPPI;
1660386 NM_030667.1    PTPRO   receptor type, 0       PTP-U2;    685.3079526 8.348860955 233
                               (PTPRO), transcript    PTPU2
                               variant 1, mRNA.
                                                      C20orfl7;
                                                      OVC10-2;
                                                      TSH2;
                               Homo sapiens teashirt  ZNF21
4890292 NM_173485.4    TSHZ2   zinc finger homeobox   ZNF218-    980.7642978 8.061974719 233
                               2 (TSHZ2), mRNA.       DKFZp686K
                                                      2480;
                                                      ZABC2
                               Homo sapiens           BCH;
3190246 NM_004067.2    CHN2    chimerin (chimaerin)   ARHGAP3;  481.9829949  6.177410311 233
          M 0406.2
         19046          HN2    2 (CHN2), transcript   RHOGAP3;
                               variant 2, mRNA.       MGC138360
                                               143

                                             TM4SF2;
                                             MRX58;
                                             MXS1;
                           Homo sapiens      DXS1692E;
 460010 NM_004615.2 TSPAN7 tetraspanin 7     CD231;    583.9037225 5.651359668 233
                           (TSPAN7), mRNA.   CCG-B7;
                                             TALLA-1;
                                             A15;
                                             TM4SF2b
                           Homo sapiens
1230477 NM 005853.4 IRX5   iroquois homeobox IRX-2a     586.184264  5.29340776 233
                           protein 5 (TRX5),
                           mRNA.
                                         144

   WHAT IS CLAIMED IS:
   1.       A method of generating an isolated progenitor cell line comprising:
            modulating the activity of a transcriptional regulator in a pluripotent stem cell; and
 5          inducing the differentiation of said pluripotent stem cell in vitro to generate a progenitor cell
   line.
   2.       The method of claim 1, wherein said pluripotent stem cell is human.
10 3.       The method of claim 2, wherein said human pluripotent stem cell is not derived from a
   human embryo.
   4.       The method of claim 1, wherein said modulating comprises increasing the activity of said
   transcriptional regulator in said pluripotent stem cell.
15
   5.       The method of claim 1, wherein said pluripotent stem cell result from the reprogranming of
   a somatic cell that is genetically modified to constitutively overexpress a transcription factor.
   6.       The method of claim 5, wherein said transcriptional regulator is OCT4.
20
   7.       The method of claim 1, wherein said modulating comprises introducing an expression vector
   encoding said transcriptional regulator into said pluripotent stem cell.
   8.       The method of claim 7, wherein said expression vector is selected from the group consisting
25 of: constitutive expression vector, inducible expression vector, retroviral vector, lentiviral vector,
   transient expression vector, and combinations thereof.
   9.       The method of claim 1, wherein said modulating comprises introducing said transcriptional
   regulator directly into said pluripotent stem cell.
30
   10.      The method of claim 9, wherein said transcriptional regulator is a protein.
   11.      The method of claim 1, further comprising increasing cell division in derivatives of said
   pluripotent stem cell.
35
   12.      The method of claim 11, wherein said increasing cell division comprises providing a cell
   cycle regulator that overcomes cell cycle inhibition in said pluripotent stem cell.
                                                       145

   13.      The method of claim 12, wherein said cell cycle regulator is selected from the group
   consisting of: p53, SV40 T antigen, adenovirus proteins ElA and ElB, papillomavirus proteins E6
   and/or E7, CDK4, and combinations thereof.
 5 14.      The method of claim 1, wherein said isolated progenitor cell line constitutively expresses a
   transcriptional regulator.
   15.      The method of claim 14, wherein said transcriptional regulator is selected from the group
   consisting of: OCT4, SIX], FOXA], SOX17, SIX2, SOX2, SOX21, PAX6, MYOD], MYOG,
10 NEUROG], NKX2.5, and LHX8.
   16.      The method of claim 1, wherein said pluripotent stem cell is selected from the group
   consisting of: ES cell, somatic cell reprogrammed to pluripotent cell including an iPS cell, ED cell,
   EG cell, and EC cell.
15
   17.      The method of claim 1, wherein said progenitor cell line is selected from the group
   consisting of: endodermal cells, mesodermal cells, ectodermal cells, neuroglial precursor cells,
   hepatic cells or hepatic precursor cells, chondrocyte or chondrocyte precursor cells, myocardial or
   myocardial precursor cells, gingival fibroblast or gingival fibroblast precursor cells, pancreatic beta
20 cells or pancreatic beta precursor cells, retinal precursor cells, hemangioblasts, dermal fibroblasts,
   18.      An isolated progenitor cell line, wherein said isolated progenitor cell line constitutively
   expresses a transcription factor selected from the group consisting of: OCT4, SIX], FOXA1, SOX] 7,
   SIX2, SOX2, SOX21, PAX6, MYOD], MYOG, NEUROG], NKX2.5, LHX8, and combinations thereof.
25
   19.      The isolated progenitor cell line of claim 18, wherein said progenitor cell line is
   14SKEL12Z.
   20.      An isolated progenitor cell line, wherein said progenitor cell line is selected from the group
30 consisting of: 14SKEL7X, 14SKEL18X, 14SKEL12Z, 14SKEL14Z, 14SKEL15Z, 14SKEL20Z,
   14SKEL24Z, 14PEND2X, 14PEND11X, 14PEND12X, 14PEND14X, 14PEND20X, 14PEND23X,
   14PEND24X, 14SMOO2X, 14SMOO8X, and 14PEND17Z.
                                                       146

<removed-apn> <removed-date>
<removed-apn> <removed-date>
<removed-apn> <removed-date>
<removed-apn> <removed-date>
<removed-date>
                   !   " # $%             &
                    $%'(% " )%*            +
                   # $,-        ,. #,- ./           *%       * '   , %
               0    % ,*/         1,*2              (
                   + 3 4        !3
                           5 6 5" 5
<removed-apn>
                            4 4
                           5 6  "
                            4 4 7
               5
               8   9%           .,* !     -,1   : *      ,
                   ;0
                   <*      .    %
                       /   $        ' '   -
              /*   / <*        /     /    <*   <*        <*    <*       <*
                   =
                   ;0
                   <*      .    %
                       /   $        ' '   -
              <*   /       /   <*   <*         <*   <*   <*
                   ;0
                   <*      .    %
                       /   $        ' '   -
              /* < % <*        /    < % <*     <*        < % <*         <*
                   ;0
                   <*      .    %
                       /   $        ' '   -
                                                                   ;%

<removed-date>
              /* < % <*          >         < % < % <*        < % <*       < %
                    ;0
                    <*      .    %
                        /   $        ' '   -
<removed-apn>
              /* < % <*         < % < % <*     <*   < % < % <*      <*
                    5
                    ;0
                    <*      .    %
                        /   $        ' '   -
                     5
              <*   < % <*       < % < % <*     <*   < % < % <*      < %
                    8
                    ;0
                    <*      .    %
                        /   $        ' '   -
                    8
              <*                /          *' ;$        <    <*     <*    #      /   *' #
                    7
                    ;0
                    <*      .    %
                        /   $        ' '   -
                    7
              < ' < % < %       $* < %     $* <*     / <*      * < % < %          * <*   ;*,   $*
                   <*   ;*, <*       < % ;*, < % <*         * < %    * <*       ;*, <*   <*    ;*,
              :%
                    =
                    8
                    ;0
                    <*      .    %
                                                               ;%

<removed-date>
                     /   $        ' '   -
                     =
              <*   <* <*     <*   <*    <*   <*
                    ;0
                    <*   .    %
<removed-apn>
                     /   $        ' '   -
              /* < % <*      < % < % < % <*       < % <*    < %
                    ;0
                    <*   .    %
                     /   $        ' '   -
              /* < % <*      < % <*     < % <*    < % <*    < %
                                                       ;%

